AACS
acetoacetyl-CoA synthetase
AACS; acetoacetyl-CoA synthetase; ACSF1; acyl CoA synthetase family member 1; FLJ12389; SUR 5; Acetoacetate CoA ligase; ACSF 1; FLJ41251; Homolog of C. elegans supressor of ras 5; Protein sur 5 homolog; SUR5; protein sur-5 homolog; acetoacetate-CoA ligase; acyl-CoA synthetase family member 1; homolog of C. elegans supressor of ras 5 (sur-5); SUR-5;
AARS
alanyl-tRNA synthetase
AARS; alanyl-tRNA synthetase; alanine--tRNA ligase, cytoplasmic; alanine tRNA ligase 1; cytoplasmic; alaRS; renal carcinoma antigen NY-REN-42; alanine tRNA ligase 1, cytoplasmic; alanyl-tRNA synthetase, cytoplasmic; CMT2N;
AASDHPPT
aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase
AASDHPPT; aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase; L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase; AASD PPT; CGI 80; LYS5; 4 phosphopantetheinyl transferase; 4-phosphopantetheinyl transferase; AASD-PPT; ADPPT_HUMAN; Alpha aminoadipic semialdehyde dehydrogenase phosphopantetheinyl transferase; Alpha-aminoadipic semialdehyde dehydrogenase-phosphopantetheinyl transferase; HAH P; LYS2; LYS5 ortholog; CGI-80;
ACOT13
acyl-CoA thioesterase 13
ACOT13; acyl-CoA thioesterase 13; THEM2, thioesterase superfamily member 2; acyl-coenzyme A thioesterase 13; HT012; hypothalamus protein HT012; thioesterase superfamily member 2; THEM2; PNAS-27;
ACYP1
acylphosphatase 1, erythrocyte (common) type
ACYP1; acylphosphatase 1, erythrocyte (common) type; acylphosphatase-1; erythrocyte isozyme; organ-common type isozyme; Acylphosphatase 1; Acylphosphatase 1 erythrocyte (common) type; Acylphosphatase 1 erythrocyte type; Acylphosphatase; Acylphosphatase erythrocyte isozyme; Acylphosphatase organ common type isozyme; Acylphosphatase1; Acylphosphate phosphohydrolase 1; ACYP 1; ACYP1_HUMAN; ACYPE; Erythrocyte acylphosphatase 1; OTTHUMP00000246802; OTTHUMP00000246804; OTTHUMP00000246805; acylphosphatase, erythrocyte isozyme; acylphosphatase, organ-common type isozyme;
ADAMTS1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
ADAMTS1; ADAM metallopeptidase with thrombospondin type 1 motif, 1; C3-C5; METH1; A disintegrin and metalloproteinase with thrombospondin motifs 1; METH-1; ADAM-TS1; ADAMTS-1; ADAM-TS 1; human metalloproteinase with thrombospondin type 1 motifs; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 1;
ADAMTS4
ADAM metallopeptidase with thrombospondin type 1 motif, 4
ADAMTS4; ADAM metallopeptidase with thrombospondin type 1 motif, 4; ADMP-1; ADAMTS-2; ADAMTS-4; A disintegrin and metalloproteinase with thrombospondin motifs 4; ADAM-TS4; ADAM-TS 4; aggrecanase-1; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 4;
ADAMTS5
ADAM metallopeptidase with thrombospondin type 1 motif, 5
ADAMTS5; ADAM metallopeptidase with thrombospondin type 1 motif, 5; ADMP-2; ADAM-TS5; ADAMTS-5; ADAMTS11; ADAM-TS 5; ADAMTS-11; ADAM-TS 11; A disintegrin and metalloproteinase with thrombospondin motifs 5; aggrecanase-2; a disintegrin and metalloproteinase with thrombospondin motifs 11; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 5 (aggrecanase-2);
AIMP1
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
AIMP1; aminoacyl tRNA synthetase complex-interacting multifunctional protein 1; p43; EMAP2; SCYE1; EMAPII; aminoacyl tRNA synthase complex-interacting multifunctional protein 1; OTTHUMP00000161877; OTTHUMP00000161878; OTTHUMP00000219673; ARS-interacting multifunctional protein 1; endothelial monocyte-activating polypeptide 2; multisynthase complex auxiliary component p43; endothelial-monocyte activating polypeptide II; multisynthetase complex auxiliary component p43; small inducible cytokine subfamily E, member 1 (endothelial monocyte-activating); AIMP1/p43; 9830137A06Rik;
AKT1
RAC-alpha serine/threonine-protein kinase
AKT 1; AKT 2; AKT 3; AKT1; AKT2; AKT3; C AKT; CAKT; DKFZP434N0250; v-akt murine thymoma viral oncogene homolog 1; Murine thymoma viral (v akt) homolog 2; murine thymoma viral (v akt) oncogene homolog 1; Murine thymoma viral (vakt) oncogene homolog 1; PKB Akt; PKB alpha; PKB; PKB beta; PKBalpha; PKBBETA; PKBG; PRKBA; PRKBB; PRKBG; Protein kinase Akt 2; Protein kinase Akt 3; Protein kinase B; Protein kinase B beta; Protein kinase B gamma; RAC alpha; RAC alpha serine/threonine protein kinase; RAC; RAC beta; RAC beta serine/threonine protein kinase; RAC gamma; RAC gamma serine/threonine protein kinase; RAC PK alpha; RAC PK beta; RAC PK gamma; Rac protein kinase alpha; Rac protein kinase beta; RAC Serine/Threonine Protein Kinase; Serine threonine protein kinase Akt 3; STK 2; STK2; V AKT Murine Thymoma Viral Oncogene Homolog 1; v akt murine thymoma viral oncogene homolog 2; v akt murine thymoma viral oncogene homolog 3; VAKT Murine Thymona Viral Oncogene 1;
AKT2
v-akt murine thymoma viral oncogene homolog 2
Akt2; AKT2_HUMAN; PKB; PKB beta; PKBBETA; PRKBBy; Protein kinase Akt 2; Protein kinase Akt-2; Protein kinase B beta; RAC BETA; RAC beta serine threonine protein kinase; RAC PK beta; Rac protein kinase beta; RAC-beta serine/threonine-protein kinase; RAC-PK-beta; RACbeta; V AKT Murine Thymoma Viral Oncogene Homolog 2;
AKT3
v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma)
AKT3; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma); PKBG; PRKBG; STK-2; PKB-GAMMA; RAC-gamma; RAC-PK-gamma; DKFZp434N0250; RAC-gamma serine/threonine-protein kinase; PKB gamma; OTTHUMP00000037911; OTTHUMP00000037912; protein kinase Akt-3; protein kinase B gamma; serine threonine protein kinase, Akt-3;
ALAS2
aminolevulinate, delta-, synthase 2
ALAS2; aminolevulinate, delta-, synthase 2; aminolevulinate, delta , synthase 2 (sideroblastic/hypochromic anemia) , ASB; 5-aminolevulinate synthase, erythroid-specific, mitochondrial; sideroblastic/hypochromic anemia; 5-aminolevulinic acid synthase; ALAS E; ALASE; ANH1; Delta aminolevulinate synthase; FLJ93603; OTTMUSP00000020679; XLSA; 5 @aminolevulinate synthase erythroid specific; 5 aminolevulinic acid synthase 2; 5-aminolevulinate synthase 2; 5-aminolevulinate synthase; Alas 2; ALAS; ALAS, erythroid; Aminolevulinic acid synthase 2, erythroid; ASB; Delta ALA synthase 2; Delta ALA synthetase; Delta aminolevulinate synthase 2; Erythroid specific ALAS; OTTHUMP00000023388; OTTHUMP00000023389; RP23-338A17.1; XLDPP; OTTHUMP00000204081; delta-ALA synthase 2; delta-ALA synthetase; 5-aminolevulinic acid synthase 2; delta-aminolevulinate synthase 2; XLEPP; ALAS-E;
AMACR
alpha-methylacyl-CoA racemase
AMACR; alpha-methylacyl-CoA racemase; RM; RACE; CBAS4; AMACRD; 2-methylacyl-CoA racemase; OTTHUMP00000115916; OTTHUMP00000115917; OTTHUMP00000219978; TTHUMP00000219979; TTHUMP00000219980; EC 5.1.99.4; P504S;
AMD1
adenosylmethionine decarboxylase 1
AMD1; adenosylmethionine decarboxylase 1; S adenosylmethionine decarboxylase 1; S-adenosylmethionine decarboxylase proenzyme; SAMDC; S-adenosylmethionine decarboxylase 1; AMD; ADOMETDC; FLJ26964; DKFZp313L1234;
AMICA1
adhesion molecule, interacts with CXADR antigen 1
AMICA1; adhesion molecule, interacts with CXADR antigen 1; junctional adhesion molecule-like; mCrea7; adhesion molecule AMICA; dendritic cell-specific protein CREA7; dendritic-cell specific protein Crea7; AMICA; Crea7; Gm638; MGC61025; JAML; CREA7-1; CREA7-4;
ASS1
argininosuccinate synthase 1
ASS1; argininosuccinate synthase 1; argininosuccinate synthase; Argininosuccinate synthetase 1; ASS; Ass-1; ASSA; ASSY_HUMAN; Citrulline aspartate ligase; Citrulline--aspartate ligase; CTLN1; citrullinemia;
ATP5O
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit
ATP5O; ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit; ATP synthase subunit O, mitochondrial; ATPO; oligomycin sensitivity conferring protein; OSCP; mitochondrial; ATP synthase O subunit mitochondrial precursor; ATP synthase subunit O; ATPO_HUMAN; EC 3.6.3.14; Mitochondrial ATP synthase, O subunit; MS505; Oligomycin sensitivity conferral protein; OTTHUMP00000067745; human ATP synthase OSCP subunit;
BAD
BCL2-associated agonist of cell death
BAD; BCL2-associated agonist of cell death; BBC2; BCL2L8; bcl2 antagonist of cell death; bcl2-L-8; BCL2-binding protein; bcl-2-like protein 8; BCL2-binding component 6; bcl-2-binding component 6; BCL-X/BCL-2 binding protein; BCL2-antagonist of cell death protein; bcl-XL/Bcl-2-associated death promoter;
BAG1
BCL2-associated athanogene
BAG1; BCL2-associated athanogene; BAG family molecular chaperone regulator 1; BAG-1; Bcl-2-binding protein; receptor-associated protein, 46-KD; Bcl-2 associating athanogene-1 protein; glucocortoid receptor-associated protein RAP46; HAP; RAP46;
BAG2
BCL2-associated athanogene 2
BAG2; BCL2-associated athanogene 2; BAG family molecular chaperone regulator 2; bcl-2-associated athanogene 2; BAG-family molecular chaperone regulator-2; dJ417I1.2 (BAG-family molecular chaperone regulator 2); BAG-2; dJ417I1.2; KIAA0576; MGC149462;
BAG3
BCL2-associated athanogene 3
BAG3; BCL2-associated athanogene 3; BIS; MFM6; BAG-3; CAIR-1; BAG family molecular chaperone regulator 3; docking protein CAIR-1; BCL2-binding athanogene 3; bcl-2-binding protein Bis;
BID
BH3 interacting domain death agonist
BID; BH3 interacting domain death agonist; FP497; BH3-interacting domain death agonist; p22 BID; BID isoform Si6; BID isoform L(2); BID isoform ES(1b); desmocollin type 4; apoptic death agonist; Human BID coding sequence;
BMPR2
bone morphogenetic protein receptor, type II (serine/threonine kinase)
BMPR2; bone morphogenetic protein receptor, type II (serine/threonine kinase); PPH1, primary pulmonary hypertension 1; bone morphogenetic protein receptor type-2; BMPR II; BMPR3; BRK 3; T ALK; BMPR-2; BMP type-2 receptor; BMP type II receptor; type II ac;
BRSK2
BR serine/threonine kinase 2
BRSK2; BR serine/threonine kinase 2; C11orf7, chromsosome 11 open reading frame 7 , STK29; serine/threonine-protein kinase BRSK2; PEN11B; serine/threonine kinase 29; protein kinase SAD1B; brain-selective kinase 2; serine/threonine-protein kinase 29; BR s;
BUB1
BUB1 mitotic checkpoint serine/threonine kinase
BUB1; BUB1 mitotic checkpoint serine/threonine kinase; BUB1A; BUB1L; hBUB1; mitotic checkpoint serine/threonine-protein kinase BUB1; mitotic spindle checkpoint kinase; putative serine/threonine-protein kinase; budding uninhibited by benzimidazoles 1 homolog; BUB1 budding uninhibited by benzimidazoles 1 homolog;
CARM1
coactivator-associated arginine methyltransferase 1
CARM1; coactivator-associated arginine methyltransferase 1; histone-arginine methyltransferase CARM1; PRMT4; protein arginine N-methyltransferase 4;
Cd36
CD36 molecule (thrombospondin receptor)
CD36; CD36 molecule (thrombospondin receptor); FAT; GP4; GP3B; GPIV; CHDS7; PASIV; SCARB3; BDPLT10; platelet glycoprotein 4; GPIIIB; PAS IV; PAS-4 protein; glycoprotein IIIb; cluster determinant 36; fatty acid translocase; platelet glycoprotein IV; scavenger receptor class B, member 3; leukocyte differentiation antigen CD36; CD36 antigen (collagen type I receptor, thrombospondin receptor);
CDH1
cadherin 1, type 1, E-cadherin (epithelial)
CDH1; cadherin 1, type 1, E-cadherin (epithelial); UVO; CDHE; ECAD; LCAM; Arc-1; CD324; cadherin-1; CAM 120/80; E-Cadherin; uvomorulin; cell-CAM 120/80; epithelial cadherin; cadherin 1, E-cadherin (epithelial); calcium-dependent adhesion protein, epithelial; Arc1; CADH1_HUMAN; Cadherin 1; cadherin 1 type 1 E-cadherin; Cadherin1; CD 234; CD324 antigen; E-Cad/CTF3; epithelial calcium dependant adhesion protein; Liver cell adhesion molecule;
CDH5
cadherin 5, type 2 (vascular endothelium)
CDH5; cadherin 5, type 2 (vascular endothelium); 7B4; CD144; cadherin-5; 7B4 antigen; VE-cadherin; cd144 antigen; endothelial-specific cadherin; vascular endothelial cadherin; cadherin 5, type 2, VE-cadherin (vascular epithelium);
CHGA
chromogranin A (parathyroid secretory protein 1)
CHGA; chromogranin A (parathyroid secretory protein 1); chromogranin-A; SP-I; pituitary secretory protein I; parathyroid secretory protein 1; betagranin (N-terminal fragment of chromogranin A); CGA; CgA; Pancreastatin;
CHL1
cell adhesion molecule with homology to L1CAM
CHL1; cell adhesion molecule with homology to L1CAM; neural cell adhesion molecule L1-like protein; CALL; Cell adhesion molecule with homology to L1CAM (close homolog of L1); Cell adhesion molecule with homology to L1CAM (close homologue of L1); Close homolog of L1; FLJ44930; L1 cell adhesion molecule 2; L1CAM2; MGC132578; Neural cell adhesion molecule; chl1-like protein; LICAM2; AI465420; A530023M13Rik;
CITED1
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1
CITED1; Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1; MSG1; cbp/p300-interacting transactivator 1; melanocyte-specific gene 1; melanocyte-specific protein 1;
CITED2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
CITED2; Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2; cbp/p300-interacting transactivator 2; Cbp/p300 interacting transactivator 2; Cbp/p300 interacting transactivator with Glu/Asp rich carboxy terminal domain 2; CITE2_HUMAN; CITED 2; MRG 1; MRG-1; MRG1; MSG related protein 1; MSG-related protein 1; P35srj; MSG1-related gene 1; melanocyte-specific gene 1-related gene 1;
CLTB
clathrin, light chain B
CLTB; clathrin, light chain B; clathrin, light polypeptide (Lcb); clathrin light chain B; Lcb; clathrin, light chain (Lcb);
COMT
catechol-O-methyltransferase
COMT; catechol-O-methyltransferase; catechol O-methyltransferase; Catechol O methyltransferase; COMT_HUMAN; EC 2.1.1.6; OTTHUMP00000197748; OTTHUMP00000197749; OTTHUMP00000197750; OTTHUMP00000197751; OTTHUMP00000197846; OTTHUMP00000198331;
CPS1
carbamoyl-phosphate synthase 1, mitochondrial
CPS1; carbamoyl-phosphate synthase 1, mitochondrial; carbamoyl phosphate synthetase 1, mitochondrial; carbamoyl-phosphate synthase [ammonia], mitochondrial; carbamoylphosphate synthetase I; CPSASE1;
CRADD
CASP2 and RIPK1 domain containing adaptor with death domain
CRADD; CASP2 and RIPK1 domain containing adaptor with death domain; MRT34; RAIDD; death domain-containing protein CRADD; death adaptor molecule RAIDD; caspase and RIP adaptor with death domain; RIP-associated protein with a death domain; RIP-associated ICH1/CED3-homologous protein with death domain;
CTGF
connective tissue growth factor
CTGF; connective tissue growth factor; CCN2; NOV2; HCS24; IGFBP8; IBP-8; IGFBP-8; CCN family member 2; IGF-binding protein 8; hypertrophic chondrocyte-specific protein 24; insulin-like growth factor-binding protein 8;
CTSA
cathepsin A
CTSA; cathepsin A; GSL, PPGB, protective protein for beta galactosidase (galactosialidosis); lysosomal protective protein; carboxypeptidase C; BETA GALACTOSIDASE PROTECTIVE PROTEIN; EC 3.4.16.5; Glactosialidosis; GLB2; Goldberg Syndrome; GSL; NEURAMINIDASE BETA GALACTOSIDASE EXPRESSION; NGBE; PPCA; PPGB; Protective protein for beta galactosidase; OTTHUMP00000031778; OTTHUMP00000031780; OTTHUMP00000031781; carboxypeptidase L; beta-galactosidase 2; protective protein cathepsin A; beta-galactosidase protective protein;
Ctsb
cathepsin B
CTSB; cathepsin B; EC 3.4.22.1; CPSB; amyloid precursor protein secretase; Cathepsin B1; cysteine protease; APPS; EC 3.4.22; APP secretase; OTTHUMP00000116009; OTTHUMP00000229510; OTTHUMP00000229511; OTTHUMP00000229512; OTTHUMP00000229514; OTTHUMP00000229515; OTTHUMP00000229516;
Ctsc
cathepsin C
CTSC; cathepsin C; PALS, PLS; dipeptidyl peptidase 1; DPP1; AI047818; CATC; Cathepsin J; CPPI; Dipeptidyl transferase; DPP I; DPPI; EC 3.4.14.1; HMS; JP; JPD; MGC126959; PALS; PLS; dipeptidyl peptidase I; dipeptidyl-peptidase I; DPP-I;
Ctsd
cathepsin D
CTSD; cathepsin D; CPSD; CLN10; HEL-S-130P; lysosomal aspartyl protease; lysosomal aspartyl peptidase; ceroid-lipofuscinosis, neuronal 10; epididymis secretory sperm binding protein Li 130P;
Ctse
cathepsin E
CTSE; cathepsin E; CATE; CATE_HUMAN; Cathepsin E form II; Erythrocyte membrane aspartic proteinase; OTTHUMP00000034345; OTTHUMP00000034346; slow-moving proteinase;
CTSH
cathepsin H
CTSH; cathepsin H; CPSB; pro-cathepsin H; ACC 4; ACC 5; aleurain; cathepsin B3; cathepsin BA; N-benzoylarginine-beta-naphthylamide hydrolase; ACC-4; ACC-5; minichain; MGC1519; DKFZp686B24257;
CTSK
cathepsin K
CTSK; cathepsin K; CTSO; PKND; PYCD; CTS02; CTSO1; CTSO2; cathepsin O; cathepsin X; cathepsin O1; cathepsin O2;
CTSL2
Cathepsin L2
UNQ268/PRO305; CATL2; CTSU; CTSV; cathepsin L2, preproprotein; cathepsin U; cathepsin V;
Ctsz
cathepsin Z
CTSZ; cathepsin Z; Cathepsin P; Cathepsin X; Cathepsin X precursor; Cathepsin Z precursor; CathepsinP; CathepsinX; CathepsinZ; CATZ_HUMAN; CTSX; FLJ17088; Preprocathepsin P; PreprocathepsinP; OTTHUMP00000031409;
DAPK1
death-associated protein kinase 1
DAPK1; death-associated protein kinase 1; DAPK; DAP kinase 1; DKFZp781I035;
DAPK2
death-associated protein kinase 2
DAPK2; death-associated protein kinase 2; DRP 1; MGC119312; DAP kinase 2; DAP-kinase-related protein 1 beta isoform; DRP1; DRP-1;
DAPK3
death-associated protein kinase 3
DAPK3; death-associated protein kinase 3; ZIP; ZIPK; dlk; ZIP-kinase; DAP kinase 3; MYPT1 kinase; DAP-like kinase; ZIP kinase isoform; zipper-interacting protein kinase; FLJ36473;
DDAH1
Dimethylarginine Dimethylaminohydrolase 1
DDAH1; N(G),N(G)-dimethylarginine dimethylaminohydrolase 1; DDAHI; DDAH-1; dimethylargininase-1; NG, NG-dimethylarginine dimethylaminohydrolase; EC 3.5.3.18; OTTHUMP00000012304; FLJ2553; FLJ21264; dimethylarginine dimethylaminohydrolase 1;
DHPS
deoxyhypusine synthase
DHPS; deoxyhypusine synthase; MIG13; migration inducing gene 13; DHS; DHYS_HUMAN; DS; migration-inducing gene 13;
DKK1
dickkopf WNT signaling pathway inhibitor 1
DKK1; dickkopf WNT signaling pathway inhibitor 1; SK; DKK-1; dickkopf-related protein 1; hDkk-1; dickkopf-1 like; dickkopf 1 homolog; dickkopf-like protein 1; dickkopf related protein-1;
DNMT1
DNA (cytosine-5-)-methyltransferase 1
DNMT1; DNA (cytosine-5-)-methyltransferase 1; AIM; DNMT; MCMT; CXXC9; HSN1E; ADCADN; DNA (cytosine-5)-methyltransferase 1; m.HsaI; DNA MTase HsaI; DNA methyltransferase HsaI; CXXC-type zinc finger protein 9;
DNMT3A
DNA (cytosine-5-)-methyltransferase 3 alpha
DNMT3A; DNA (cytosine-5-)-methyltransferase 3 alpha; DNMT3A2; M.HsaIIIA; DNA (cytosine-5)-methyltransferase 3A; DNA MTase HsaIIIA; DNA cytosine methyltransferase 3A2;
DOT1L
DOT1-like histone H3K79 methyltransferase
DOT1L; DOT1-like histone H3K79 methyltransferase; DOT1; KMT4; histone-lysine N-methyltransferase, H3 lysine-79 specific; H3-K79-HMTase; DOT1-like protein; lysine N-methyltransferase 4; histone methyltransferase DOT1L; histone H3-K79 methyltransferase; DOT1-like, histone H3 methyltransferase;
DSTYK
dual serine/threonine and tyrosine protein kinase
DSTYK; dual serine/threonine and tyrosine protein kinase; receptor interacting protein kinase 5 , RIPK5; DustyPK; KIAA0472; RIP5; Dusty PK; Dusty protein kinase; HDCMD38P; Receptor interacting protein 5; Receptor interacting protein kinase 5; Receptor interacting serine/threonine protein kinase 5; RIP homologous kinase; SGK496; Sugen kinase 496; OTTHUMP00000035175; OTTHUMP00000035299; RIP-homologous kinase; receptor-interacting s; RIPK5;
ECE2
endothelin converting enzyme 2
ECE2; endothelin converting enzyme 2; endothelin-converting enzyme 2; KIAA0604; MGC2408; MGC78487; ECE 2; ECE-2; ECE2_HUMAN; Endothelin-converting enzyme 2 region; Hypothetical protein MGC2408; MGC17664;
EDF1
endothelial differentiation-related factor 1
EDF1; endothelial differentiation-related factor 1; EDF 1; multiprotein bridging factor 1; MBF1; EDF-1; MGC9058;
EGF
epidermal growth factor
Beta urogastrone; EGF; EGF-HUMAN; Epidermal Growth Factor; HOMG4; OTTHUMP00000219721; OTTHUMP00000219722; Pro epidermal growth factor; URG; Urogastrone;
EGFR
epidermal growth factor receptor
EGFR; epidermal growth factor receptor; epidermal growth factor receptor (avian erythroblastic leukemia viral (v erb b) oncogene homolog) , ERBB; ERBB1; erythroblastic leukemia viral (v erb b) oncogene homolog (avian); proto-oncogene c-ErbB-1; cell growth inhibiting protein 40; cell proliferation-inducing protein 61; receptor tyrosine-protein kinase erbB-1; avian erythroblastic leukemia viral (v-erb-b) oncogene homolog; ERBB; HER1; mENA; PIG61;
EGR1
early growth response 1
EGR1; early growth response 1; TIS8; AT225; G0S30; NGFI-A; ZNF225; KROX-24; ZIF-268; early growth response protein 1; EGR-1; zinc finger protein 225; transcription factor ETR103; transcription factor Zif268; zinc finger protein Krox-24; nerve growth factor-induced protein A;
EGR3
early growth response 3
EGR3; early growth response 3; EGR-3; PILOT; early growth response protein 3; zinc finger protein pilot;
EGR4
early growth response 4
EGR4; early growth response 4; early growth response protein 4; NGFI C; PAT133; AT133; Nerve growth factor induced clone C; NGFIC; EGR-4; NGFI-C;
EHMT2
EHMT2 euchromatic histone-lysine N-methyltransferase 2
EHMT2; euchromatic histone-lysine N-methyltransferase 2; BAT8, C6orf30, chromosome 6 open reading frame 30 , HLA B associated transcript 8; histone-lysine N-methyltransferase EHMT2; Em:AF134726.3; G9A; KMT1C; NG36/G9a; protein G9a; H3-K9-HMTase 3; G9A histone methyltransferase; HLA-B associated transcript 8; HLA-B-associated transcript 8; lysine N-methyltransferase 1C; ankyrin repeat-containing protein; histone H3-K9 methyltransferase 3; histone-lysine N-methyltransferase, H3 lysine-9 specific 3; BAT8; GAT8; NG36; C6orf30; FLJ35547; DKFZp686H08213;
EPCAM
epithelial cell adhesion molecule
EPCAM; epithelial cell adhesion molecule; ESA; KSA; M4S1; MK-1; DIAR5; EGP-2; EGP40; KS1/4; MIC18; TROP1; EGP314; HNPCC8; TACSTD1; antigen identified by monoclonal antibody AUA1; tumor-associated calcium signal transducer 1; 17-1A; 323/A3; CD326; CO-17A; EGP34; EGP40; GA733-2; HEA125; Ly74; MH99; MOC31; TACST-1; Adenocarcinoma-associated antigen; Cell surface glycoprotein Trop-1; Epithelial cell surface antigen; Epithelial glycoprotein; Epithelial glycoprotein 314; KS 1/4 antigen; Major gastrointestinal tumor-associated protein GA733-2; TACSTD1; human epithelial glycoprotein-2; Ep-CAM; membrane component, chromosome 4, surface marker (35kD glycoprotein); EGP; M1S2; CD326 antigen; Hegp314; ACSTD1; Adecatumumab; 503605-66-1; Citatuzumab bogatox; 945228-49-9; Citatuzumab bogatox; 945228-49-9; Tucotuzumab celmoleukin; 339986-90-2; Solitomab; 503605-66-1;
EPGN
epithelial mitogen homolog
UNQ3072; ALGV3072; EPG; PRO9904; epigen; epithelial mitogen homolog;
ERBB2
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2
ERBB2; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2; NEU; NGL; HER2; TKR1; CD340; HER-2; MLN 19; HER-2/neu; receptor tyrosine-protein kinase erbB-2; herstatin; p185erbB2; proto-oncogene Neu; c-erb B2/neu protein; proto-oncogene c-ErbB-2; metastatic lymph node gene 19 protein; neuro/glioblastoma derived oncogene homolog; tyrosine kinase-type cell surface receptor HER2; neuroblastoma/glioblastoma derived oncogene homolog; v-erb-b2 avian erythroblastic leukemia viral oncoprotein 2; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog;
ERBB3
ERBB3 v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)
ERBB3; v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian); LCCS2, lethal congenital contracture syndrome 2; receptor tyrosine-protein kinase erbB-3; HER3; proto-oncogene-like protein c-ErbB-3; tyrosine kinase-type cell surface receptor HER3; LCCS2; ErbB-3; c-erbB3; erbB3-S; MDA-BF-1; c-erbB-3; p180-ErbB3; p45-sErbB3; p85-sErbB3; MGC88033;
ERBB4
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian)
ERBB4; v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian); v erb a avian erythroblastic leukemia viral oncogene homolog like 4; receptor tyrosine-protein kinase erbB-4; proto-oncogene-like protein c-ErbB-4; tyrosine kinase-type cell surface receptor HER4; avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 4; HER4; p180erbB4; MGC138404;
ESAM
endothelial cell adhesion molecule
ESAM; endothelial cell adhesion molecule; W117m; endothelial cell-selective adhesion molecule; 2310008D05Rik; LP4791 protein; HUEL (C4orf1)-interacting protein;
ETS1
v-ets erythroblastosis virus E26 oncogene homolog 1 (avian)
ETS1; v-ets erythroblastosis virus E26 oncogene homolog 1 (avian); EWSR2, v ets avian erythroblastosis virus E26 oncogene homolog 1; protein C-ets-1; Avian erythroblastosis virus E26 (v ets) oncogene homolog 1; ets protein; ETS 1; FLJ10768; p54; v-ets avian erythroblastosis virus E2 oncogene homolog 1; Avian erythroblastosis virus E26 (v-ets) oncogene homolog-1; ETS-1; EWSR2;
F3
coagulation factor III (thromboplastin, tissue factor)
F3; coagulation factor III (thromboplastin, tissue factor); TF; TFA; CD142; tissue factor;
F7
coagulation factor VII (serum prothrombin conversion accelerator)
F7; coagulation factor VII; SPCA; eptacog alfa; proconvertin; OTTHUMP00000018733; OTTHUMP00000018734; FVII coagulation protein; serum prothrombin conversion accelerator; factor VII;
FADD
Fas (TNFRSF6)-associated via death domain
FADD; Fas (TNFRSF6)-associated via death domain; GIG3; MORT1; FAS-associated death domain protein; growth-inhibiting gene 3 protein; mediator of receptor induced toxicity; mediator of receptor-induced toxicity; Fas-associating protein with death domain; Fas-associating death domain-containing protein;
FAM19A2
family with sequence similarity 19 (chemokine (C-C motif)-like), member A2
FAM19A2; family with sequence similarity 19 (chemokine (C-C motif)-like), member A2; protein FAM19A2; TAFA 2; chemokine-like protein TAFA-2; TAFA2; TAFA-2; MGC42403; DKFZp761E1217; DKFZp781P0552;
FAM3C
family with sequence similarity 3, member C
FAM3C; family with sequence similarity 3, member C; protein FAM3C; GS3876; ILEI; interleukin like EMT inducer; predicted osteoblast protein; interleukin-like EMT inducer; GS3786;
FARS2
phenylalanyl-tRNA synthetase 2, mitochondrial
FARS2; phenylalanyl-tRNA synthetase 2, mitochondrial; FARS1, phenylalanine tRNA synthetase 1 (mitochondrial); phenylalanyl-tRNA synthetase, mitochondrial; dJ236A3.1; phenylalanine tRNA ligase 2; mitochondrial; dJ236A3.1 (phenylalanine tRNA synthetase); dJ520B18.2 (FARS1 (phenylalanine tRNA synthetase)); FARS1; HSPC320; Phenylalanine translase; Phenylalanine tRNA ligase 2, mitochondrial; Phenylalanine tRNA ligase; Phenylalanine tRNA synthetase 1 (mitochondrial); Phenylalanine tRNA synthetase 2 (mitochondrial); Phenylalanine--tRNA ligase; Phenylalanyl tRNA synthetase 2; PheRS; SYFM_HUMAN; OTTHUMP00000015986; dJ236A3.1 (phenylalanine-tRNA synthetase); phenylalanine-tRNA synthetase 1 (mitochondrial); phenylal; dJ520B18.2;
FAS
Fas cell surface death receptor
FAS; Fas cell surface death receptor; APT1; CD95; FAS1; APO-1; FASTM; ALPS1A; TNFRSF6;
FASTK
Fas-activated serine/threonine kinase
FASTK; Fas-activated serine/threonine kinase; FAST; Fas activated serine threonine kinase; Fas activated serine threonine kinase isoform 1; Fas activated serine threonine kinase isoform 4; FAST kinase; FLJ13079;
FGF1
fibroblast growth factor 1 (acidic)
FGF1; Fibroblast Growth Factor-acidic; FGF-acidic; Basic fibroblast growth factor; BFGF; FGF 2; FGF B; FGF2; FGF2 basic; FGF2_HUMAN; FGFB; Fibroblast growth factor 2 (basic); HBGF 2; HBGF-2; HBGF2; HBGH 2; HBGH2; Heparin binding growth factor 2 precursor; Heparin-binding growth factor 2; Prostatropin;
FGF10
fibroblast growth factor 10
FGF10; fibroblast growth factor 10; FGF-10; keratinocyte growth factor 2; produced by fibroblasts of urinary bladder lamina propria;
FGF12
fibroblast growth factor 12
FGF12; fibroblast growth factor 12; FGF12B; FHF1; fibroblast growth factor 12B; fibroblast growth factor FGF 12b; fibroblast growth factor homologous factor 1; myocyte activating factor; FHF-1; FGF-12; myocyte-activating factor; fibroblast growth factor F;
FGF17
fibroblast growth factor 17
FGF17; fibroblast growth factor 17; FGF 13; FGF13; FGF-17; OTTHUMP00000122553; OTTHUMP00000224730; FGF-13;
FGF2
Fibroblast Growth Factor 2 (basic)
FGF2; fibroblast growth factor 2 (basic); BFGF; FGFB; HBGF-2; heparin-binding growth factor 2; prostatropin; OTTHUMP00000037513; basic fibroblast growth factor bFGF; Fgf-2;
FGF23
fibroblast growth factor 23
FGF23; fibroblast growth factor 23; ADHR; FGFN; HYPF; HPDR2; PHPTC; phosphatonin; tumor-derived hypophosphatemia inducing factor;
FGF4
fibroblast growth factor 4
FGF4; fibroblast growth factor 4; heparin secretory transforming protein 1 , HSTF1; HBGF 4; HST; HST 1; human stomach cancer; transforming factor from FGF related oncogene; K FGF; kaposi sarcoma oncogene; KFGF; transforming protein KS3; FGF-4; HSTF-1; onc;
FGF5
fibroblast growth factor 5
FGF5; fibroblast growth factor 5; heparin-binding growth factor 5; HBGF-5; Smag-82;
FGF6
fibroblast growth factor 6
FGF6; fibroblast growth factor 6; FGF-6; HST-2; HSTF-2; OTTHUMP00000238378; heparin-binding growth factor 6; heparin secretory-transforming protein 2; HST2; HBGF-6;
FGF7
Fibroblast growth factor 7
FGF7; fibroblast growth factor 7; KGF; HBGF-7; keratinocyte growth factor; OTTHUMP00000162252; heparin-binding growth factor 7; HBGF 7; HBGF7; FGF 7; FGF-7; Heparin binding growth factor 7;
FGF8
fibroblast growth factor 8 (androgen-induced)
FGF8; fibroblast growth factor 8 (androgen-induced); fibroblast growth factor 8; AIGF; androgen-induced growth factor; heparin-binding growth factor 8; KAL6; FGF-8; HBGF-8; MGC149376;
FGF9
Fibroblast growth factor 9 (glia-activating factor)
FGF9; fibroblast growth factor 9 (glia-activating factor); GAF; SYNS3; HBFG-9; Glia-activating factor; Fibroblast growth factor 9; FGF-9; Heparin-binding growth factor 9; OTTHUMP00000018804; heparin-binding growth factor;
FGFR1
fibroblast growth factor receptor 1
FLG; FGFR1; fibroblast growth factor receptor 1; CEK; OGD; FLT2; KAL2; BFGFR; CD331; FGFBR; FLT-2; HBGFR; N-SAM; FGFR-1; FLJ99988; bFGF-R-1; OTTHUMP00000190874; OTTHUMP00000190875; OTTHUMP00000190876; OTTHUMP00000190877; OTTHUMP00000190879; OTTHUMP00000190880; OTTHUMP00000190881; OTTHUMP00000190885; proto-oncogene c-Fgr; FMS-like tyrosine kinase 2; hydroxyaryl-protein kinase; fms-related tyrosine kinase 2; heparin-binding growth factor receptor; H2; H3; H4; H5; Basic fibroblast growth factor receptor 1; N sam tyrosine kinase; Protein tyrosine kinase; Tyrosylprotein kinase; Hydroxyaryl protein kinase; Heparin binding growth factor receptor;
FGFR2
fibroblast growth factor receptor 2
FGFR2; BEK; JWS; CEK3; CFD1; ECT1; KGFR; TK14; TK25; BFR-1; CD332; K-SAM; Crouzon syndrome; Pfeiffer syndrome; fibroblast growth factor receptor 2; OTTHUMP00000020623; Keratinocyte growth factor receptor; OTTHUMP00000020624; OTTHUMP00000020625; OTTHUMP00000020626; OTTHUMP00000020627; OTTHUMP00000020628; OTTHUMP00000020629; OTTHUMP00000020630; OTTHUMP00000020631; bacteria-expressed kinase; OTTHUMP00000020632; FGFR-2; BEK fibroblast growth factor receptor; FGF receptor; EC 2.7.10.1; hydroxyaryl-protein kinase; protein tyrosine kinase, receptor like 14; soluble FGFR4 variant 4; craniofacial dysostosis 1; Jackson-Weiss syndrome; KSAM; CD332 antigen; FLJ98662; EC 2.7.10; OTTHUMP00000020621;
Fgfr3
fibroblast growth factor receptor 3
FGFR3; fibroblast growth factor receptor 3; ACH; CEK2; JTK4; CD333; HSFGFR3EX; FGFR-3; tyrosine kinase JTK4; hydroxyaryl-protein kinase; fibroblast growth factor receptor 3 variant 4;
FGFR4
fibroblast growth factor receptor 4
FGFR4; fibroblast growth factor receptor 4; TKF; JTK2; CD334; FGFR-4; tyrosylprotein kinase; protein-tyrosine kinase; hydroxyaryl-protein kinase; tyrosine kinase related to fibroblast growth factor receptor;
FGFRL1
fibroblast growth factor receptor-like 1
FGFRL1; fibroblast growth factor receptor-like 1; FGF homologous factor receptor; FGF receptor like protein 1; FGFR 5; FGFR like protein; FGFR5; FHFR; Fibroblast growth factor receptor 5; Fibroblast growth factor receptor like 1; FGFR-5; FGFR-like protein; FGF receptor-like protein 1;
FIBP
fibroblast growth factor (acidic) intracellular binding protein
FIBP;fibroblast growth factor (acidic) intracellular binding protein;acidic fibroblast growth factor intracellular-binding protein;FGFIBP;aFGF intracellular-binding protein;FGF-1 intracellular-binding protein;FIBP-1;
FIGF
C-fos induced growth factor (vascular endothelial growth factor D)
VEGF-D; VEGFD; vascular endothelial growth factor D;
FRS3
Frs3 fibroblast growth factor receptor substrate 3
FRS3; fibroblast growth factor receptor substrate 3; FRS2-beta; FGFR substrate 3; suc1-associated neurotrophic factor target 2 (FGFR signalling adaptor); Snt2; AI449674; Frs2beta; 4930417B13Rik; MGC25496;
GADD45A
growth arrest and DNA-damage-inducible, alpha
GADD45A; growth arrest and DNA-damage-inducible, alpha; DDIT1; growth arrest and DNA damage-inducible protein GADD45 alpha; GADD45; DDIT-1; DNA damage-inducible transcript-1; DNA-damage-inducible transcript 1; DNA damage-inducible transcript 1 protein; gr;
GADD45B
growth arrest and DNA-damage-inducible, beta
GADD45B; growth arrest and DNA-damage-inducible, beta; MYD118; growth arrest and DNA damage-inducible protein GADD45 beta; DKFZP566B133; GADD45BETA; growth arrest and DNA damage inducible beta; myeloid differentiation primary response; negative growth reg;
GADD45G
growth arrest and DNA-damage-inducible, gamma
GADD45G; growth arrest and DNA-damage-inducible, gamma; growth arrest and DNA damage-inducible protein GADD45 gamma; CR6; DDIT2; gadd related protein; 17 kD; GADD45gamma; growth arrest and DNA damage inducible gamma; GRP17; DDIT-2; GADD45-gamma; gadd-rela;
GAMT
Gamt guanidinoacetate methyltransferase
GAMT; guanidinoacetate methyltransferase; guanidinoacetate N-methyltransferase; Spintz1; AA571402;
Gas6
growth arrest-specific 6
GAS6; growth arrest-specific 6; AXSF; AXLLG; growth arrest-specific protein 6; AXL stimulatory factor; AXL receptor tyrosine kinase ligand;
GAS7
growth arrest-specific 7
GAS7; growth arrest-specific 7; growth arrest-specific protein 7; KIAA0394; MGC1348; Growth arrest specific 7; GAS 7; GAS-7; GAS7_HUMAN; MLL/GAS7; MLL/GAS7 fusion protein;
GDF10
growth differentiation factor 10
GDF10; growth differentiation factor 10; bone morphogenetic protein 3B; BMP 3b; BIP; GDF-10; bone-inducing protein; BMP3B; BMP-3b;
GDF11
growth differentiation factor 11
GDF11; growth differentiation factor 11; growth/differentiation factor 11; BMP 11; GDF-11; bone morphogenetic protein 11; BMP11; BMP-11;
GDF15
growth differentiation factor 15
GDF15; growth differentiation factor 15; PDF; MIC1; PLAB; MIC-1; NAG-1; PTGFB; GDF-15; growth/differentiation factor 15; NRG-1; PTGF-beta; placental TGF-beta; NSAID-activated gene 1 protein; NSAID-regulated gene 1 protein; prostate differentiation factor; macrophage inhibitory cytokine 1; placental bone morphogenetic protein; NSAID (nonsteroidal anti-inflammatory drug)-activated protein 1;
GDF2
growth differentiation factor 2
BMP-9; BMP9; GDF2; growth differentiation factor 2; GDF-2; bone morphogenetic protein 9; growth/differentiation factor 2; Human BMP9 ELISA KIT; Human; BMP9 ELISA KIT; ELISA KIT; BMP9 ELISA; KIT; ELISA;
GDF3
growth differentiation factor 3
GDF3; growth differentiation factor 3; KFS3; MCOP7; MCOPCB6; growth/differentiation factor 3; GDF-3;
GDF5
growth differentiation factor 5
GDF5; growth differentiation factor 5; growth/differentiation factor 5; BMP14; cartilage derived morphogenetic protein 1; CDMP1; GDF-5; CDMP-1; radotermin; cartilage-derived morphogenetic protein-1; OS5; LAP4; SYNS2;
GDF6
growth differentiation factor 6
GDF6; growth differentiation factor 6; growth/differentiation factor 6; BMP13; GDF-6; Klippel-Feil syndrome; Klip-Feil malformation; Klippel-Feil malformation; growth/differentiation factor 16; KFM; KFS; KFS1; KFSL; SGM1; CDMP2; MCOP4; SCDO4; MCOPCB6; MGC;
GDF9
growth differentiation factor 9
GDF9; growth differentiation factor 9; growth/differentiation factor 9; GDF-9;
GGPS1
geranylgeranyl diphosphate synthase 1
GGPS1; geranylgeranyl diphosphate synthase 1; geranylgeranyl pyrophosphate synthase; GGPPS1; GGPPSase; GGPP synthase; geranyltranstransferase; farnesyltranstransferase; dimethylallyltranstransferase; farnesyl diphosphate synthase; (2E,6E)-farnesyl diphosp;
GH1
growth hormone 1
gH; GH-N; GH1; GHN; Growth hormone 1; Growth hormone; Growth hormone, normal; Growth hormone, pituitary; HG1; hGH-N; IGHD1B; Pituitary growth hormone; RNGHGP; SOMA_HUMAN; Somatotropin;
GH2
growth hormone 2
GH2; growth hormone 2; growth hormone variant; GH V; GHL; GHV; hGH V; placenta specific growth hormone; placental specific growth hormone; GH 2; hGHV; placenta-specific growth hormone; placental-specific growth hormone; GH-V; hGH-V;
GHR
growth hormone receptor
GHR; growth hormone receptor; GHBP; GH receptor; serum binding protein; somatotropin receptor; growth hormone binding protein;
GHRH
Ghrh growth hormone releasing hormone
GHRH; growth hormone releasing hormone; somatoliberin; GRF; growth hormone-releasing factor; growth hormone-releasing hormone; GHRF;
GIF
gastric intrinsic factor (vitamin B synthesis)
Gastric Intrinsic Factor; Gastric intrinsic factor (vitamin B synthesis); GIF; IF; IFMH; INF; Intrinsic factor; TCM3; TCN3; Intrinsic Factor Ab;
GLIPR1
GLI pathogenesis-related 1
GLIPR1; GLI pathogenesis-related 1; GLI pathogenesis related 1 (glioma); glioma pathogenesis-related protein 1; GliPR; RTVP1; CRISP 7; CRISP7; GLI pathogenesis related 1; GLI pathogenesis-related 1 (glioma); Glioma pathogenesis related protein 1; GLIP1_HUMAN; GliPR 1; Protein RTVP-1; RELATED TO TESTIS SPECIFIC, VESPID, AND PATHOGENESIS PROTEINS 1; RTVP 1; Testes specific vespid and pathogenesis protein 1; testes-specific vespid and pathogenesis protein 1; related to testis-specific, vespid, and pathogenesis proteins 1;
GLRX
glutaredoxin (thioltransferase)
GLRX; glutaredoxin (thioltransferase); GRX; GRX1; glutaredoxin-1; TTase-1; thioltransferase-1;
GNMT
glycine N-methyltransferase
GNMT; glycine N-methyltransferase; EC 2.1.1.20; Glycine N methyltransferase; GNMT_HUMAN; OTTHUMP00000016412;
GPX3
glutathione peroxidase 3 (plasma)
GPX3; glutathione peroxidase 3 (plasma); glutathione peroxidase 3; GPx-3; plasma glutathione peroxidase; extracellular glutathione peroxidase; GPx-P; GSHPx-3; GSHPx-P;
GRB10
growth factor receptor-bound protein 10
GRB10; growth factor receptor-bound protein 10; GRB10 adapter protein; GRB10 adaptor protein; maternally expressed gene 1; insulin receptor-binding protein Grb-IR; RSS; IRBP; MEG1; GRB-IR; Grb-10; KIAA0207;
GRB2
growth factor receptor-bound protein 2
GRB2; growth factor receptor-bound protein 2; ASH; Grb3-3; MST084; NCKAP2; MSTP084; EGFRBP-GRB2; HT027; protein Ash; SH2/SH3 adapter GRB2; abundant SRC homology; growth factor receptor-bound protein 3; epidermal growth factor receptor-binding protein GRB2;
GSK3A
glycogen synthase kinase 3 alpha
GSK3A; glycogen synthase kinase 3 alpha; glycogen synthase kinase-3 alpha; GSK-3 alpha; serine/threonine-protein kinase GSK3A;
GSK3B
glycogen synthase kinase 3 beta
GSK3B; glycogen synthase kinase 3 beta; glycogen synthase kinase-3 beta; GSK-3 beta; GSK3beta isoform; serine/threonine-protein kinase GSK3B;
GSS
glutathione synthetase
GSS; glutathione synthetase; GSH-S; GSH synthetase; glutathione synthase; GSHS; MGC14098;
GSTA1
Glutathione S-transferase A1
Glutathione S alkyltransferase A1; Glutathione S aryltransferase A1; Glutathione S transferase 2; Glutathione S transferase A1; Glutathione S transferase alpha 1; Glutathione S transferase Ha subunit 1; Glutathione S-transferase A1; GST class-alpha member 1; GST epsilon; GST HA subunit 1; GST, class alpha, 1; GST-epsilon; GST2; GSTA1 1; GSTA1; GSTA1-1; GSTA1_HUMAN; GTH1; HA subunit 1; MGC131939; OTTHUMP00000016611; S (hydroxyalkyl)glutathione lyase A1;
GSTA3
glutathione S-transferase alpha 3
GSTA3; glutathione S-transferase alpha 3; glutathione S transferase A3; glutathione S-transferase A3; GST class-alpha member 3; glutathione S-transferase A3-3; glutathione S-aryltransferase A3; glutathione S-alkyltransferase A3; glutathione S-aralkyltrans;
GSTK1
glutathione S-transferase kappa 1
GSTK1; glutathione S-transferase kappa 1; GST13; GST class-kappa; glutathione S-transferase k1; glutathione S-transferase subunit 13 homolog; GST; hGSTK1; GSTK1-1; GST13-13; GST 13-13;
GSTM1
glutathione S-transferase mu 1
GSTA3; GST 3-3; GST Yb1; GSTM1-1; glutathione S-transferase M1; glutathione S-transferase Mu 1; glutathione S-transferase Yb-1 subunit; glutathione-S-transferase mu type 1 (Yb1); glutathione-S-transferase, mu type 1 (Yb1);
GSTM2
glutathione S-transferase mu 2 (muscle)
GSTM2; glutathione S-transferase mu 2 (muscle); glutathione S transferase M2 (muscle); glutathione S-transferase Mu 2; GST4; GST, muscle; GST class-mu 2; glutathione S-transferase 4; glutathione S-transferase M1; glutathione S-aryltransferase M2; glutathi;
GSTM4
glutathione S-transferase mu 4
GSTM4; glutathione S-transferase mu 4; glutathione S transferase M4; Glutathione S transferase Mu 4; GST class mu 4; GST class-mu 4; GST-Mu2; GSTM4 4; GSTM4-4; GSTM4_HUMAN; GTM4; GTS Mu2; MGC131945; MGC9247; GTS-Mu2; OTTHUMP00000013356; OTTHUMP00000013358; glutathione S-transferase M4; glutathione S-aryltransferase M4; glutathione S-alkyltransferase M4; glutathione S-aralkyltransferase M4; S-(hydroxyalkyl)glutath;
GSTO1
glutathione S-transferase omega 1
GSTO1; glutathione S-transferase omega 1; glutathione S-transferase omega-1; GSTTLp28; P28; AA407097; AI194287; AU018802; DKFZp686H13163; EC 2.5.1.18; Glutathione S transferase omega 1; Glutathione S-transferase omega 1-1; Glutathione S-transferase omega; Glutathione transferase omega 1; Glutathione-dependent dehydroascorbate reductase; Glutathione-S-transferase like; Glutathione-S-transferase omega 1; GSTO 1-1; GSTO1 1; GSTX; Gtsttl; MGC94845; OTTHUMP00000020429; GSTO-1; OTTHUMP00000020430; OTTHUMP00000020431;
GSTP1
glutathione S-transferase pi 1
GSTP1; glutathione S-transferase pi 1; FAEES3, GST3; glutathione S-transferase P; GSTP; GSTP1-1; GST class-pi; deafness, X-linked 7; fatty acid ethyl ester synthase III; PI; DFN7; GST3; FAEES3;
GSTT1
glutathione S-transferase theta 1
GSTT1; glutathione S-transferase theta 1; glutathione S-transferase theta-1; EC 2.5.1.18; Glutathione S transferase 5; Glutathione S transferase theta 1; Glutathione transferase T1 1; Glutathione transferase T1-1; GST 5 5; GST CL1; GST class theta 1; GST class-theta-1; GSTT1_HUMAN; OTTHUMP00000198547; OTTHUMP00000198549; EC 2.5.1.18; Glutathione S transferase 5; GST class-theta-1; GSTT1; Glutathione S Transferase theta 1; GST theta 1;
GSTZ1
glutathione transferase zeta 1
GSTZ1; glutathione transferase zeta 1; maleylacetoacetate isomerase; GSTZ1 1; MAAI; MAI; EC 2.5.1.18; EC 5.2.1.2; Glutathione S transferase zeta 1; GSTZ1-1; OTTHUMP00000246405; OTTHUMP00000246406; OTTHUMP00000246407; OTTHUMP00000246408; OTTHUMP00000246409; OTTHUMP00000246410; OTTHUMP00000246413; maleylacetone isomerase; glutathione S-aryltransferase; glutathione S-alkyltransferase; glutathi;
GZMH
granzyme H (cathepsin G-like 2, protein h-CCPX)
GZMH; granzyme H (cathepsin G-like 2, protein h-CCPX); CTSGL2; granzyme H; CCP X; CGL 2; CSP C; CTLA1; Cathepsin G like 2; CGL2; Cytotoxic serine protease C; Cytotoxic T lymphocyte associated serine esterase 1; Cytotoxic T lymphocyte proteinase; EC 3.4.21.-; Protein h CCPX; OTTHUMP00000178753; OTTHUMP00000245745; cathepsin G-like 2; cytotoxin serine protease-C; cytotoxic T-lymphocyte proteinase; cytotoxic T-lymphocyte-associated serine esterase 1; CCP-X; CGL-2; CSP-C;
HAGH
hydroxyacylglutathione hydrolase
HAGH; hydroxyacylglutathione hydrolase; hydroxyacyl glutathione hydrolase; hydroxyacylglutathione hydrolase, mitochondrial; GLO2; GLXII; HAGH1; GLX II; Glyoxalase II; OTTHUMP00000158839; OTTHUMP00000158840; hydroxyacylglutathione hydroxylase; GLX2;
HARS
histidyl-tRNA synthetase
HARS; histidyl-tRNA synthetase; histidyl-tRNA synthetase, cytoplasmic; histidine tRNA ligase 1; cytoplasmic; EC 6.1.1.21; FLJ20491; HisRS; histidine translase; Histidine tRNA ligase; Histidyl tRNA synthetase; HRS; Human histidyl tRNA synthetase homolog (HO3) mRNA complete cds; OTTHUMP00000159884; OTTHUMP00000223659; OTTHUMP00000223661; OTTHUMP00000223662; OTTHUMP00000223663; OTTHUMP00000223664; OTTHUMP00000224325; histidine-tRNA ligase; histidine--tRNA ligase; histidine tRN;
HBEGF
heparin-binding EGF-like growth factor
HBEGF; heparin-binding EGF-like growth factor; diphtheria toxin receptor (heparin binding epidermal growth factor like growth factor) , DTR, DTS, HEGFL; proheparin-binding EGF-like growth factor; Diphtheria toxin receptor (heparin binding EGF like growth factor); heparin binding epidermal growth factor; Diphtheria toxin receptor; DT R; DT-R; DTR; DTS; DTSF; HB-EGF; HBEGF_HUMAN; HEGFL; Heparin binding EGF like growth factor; Heparin binding epidermal growth factor like growth factor; OTTHUMP00000159876; heparin-binding epidermal growth factor; diphtheria toxin receptor (heparin-binding EGF-like growth factor); diphtheria toxin receptor (heparin-binding epidermal growth factor-like growth factor);
HDGF
hepatoma-derived growth factor
HDGF; hepatoma-derived growth factor; hepatoma derived growth factor (high mobility group protein 1 like); high mobility group protein 1 like; HMG1L2; HMG-1L2; high mobility group protein 1-like 2; FLJ96580; DKFZp686J1764;
HEXIM1
hexamethylene bis-acetamide inducible 1
HEXIM1; hexamethylene bis-acetamide inducible 1; CLP1; EDG1; HIS1; MAQ1; protein HEXIM1; HMBA-inducible; menage a quatre 1; cardiac lineage protein 1; menage a quatre protein 1; estrogen down-regulated gene 1 protein; hexamthylene bis-acetamide inducible 1; hexamethylene bisacetamide-inducible protein; hexamethylene bis-acetamide-inducible protein 1; hexamethylene-bis-acetamide-inducible transcript 1;
HEY1
hairy/enhancer-of-split related with YRPW motif 1
HEY1; hairy/enhancer-of-split related with YRPW motif 1; hairy/enhancer-of-split related with YRPW motif protein 1; BHLHb31; CHF 2; CHF2; HERP2; HESR 1; HESR1; HRT 1; Basic helix loop helix protein OAF1; Cardiovascular helix loop helix factor 2; Cardiovascular helix loop-helix factor 2; Cardiovascular helix-loop-helix factor 2; CHF-2; Class B basic helix-loop-helix protein 31; Hairy and enhancer of split related protein 1; Hairy and enhancer of split-related protein 1; Hairy enhancer-of-split related with YRPW motif protein 1; Hairy related transcription factor 1; Hairy-related transcription factor 1; Hairy/enhancer of split related with YRPW motif 1; HERP 2; HES related repressor protein 1; HES-related repressor protein 1; HES-related repressor protein 2; HESR-1; HEY 1; HEY1_HUMAN; hHRT1; HRT-1; HRT1; MGC1274; OAF 1; OAF1; basic helix-loop-helix protein OAF1; class B basic;
HGF
hepatocyte growth factor (hepapoietin A; scatter factor)
SF; HGFB; HPTA; F-TCF; DFNB39;Fibroblast derived tumor cytotoxic factor; Hepatocyte growth factor; Hepatocyte growth factor beta chain; Hepatocyte growth factor precursor; Hepatopoeitin-A; Hepatopoietin A; Hgf; Lung fibroblast derived mitogen; OTTHUMP00000161349; OTTHUMP00000206710; OTTHUMP00000206711; OTTHUMP00000206712; OTTHUMP00000206713; OTTHUMP00000206730; Scatter factor; Rilotumumab; 872514-65-3; Flanvotumab; 1188277-05-5;
HMTase
similar to Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific (H3-K36-HMTase) (H4-K20-HMTase) (Nuclear receptor binding SET domain containing protein 1) (NR-binding SET domain containing protein)
SETD7; SET7; FLJ21193; KIAA1717; KMT7; SET7/9; SET9; EC 2.1.1.43; Set9; H3-K4-HMTase; H3-K4-HMTase SETD7; H3 lysine-4 specific SET7; Histone-lysine N-methyltransferase; Histone H3-K4 methyltransferase; histone H3-lysine 4-specific methyltransferase; SET domain-containing protein 7; Histone H3-K4 methyltransferase SETD7; Lysine N-methyltransferase 7; SET domain containing (lysine methyltransferase) 7; histone H3-K4 methyltransferase; histone-lysine N-methyltransferase; protein methylase III; protein methylase 3; protein (lysine) methyltransferase; protein methyltransferase II; protein-lysine N-methyltransferase; histone H1-specific S-adenosylmethionine:protein-lysine N-methyltransferase; S-adenosyl-L-methionine:histone-L-lysine N6-methyltransferase;
HPRT1
hypoxanthine phosphoribosyltransferase 1
HPRT1; hypoxanthine phosphoribosyltransferase 1; HPRT; hypoxanthine-guanine phosphoribosyltransferase; HGPRT; Lesch Nyhan syndrome; HGPRTase; HPRT 1; HPRT_HUMAN; Hypoxanthine guanine phosphoribosyltransferase; Hypoxanthine phosphoribosyltransferase 1 (Lesch Nyhan syndrome);
IGF1
Insulin-like growth factor 1
ProIGF-I; Insulin-like Growth Factor-I Precursor; IGF-IEB; IGF1; IGFI; Insulin-like Growth Factor-I; insulin-like growth factor 1 (somatomedin C); insulin-like growth factor 1; IGF1A; insulin-like growth factor I; Mechano growth factor; insulin-like growth factor IA; IGF-I; insulin-like growth factor IB; MGF; somatomedin-C; IGF-IA; IBP1; IGF-IB; Somatomedin-C; IGFI; Teprotumumab; 89957-37-9; Ganitumab; 905703-97-1;
IGF1R
insulin-like growth factor 1 receptor
IGF1R; insulin-like growth factor 1 receptor; IGFR; CD221; IGFIR; JTK13; IGF-I receptor; soluble IGF1R variant 1; soluble IGF1R variant 2; insulin-like growth factor I receptor;
IGF2
Insulin-like Growth Factor-II
IGF2; IGF-II; PP9974; C11orf43; insulin-like growth factor 2 (somatomedin A); insulin-like growth factor II; insulin-like growth factor type 2; GF2; FLJ22066; FLJ44734; insulin-like growth factor 2 (somatomedin A); C11orf43, chromosome 11 open reading frame 43; insulin-like growth factor II; somatomedin-A; insulin-like growth factor type 2; PP9974;
IGF2R
Insulin-like Growth Factor 2 Receptor
cation-independent mannose-6-phosphate receptor; M6PR; CI-MPR; MPR 300; M6P/IGF2R; IGF-II receptor; M6P/IGF2 receptor; OTTHUMP00000017536; CI Man-6-P receptor; 300 kDa mannose 6-phosphate receptor; MPR1; insulin-like growth factor II receptor; cation-independent mannose-6 phosphate receptor; CD222 antigen; MPRI; CD222; CIMPR; M6P-R; IGF2R; insulin-like growth factor 2 receptor;
IGFBP1
Insulin-like Growth Factor Binding Protein 1
AFBP; IBP1; PP12; IGF-BP25; hIGFBP-1; IGFBP1; insulin-like growth factor-binding protein 1; IBP-1; IGFBP-1; OTTHUMP00000159561; OTTHUMP00000207990; OTTHUMP00000214348; binding protein-25; binding protein-26; binding protein-28; placental protein 12; IGF-binding protein 1; amniotic fluid binding protein; growth hormone independent-binding protein; alpha-pregnancy-associated endometrial globulin;
IGFBP2
insulin-like growth factor binding protein 2, 36kDa
IGFBP2; insulin-like growth factor binding protein 2, 36kDa; IBP2; IGF-BP53; insulin-like growth factor-binding protein 2; IBP-2; IGFBP-2; IGF-binding protein 2;
IGFBP3
IGFBP3 insulin-like growth factor binding protein 3
IGFBP3; insulin-like growth factor binding protein 3; insulin-like growth factor-binding protein 3; acid stable subunit of the 140 K IGF complex; binding protein 29; binding protein 53; BP 53; growth hormone dependent binding protein; IBP3; IGF binding protein 3; IBP-3; IGFBP-3; IGF-binding protein 3; growth hormone-dependent binding protein; BP-53;
IGFBP4
insulin-like growth factor binding protein 4
IGFBP4; insulin-like growth factor binding protein 4; BP-4; IBP4; IGFBP-4; HT29-IGFBP; insulin-like growth factor-binding protein 4; IBP-4; IGF-binding protein 4; Insulin-like growth factor-binding protein 4;
IGFBP5
insulin-like growth factor binding protein 5
IGFBP5; insulin-like growth factor binding protein 5; IBP5; insulin-like growth factor-binding protein 5; IBP-5; IGFBP-5; IGF-binding protein 5; Insulin-like growth factor-binding protein 5;
IGFBP6
IGFBP6 insulin-like growth factor binding protein 6
IGFBP6; insulin-like growth factor binding protein 6; insulin-like growth factor-binding protein 6; IBP-6; IGFBP-6; IGF binding protein 6; IGF-binding protein 6; IBP6;
IGFBP7
insulin-like growth factor binding protein 7
IGFBP7; insulin-like growth factor binding protein 7; AGM; PSF; TAF; FSTL2; IBP-7; MAC25; IGFBP-7; RAMSVPS; IGFBP-7v; IGFBPRP1; insulin-like growth factor-binding protein 7; IGFBP-rP1; angiomodulin; IGF-binding protein 7; PGI2-stimulating factor; tumor-derived adhesion factor; prostacyclin-stimulating factor;
ING1
inhibitor of growth family, member 1
ING1; inhibitor of growth family, member 1; inhibitor of growth protein 1; growth inhibitor ING1; growth inhibitory protein ING1; inhibitor of growth 1; p24ING1c; p33; p33ING1; p33ING1b; p47; p47ING1a; tumor suppressor ING1;
KDM4C
lysine (K)-specific demethylase 4C
KDM4C; lysine (K)-specific demethylase 4C; GASC1; JHDM3C; JMJD2C; TDRD14C; bA146B14.1; lysine-specific demethylase 4C; GASC-1 protein; tudor domain containing 14C; jumonji domain containing 2C; jumonji domain-containing protein 2C; gene amplified in squamous cell carcinoma 1 protein; JmjC domain-containing histone demethylation protein 3C;
KIR3DL1
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
KIR3DL1; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1; KIR; killer cell immunoglobulin-like receptor 3DL1; AMB11; CD158e1; CD158e1/2; CD158e2; cl 2; cl 11; nkat3; NKB1; NKB1B; CD158 antigen-like family member E; CD158E; CD158e antigen; CL11; CL2; HLA-BW4-specific inhibitory NK cell receptor; killer cell immunoglobulin like receptor; Killer cell immunoglobulin like receptor three domains , short cytoplasmic tail, 1; Killer cell immunoglobulin like receptor three domains long cytoplasmic tail 1; KIR antigen 3DL1; KIR G1; KIR3DS1; Kirl1; Kirl2; Krl1; MGC119726; MGC119728; MGC126589; MGC126591; MHC class I NK cell receptor; Natural killer associated transcript 3; Natural killer cell inhibitory receptor; NK receptor; NK-associated transcript 10; NK-associated transcript 3; NK-associated transcript 3delIg1; NKAT10; p70 killer cell inhibitory receptor; p70 natural killer cell receptor clones CL 2/CL 11; NKAT-3; NK-receptor; OTTHUMP00000068687; OTTHUMP00000068688; OTTHUMP00000081758; killer Ig receptor; p70 NK receptor CL-2/CL-11; p70 ki; KIR3DL1/S1;
LCAT
lecithin-cholesterol acyltransferase
LCAT; lecithin-cholesterol acyltransferase; phosphatidylcholine-sterol acyltransferase; LCAT_HUMAN; Lecithin cholesterol acyltransferase; Phosphatidylcholine sterol acyltransferase; Phospholipid cholesterol acyltransferase; Phospholipid-cholesterol acyltransferase;
LILRB3
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3
LILRB3; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3; leukocyte immunoglobulin-like receptor subfamily B member 3; CD85a; HL9; ILT5; LIR 3; LIR3; CD85 antigen like family member A; CD85a antigen; IL T5; Immunoglobulin like transcript 5; Leukocyte immunoglobulin like receptor 3; Leukocyte immunoglobulin like receptor subfamily B (with TM and ITIM domains) member 3; Leukocyte immunoglobulin like receptor subfamily B member 3; MGC138403; Monocyte inhibitory receptor HL9; PIRB; ILT-5; OTTHUMP00000069587; OTTHUMP00000197712; OTTHUMP00000237014; immunoglobulin-like transcript 5; CD85 antigen-like family member A; leukocyte immunoglobulin-like re; LIR-3;
LIPG
lipase, endothelial
LIPG; lipase, endothelial; EL; EDL; PRO719; endothelial lipase; lipoprotein lipase H; endothelial cell-derived lipase;
LOC100136741
insulin-like growth factor I
LOC100136741; insulin-like growth factor I; igf1; IGF-I; somatomedin;
LTC4S
leukotriene C4 synthase
LTC4S; leukotriene C4 synthase; MGC33147; Leukotriene C(4) synthase; LTC4 synthase; OTTHUMP00000197039;
LYVE1
lymphatic vessel endothelial hyaluronan receptor 1
LYVE1; lymphatic vessel endothelial hyaluronan receptor 1; Xlkd1; Lyve-1; Crsbp-1; 1200012G08Rik; lymphatic vessel endothelial hyaluronic acid receptor 1; extra cellular link domain-containing 1; lymphatic vessel endothelial HA recptor-1; lymphatic vessel endothelial HA receptor-1; extracellular link domain-containing protein 1; cell surface retention sequence binding protein-1; cell surface retention sequence-binding protein 1; HAR;
Marco
macrophage receptor with collagenous structure
MARCO; SCARA2; Macrophage receptor MARCO; Macrophage receptor with collagenous structure; MARCO_HUMAN; Scavenger receptor class A member 2;
MAT1A
methionine adenosyltransferase I, alpha
MAT1A;methionine adenosyltransferase I, alpha;S-adenosylmethionine synthase isoform type-1;MAT;MATA1;S adenosylmethionine synthetase;SAMS;SAMS1;MAT 1;MAT-I/III;adoMet synthase 1;adoMet synthetase 1;methionine adenosyltransferase 1;methionine adenosyltransferase I/III;S-adenosylmethionine synthetase isoform type-1;
MAT2A
methionine adenosyltransferase II, alpha
MAT2A; methionine adenosyltransferase II, alpha; S-adenosylmethionine synthase isoform type-2; MATA2; MATII; SAMS2; MAT 2; MAT-II; adoMet synthase 2; adoMet synthetase 2; methionine adenosyltransferase 2;
MAT2B
methionine adenosyltransferase II, beta
MAT2B; methionine adenosyltransferase II, beta; methionine adenosyltransferase 2 subunit beta; MATIIbeta; SDR23E1; short chain dehydrogenase/reductase family 23E; member 1; 1110064C04Rik; 2410018D16Rik; AI182287; AU022853; MAT II; MGC12237; Nbla02999; Beta regulatory subunit of methionine adenosyltransferase; dTDP 4 keto 6 deoxy D glucose 4 reductase; DTDP-4-keto-6-deoxy-D-glucose 4-reductase; MAT II beta; MAT2B_HUMAN; Methionine adenosyltransferase 2 beta subunit; Methionine adenosyltransferase II beta; OTTMUSP00000005600; Putative protein product of Nbla02999; RP23-382C18.2; Short chain dehydrogenase/reductase family 23E member 1; TGR; putative dTDP-4-keto-6-deoxy-D-glucose 4-reductase; short chain dehydrogenase/reductase family 23E, member 1; MAT-II;
MCEE
methylmalonyl CoA epimerase
MCEE; methylmalonyl CoA epimerase; methylmalonyl-CoA epimerase, mitochondrial; GLOD2; glyoxalase domain containing 2; mitochondrial; DL methylmalonyl CoA racemase; DL-methylmalonyl-CoA racemase; EC 5.1.99.1; MCEE_HUMAN; METHYLMALONYL CoA RACEMASE; Methylmalonyl-CoA epimerase;
METAP1
methionyl aminopeptidase 1
METAP1; methionyl aminopeptidase 1; methionine aminopeptidase 1; KIAA0094; MAP1A; MetAP1A; Peptidase M; DKFZp781C0419; MAP 1; MetAP 1; Peptidase M 1;
METAP2
methionyl aminopeptidase 2
METAP2; methionyl aminopeptidase 2; methionine aminopeptidase 2; MAP2; MNPEP; p67; Peptidase M; MAP 2; metAP 2; peptidase M 2; eIF-2-associated p67 homolog; initiation factor 2-associated 67 kDa glycoprotein; p67eIF2;
METTL1
methyltransferase like 1
METTL1; methyltransferase like 1; C12orf1, methyltransferase like 1; tRNA (guanine-N(7)-)-methyltransferase; TRM8; C12orf1; D1075 like gene product; FLJ95748; Methyltransferase like protein 1; tRNA (guanine N(7) ) methyltransferase; tRNA(m7G46) methyltransferase; YDL201w; D1075-like gene product; methyltransferase-like 1; tRNA(m7G46)-methyltransferase; methyltransferase-like protein 1;
METTL11A
methyltransferase like 11A
METTL11A; methyltransferase like 11A; C9orf32, chromosome 9 open reading frame 32; alpha N-terminal protein methyltransferase 1A; AD 003; C9orf32; Chromosome 9 open reading frame 32; Methyltransferase-like protein 11A; N-terminal RCC1 methyltransferase; NRMT; NTM1A; NTM1A_HUMAN; NTMT1; X-Pro-Lys N-terminal protein methyltransferase 1A; AD-003;
MGMT
O-6-methylguanine-DNA methyltransferase
MGMT; O-6-methylguanine-DNA methyltransferase; methylated-DNA--protein-cysteine methyltransferase; methylguanine-DNA methyltransferase; O-6-methylguanine-DNA-alkyltransferase; O6-methylguanine-DNA methyltransferase; 6-O-methylguanine-DNA methyltransferase;
MITF
microphthalmia-associated transcription factor
MITF; microphthalmia-associated transcription factor; MI; WS2; CMM8; WS2A; bHLHe32; class E basic helix-loop-helix protein 32;
MKNK1
MAP kinase interacting serine/threonine kinase 1
MKNK1; MAP kinase interacting serine/threonine kinase 1; MAP kinase-interacting serine/threonine-protein kinase 1; MNK1; MAPK signal-integrating kinase 1; MAP kinase signal-integrating kinase 1;
MKNK2
MAP kinase interacting serine/threonine kinase 2
MKNK2; MAP kinase interacting serine/threonine kinase 2; G protein coupled receptor kinase 7 , GPRK7; MAP kinase-interacting serine/threonine-protein kinase 2; MNK2; Putative map kinase interacting kinase; MAP kinase signal integrating kinase 2; G protein coupled receptor kinase 7; GPRK7; MAP kinase interacting serine threonine kinase 2; MAP kinase interacting serine threonine kinase; MAP kinase interacting serine threonine protein kinase 2; MAP kinase signal-integrating kinase 2; MAPK interacting kinase 2; Mitogen activated protein kinase interacting serine threonine kinase 2; MKNK2_HUMAN; G protein-coupled receptor kinase 7;
MLLT4
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4
MLLT4; myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4; myeloid/lymphoid or mixed lineage leukemia (trithorax (Drosophila) homolog); afadin; AF 6; AF6; protein AF-6; ALL1-fused gene from c;
MMAB
methylmalonic aciduria (cobalamin deficiency) cblB type
MMAB; methylmalonic aciduria (cobalamin deficiency) cblB type; methylmalonic aciduria (cobalamin deficiency) type B; cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial; ATP:cob(I)alamin adenosyltransferase; cblB; mitochondrial; aquocob(I)alamin vitamin B12s adenosyltransferase; ATP:corrinoid adenosyltransferase; ATR; c-diamide adenosyltransferase; Cob; Cob(I)alamin adenosyltransferase; Cob(I)yrinic acid a; Methylmalonic aciduria type B protein; MGC20496; MMAB_HUMAN; OTTHUMP00000240563; OTTHUMP00000240564;
MSRA
MSRA methionine sulfoxide reductase A
MSRA; methionine sulfoxide reductase A; mitochondrial peptide methionine sulfoxide reductase; peptide Met(O) reductase; peptide met (O) reductase; protein-methionine-S-oxide reductase; peptide methionine sulfoxide reductase; peptide-methionine (S)-S-oxide reductase; cytosolic methionine-S-sulfoxide reductase; PMSR;
msrB
methionine sulfoxide reductase B
msrB; methionine sulfoxide reductase B; ECK1776; JW1767; EC 1.8.4.12;
MSRB2
methionine sulfoxide reductase B2
MSRB2; methionine sulfoxide reductase B2; methionine sulfoxide reductase B , MSRB; methionine-R-sulfoxide reductase B2, mitochondrial; CBS 1; CBS1; CGI 131; PILB; MGC26104; MSRB 2; MSRB; Pilin like transcription factor; OTTHUMP00000019305; pilin-like transcription factor; CBS-1; CGI-131;
MSRB3
methionine sulfoxide reductase B3
MSRB3; methionine sulfoxide reductase B3; deafness, autosomal recessive 74 , DFNB74; methionine-R-sulfoxide reductase B3; DKFZp686C1178; FLJ36866; Methionine R sulfoxide reductase B mitochondrial; MSRB3_HUMAN; methionine-R-sulfoxide reductase B3, mitochondrial; DFNB74;
MST1
macrophage stimulating 1 (hepatocyte growth factor-like)
MST1; macrophage stimulating 1 (hepatocyte growth factor-like); D3F15S2, DNF15S2, HGFL; hepatocyte growth factor-like protein; hepatocyte growth factor like protein homolog; MSP; NF15S2; macrophage-stimulating protein; hepatocyte growth factor-like protei;
MST4
serine/threonine protein kinase MST4
RP6-213H19.1; MASK; serine/threonine-protein kinase MST4; OTTHUMP00000024034; OTTHUMP00000215131; OTTHUMP00000215132; OTTHUMP00000215133; OTTHUMP00000215134; STE20-like kinase MST4; mammalian sterile 20-like 4; Mst3 and SOK1-related kinase; serine/threonine-protein kinase MASK; mammalian Ste20-like protein kinase 4;
MTAP
methylthioadenosine phosphorylase
MTAP; methylthioadenosine phosphorylase; S-methyl-5-thioadenosine phosphorylase; c86fus; MSAP; MTAPase; MTA phosphorylase; MeSAdo phosphorylase; 5-methylthioadenosine phosphorylase;
MTHFD2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
MTHFD2; methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase; bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial; NAD-dependent methylene tetrahydrofolate dehydrogenase cycloh;
MTHFS
5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase)
MTHFS; 5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase); 5-formyltetrahydrofolate cyclo-ligase; HsT19268; 10-methenyl-tetrahydrofolate synthetase; 5; 5 formyltetrahydrofolate cyclo ligase; 5,10 methenyl tetrahydrofolate synthetase; FLJ30410; Methenyl THF synthetase; Methenyl-THF synthetase; MTHFS_HUMAN; OTTHUMP00000185568;
MYL6
myosin, light chain 6, alkali, smooth muscle and non-muscle
MYL6; myosin, light chain 6, alkali, smooth muscle and non-muscle; myosin, light polypeptide 6, alkali, smooth muscle and non muscle; myosin light polypeptide 6; ESMLC; MLC1SM; MLC3NM; myosin light chain A3; 17 kDa myosin light chain; myosin light chain a;
NANS
N-acetylneuraminic acid synthase
NANS; N-acetylneuraminic acid synthase; sialic acid synthase; SAS; EC 2.5.1.56; EC 2.5.1.57; N acetylneuraminate 9 phosphate synthase; N acetylneuraminate synthase; N acetylneuraminic acid phosphate synthase; N acetylneuraminic acid synthase; OTTHUMP00000;
NAPG
N-ethylmaleimide-sensitive factor attachment protein, gamma
NAPG;N-ethylmaleimide-sensitive factor attachment protein, gamma;gamma-soluble NSF attachment protein;gamma SNAP;SNAP-gamma;soluble NSF attachment protein;GAMMASNAP;
Ngf
nerve growth factor (beta polypeptide)
NGF; nerve growth factor (beta polypeptide); NGFB; HSAN5; Beta-NGF; beta-nerve growth factor; nerve growth factor, beta subunit;
NGFR
nerve growth factor receptor
NGFR; nerve growth factor receptor; p75; LNGFR; p75NTR; RNNGFRR; Tnfrsf16; tumor necrosis factor receptor superfamily member 16; p75 ICD; gp80-LNGFR; NGF receptor; nerve growth factor receptor, fast; low affinity nerve growth factor receptor; low affinity neurotrophin receptor p75NTR; low-affinity nerve growth factor receptor; nerve growth factor receptor (TNFR superfamily, member 16);
NGRN
neugrin, neurite outgrowth associated
NGRN; neugrin, neurite outgrowth associated; neugrin; DSC92; FI58Gm; Mesenchymal stem cell protein DSC92; Neugrin neurite outgrowth associated; Neurite outgrowth associated protein; Neurite outgrowth-associated protein; NGRN_HUMAN; Spinal cord-derived protein FI58G; OTTHUMP00000194683;
NOS1
Nos1 nitric oxide synthase 1, neuronal
NOS1; nitric oxide synthase 1, neuronal; nitric oxide synthase, brain; N-NOS; NC-NOS; NOS type I; neuronal NOS; constitutive NOS; neuronal nitric oxide synthase; peptidyl-cysteine S-nitrosylase NOS1; NO; bNOS; nNOS; NOS-I; Nos-1; 2310005C01Rik;
NOS1AP
nitric oxide synthase 1 (neuronal) adaptor protein
NOS1AP; nitric oxide synthase 1 (neuronal) adaptor protein; carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein; C terminal PDZ domain ligand of neuronal nitric oxide synthase; CAPON; KIAA0464; nitric oxide synthase 1 adaptor protein; C;
NOS2
nitric oxide synthase 2, inducible
NOS2; nitric oxide synthase 2, inducible; HEP-NOS; NOS; nitric oxide synthase 2A (inducible, hepatocytes); Hepatocyte NOS; Inducible NO synthase; Peptidyl-cysteine S-nitrosylase NOS2; NOS type II; EC 1.14.13.39; INOS; nitric oxide synthase, inducible; nitric oxide synthase, macrophage; NOS, type II; inducible NOS; OTTHUMP00000163279; NOS2A;
NOS3
nitric oxide synthase 3
NOS3; Nitric oxide synthase 3 (endothelial cell); eNOS; ECNOS; Constitutive NOS; Endothelial NOS; EC-NOS; NOSIII; cNOS; NOS type III; EC 1.14.13.39; nitric oxide synthase, endothelial; OTTHUMP00000213183; OTTHUMP00000212826; OTTHUMP00000213184; OTTHUMP00000213185;
NPL
N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase)
NPL; N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase); C1orf13, chromosome 1 open reading frame 13; N-acetylneuraminate lyase; DHDPS1; dihydrodipicolinate synthetase homolog 1 (E. coli); NPL1; NALase; sialic acid aldolase; sialate-pyruva;
OAS1
2-5-oligoadenylate synthetase 1, 40/46kDa
OAS1; 2-5-oligoadenylate synthetase 1, 40/46kDa; 2,5 oligoadenylate synthetase 1 (40 46 kD) , OIAS; 2-5-oligoadenylate synthase 1; IFI 4; OIASI; E18/E16; p46/p42 OAS; 2-5A synthase 1; 2-5A synthetase 1; (2-5)oligo(A) synthase 1; 2,5-oligo A synthetase 1;
OAT
ornithine aminotransferase
OAT; ornithine aminotransferase; ornithine aminotransferase, mitochondrial; gyrate atrophy; HOGA; ornithine aminotransferase precursor; GACR; OATASE; OKT; Ornithine aminotransferase (gyrate atrophy); Ornithine aminotransferase mitochondrial; Ornithine aminotransferase, mitochondrial precursor; Ornithine delta aminotransferase; Ornithine oxo acid aminotransferase; OTTHUMP00000020690; ornithine delta-aminotransferase; ornithine-delta-aminotransferase; ornithine-oxo-acid aminotransferase; ornithine--oxo-acid aminotransferase;
OSGIN1
oxidative stress induced growth inhibitor 1
OSGIN1; oxidative stress induced growth inhibitor 1; oxidative stress-induced growth inhibitor 1; BDGI; bone marrow stromal cell derived growth inhibitor; OKL38; pregnancy induced growth inhibitor; 1700012B18Rik; huOKL38; OKL 38; OSGIN 1; OTTHUMP00000174992; OTTHUMP00000174993; Ovary kidney and liver protein 38; Pregnancy induced growth inhibitor OKL38; ovary, kidney and liver protein 38; pregnancy-induced growth inhibitor OKL38; bone marrow stromal cell-derived growth inhibitor;
PASK
PAS domain containing serine/threonine kinase
PASK; PAS domain containing serine/threonine kinase; PAS domain-containing serine/threonine-protein kinase; KIAA0135; PASKIN; STK37; per-arnt-sim (PAS) domain kinase; DKFZp434O051; DKFZp686P2031;
PBLD
phenazine biosynthesis-like protein domain containing
PBLD; phenazine biosynthesis-like protein domain containing; phenazine biosynthesis-like domain-containing protein; FLJ14767; MAWBP; MAWD binding protein; MAWDBP; FLJ35507; MAWD-binding protein; OTTHUMP00000019698; OTTHUMP00000082489; PBLD_HUMAN; Phenazine biosynthesis like domain containing protein; Phenazine biosynthesis like protein domain containing; Unknown protein 32 from 2D page of liver tissue; Unknown protein 32 from 2D-page of liver tissue;
PCMT1
protein-L-isoaspartate (D-aspartate) O-methyltransferase
PCMT1; protein-L-isoaspartate (D-aspartate) O-methyltransferase; protein-L-isoaspartate(D-aspartate) O-methyltransferase; L isoaspartyl protein carboxyl methyltransferase; L isoaspartyl/D aspartyl methyltransferase; PCMT 1; PIMT; Protein beta aspartate methyltransferase; Protein L isoaspartate (D aspartate) O methyltransferase; Protein L isoaspartyl/D aspartyl methyltransferase; OTTHUMP00000017397; OTTHUMP00000017398; OTTHUMP00000017400; protein-beta-aspartate methyltransferase; L-isoaspartyl protein carboxyl methyltransferase; protein L-isoaspartyl/D-aspartyl methyltransferase;
PDCD1
Pdcd1 programmed cell death 1
PDCD1; programmed cell death 1; programmed cell death protein 1; mPD-1; protein PD-1; PD-1; Pdc1; Ly101;
PDCD1LG2
PDCD1LG2 programmed cell death 1 ligand 2
PDCD1LG2; programmed cell death 1 ligand 2; B7 dendritic cell molecule; B7 DC; bA574F11.2; Btdc; CD273; PD L2; PDL2; B7-DC; PD-1 ligand 2; PD-1-ligand 2; PDCD1 ligand 2; butyrophilin B7-DC; programmed death ligand 2; B7DC; PD-L2; PDCD1L2; MGC142238; MGC142240;
PDCD2
programmed cell death 2
PDCD2;programmed cell death 2;programmed cell death protein 2;RP8;ZMYND7;zinc finger protein Rp-8;zinc finger MYND domain-containing protein 7;MGC12347;
PDCD4
programmed cell death 4 (neoplastic transformation inhibitor)
PDCD4; programmed cell death 4 (neoplastic transformation inhibitor); H731; programmed cell death protein 4; protein 197/15a; nuclear antigen H731; neoplastic transformation inhibitor protein;
PDCD5
programmed cell death 5
PDCD5; programmed cell death 5; programmed cell death protein 5; MGC9294; TF1 cell apoptosis related gene 19; TFAR19; TFAR19 novel apoptosis related; TFAR19 novel apoptosis-related; TF1 cell apoptosis-related gene 19; TF-1 cell apoptosis-related protein 1;
PDCD6
programmed cell death 6
PDCD6; programmed cell death 6; programmed cell death protein 6; ALG 2; apoptosis linked gene 2; PEF1B; apoptosis-linked gene-2; apoptosis-linked gene 2 protein; probable calcium-binding protein ALG-2; ALG-2; MGC9123; FLJ46208; MGC111017; MGC119050;
PDCD6IP
programmed cell death 6 interacting protein
PDCD6IP; programmed cell death 6 interacting protein; AIP1; ALIX; HP95; DRIP4; programmed cell death 6-interacting protein; PDCD6-interacting protein; ALG-2 interacting protein 1; ALG-2-interacting protein X; dopamine receptor interacting protein 4; apoptosis-linked gene 2-interacting protein X;
Pdgfa
platelet-derived growth factor alpha polypeptide
PDGFA; platelet-derived growth factor alpha polypeptide; PDGF1; PDGF-A; PDGF A-chain; platelet-derived growth factor alpha chain; Platelet-derived growth factor subunit A; PDGF subunit A; Platelet-derived growth factor A chain; PDGF-1; OTTHUMP00000199955; OTTHUMP00000199956; platelet-derived growth factor alpha isoform 2 preproprotein;
PDGFB
platelet-derived growth factor beta polypeptide
PDGFB; platelet-derived growth factor beta polypeptide; SIS; SSV; IBGC5; PDGF2; c-sis; PDGF-2; platelet-derived growth factor subunit B; becaplermin; PDGF, B chain; PDGF subunit B; proto-oncogene c-Sis; platelet-derived growth factor 2; platelet-derived growth factor B chain; platelet-derived growth factor, beta polypeptide (oncogene SIS); platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog);
PDGFC
platelet derived growth factor C
PDGFC; platelet derived growth factor C; platelet-derived growth factor C; fallotein; SCDGF; PDGF-C; VEGF-E; spinal cord-derived growth factor; secretory growth factor-like protein; AI647969; 1110064L01Rik;
PDGFD
platelet derived growth factor D
PDGFD; platelet derived growth factor D; platelet-derived growth factor D; IEGF; MSTP036; SCDGF B; spinal cord derived growth factor B; PDGF-D; iris-expressed growth factor; spinal cord-derived growth factor B; spinal cord-derived growth factor-B; SCDGFB; SCDGF-B;
PDGFRA
platelet-derived growth factor receptor, alpha polypeptide
PDGFRA; platelet-derived growth factor receptor, alpha polypeptide; platelet-derived growth factor receptor alpha; CD140a; PDGFR2; PDGFR-alpha; PDGF-R-alpha; CD140a antigen; PDGFRA/BCR fusion; CD140 antigen-like family member A; platelet-derived growth factor receptor 2; alpha-type platelet-derived growth factor receptor; rearranged-in-hypereosinophilia-platelet derived growth factor receptor alpha fusion protein; CD140A; PDGFR-2; RHEPDGFRA; MGC74795;
PDGFRB
platelet derived growth factor receptor, beta polypeptide
PDGFRB; platelet derived growth factor receptor, beta polypeptide; beta-type platelet-derived growth factor receptor; CD140B; Beta platelet derived growth factor receptor; Beta-type platelet-derived growth factor receptor; CD 140B; CD140 antigen-like family member B; CD140b antigen; JTK12; OTTHUMP00000160528; PDGF R beta; PDGF-R-beta; PDGFR; PDGFR1; PDGFRB; PGFRB_HUMAN; Platelet derived growth factor receptor beta; Platelet derived growth factor receptor beta polypeptide; PDGF-R-beta; PDGF beta chain; OTTMUSP00000015854; OTTMUSP00000015855; CD140 antigen-like family member B; platelet-derived growth factor receptor beta variant 1; Pdgfr; CD140b; AI528809;
PEBP1
phosphatidylethanolamine binding protein 1
PEBP1; phosphatidylethanolamine binding protein 1; PBP, prostatic binding protein; phosphatidylethanolamine-binding protein 1; HCNP; hippocampal cholinergic neurostimulating peptide; PEBP; Raf kinase inhibitory protein; RKIP; neuropolypeptide h3; prostat;
PECAM1
platelet/endothelial cell adhesion molecule 1
PECAM1; platelet/endothelial cell adhesion molecule 1; CD31; PECA1; GPIIA; PECAM-1; endoCAM; CD31/EndoCAM; platelet endothelial cell adhesion molecule; CD31 antigen; Pecam;
Pgf
placental growth factor
PGF; placental growth factor; PGFL; PLGF; PlGF-2; D12S1900; SHGC-10760; placenta growth factor; placental growth factor, vascular endothelial growth factor-related protein;
Pigf
phosphatidylinositol glycan anchor biosynthesis, class F
PIGF; phosphatidylinositol glycan anchor biosynthesis, class F; phosphatidylinositol glycan, class F; phosphatidylinositol-glycan biosynthesis class F protein; PIG-F; GPI11 homolog; MGC32646; MGC33136;
PNMT
phenylethanolamine N-methyltransferase
PNMT; phenylethanolamine N-methyltransferase; PENT; PNMTase; phenylethanolamine N-methylase; noradrenaline N-methyltransferase;
PPCDC
phosphopantothenoylcysteine decarboxylase
PPCDC; phosphopantothenoylcysteine decarboxylase; FLJ14585; MDS018; CoaC; MGC102190; 1810057I13Rik; 8430432M10Rik; COAC_HUMAN; PPC-DC; RGD1306267;
PPCS
phosphopantothenoylcysteine synthetase
PPCS; phosphopantothenoylcysteine synthetase; phosphopantothenate--cysteine ligase; FLJ11838; PPC synthetase; RP11-163G10.1; MGC117357; MGC138220;
PRDM2
PR domain containing 2, with ZNF domain
PRDM2; PR domain containing 2, with ZNF domain; RIZ; KMT8; RIZ1; RIZ2; MTB-ZF; HUMHOXY1; PR domain zinc finger protein 2; MTE-binding protein; zinc finger protein RIZ; GATA-3 binding protein G3B; GATA-3-binding protein G3B; lysine N-methyltransferase 8; PR domain-containing protein 2; zinc-finger DNA-binding protein; retinoblastoma protein-binding zinc finger protein; retinoblastoma protein-interacting zinc finger protein;
PRKCQ
protein kinase C, theta
PRKCQ; protein kinase C, theta; protein kinase C theta type; PRKCT; nPKC-theta; MGC126514; MGC141919;
PRMT1
protein arginine methyltransferase 1
PRMT1; protein arginine methyltransferase 1; ANM1; HCP1; IR1B4; HRMT1L2; protein arginine N-methyltransferase 1; interferon receptor 1-bound protein 4; histone-arginine N-methyltransferase PRMT1; HMT1 (hnRNP methyltransferase, S. cerevisiae)-like 2; heterogeneous nuclear ribonucleoprotein methyltransferase 1-like 2;
PRMT3
protein arginine methyltransferase 3
PRMT3; protein arginine methyltransferase 3; HMT1 hnRNP methyltransferase like 3 (S. cerevisiae) , HRMT1L3; protein arginine N-methyltransferase 3; HMT1 hnRNP methyltransferase-like 3; heterogeneous nuclear ribonucleoprotein methyltransferase-like 3; heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3; HRMT1L3;
PRMT5
protein arginine methyltransferase 5
PRMT5; protein arginine methyltransferase 5; JBP1; SKB1; IBP72; SKB1Hs; HRMT1L5; protein arginine N-methyltransferase 5; SKB1 homolog; jak-binding protein 1; 72 kDa ICln-binding protein; HMT1 hnRNP methyltransferase-like 5; shk1 kinase-binding protein 1 homolog; histone-arginine N-methyltransferase PRMT5;
PRMT6
protein arginine methyltransferase 6
PRMT6; protein arginine methyltransferase 6; HMT1 hnRNP methyltransferase like 6 (S. cerevisiae) , HRMT1L6; protein arginine N-methyltransferase 6; FLJ10559; HMT1 hnRNP methyltransferase-like 6; histone-arginine N-methyltransferase PRMT6; heterogeneous nu;
PRPS1
phosphoribosyl pyrophosphate synthetase 1
PRPS1; phosphoribosyl pyrophosphate synthetase 1; deafness, X linked 2, perceptive, congenital , DFN2; ribose-phosphate pyrophosphokinase 1; CMTX5; DFNX1; PRS I; ribose phosphate diphosphokinase 1; deafness 2, perceptive, congenital; ribose-phosphate diph;
PTGDS
prostaglandin D2 synthase 21kDa (brain)
PTGDS; prostaglandin D2 synthase 21kDa (brain); prostaglandin D2 synthase (21kD, brain); prostaglandin-H2 D-isomerase; L PGDS; lipocalin type prostaglandin D synthase; PGDS; cerebrin-28; PGD2 synthase; beta-trace protein; prostaglandin D synthase; prostaglandin-D2 synthase; glutathione-independent PGD synthase; glutathione-independent PGD synthetase; lipocalin-type prostaglandin D synthase; lipocalin-type prostaglandin-D synthase; PDS; PGD2; LPGDS; PGDS2; L-PGDS;
PTGES
prostaglandin E synthase
PTGES; prostaglandin E synthase; MGST1L1; glutathione S transferase 1 like 1; MGST IV; MGST1 L1; MGST1 like 1; microsomal glutathione S transferase 1 like 1; microsomal prostaglandin E synthase 1; p53 induced gene 12; PIG12; TP53I12; tumor protein p53 ind;
PTGES2
prostaglandin E synthase 2
PTGES2; prostaglandin E synthase 2; C9orf15, chromosome 9 open reading frame 15; FLJ14038; C9orf15; Gamma interferon activated transcriptional element binding factor 1; GATE binding factor 1; GBF1; Membrane associated prostaglandin E synthase 2; MGC11289; Microsomal prostaglandin E synthase 2; mPGES 2; mPGES-2; PGES2; PGES2_HUMAN; Prostaglandin E synthase 2 truncated form; PTGES 2; OTTHUMP00000022231; OTTHUMP00000022232; OTTHUMP00000215363; GATE-binding factor 1; microsomal prostaglandin E synthase-2; membrane-associated prostaglandin E synthase 2; gamma-interferon-activated;
PTGES3
prostaglandin E synthase 3 (cytosolic)
PTGES3; prostaglandin E synthase 3 (cytosolic); prostaglandin E synthase 3; cPGES; p23; TEBP; Hsp90 co-chaperone; telomerase-binding protein p23; progesterone receptor complex p23; cytosolic prostaglandin E synthase; cytosolic prostaglandin E2 synthase; u;
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
Ptgs2; prostaglandin-endoperoxide synthase 2; COX2; Cox-2; PHS-2; Pghs2; TIS10; PGHS-2; PES-2; PHS II; gripghs; PGH synthase 2; cyclooxygenase 2; cyclooxygenase-2; prostaglandin H2 synthase 2; glucocorticoid-regulated inflammatory cyclooxygenase; macrophage activation-associated marker protein P71/73; prostaglandin G/H synthase, Tis10;
PTH
parathyroid hormone
hPTH; Parathormone; Parathyrin; Parathyroid hormone; Parathyroid hormone/parathyroid hormone-related peptide receptor; PTH; PTH/PTHr receptor; PTH/PTHrP type I receptor; PTH1 receptor; PTH1R; PTHR; PTHR1; PTHY-HUMAN; PTH C-terminal (a.a. 53-84);
PTHLH
parathyroid hormone-like hormone
PTHLH; HHM; PLP; BDE2; PTHR; PTHRP; MGC14611; parathyroid hormone-like hormone; Parathyroid hormone-related protein;
PTMA
prothymosin, alpha
PTMA; MGC104802; TMSA; prothymosin, alpha; OTTHUMP00000204428; OTTHUMP00000204433; prothymosin, alpha (gene sequence 28); gene sequence 28; prothymosin alpha; OTTHUMP00000204425; prothymosin alpha protein; OTTHUMP00000204427;
PTS
6-pyruvoyltetrahydropterin synthase
PTS; 6-pyruvoyltetrahydropterin synthase; 6-pyruvoyl tetrahydrobiopterin synthase; PTPS; 6 pyruvoyl tetrahydrobiopterin synthase; 6 pyruvoyl tetrahydropterin synthase; 6 pyruvoyltetrahydropterin synthase; EC 4.2.3.12; FLJ97081; OTTHUMP00000235385; PTP synthase; PTPS_HUMAN;
RELA
v-rel reticuloendotheliosis viral oncogene homolog A
RELA; v-rel reticuloendotheliosis viral oncogene homolog A (avian); NFKB3; p65; Nuclear factor NF-kappa-B p65 subunit; MGC131774; transcription factor p65; OTTHUMP00000233473; OTHUMP00000233474; OTTHUMP00000233475; OTTHUMP00000233476; OTTHUMP00000233900; nuclear factor of kappa light polypeptide gene enhancer in B-cells 3; v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65; v-rel avian reticuloendotheliosis; viral oncogene homolog A (nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 (p65));
RELB
RELB v-rel reticuloendotheliosis viral oncogene homolog B
RELB; v-rel reticuloendotheliosis viral oncogene homolog B; v rel avian reticuloendotheliosis viral oncogene homolog B (nuclear factor of kappa light polypeptide gene enhancer in B cells 3); transcription factor RelB; REL B; v-rel reticuloendotheliosis viral oncogene homolog B, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3; v-rel avian reticuloendotheliosis viral oncogene homolog B (nuclear factor of kappa light polypeptide gene enhancer in B-cells 3); IREL; I-REL; REL-B;
RERG
RAS-like, estrogen-regulated, growth inhibitor
RERG; RAS-like, estrogen-regulated, growth inhibitor; ras-related and estrogen-regulated growth inhibitor; MGC15754; RAS like estrogen regulated growth inhibitor; Ras related and estrogen regulated growth inhibitor; RERG_HUMAN; Weakly similar to N ras protein [H.sapiens];
RIPK2
receptor-interacting serine-threonine kinase 2
RIPK2; receptor-interacting serine-threonine kinase 2; CCK; RICK; RIP2; CARD3; GIG30; CARDIAK; receptor-interacting serine/threonine-protein kinase 2; RIP-2; CARD-carrying kinase; growth-inhibiting gene 30; tyrosine-protein kinase RIPK2; receptor-interacting protein 2; CARD-containing IL-1 beta ICE-kinase; CARD-containing interleukin-1 beta-converting enzyme (ICE)-associated kinase; receptor-interacting protein (RIP)-like interacting caspase-like apoptosis regulatory protein (CLARP) kinase;
SEMA5A
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
SEMA5A; sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A; semF; SEMAF; semaphorin-5A; sema F; semaphorin F; semaphorin-F; semaphorin 5A;
SEPSECS
Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase
SEPSECS;Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase;
SERPINC1
serpin peptidase inhibitor, clade C (antithrombin), member 1
SERPINC1; serpin peptidase inhibitor, clade C (antithrombin), member 1; AT3; ATIII; MGC22579; antithrombin (aa 375-432); antithrombin III; coding sequence signal peptide antithrombin part 1; signal peptide antithrombin part 1; serine (or cysteine) proteinase inhibitor, clade C (antithrombin), member 1; Antithrombin-III; Serpin C1; PRO0309; OTTHUMP00000035393; serine-cysteine proteinase inhibitor clade C member 1;
SERPINF1
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
SERPINF1; serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1; OI6; OI12; PEDF; EPC-1; PIG35; pigment epithelium-derived factor; serpin F1; cell proliferation-inducing gene 35 protein; serine (or cysteine) proteinase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1;
Serpinf2
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor)
Serpinf2; serine (or cysteine) peptidase inhibitor, clade F, member 2; Pli; AI747498; Serpimf2; alpha-2-antiplasmin; serpin F2; alpha-2-AP; alpha-2-PI; OTTMUSP00000006499; OTTMUSP00000006500; alpha 2 antiplasmin; alpha-2-plasmin inhibitor; plasmin inhibitor alpha 2; pigment epithelium derived factor; serine (or cysteine) proteinase inhibitor, clade F, member 2;
SETD7
SET domain containing (lysine methyltransferase) 7
SETD7; SET domain containing (lysine methyltransferase) 7; histone-lysine N-methyltransferase SETD7; KIAA1717; KMT7; SET7; SET7/9; Set9; H3-K4-HMTase SETD7; lysine N-methyltransferase 7; SET domain-containing protein 7; histone H3-K4 methyltransferase SET;
SETD8
SET domain containing (lysine methyltransferase) 8
SETD8; SET domain containing (lysine methyltransferase) 8; N-lysine methyltransferase SETD8; KMT5A; PR Set7; SET07; SET8; PR/SET07; H4-K20-HMTase SETD8; lysine N-methyltransferase 5A; SET domain-containing protein 8; PR/SET domain containing protein 8; PR;
SLC25A15
solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15
SLC25A15; solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15; HHH, ORNT1; mitochondrial ornithine transporter 1; D13S327; ORC1; ornithine transporter 1; ORNT1; Solute carrier family 25 member 15; HHH; Ornithine transporter, mitochondrial; ORNT1_HUMAN;
SPTA1
spectrin, alpha, erythrocytic 1 (elliptocytosis 2)
SPTA1; spectrin, alpha, erythrocytic 1 (elliptocytosis 2); spectrin alpha chain, erythrocyte; EL2; alpha-I spectrin; erythroid alpha-spectrin; HPP; HS3; SPH3; SPTA;
SPTAN1
spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)
SPTAN1; spectrin, alpha, non-erythrocytic 1 (alpha-fodrin); spectrin alpha chain, brain; alpha-II spectrin; fodrin alpha chain; spectrin, non-erythroid alpha chain; NEAS; EIEE5; SPTA2; FLJ17738; FLJ44613;
SRM
spermidine synthase
SRM; spermidine synthase; SRML1; SPS1; OTTHUMP00000002170; PAPT; Putrescine aminopropyltransferase; SPDSY; SPEE_HUMAN; Spermidine synthase 1; spermidine synthase-1;
STK10
serine/threonine kinase 10
STK10; serine/threonine kinase 10; serine/threonine-protein kinase 10; LOK; PRO2729; lymphocyte-oriented kinase;
STK16
serine/threonine kinase 16
STK16; serine/threonine kinase 16; serine/threonine-protein kinase 16; MPSK; PKL12; hPSK; TSF-1; protein kinase PKL12; TGF-beta-stimulated factor 1; tyrosine-protein kinase STK16; protein kinase expressed in day 12 fetal liver; myristoylated and palmitoyl;
STK24
serine/threonine kinase 24
STK24; serine/threonine kinase 24; serine/threonine kinase 24 (Ste20, yeast homolog); serine/threonine-protein kinase 24; MST 3; MST3; MST3B; STE20; STE20 like kinase 3; sterile 20 like kinase 3; STK3; STE20-like kinase 3; STE20-like kinase MST3; sterile;
STK3
serine/threonine kinase 3
STK3; serine/threonine kinase 3; serine/threonine kinase 3 (Ste20, yeast homolog); serine/threonine-protein kinase 3; KRS1; MST2; MST-2; STE20-like kinase MST2; mammalian STE20-like protein kinase 2; serine/threonine-protein kinase Krs-1; serine/threonine;
STK33
serine/threonine kinase 33
STK33; serine/threonine kinase 33; serine/threonine-protein kinase 33;
STK4
serine/threonine kinase 4
STK4; serine/threonine kinase 4; KRS2; MST1; YSK3; TIIAC; serine/threonine-protein kinase 4; MST-1; STE20-like kinase MST1; mammalian sterile 20-like 1; kinase responsive to stress 2; mammalian STE20-like protein kinase 1; serine/threonine-protein kinase Krs-2; dJ211D12.2 (serine/threonine kinase 4 (MST1, KRS2));
STMN1
STMN1 stathmin 1
STMN1; stathmin 1; C1orf215, chromosome 1 open reading frame 215 , LAP18, stathmin 1/oncoprotein 18; stathmin; FLJ32206; Lag; oncoprotein 18; OP18; PP17; PP19; PR22; SMN; prosolin; metablastin; phosphoprotein 19; phosphoprotein p19; stathmin 1/oncoprotein 18; transmembrane protein C1orf215; leukemia-associated phosphoprotein p18; LAP18; C1orf215; MGC138869; MGC138870;
STMN2
stathmin-like 2
STMN2; stathmin-like 2; SCGN10; stathmin-2; SCG10; Neuronal growth associated protein; Protein SCG10; SCG 10; SCG10 protein; SCGN 10; SGC 10; SGC10; Stathmin 2; Stathmin like 2; STMN 2; STMN2_HUMAN; Superior cervical ganglia neural specific 10; Superior cervical ganglion 10 protein; Superior cervical ganglion-10 protein; Superiorcervical ganglia neural specific 10; OTTHUMP00000226983; OTTHUMP00000226984; OTTHUMP00000227682; neuron-specific growth-associated protein; superior cervical ganglia, neural specific 10; neuronal growth-associated protein (silencer element);
STMN3
stathmin-like 3
STMN3; stathmin-like 3; stathmin-3; SCLIP; AI604839; R75323; RP23-83A14.1; SCG10-like protein; Scgn10 like protein; Stathmin like 3; OTTHUMP00000031570; SCG10-like-protein;
TARS
threonyl-tRNA synthetase
TARS; threonyl-tRNA synthetase; threonine--tRNA ligase, cytoplasmic; threonine tRNA ligase 1; cytoplasmic; threonine tRNA ligase 1, cytoplasmic; threonyl-tRNA synthetase, cytoplasmic; ThrRS; MGC9344;
TDGF1
teratocarcinoma-derived growth factor 1
TDGF1; teratocarcinoma-derived growth factor 1; CR; CRGF; CRIPTO; cripto-1 growth factor; epidermal growth factor-like cripto protein CR1;
Tek
TEK tyrosine kinase, endothelial
TEK; TEK tyrosine kinase, endothelial; TIE2; VMCM; TIE-2; VMCM1; CD202B; venous malformations, multiple cutaneous and mucosal; Angiopoietin-1 receptor; EC=2.7.10.1; Tunica interna endothelial cell kinase; Tyrosine-protein kinase receptor TEK; Tyrosine-protein kinase receptor TIE-2; hTIE2; p140 TEK; OTTHUMP00000021167; OTTHUMP00000227067; OTTHUMP00000227068; OTTHUMP00000227069; soluble TIE2 variant 1; soluble TIE2 variant 2;
Tfpi
Tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
TFPI; EPI; TFI; LACI; TFPI1; tissue factor pathway inhibitor; anti-convertin; extrinsic pathway inhibitor;
TFPI2
tissue factor pathway inhibitor 2
TFPI2; tissue factor pathway inhibitor 2; PP5; REF1; TFPI 2; placental protein 5; TFPI-2; FLJ21164;
Tgfb1
Transforming Growth Factor, Beta 1
Tgfb1; transforming growth factor, beta 1; CED; LAP; DPD1; TGFB; TGFbeta; TGF-beta 1 protein; latency-associated peptide; Camurati-Engelmann disease; Transforming growth factor beta-1; TGF-beta-1; Camui Engelmann disease; Diaphyseal dysplasia 1 progressive; TGF beta 1; TGF beta; TGF beta 1 protein; TGF-beta-5; TGF-beta1; Tgfb-1; TGFB1_HUMAN; TGFbeta1; Transforming Growth Factor b1; Transforming Growth Factor beta 1; Transforming growth factor beta 1a;
TGFB2
transforming growth factor, beta 2
TGFB2; transforming growth factor, beta 2; transforming growth factor beta-2; G-TSF; cetermin; polyergin; BSC-1 cell growth inhibitor; glioblastoma-derived T-cell suppressor factor; TGF-beta2; MGC116892; LDS4;
TGFB3
transforming growth factor, beta 3
TGFB3; transforming growth factor, beta 3; ARVD; FLJ16571; TGF-beta3; transforming growth factor beta-3; TGF-beta-3; MGC105479; MGC118722; TGF beta 3; TGF beta3; TGFB 3; TGFB3_HUMAN; transforming growth factor beta 3; OTTHUMP00000246179; OTTHUMP00000246180;
TGFBI
TGFBI transforming growth factor, beta-induced, 68kDa
TGFBI; transforming growth factor, beta-induced, 68kDa; CSD1, CSD2, CSD3, LCD1, transforming growth factor, beta induced, 68kD; transforming growth factor-beta-induced protein ig-h3; BIGH3; CDB1; CDGG1; RGD-CAP; beta ig-h3; kerato-epithelin; RGD-containing collagen-associated protein; CSD; CDG2; CSD1; CSD2; CSD3; EBMD; LCD1;
TGFBR1
transforming growth factor, beta receptor 1
TGFBR1; transforming growth factor, beta receptor 1; transforming growth factor, beta receptor I (activin A receptor type II like kinase, 53kD); TGF-beta receptor type-1; activin A receptor type II like kinase; 53kDa; ACVRLK4; ALK 5; tbetaR-I; TGF-beta re;
TGFBR2
transforming growth factor, beta receptor II (70/80kDa)
TGFBR2; transforming growth factor, beta receptor II (70/80kDa); AAT3; FAA3; LDS2; MFS2; RIIC; LDS1B; LDS2B; TAAD2; TGFR-2; TGFbeta-RII; TGF-beta receptor type-2; tbetaR-II; TGF-beta type II receptor; TGF-beta receptor type IIB; transforming growth factor beta receptor type IIC; transforming growth factor, beta receptor II beta; transforming growth factor, beta receptor II alpha; transforming growth factor, beta receptor II delta; transforming growth factor, beta receptor II gamma; transforming growth factor, beta receptor II epsilon;
TGFBR3
transforming growth factor, beta receptor III
TGFBR3; transforming growth factor, beta receptor III; transforming growth factor, beta receptor III (betaglycan, 300kDa); transforming growth factor beta receptor type 3; betaglycan; betaglycan proteoglycan; BGCAN; TGFR-3; TGF-beta receptor type 3; TGF-b;
THBD
thrombomodulin
THBD; thrombomodulin; CD141; fetomodulin; CD141 antigen; TM; THRM; AHUS6; BDCA3; THPH12;
THBS1
thrombospondin 1
THBS1; thrombospondin 1; TSP; THBS; TSP1; TSP-1; THBS-1; thrombospondin-1; thrombospondin-1p180;
THEM2
thioesterase superfamily member 2
HT012; THEM2; ACOT13; MGC4961; PNAS-27; 15 Kd protein; OTTHUMP00000016090; OTTHUMP00000039398; hypothalamus protein HT012;
THOC5
THO complex 5
THOC5; THO complex 5; C22orf19, chromosome 22 open reading frame 19; THO complex subunit 5 homolog; Fmip; fSAP79; functional spliceosome associated protein 79; KIAA0983; PK1.3; C22orf19; Chromosome 22 open reading frame 19; Fms interacting protein; Functional spliceosome-associated protein 79; LOC400922; NF2/meningioma region protein pK1.3; Placental protein 39.2; PP39.2; hTREX90; OTTHUMP00000199690; OTTHUMP00000199692; Fms-interacting protein;
THPO
thrombopoietin
THPO; thrombopoietin; ML; TPO; MGDF; MKCSF; MPLLG; THCYT1; MPL ligand; c-mpl ligand; prepro-thrombopoietin; megakaryocyte stimulating factor; megakaryocyte colony-stimulating factor; megakaryocyte growth and development factor; myeloproliferative leukemia virus oncogene ligand;
THRA
thyroid hormone receptor, alpha
THRA; thyroid hormone receptor, alpha; ERBA1, THRA1, THRA2, thyroid hormone receptor, alpha (avian erythroblastic leukemia viral (v erb a) oncogene homolog) , thyroid hormone receptor, alpha (erythroblastic leukemia viral (v erb a) oncogene homolog, avian); thyroid hormone receptor alpha; AR7; EAR 7.1/EAR 7.2; ERBA; NR1A1; THRA3; c erbA 1; C erbA alpha; EAR7; ERBA1; Thyroid hormone receptor alpha 2; TR alpha 2; EAR-7; c-erbA-alpha; ERBA-related 7; OTTHUMP00000164469; OTTHUMP00000164470; V-erbA-related protein 7; triiodothyronine receptor; nuclear receptor subfamily 1 group A member 1; thyroid normone nuclear receptor alpha variant 1; thyroi; THRA1; THRA2; ERB-T-1; c-ERBA-1;
THRB
THRB thyroid hormone receptor, beta
THRB; thyroid hormone receptor, beta; ERBA2, pituitary resistance to thyroid hormone , PRTH, thyroid hormone receptor, beta (avian erythroblastic leukemia viral (v erb a) oncogene homolog 2) , thyroid hormone receptor, beta (erythroblastic leukemia viral (v erb a) oncogene homolog 2, avian); thyroid hormone receptor beta; avian erythroblastic leukemia viral (v erb a) oncogene homolog 2; ERBA BETA; generalized resistance to thyroid hormone; GRTH; NR1A2; oncogene ERBA2; THR1; THRB1; THRB2; thyroid hormone receptor beta 1; nuclear receptor subfamily 1 group A member 2; thyroid hormone nuclear receptor beta variant 1; thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian); PRTH; ERBA2; C-ERBA-2; C-ERBA-BETA; MGC126109; MGC126110;
F2
coagulation factor II (thrombin)
F2; coagulation factor II (thrombin); prothrombin; serine protease; prothrombin B-chain; PT; THPH1;
Thsd1
thrombospondin, type I, domain containing 1
THSD1; thrombospondin, type I, domain containing 1; thrombospondin, type I, domain 1; thrombospondin type-1 domain-containing protein 1; TMTSP; 4833423O18Rik; transmembrane molecule with thrombospondin module; UNQ3010; MGC74971;
THTPA
thiamine triphosphatase
THTPA; thiamine triphosphatase; thiamine-triphosphatase; THTPASE; THTP; MGC2652; FLJ33428; FLJ36892;
Thy1
thymus cell antigen 1, theta
THY1; thymus cell antigen 1, theta; thy-1 membrane glycoprotein; Thy 1.2; thy-1 antigen; T25; CD90; Thy-1; Thy1.1; Thy1.2; Thy-1.2;
THYN1
thymocyte nuclear protein 1
THYN1; thymocyte nuclear protein 1; THY28; thymocyte protein thy28; MY105; MDS012; HSPC144; THY28KD; MGC12187;
TIE1
TIE1 tyrosine kinase with immunoglobulin-like and EGF-like domains 1
TIE1; tyrosine kinase with immunoglobulin-like and EGF-like domains 1; TIE, tyrosine kinase with immunoglobulin and epidermal growth factor homology domains 1; tyrosine-protein kinase receptor Tie-1; JTK14; tyrosine kinase with immunoglobulin and epidermal growth factor homology domains 1; TIE;
TIGIT
T cell immunoreceptor with Ig and ITIM domains
TIGIT; T cell immunoreceptor with Ig and ITIM domains; V set and immunoglobulin domain containing 9 , V set and transmembrane domain containing 3 , VSIG9, VSTM3; T-cell immunoreceptor with Ig and ITIM domains; DKFZp667A205; FLJ39873; V-set and transmembrane domain containing 3; V-set and immunoglobulin domain containing 9; Washington University cell adhesion molecule; V-set and transmembrane domain-containing protein 3; V-set and immunoglobulin domain-containing protein 9; VSIG9; VSTM3; WUCAM;
TNFAIP1
tumor necrosis factor, alpha-induced protein 1 (endothelial)
TNFAIP1; tumor necrosis factor, alpha-induced protein 1 (endothelial); EDP1; BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2; B12; B61; MGC2317; BTB/POZ domain-containing protein TNFAIP1; hBACURD2;
TNFRSF10C
tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
TNFRSF10C; CD263; DCR1; DCR1-TNFR; LIT; TRAIL-R3; TRAILR3; TRID; tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain;
TNFRSF10D
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
TNFRSF10D; tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain; tumor necrosis factor receptor superfamily member 10D; CD264; DcR2; TRAILR4; TRUNDD; TRAIL receptor 4; decoy receptor 2; decoy with truncated death domai;
TPMT
thiopurine S-methyltransferase
TPMT; thiopurine S-methyltransferase; S-adenosyl-L-methionine:thiopurine S-methyltransferase;
TPO
thyroid peroxidase
TPO; thyroid peroxidase; MSA; TPX; TDH2A; thyroperoxidase; thyroid microsomal antigen; EC 1.11.1.8; Thyroid peroxidase;
TRDMT1
tRNA aspartic acid methyltransferase 1
TRDMT1; tRNA aspartic acid methyltransferase 1; DNA (cytosine 5 ) methyltransferase 2 , DNMT2; tRNA (cytosine(38)-C(5))-methyltransferase; RNMT1; DNA methyltransferase-2; DNA MTase homolog HsaIIP; tRNA (cytosine-5-)-methyltransferase; DNA (cytosine-5)-met;
TREX2
three prime repair exonuclease 2
TREX2; three prime repair exonuclease 2; 3-5 exonuclease TREX2 long form;
TRIP13
thyroid hormone receptor interactor 13
TRIP13; thyroid hormone receptor interactor 13; pachytene checkpoint protein 2 homolog; 16E1BP; thyroid receptor interacting protein 13; 16E1-BP; Homo sapiens HPV16 E1 protein binding protein mRNA complete cds; HPV16 E1 protein binding protein; HPV16 E1 protein-binding protein; Human papillomavirus type 16 E1 protein binding protein; Human papillomavirus type 16 E1 protein-binding protein; Thyroid receptor-interacting protein 13; TR-interacting protein 13; TRIP-13; TRP13_HUMAN;
Trl
Trithorax-like
TRL; Trithorax-like; CG33261 gene product from transcript CG33261-RI; GAF; GAGA factor; Nc70F; TFGAGA; Transcription factor GAGA; Trithorax like protein; Trithorax-like, isoform I; CG33261-PI; Trl-PI; GAGA transcription factor; anon-fast-evolving-2E12; GAGA-factor; transcription-factor-Adh2; Adh transcription factor 2; neural conserved at 70F; GAGA element; Trithorax-like, isoform B; CG33261-PB; Trl-PB; Trithorax-like, isoform A; CG33261-PA; Trl-PA; Trithorax-like, isoform D; CG33261-PD; Trl-PD; Trithorax-like, isoform F; CG33261-PF; Trl-PF; Trithorax-like, isoform H; CG33261-PH; Trl-PH; Trithorax-like, isoform G; CG33261-PG; Trl-PG; Trithorax-like, isoform C; CG33261-PC; Trl-PC; Trithorax-like, isoform E; CG33261-PE; Trl-PE; Adf-2; Adf-2-519; Adf2; anon-EST:fe2E12; CG33261; CG9343; Dmel\CG33261; E(var)3-trl; E(var)62; gaga; l(3)s2325; TfGAGA/Adf-2; Trl-GAGA;
TrxR
Thioredoxin reductase-1
Thioredoxin Reductase (NADPH); Thioredoxin Reductase; NTR; TrxR; EC 1.8.1.9; GRIM-12; KDRF; MGC9145; TR; TR1; TRXR1; TXNR; Trxr1; oxidoreductase; Gene associated with retinoid-IFN-induced mortality 12 protein; KM-102-derived reductase-like factor; Thioredoxin reductase TR1; thioredoxin reductase 1; thioredoxin reductase GRIM-12; thioredoxin-disulfide reductase; NADP-thioredoxin reductase; NADPH-thioredoxin reductase; thioredoxin reductase (NADPH); NADPH2:oxidized thioredoxin oxidoreductase; thioredoxin:NADP+ oxidoreductase;
TSHB
thyroid stimulating hormone, beta
TSHB; thyroid stimulating hormone, beta; TSH-B; TSH-BETA; thyrotropin subunit beta; thyrotropin beta chain; Thyrotropin subunit beta; Thyroid-stimulating hormone subunit beta; Thyrotropin beta chain; Thyrotropin alfa;
TSLP
thymic stromal lymphopoietin
TSLP; Thymic Stromal Lymphopoietin; Thymic stromal lymphopoietin Precursor;
TSSK2
testis specific serine threonine kinase 2
TSSK2; testis specific serine threonine kinase 2; DGS-G;
TST
thiosulfate sulfurtransferase (rhodanese)
TST; thiosulfate sulfurtransferase (rhodanese); thiosulfate sulfurtransferase; RDS; Rhodanese; THTR_HUMAN;
TTR
transthyretin
TTR; transthyretin; CTS; CTS1; PALB; TBPA; HEL111; HsT2651; ATTR; carpal tunnel syndrome 1; thyroxine-binding prealbumin; epididymis luminal protein 111; prealbumin, amyloidosis type I;
TXN
thioredoxin
TXN; thioredoxin; TRX; ADF; SASP; TXN delta 3; ATL-derived factor; thioredoxin delta 3; surface-associated sulphydryl protein; TRDX; TRX1; MGC61975; DKFZp686B1993;
TXN2
thioredoxin 2
TXN2; thioredoxin 2; thioredoxin, mitochondrial; MT TRX; thioredoxin-2; mitochondrial thioredoxin; MTRX; TRX2; MT-TRX;
TXNDC9
thioredoxin domain containing 9
TXNDC9; thioredoxin domain containing 9; thioredoxin domain-containing protein 9; APACD; ATP binding protein associated with cell differentiation; ES cell related protein; PHLP3; Phosducin like protein 3; Protein 1 4; Thioredoxin domain containing protein 9; TXNDC9 protein; protein 1-4; OTTHUMP00000161221; OTTHUMP00000203480; ATP-binding protein associated with cell differentiation;
TXNL1
thioredoxin-like 1
TXNL1; thioredoxin-like 1; thioredoxin like, 32kDa , TXNL; thioredoxin-like protein 1; thioredoxin like; 32kD; TRP32; Txl; 32 kDa thioredoxin related protein; Thioredoxin like 1; Thioredoxin like 32kD; Thioredoxin like 32kDa; Thioredoxin like protein 1; Thioredoxin related 32 kDa protein; TRP 32; TRxL; TXL 1; TXL1; TXN L1; TXNL 1; TXNL; thioredoxin-related protein 1; 32 kDa thioredoxin-related protein; thioredoxin-related 32 kDa protein; TXL-1;
TXNRD1
thioredoxin reductase 1
TXNRD1; thioredoxin reductase 1; thioredoxin reductase 1, cytoplasmic; GRIM 12; Trxr1; TXNR; oxidoreductase; thioredoxin reductase TR1; thioredoxin reductase GRIM-12; KM-102-derived reductase-like factor; gene associated with retinoic and IFN-induced mort;
TYMP
thymidine phosphorylase
TYMP; thymidine phosphorylase; TP; ECGF; ECGF1; MNGIE; MEDPS1; MTDPS1; PDECGF; hPD-ECGF; tdRPase; gliostatin;
TYMS
thymidylate synthetase
d TMP synthase; EC 2.1.1.45; HsT422; MGC88736; OTTHUMP00000162195; Thymidylate synthase; thymidylate synthetase; TMS; TS; TSase; TYMS; TYMS protein; Tyms thymidylate synthetase;
UCHL1
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
UCHL1; ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase); NDGOA; PARK5; PGP95; PGP9.5; Uch-L1; HEL-117; PGP 9.5; ubiquitin carboxyl-terminal hydrolase isozyme L1; ubiquitin thioesterase L1; epididymis luminal protein 117; neuron cytoplasmic protein 9.5; ubiquitin C-terminal hydrolase;
UCHL3
ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase)
UCHL3; ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase); ubiquitin carboxyl-terminal hydrolase isozyme L3; ubiquitin thiolesterase; ubiquitin thioesterase L3; UCH-L3;
UROS
uroporphyrinogen III synthase
UROS; uroporphyrinogen III synthase; uroporphyrinogen-III synthase; congenital erythropoietic porphyria; HEM4_HUMAN; Hydroxymethylbilane hydrolyase [cyclizing]; Hydroxymethylbilane hydrolyase; UROIIIS; Uroporphyrinogen III cosynthetase; Uroporphyrinogen III synthase (congenital erythropoietic porphyria); Uroporphyrinogen-III cosynthase; OTTHUMP00000020709; OTTHUMP00000020710; OTTHUMP00000020712;
VEGF
vascular endothelial growth factor
MGC70609; Vascular endothelial growth factor; Vascular endo-thelial growth factor A; Vascular Permeability Factor; VEGF-A; VEGFA; VEG-FA_HUMAN; VPF; PIGF; Plgf; AI854365; VEGFD; VEGF-D; FIGF; VRP; Flt4-L; VEGFC; VEGF-C; Vascular endothelial growth factor D; c-Fos-induced growth factor; vascular endothelial growth factor B; vascular endothelial growth factor C; Flt4 ligand; Vascular endothelial growth factor-related protein; VRF; VEGFL; VEGF-B; VEGFB; VEGF-related factor; OTTHUMP00000022960; c-fos induced growth factor (vascular endothelial growth factor D); OT-THUMP00000218843; FLT4 ligand DHM; OT-THUMP00000236927; OTTHUMP00000236928;
Vegfa
vascular endothelial growth factor A
VEGFA; vascular endothelial growth factor A; VPF; VEGF; MVCD1; vascular permeability factor; Vegf120; Vegf164; Vegf188;
VEGFB
vascular endothelial growth factor B
VEGFB; vascular endothelial growth factor B; VEGF-related factor; Vrf; VEGF-B;
VEGFC
vascular endothelial growth factor C
VEGFC; vascular endothelial growth factor C; VRP; Flt4-L; FLT4 ligand DHM; vascular endothelial growth factor-related protein; VEGF-C; AW228853;
VEGFD
c-fos induced growth factor (vascular endothelial growth factor D)
FIGF; c-fos induced growth factor (vascular endothelial growth factor D); VEGFD; VEGF-D; vascular endothelial growth factor D; c-fos-induced growth factor; OTTHUMP00000022960 ;
WARS
tryptophanyl-tRNA synthetase
WARS; tryptophanyl-tRNA synthetase; IFI53; tryptophanyl-tRNA synthetase, cytoplasmic; IFP53; tryptophan tRNA ligase 1; cytoplasmic; Gamma 2; Gamma2; hWRS; IFI 53; IFP 53; Interferon induced protein 53; Interferon-induced protein 53; SYWC_HUMAN; T2-TrpRS; TrpRS; Tryptophan tRNA ligase 1 cytoplasmic; Tryptophan tRNA ligase; Tryptophan--tRNA ligase; Tryptophanyl tRNA synthetase; Tryptophanyl tRNA synthetase cytoplasmic; WARS protein; WRS; OTTHUMP00000246493; OTTHUMP00000246494; OTTHUMP00000246495; OTTHUMP00000246496; OTTHUMP00000246497; OTTHUMP00000246498; tryptophan tRNA ligase 1, cytoplasmic; GAMMA-2;
WIBG
within bgcn homolog
WIBG; within bgcn homolog (Drosophila); partner of Y14 and mago; PYM; protein wibg homolog; MGC13064;
WISP1
WNT1 inducible signaling pathway protein 1
WISP1; WNT1 inducible signaling pathway protein 1; CCN4; WISP1c; WISP1i; WISP1tc; WNT1-inducible-signaling pathway protein 1; CTC-458A3.8; CCN family member 4; WNT1 induced secreted protein 1; Wnt-1 inducible signaling pathway protein 1;
WISP2
WNT1 inducible signaling pathway protein 2
WISP2; WNT1 inducible signaling pathway protein 2; WNT1-inducible-signaling pathway protein 2; CCN5; CT58; CTGF L; CCN family member 5; Connective tissue growth factor like protein; Connective tissue growth factor related protein 58; Connective tissue growth factor-like protein; Connective tissue growth factor-related protein 58; CTGF-L; WISP 2; WISP-2; WISP2_HUMAN; OTTHUMP00000031770; OTTHUMP00000063227; wnt-1 signaling pathway protein 2;
WISP3
WNT1 inducible signaling pathway protein 3
WISP3; WNT1 inducible signaling pathway protein 3; WNT1-inducible-signaling pathway protein 3; CCN6; WISP-3; CCN family member 6; PPD; LIBC; PPAC; MGC125987; MGC125988; MGC125989;
YARS
tyrosyl-tRNA synthetase
YARS; tyrosyl-tRNA synthetase; tyrosyl-tRNA synthetase, cytoplasmic; tyrosine tRNA ligase 1; cytoplasmic; tyrRS; YRS; YTS; CMTDIC; SYYC_HUMAN; Tyrosyl tRNA synthetase; Tyrosyl--tRNA ligase; OTTHUMP00000004027; tyrosine tRNA ligase 1, cytoplasmic;
YWHAQ
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide
YWHAQ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide; 14-3-3 protein theta; 14 3 3; HS1; protein tau; 14-3-3 protein tau; 14-3-3 protein T-cell; 1C5; 14-3-3;
DEFA5
defensin, alpha 5, Paneth cell-specific
DEFA5; defensin, alpha 5, Paneth cell-specific; DEF5; defensin-5; HD 5; defensin 5; defensin, alpha 5, preproprotein; HD-5; MGC129728;
DEFA6
defensin, alpha 6, Paneth cell-specific
DEFA6; defensin, alpha 6, Paneth cell-specific; defensin-6; DEF6; HD 6; alpha 6; DEF6_HUMAN; DEFA 6; Defensin 6; Defensin alpha 6; Defensin alpha 6 Paneth cell specific; Defensin; HD6; OTTHUMP00000115425; HD-6;
ESRP1
epithelial splicing regulatory protein 1
ESRP1; epithelial splicing regulatory protein 1; RNA-binding protein 35A; RNA binding motif protein 35A; RNA-binding motif protein 35A; Rbm35a; BC031468; A630065D16; RP23-322G9.1; 2210008M09Rik; MGC25805; Esrp1; epithelial splicing regulatory protein 1;
ESRP2
epithelial splicing regulatory protein 2
ESRP2; epithelial splicing regulatory protein 2; RBM35B, RNA binding motif protein 35B; FLJ21918; ESRP 2; ESRP2_HUMAN; FLJ22248; RBM35B; RNA binding motif protein 35A; RNA binding motif protein 35B; RNA binding protein 35B; RNA-binding motif protein 35B; RNA-binding protein 35B;
MSLN
mesothelin
MPF; SMRP; CAK1 antigen; megakaryocyte potentiating factor; pre-pro-megakaryocyte-potentiating factor; soluble MPF mesothelin related protein;
ATR
Anthrax Toxin Receptor
ANTXR1; ATR; TEM8; FLJ10601; FLJ11298; FLJ21776; anthrax toxin receptor 1; OTTHUMP00000159975; OTTHUMP00000202140; OTTHUMP00000202171; tumor endothelial marker 8; 2310008J16Rik; 2810405N18Rik; anthrax toxin receptor; tumor endothelial marker 8 precursor;
FAM129A
family with sequence similarity 129, member A
FAM129A; family with sequence similarity 129, member A; C1orf24, chromosome 1 open reading frame 24; protein Niban; cell growth inhibiting protein 39; GIG39; NIBAN; Cell growth inhibiting gene 39 protein; Protein FAM129A; cell growth-inhibiting gene 39 protein; C1orf24;
FAM129B
family with sequence similarity 129, member B
FAM129B; family with sequence similarity 129, member B; C9orf88, chromosome 9 open reading frame 88; niban-like protein 1; bA356B19.6; DKFZP434H0820; FLJ13518; FLJ22151; FLJ22298; MINERVA; melanoma invasion by ERK; OC58; MEG-3; C9orf88;
GAP43
Gap43 growth associated protein 43
GAP43; growth associated protein 43; neuromodulin; growth-associated protein 43; axonal membrane protein GAP-43; growth accentuating protein 43; calmodulin-binding protein P-57; brain abundant, membrane attached signal protein 2; B-50; Basp2; GAP-43;
GRIN1
glutamate receptor, ionotropic, N-methyl D-aspartate 1
GRIN1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; NR1; MRD8; GluN1; NMDA1; NMDAR1; glutamate receptor ionotropic, NMDA 1; NMD-R1; glutamate [NMDA] receptor subunit zeta 1; glutamate [NMDA] receptor subunit zeta-1; N-methyl-D-aspartate receptor subunit NR1; N-methyl-D-aspartate receptor channel, subunit zeta-1;
GRIN2B
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
GRIN2B; glutamate receptor, ionotropic, N-methyl D-aspartate 2B; MRD6; NR2B; hNR3; GluN2B; NMDAR2B; glutamate receptor ionotropic, NMDA 2B; NR3; glutamate receptor subunit epsilon-2; N-methyl-D-aspartate receptor subunit 3; N-methyl D-aspartate receptor subtype 2B; glutamate [NMDA] receptor subunit epsilon-2;
GSK3β
Glycogen Synthase Kinase 3 Beta
GSK3β; glycogen synthase kinase 3 beta; Glycogen synthase kinase-3 beta; GSK-3 beta; EC 2.7.11.26; glycogen synthase kinase -3 beta; GSK3 beta isoform;
MTOR
mechanistic target of rapamycin (serine/threonine kinase)
MTOR; mechanistic target of rapamycin (serine/threonine kinase); FRAP; FRAP1; FRAP2; RAFT1; RAPT1; serine/threonine-protein kinase mTOR; rapamycin target protein 1; mammalian target of rapamycin; rapamycin and FKBP12 target 1; FKBP-rapamycin associated protein; rapamycin associated protein FRAP2; FKBP12-rapamycin complex-associated protein 1; FK506 binding protein 12-rapamycin associated protein 2; FK506-binding protein 12-rapamycin complex-associated protein 1;
TH
tyrosine hydroxylase
TH; tyrosine hydroxylase; TYH; DYT14; DYT5b; tyrosine 3-monooxygenase; dystonia 14; tyrosine 3-hydroxylase;
STRAP
serine/threonine kinase receptor associated protein
STRAP; serine/threonine kinase receptor associated protein; serine-threonine kinase receptor-associated protein; MAWD; pt wd; Unr interacting protein; UNRIP; unr-interacting protein; WD-40 repeat protein PT-WD; MAP activator with WD repeats; PT-WD;
KARS
lysyl-tRNA synthetase
KARS; lysyl-tRNA synthetase; lysine--tRNA ligase; KARS2; lysine tRNA ligase; lysRS; KRS; CMTRIB; KIAA0070;
ATP5D
ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit
ATP5D; ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit; ATP synthase subunit delta, mitochondrial; F-ATPase delta subunit; mitochondrial ATP synthase, delta subunit; mitochondrial ATP synthase complex delta-subunit precusor;
DTYMK
deoxythymidylate kinase (thymidylate kinase)
DTYMK; deoxythymidylate kinase (thymidylate kinase); thymidylate kinase; CDC8; dTMP kinase; thymidylate (dTMP) kinase; TMPK; TYMK; PP3731; FLJ44192; MGC198617;
MPG
N-methylpurine-DNA glycosylase
MPG; N-methylpurine-DNA glycosylase; DNA-3-methyladenine glycosylase; alkyladenine DNA glycosylase; MDG; 3-alkyladenine DNA glycosylase; 3-methyladenine DNA glycosidase; proliferation-inducing protein 11; proliferation-inducing protein 16; N-methylpurine-;
PPME1
protein phosphatase methylesterase 1
PPME1; protein phosphatase methylesterase 1; PME 1; PME-1; PME1; PPME1_HUMAN; protein phosphatase methylesterase-1;
GPS2
G protein pathway suppressor 2
GPS2; G protein pathway suppressor 2; GPS-2; AMF-1; MGC104294; MGC119287; MGC119288; MGC119289;
PRPS1L1
phosphoribosyl pyrophosphate synthetase 1-like 1
PRPS1L1; phosphoribosyl pyrophosphate synthetase 1-like 1; PRPSL; ribose-phosphate pyrophosphokinase 3; PRPS3; Phosphoribosyl pyrophosphate synthetase 1 like 1; Phosphoribosyl pyrophosphate synthetase III; Phosphoribosylpyrophosphate synthetase 1-like 1; Phosphoribosylpyrophosphate synthetase 3; PRPS1; PRPS1 like 1; PRS III; PRSIII; Ribose phosphate pyrophosphokinase 3; Ribose phosphate pyrophosphokinase III; Ribose-phosphate pyrophosphokinase; PRPS1-like 1; OTTHUMP00000202305; ribose-phosphate pyrophosphokinase III; phosphoribosyl pyrophosphate synthase III; phosphoribosyl pyrophosphate synthase 1-like 1; phosphoribosylpyrophosphate synthetase subunit III; ribose-; PRS-III;
FAM189A2
family with sequence similarity 189, member A2
FAM189A2; family with sequence similarity 189, member A2; C9orf61, chromosome 9 open reading frame 61; protein FAM189A2; X123; Chromosome 9 open reading frame 61; Friedreich ataxia region gene X123; MGC142243; MGC142245; OTTHUMP00000063356; Protein X123; RP11 548B3.1; Uncharacterized protein C9orf61; OTTHUMP00000021434; C9orf61; RP11-548B3.1;
IGFPB2
Insulin-Like Growth Factor Binding Protein 2, 36kDa
BP2; IBP2; IBP-2; IGF-binding protein 2; IGFBP2; IGFBP-2; IGF-BP53; insulin-like growth factor binding protein 2 (36kD); insulin-like growth factor binding protein 2, 36kDa; insulin-like growth factor-binding protein 2; OTTHUMP00000207751; OTTHUMP00000207753.;
IGFPB6
Insulin-Like Growth Factor Binding Protein 6
IGFBP6; insulin-like growth factor binding protein 6; IBP6; IGF binding protein 6; Insulin-like growth factor-binding protein 6; IGF-binding protein 6; IGFBP-6; IBP-6;
ACAP2
ArfGAP with coiled-coil, ankyrin repeat and PH domains 2
ACAP2; ArfGAP with coiled-coil, ankyrin repeat and PH domains 2; centaurin, beta 2 , CENTB2; arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2; CNT B2; KIAA0041; ACAP 2; Arf GAP with coiled coil ANK repeat and PH domains 2; CENT B 2; Centaurin beta2; CENTB 2; CENTB2; Cntb2; Similar to yeast ZINC FINGER PROTEIN GCS1; centaurin-beta-2; centaurin, beta 2; OTTHUMP00000208844; Arf GAP with coiled coil, ANK repeat and PH domains 2; CNT-B2;
ACCS
1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional)
ACCS; 1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional); 1-aminocyclopropane-1-carboxylate synthase-like protein 1; ACS; PHACS; ACC synthase-like protein 1;
ACOT11
acyl-CoA thioesterase 11
ACOT11; acyl-CoA thioesterase 11; THEA, thioesterase, adipose associated; acyl-coenzyme A thioesterase 11; BFIT; BFIT1; KIAA0707; StAR related lipid transfer (START) domain containing 14; STARD14; THEM1; START domain containing 14; acyl-CoA thioester hyd;
ACOT9
acyl-CoA thioesterase 9
ACOT9; acyl-CoA thioesterase 9; acyl-coenzyme A thioesterase 9, mitochondrial; ACATE2; CGI 16; MT ACT48; acyl-CoA thioester hydrolase 9; mitochondrial Acyl-CoA Thioesterase; acyl-Coenzyme A thioesterase 2, mitochondrial; CGI-16; MTACT48; MT-ACT48;
ACSL1
acyl-CoA synthetase long-chain family member 1
ACSL1; acyl-CoA synthetase long-chain family member 1; ACS1; LACS; FACL1; FACL2; LACS1; LACS2; long-chain-fatty-acid--CoA ligase 1; LACS 1; LACS 2; acyl-CoA synthetase 1; palmitoyl-CoA ligase 1; palmitoyl-CoA ligase 2; paltimoyl-CoA ligase 1; lignoceroyl-CoA synthase; long-chain acyl-CoA synthetase 1; long-chain acyl-CoA synthetase 2; long-chain fatty acid-CoA ligase 2; long-chain fatty-acid-coenzyme A ligase 1; fatty-acid-Coenzyme A ligase, long-chain 1; fatty-acid-Coenzyme A ligase, long-chain 2;
ACTA2
actin, alpha 2, smooth muscle, aorta
ACTA2; actin, alpha 2, smooth muscle, aorta; AAT6; ACTSA; MYMY5; actin, aortic smooth muscle; alpha-cardiac actin; cell growth-inhibiting gene 46 protein;
ACTG2
actin, gamma 2, smooth muscle, enteric
ACTG2; actin, gamma 2, smooth muscle, enteric; ACTA3, ACTL3; actin, gamma-enteric smooth muscle; ACTSG; alpha-actin 3; alpha-actin-3; gamma-2-actin; actin-like protein; smooth muscle gamma actin; smooth muscle gamma-actin; ACT; ACTE; ACTA3; ACTL3;
ADAMST8
ADAM Metallopeptidase With Thrombospondin Type 1 Motif, 8
ADAM metallopeptidase with thrombospondin type 1 motif, 8; METH2; ADAM-TS8; FLJ41712; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 8; ADAMTS-8; METH-2; METH-8; ADAM-TS 8; A disintegrin and metalloproteinase with thrombospondin motifs 8; EC 3.4.24.; EC 3.4.24; EC 3.4.24.14; EC 3.4.24.82; ADAMTS8; OTTHUMP00000230650;
ADAMTS13
ADAM metallopeptidase with thrombospondin type 1 motif, 13
ADAMTS13; ADAM metallopeptidase with thrombospondin type 1 motif, 13; VWFCP; C9orf8; vWF-CP; ADAM-TS13; ADAMTS-13; A disintegrin and metalloproteinase with thrombospondin motifs 13; vWF-cleaving protease; von Willebrand factor-cleaving protease; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 13;
ADAMTS17
ADAM metallopeptidase with thrombospondin type 1 motif, 17
ADAMTS17; ADAM metallopeptidase with thrombospondin type 1 motif, 17; A disintegrin and metalloproteinase with thrombospondin motifs 17; ADAM-TS17; ADAMTS-17; ADAM-TS 17; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 17;
ADAMTS2
ADAM metallopeptidase with thrombospondin type 1 motif, 2
ADAMTS2; ADAM metallopeptidase with thrombospondin type 1 motif, 2; NPI; PNPI; PCINP; PCPNI; PCI-NP; PC I-NP; ADAM-TS2; ADAMTS-2; ADAMTS-3; A disintegrin and metalloproteinase with thrombospondin motifs 2; procollagen I N-proteinase; procollagen N-endopeptidase; procollagen I/II amino propeptide-processing enzyme; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 2;
ADAMTS8
ADAM metallopeptidase with thrombospondin type 1 motif, 8
ADAMTS8; ADAM metallopeptidase with thrombospondin type 1 motif, 8; METH2; ADAM-TS8; A disintegrin and metalloproteinase with thrombospondin motifs 8; METH-2; METH-8; ADAMTS-8; ADAM-TS 8; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 8;
ALAS1
aminolevulinate, delta-, synthase 1
ALAS1; aminolevulinate, delta-, synthase 1; ALAS, ALAS3; 5-aminolevulinate synthase, nonspecific, mitochondrial; mitochondrial; nonspecific; 5 aminolevulinate synthase; 5 aminolevulinate synthase nonspecific mitochondrial; 5 aminolevulinic acid synthase; 5-aminolevulinate synthase; 5-aminolevulinic acid synthase 1; Alas 1; ALAS 3; ALAS; ALAS H; ALAS HOUSEKEEPING TYPE; ALAS N; ALAS-H; ALAS3; ALASH; Aminolevulinate delta synthase 1; Aminolevulinic acid synthase 1; Delta ALA synthetase; Delta aminolevulinate synthase; Delta-ALA synthase 1; Delta-aminolevulinate synthase 1; HEM1_HUMAN; MIG 4; MIG4; Migration inducing protein 4; OTTHUMP00000212619; OTTHUMP00000212620; OTTHUMP00000212621; OTTHUMP00000212622; migration-inducing protein 4;
ASAP1
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1
ASAP1; ArfGAP with SH3 domain, ankyrin repeat and PH domain 1; DDEF1, development and differentiation enhancing factor 1; arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1; centaurin; beta 4; CENTB4; KIAA1249; PAP; ZG14P; DEF-1; cent;
ATP5E
ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit
ATP5E; ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit; ATP synthase subunit epsilon, mitochondrial; F(0)F(1)-ATPase; mitochondrial ATPase; H(+)-transporting two-sector ATPase; mitochondrial ATP synthase epsilon chain; ATPE; MC5DN;
ATP5G1
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)
ATP5G1; ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9); ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (subunit 9), isoform 1 , ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C1 (subunit 9) , ATP5G; ATP synthase lipid-binding protein, mitochondrial; ATP synthase lipid binding protein mitochondrial; ATP synthase proteolipid P1; ATPase protein 9; ATPase subunit C; ATPase subunit 9; OTTHUMP00000218389; OTTHUMP00000218391; OTTHUMP00000218448; OTTHUMP00000218449; OTTHUMP00000218450; mitochondrial ATP synthase, sub; ATP5A; ATP5G;
ATRX
alpha thalassemia/mental retardation syndrome X-linked
ATRX; alpha thalassemia/mental retardation syndrome X-linked; alpha thalassemia/mental retardation syndrome X linked (RAD54 (S. cerevisiae) homolog) , JMS, Juberg Marsidi syndrome , RAD54; transcriptional regulator ATRX; RAD54 homolog (S. cerevisiae); XH;
BAG5
BCL2-associated athanogene 5
BAG5; BCL2-associated athanogene 5; BAG family molecular chaperone regulator 5; bcl-2-associated athanogene 5; BAG-family molecular chaperone regulator-5; BAG-5;
C1GALT1
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1
C1GALT1; core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1; C1GALT; core 1 beta3 Gal T; T synthase; B3Gal-T8; core 1 beta3-Gal-T1; core 1 O-glycan T-synth;
CAD
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
CAD; carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase; CAD protein; CAD trifunctional protein; multifunctional protein CAD;
CAMP
cathelicidin antimicrobial peptide
CAMP; cathelicidin antimicrobial peptide; Cnlp; MCLP; CAP18; Cramp; FALL39; cathelin-related antimicrobial peptide; CLP; cathelin-like protein;
CBS
cystathionine-beta-synthase
CBS; cystathionine-beta-synthase; cystathionine beta-synthase; HIP4; beta-thionase; serine sulfhydrase; methylcysteine synthase;
CCT8L2
chaperonin containing TCP1, subunit 8 (theta)-like 2
CCT8L2; chaperonin containing TCP1, subunit 8 (theta)-like 2; putative T-complex protein 1 subunit theta-like 2; CESK1; MGC118839; CESK 1; Chaperonin containing TCP1 subunit 8 (theta) like 2; KCNMB3L; MGC118840; T complex protein 1; T-complex protein 1;
CDS2
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2
CDS2; CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2; phosphatidate cytidylyltransferase 2; CDP-DAG synthase 2; CDP-DG synthetase 2; CDP-diacylglycerol synthase 2; CDP-diglyceride pyrophosphorylase 2; CDP-diglyceride synthetase 2; CTP:phosphatidate cytidylyltransferase 2; CDS 2; CDP-DG synthase 2; OTTHUMP00000030194; OTTHUMP00000030195; CDP-diglyceride synthase 2; CDP-diglyceride diphosphorylase;
CGREF1
cell growth regulator with EF-hand domain 1
CGREF1; cell growth regulator with EF-hand domain 1; cell growth regulator with EF hand domain protein 1; CGR11; Cell growth regulator with EF hand domain 1; Cell growth regulatory gene 11; Cell growth regulatory gene 11 protein; CGR 11; CGREF 1; hydrophobestin; OTTHUMP00000200952; OTTHUMP00000200954; OTTHUMP00000200955; OTTHUMP00000200956; OTTHUMP00000200957;
CHFR
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
CHFR; checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase; RNF116; RNF196; E3 ubiquitin-protein ligase CHFR; RING finger protein 196;
CIDEB
cell death-inducing DFFA-like effector b
CIDEB; cell death-inducing DFFA-like effector b; cell death activator CIDE-B;
CITED4
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4
CITED4; Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4; cbp/p300-interacting transactivator 4; transcriptional co activator 4; MRG-2; MSG1-related protein 2; transcriptional co-activator 4;
CLINT1
clathrin interactor 1
CLINT1; clathrin interactor 1; CLINT; ENTH; EPNR; KIAA0171; epsinR; epsin 4; enthoprotin; epsin-related protein; clathrin interacting protein localized in the trans-Golgi region; EPN4; FLJ46753;
CMAS
cytidine monophosphate N-acetylneuraminic acid synthetase
CMAS; cytidine monophosphate N-acetylneuraminic acid synthetase; N-acylneuraminate cytidylyltransferase; CMP Neu5Ac synthetase; CMP-NeuNAc synthase; CMP-Neu5Ac synthetase; CMP-NeuNAc synthetase; CMP-N-acetylneuraminic acid synthase; CMP-N-acetylneuraminic;
CNN1
calponin 1, basic, smooth muscle
CNN1; calponin 1, basic, smooth muscle; SMCC; Sm-Calp; HEL-S-14; calponin-1; basic calponin; calponins, basic; calponin H1, smooth muscle; epididymis secretory protein Li 14;
COASY
CoA synthase
COASY; CoA synthase; NBP; DPCK; PPAT; UKR1; NBIA6; pOV-2; bifunctional coenzyme A synthase; nucleotide binding protein; phosphopantetheine adenylyltransferase / dephosphocoenzyme A kinase; bifunctional phosphopantetheine adenylyl transferase/dephospho CoA kinase;
CTH
cystathionase (cystathionine gamma-lyase)
CTH; cystathionase (cystathionine gamma-lyase); cystathionine gamma-lyase; gamma-cystathionase; homoserine deaminase; cysteine desulfhydrase; homoserine dehydratase; cysteine-protein sulfhydrase; MGC9471;
CTSW
cathepsin W
CTSW; cathepsin W; cathepsin W (lymphopain); lymphopain; LYPN; OTTHUMP00000233962; OTTHUMP00000233963;
DAD1
Defender Against Cell Death 1
OST2; DAD1; Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1; Oligosaccharyl transferase subunit DAD1; EC=2.4.1.119; Defender against cell death 1; AD-1; OTTHUMP00000164488; OTTHUMP00000239715; OTTHUMP00000239717; DAD-1; dolichyl-diphosphooligosaccharide--protein glycosyltransfe-rase subunit DAD1; EC 2.4.1.119; oligosaccharyltransferase 2 homolog;
DAXX
death-domain associated protein
DAXX; death-domain associated protein; death associated protein 6; death domain-associated protein 6; DAP6; Fas-binding protein; CENP-C binding protein; ETS1-associated protein 1; death-associated protein 6; fas death domain-associated protein; EAP1; BING2; MGC126245; MGC126246;
DEDD
death effector domain containing
DEDD; death effector domain containing; death effector domain-containing protein; CASP8IP1; DEDD1; DEFT; FLDED1; KE05; Death effector domain containing protein; Death effector domain containing testicular molecule; DEDD 1; DEDPro 1; DEDPro1; FLDED 1; KE 05; OTTHUMP00000031822; FLDED-1; OTTHUMP00000031821; death effector domain-containing testicular molecule;
DNMT3B
Dnmt3b DNA methyltransferase 3B
DNMT3B; DNA methyltransferase 3B; DNA (cytosine-5)-methyltransferase 3B; m.MmuIIIB; DNA MTase MmuIIIB; DNA methyltransferase MmuIIIB; MGC124407;
EDN1
endothelin 1
EDN1; endothelin 1; ET1; PPET1; HDLCQ7; endothelin-1; OTTHUMP00000016038; preproendothelin-1;
EDN2
EDN2 endothelin 2
EDN2; endothelin 2; endothelin-2; ET2; ET-2; preproendothelin 2; preproendothelin-2; PPET2;
EDN3
EDN3 endothelin 3
EDN3; endothelin 3; endothelin-3; ET3; preproendothelin-3; ET-3; WS4B; HSCR4; PPET3; MGC15067; MGC61498;
EHMT1
euchromatic histone-lysine N-methyltransferase 1
EHMT1; euchromatic histone-lysine N-methyltransferase 1; euchromatic histone methyltransferase 1; histone-lysine N-methyltransferase EHMT1; bA188C12.1; Eu HMTase1; FLJ12879; KIAA1876; KMT1D; H3-K9-HMTase 5; G9a like protein; G9a-like protein 1; lysine N-m;
ELAVL4
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D)
ELAVL4; ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D); HUD; ELAV-like protein 4; PNEM; hu-antigen D; paraneoplastic encephalomyelitis antigen HuD; Embryonic lethal, abnormal vision, Drosophila, homolog of, like-4;
ELF3
E74-like factor 3 (ets domain transcription factor, epithelial-specific )
ELF3; E74-like factor 3 (ets domain transcription factor, epithelial-specific ); ESX; ETS-related transcription factor Elf-3; EPR 1; ERT; ESE 1; E74 like factor 3; E74 like factor 3 ets domain transcription factor; E74 like factor 3 ets domain transcription factor epithelial specific; E74 like factor 3 ETS domain transcription factor serine box epithelial specific; E74-like factor 3; ELF3_HUMAN; Epithelial restricted with serine box; Epithelial-restricted with serine box; Epithelium restricted Ets protein ESX; Epithelium specific Ets factor 1; Epithelium specific Ets transcription factor 1; Epithelium-restricted Ets protein ESX; Epithelium-specific Ets transcription factor 1; EPR1; ESE-1; Ets domain transcription factor serine box; Ets domain transcription factor serine box epithelial specific; Ets transcription factor; jen; MGC139318; OTTHUMP00000034050; OTTHUMP00000034051; OTTHUMP00000034052; OTTHUMP00000034053; EPR-1;
EMP3
epithelial membrane protein 3
EMP3; epithelial membrane protein 3; YMP; EMP-3; HNMP-1; hematopoietic neural membrane protein 1;
ENC1
ectodermal-neural cortex 1 (with BTB-like domain)
ENC1; ectodermal-neural cortex 1 (with BTB-like domain); NRPB; ectoderm-neural cortex protein 1; ENC 1; kelch like 37 (Drosophila); KLHL37; PIG10; TP53I10; CCL 28; CCL28; Ectoderm neural cortex protein 1; Ectodermal neural cortex (with BTB like domain); ENC-1; ENC1_HUMAN; FLJ39259; Kelch like 35; Kelch-like protein 37; KLHL 35; KLHL35; Nuclear matrix protein NRP/B; Nuclear restricted protein BTB domain like (brain); p53 induced gene 10 protein; p53-induced gene 10 protein; PIG 10; Tumor protein p53 inducible protein 10; kelch-like 35; kelch-like 37; OTTHUMP00000128235; OTTHUMP00000222054; ectodermal-neural cortex (with BTB-lik;
EPB41
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked)
EPB41; erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked); EL1; protein 4.1; 4.1R; P4.1; EPB4.1; band 4.1; erythrocyte surface protein band 4.1; HE;
EPB41L3
erythrocyte membrane protein band 4.1-like 3
EPB41L3; erythrocyte membrane protein band 4.1-like 3; band 4.1-like protein 3; erythrocyte protein band 4.1-like 3; Epb4.1l3; Kiaa0987;
EPS15L1
epidermal growth factor receptor pathway substrate 15-like 1
EPS15L1; epidermal growth factor receptor pathway substrate 15-like 1; epidermal growth factor receptor substrate 15-like 1; eps15R; eps15-related protein; epidermal growth factor receptor substrate EPS15R;
EPSTI1
epithelial stromal interaction 1 (breast)
EPSTI1; epithelial stromal interaction 1 (breast); epithelial-stromal interaction protein 1; BRESI1; epithelial stromal interaction protein 1; MGC29634;
ERG
v-ets avian erythroblastosis virus E26 oncogene homolog
ERG; v-ets avian erythroblastosis virus E26 oncogene homolog; p55; erg-3; transcriptional regulator ERG; ets-related; TMPRSS2/ERG fusion; v-ets erythroblastosis virus E26 oncogene like; v-ets erythroblastosis virus E26 oncogene homolog; v-ets avian erythroblastosis virus E26 oncogene related; transcriptional regulator ERG (transforming protein ERG);
ERMAP
erythroblast membrane-associated protein (Scianna blood group)
ERMAP; erythroblast membrane-associated protein (Scianna blood group); erythroblast membrane associated protein , erythroblast membrane associated protein (RD and SC blood groups) , Radin blood group , RD, SC, Scianna blood group; erythroid membrane-associated protein; ERMAP_HUMAN; Erythroblast membrane associated protein; Erythroid membrane associated protein; hERMAP; MGC118810; MGC118811; MGC118812; MGC118813; PRO2801; Radin blood group (Rd); Radin blood group antigen; RD; SC; Scianna blood group (Sc); Scianna blood group antigen; OTTHUMP00000008916; OTTHUMP00000008917; OTTHUMP00000008918;
F2RL3
coagulation factor II (thrombin) receptor-like 3
F2RL3; coagulation factor II (thrombin) receptor-like 3; proteinase-activated receptor 4; PAR4; proteinase activated receptor 4; PAR-4; thrombin receptor-like 3; protease-activated receptor-4; proteinase-activated receptor-4; coagulation factor II recepto;
FAM200A
family with sequence similarity 200, member A
C7orf38; FLJ36794; DKFZp727G131; hypothetical protein LOC221786; OTTHUMP00000210467; family with sequence similarity 200, member A; FAM200A;
FAM50A
family with sequence similarity 50, member A
FAM50A; family with sequence similarity 50, member A; protein FAM50A; 9F; DNA segment on chromosome X (unique) 9928 expressed sequence; DXS9928E; HXC 26; XAP5; protein XAP-5; HXC26; HXC-26;
FAM65B
family with sequence similarity 65, member B
FAM65B; family with sequence similarity 65, member B; C6orf32, chromosome 6 open reading frame 32; protein FAM65B; DIFF48; KIAA0386; PL48; OTTHUMP00000016104; OTTHUMP00000016105; DIFF40; C6orf32;
FAM84A
family with sequence similarity 84, member A
FAM84A; family with sequence similarity 84, member A; protein FAM84A; FLJ35392; neurological/sensory 1; NSE1; FAM 84A; Family with sequence similarity 84 member A; Neurologic sensory protein 1; NSE 1; PP11517; Protein NSE1; OTTHUMP00000147636;
FRS2
fibroblast growth factor receptor substrate 2
FRS2; fibroblast growth factor receptor substrate 2; FRS2A; FRS2alpha; SNT 1; SNT1; FGFR signaling adaptor SNT; FGFR signalling adaptor; FGFR substrate 2; FGFR-signaling adaptor SNT; FRS 2; FRS2_HUMAN; SNT; SNT-1; Suc 1 Associated Neurotrophic Factor Target; Suc1 associated neurotrophic factor target 1; Suc1-associated neurotrophic factor target 1;
GART
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
GART; phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase; PGFT, PRGS; trifunctional purine biosynthetic protein adenosine-3; AIRS; GARS; PAIS; PGFT; PRGS; GARTF; MGC47764;
GAS2
growth arrest-specific 2
GAS2; growth arrest-specific 2; growth arrest-specific protein 2; GAS-2; MGC32610;
GAS2L3
growth arrest-specific 2 like 3
GAS2L3; growth arrest-specific 2 like 3; GAS2-like protein 3; GAS2 like protein 3; Gm240; Growth arrest specific 2 like 3; Growth arrest specific protein 2 like 3; OTTHUMP00000243791; OTTHUMP00000243792; growth arrest-specific protein 2-like 3; G2L3;
GCSH
glycine cleavage system protein H (aminomethyl carrier)
GCSH; glycine cleavage system protein H (aminomethyl carrier); glycine cleavage system H protein, mitochondrial; lipoic acid containing protein; mitochondrial; GCE; GCSH_HUMAN; Glycine cleavage system H protein; Glycine cleavage system H protein mitochondrial; Glycine cleavage system protein H; Mitochondrial glycine cleavage system H protein; NKH; OTTHUMP00000174971; lipoic acid-containing protein; mitochondrial glycine cleavage system H-protein;
GDF7
growth differentiation factor 7
GDF7; growth differentiation factor 7; growth/differentiation factor 7; BMP12; bone morphogenetic protein 12; GDF-7; GDF7_HUMAN; OTTHUMP00000115986;
GFI1
growth factor independent 1 transcription repressor
GFI1; growth factor independent 1 transcription repressor; SCN2; GFI-1; GFI1A; ZNF163; zinc finger protein Gfi-1; zinc finger protein 163; growth factor independence-1; growth factor independent protein 1;
GMPS
guanine monphosphate synthetase
GMPS; guanine monphosphate synthetase; GMP synthase [glutamine-hydrolyzing]; GMP synthase; GMP synthetase; MLL/GMPS fusion protein; glutamine amidotransferase; guanosine 5-monophosphate synthase;
GPS1
G protein pathway suppressor 1
GPS1; G protein pathway suppressor 1; COP9 signalosome complex subunit 1; COPS1; CSN1; 5S342; Arabidopsis Fus6/Cop 11 homolog; constitutive photomorphogenic homolog subunit 1; COP9; CSN 1; CSN1_HUMAN; GPS-1; JAB1-containing signalosome subunit 1; MFH protein; Protein GPS1; Protein MFH; SGN1; Signalosome subunit 1; Y59A8A.1;
GSR
glutathione reductase
GSR; glutathione reductase; HEL-75; glutathione reductase, mitochondrial; GR; GRase; epididymis luminal protein 75;
GSTA6P
Glutathione S-transferase Alpha 6, Pseudogene
GSTA6P; GSTAP1; glutathione S-transferase alpha 6, pseudogene; glycogen synthase kinase 3 beta; GSK-3 beta; GSK3beta isoform;glycogen synthase kinase-3 beta; EC 2.7.11.26;
GSTM5
glutathione S-transferase mu 5
GSTM5; glutathione S-transferase mu 5; glutathione S transferase M5; Glutathione S alkyltransferase M5; Glutathione S aralkyltransferase M5; Glutathione S aryltransferase M5; Glutathione S transferase Mu 5; GST class mu 5; GST class-mu 5; GSTM 5; GSTM5 5; GSTM5-5; GSTM5_HUMAN; GTM 5; GTM5; OTTHUMP00000013359; OTTHUMP00000013361; S (hydroxyalkyl)glutathione lyase M5; glutathione S-transferase M5; glutathione S-aryltransferase M5; glutathione S-alkyltransferase M5; glutathione S-aralkyltransferase M5; S-(hydroxyalkyl)glutathione lyase M5;
HDGFRP3
hepatoma-derived growth factor, related protein 3
HDGFRP3; hepatoma-derived growth factor, related protein 3; hepatoma-derived growth factor-related protein 3; HRP-3; 2700022B06Rik;
HELZ
helicase with zinc finger
HELZ; helicase with zinc finger; probable helicase with zinc finger domain; DHRC; down regulated in human cancers; HUMORF5; KIAA0054; helicase with zinc finger domain; down-regulated in human cancers protein; DRHC; MGC163454; DKFZp586G1924;
HEYL
hairy/enhancer-of-split related with YRPW motif-like
HEYL; hairy/enhancer-of-split related with YRPW motif-like; hairy/enhancer-of-split related with YRPW motif-like protein; bHLHb33; hairy/enhancer of split related with YRPW motif 3; HEY3; HRT-3; hHRT3; hHeyL; HEY-like protein; hairy-related transcription;
HGS
hepatocyte growth factor-regulated tyrosine kinase substrate
HGS; hepatocyte growth factor-regulated tyrosine kinase substrate; Hrs; Vps27; ZFYVE8; protein pp110; human growth factor-regulated tyrosine kinase substrate; FLJ11421; FLJ39878;
HIC1
hypermethylated in cancer 1
HIC1; hypermethylated in cancer 1; hic-1; ZBTB29; ZNF901; hypermethylated in cancer 1 protein; zinc finger and BTB domain-containing protein 29;
ING3
inhibitor of growth family, member 3
ING3; inhibitor of growth family, member 3; inhibitor of growth protein 3; Eaf4; FLJ20089; MEAF4; p47ING3; ING2;
KDM2B
lysine (K)-specific demethylase 2B
KDM2B; lysine (K)-specific demethylase 2B; CXXC2; Fbl10; PCCX2; FBXL10; JHDM1B; lysine-specific demethylase 2B; F-box protein FBL10; F-box/LRR-repeat protein 10; CXXC-type zinc finger protein 2; protein-containing CXXC domain 2; [Histone-H3]-lysine-36 demethylase 1B; F-box and leucine-rich repeat protein 10; jumonji C domain-containing histone demethylase 1B; jmjC domain-containing histone demethylation protein 1B; JEMMA (Jumonji domain, EMSY-interactor, methyltransferase motif) protein;
KDM5A
lysine (K)-specific demethylase 5A
RBP2; RBBP2; RBBP-2; JARID1A; lysine-specific demethylase 5A; OTTHUMP00000237742; histone demethylase JARID1A; retinoblastoma binding protein 2; retinoblastoma-binding protein 2; jumonji/ARID domain-containing protein 1A; Jumonji, AT rich interactive domain 1A (RBP2-like); Jumonji, AT rich interactive domain 1A (RBBP2-like); KDM5A; lysine (K)-specific demethylase 5A;
KDM5B
lysine (K)-specific demethylase 5B
CT31; PLU1; PUT1; PLU-1; JARID1B; FLJ10538; FLJ12459; FLJ12491; FLJ16281; FLJ23670; RBBP2H1A; lysine-specific demethylase 5B; RBP2-H1; OTTHUMP00000038815; OTTHUMP00000038816; OTTHUMP00000197658; cancer/testis antigen 31; histone demethylase JARID1B; putative DNA/chromatin binding motif; jumonji, AT rich interactive domain 1B; jumonji/ARID domain-containing protein 1B; retinoblastoma-binding protein 2 homolog 1; retinoblastoma-binding protein 2, homolog 1A; KDM5B; lysine (K)-specific demethylase 5B;
KLF1
Kruppel-like factor 1 (erythroid)
KLF1; Kruppel-like factor 1 (erythroid); Krueppel-like factor 1; EKLF; erythroid Kruppel like factor; monoclonal A3D8; erythroid Kruppel-like factor; erythroid krueppel-like transcription factor; erythroid-specific transcription factor EKLF; INLU; HBFQT;
LASS2
LAG1 homolog, ceramide synthase 2
LAG1 homolog, ceramide synthase 2; LAG1 longevity assurance homolog 2 (S. cerevisiae); SP260; MGC987; CerS2; OTTHUMP00000033029; FLJ10243; OTTHUMP00000033030; L3; OTTHUMP00000033031; longevity assurance (LAG1, S. cerevisiae) homolog 2; ceramide synthase 2; Tumor metastasis-suppressor gene 1 protein; LAG1 longevity assurance 2; TMSG1; LAG1 longevity assurance homolog 2; LASS2; OTTHUMP00000033028;
LASS4
ceramide synthase 4
LAG1 homolog, ceramide synthase 4; CerS4; FLJ12089; Trh1; LAG1 longevity assurance homolog 4 (S. cerevisiae); LAG1 longevity assurance homolog 4; LASS4; ceramide synthase 4;
LILRA3
leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3
LILRA3; leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3; leukocyte immunoglobulin-like receptor subfamily A member 3; CD85e; HM31; HM43; ILT6; LIR 4; LIR4; CD 85E; CD85 antigen-like family member E; CD85e antigen; e3; HM 31; HM 43; ILT 6; ILT-6; Immunoglobulin like transcript 6; Immunoglobulin-like transcript 6; Leucocyte immunoglobulin like receptor; Leukocyte immunoglobulin like receptor 4; Leukocyte immunoglobulin like receptor A3; Leukocyte immunoglobulin like receptor subfamily A (without TM domain) member 3; Leukocyte immunoglobulin like receptor subfamily A member 3; Leukocyte immunoglobulin-like receptor 4; LILRA 3; LIR-4; LIRA3_HUMAN; Monocyte inhibitory receptor HM43/HM31; OTTHUMP00000067955; OTTHUMP00000067956; OTTHUMP00000067957; leucocyte immunoglobulin-like receptor; monocyte inhibitory recept;
LILRB1
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
LILRB1; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1; leukocyte immunoglobulin-like receptor subfamily B member 1; CD85; CD85j; ILT2; LIR 1; LIR1; MIR 7; ILT-2; CD85 antigen; Ig-like transcript 2; leukocyte Ig-like receptor-1; immunoglobulin-like transcript 2; CD85 antigen-like family member J; leukocyte immunoglobulin-like receptor 1; monocyte/macrophage immunoglobulin-like receptor 7; leukocyte immunoglobulin-like receptor subfamily B member 1 soluble isoform; MIR7; LIR-1; MIR-7; FLJ37515;
LILRB2
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
LILRB2; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2; leukocyte immunoglobulin-like receptor subfamily B member 2; CD85d; ILT4; LIR 2; LIR2; MIR 10; MIR10; ILT-4; Ig-like transcript 4; immunoglobulin-like transcript 4; CD85 antigen-like family member D; leukocyte immunoglobulin-like receptor 2; monocyte/macrophage immunoglobulin-like receptor 10; leukocyte immunoglobulin-like receptor subfamily B member 2 soluble isoform; eukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6; LIR-2; LILRA6; MIR-10;
LRAT
lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)
LRAT; lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase); lecithin retinol acyltransferase; LCA14; MGC33103;
MARS
methionyl-tRNA synthetase
MARS; methionyl-tRNA synthetase; methionyl-tRNA synthetase, cytoplasmic; methionine tRNA ligase 1; cytoplasmic; MetRS; Methionine tRNA ligase 1, cytoplasmic; Methionine tRNA ligase; Methionine tRNA synthetase; Methionyl tRNA synthetase; MTRNS; cytosolic methionyl-tRNA synthetase; MRS;
MASTL
microtubule associated serine/threonine kinase-like
MASTL; microtubule associated serine/threonine kinase-like; serine/threonine-protein kinase greatwall; FLJ14813; THC2; 2700091H24Rik; C88295; GW; GWL; GWL_HUMAN; hGWL; MAST-L; MGC117975; microtubule associated serine/threonine kinase like; Microtubule-associated serine/threonine-protein kinase-like; RP11 85G18.2; greatwall protein kinase; GREATWALL; RP11-85G18.2;
MBD1
methyl-CpG binding domain protein 1
MBD1; methyl-CpG binding domain protein 1; methyl-CpG-binding domain protein 1; CXXC3; PCM1; CXXC-type zinc finger protein 3; protein containing methyl-CpG-binding domain 1; methyl-CpG binding domain protein 1 isoform PCM1; the regulator of fibroblast gro;
MCCC1
methylcrotonoyl-CoA carboxylase 1 (alpha)
MCCC1; methylcrotonoyl-CoA carboxylase 1 (alpha); methylcrotonoyl Coenzyme A carboxylase 1 (alpha); methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial; MCCA; 3-methylcrotonyl-CoA carboxylase 1; MCCase subunit alpha; OTTHUMP00000212827; OTTHUMP00000212828; OTTHUMP00000212829; OTTHUMP00000212832; methylcrotonoyl-Coenzyme A carboxylase 1 (alpha); 3-methylcroto; MCC-B;
MLL
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)
MLL; myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); myeloid/lymphoid or mixed lineage leukemia (trithorax (Drosophila) homolog); histone-lysine N-methyltransferase MLL; ALL 1; CXXC7; HRX; HTRX1; KMT2A; MLL1A; TRX1; trithorax-l;
MLLT11
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11
MLLT11; myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11; protein AF1q; AF1Q; ALL1 fused gene from chromosome 1q; MLLT 11; Myeloid/lymphoid or mixed lineage leukemia (trithorax homolog, Drosophila) translocated to 11; RP11 316M1.10; OTTHUMP00000033120; ALL1-fused gene from chromosome 1q; RP11-316M1.10;
MOCS3
molybdenum cofactor synthesis 3
MOCS3; molybdenum cofactor synthesis 3; adenylyltransferase and sulfurtransferase MOCS3; dJ914P20.3; UBA4; ubiquitin activating enzyme E1 homolog (yeast); ubiquitin like modifier activating enzyme 4; MGC9252; MOCS 3; Molybdenum cofactor synthesis protein 3; Molybdopterin synthase sulfurylase; MPT synthase sulfurylase; UBA 4; UBA4ubiquitin activating enzyme E1 homolog; OTTHUMP00000031284; ubiquitin-like modifier activating enzyme 4; UBA4, ubiquitin-activating enzyme E1 homolog;
MYL6B
myosin, light chain 6B, alkali, smooth muscle and non-muscle
MYL6B; myosin, light chain 6B, alkali, smooth muscle and non-muscle; myosin, light polypeptide 6B, alkali, smooth muscle and non muscle; myosin light chain 6B; MLC1SA; myosin light chain 1 slow a; MYL 6B; MYL6B_HUMAN; Myosin alkali light chain 1 slow a; Myosin light chain 1 slow twitch muscle A isoform; Myosin light chain 1 slow-twitch muscle A isoform; Myosin light chain 6B alkali smooth muscle and non muscle; Myosin light polypeptide 6B alkali smooth muscle and non muscle; Myosin light polypeptide 6B; Smooth muscle and non muscle myosin alkali light chain 6B; Smooth muscle and nonmuscle myosin light chain alkali 6B; OTTHUMP00000243208; OTTHUMP00000243210; OTTHUMP00000243299; myosin light chain 1, slow-twitch muscle A isoform; smooth muscl;
NAAA
N-acylethanolamine acid amidase
NAAA; N-acylethanolamine acid amidase; ASAHL, N acylsphingosine amidohydrolase (acid ceramidase) like; N-acylethanolamine-hydrolyzing acid amidase; Acid ceramidase like protein; ASAH like protein; N acylethanolamine acid amidase; N acylethanolamine hydrolyzing acid amidase; N acylsphingosine amidohydrolase (acid ceramidase) like; N acylsphingosine amidohydrolase like; N acylsphingosine amidohydrolase like protein; PLT; ASAH-like protein; OTTHUMP00000219231; OTTHUMP00000219430; OTTHUMP00000221103; acid ceramidase-like protein; ASAHL;
NEGR1
neuronal growth regulator 1
NEGR1; neuronal growth regulator 1; a kindred of IgLON; IgLON family member 4; IGLON4; KILON; MGC46680; neurotractin; Ntra; PRO4993; UNQ2433; DMML2433;
NFE2
nuclear factor (erythroid-derived 2), 45kDa
NFE2; nuclear factor (erythroid-derived 2), 45kDa; nuclear factor (erythroid derived 2), 45kD; transcription factor NF-E2 45 kDa subunit; NF E2; erythroid-derived 2 45 kDa subunit; Leucine zipper protein NF-E2; Leucine zipper protein NFE2; NFE2_HUMAN; Nuclear factor (erythroid derived 2), 45kDa; Nuclear factor; Nuclear factor, erythroid derived 2 45 kDa subunit; p45; p45 NF-E2; p45 NFE2; Transcription factor NFE2 45 kDa subunit; OTTHUMP00000242012; OTTHUMP00000242013; OTTHUMP00000242015; nuclear factor, erythroid-derived 2 45 kDa subunit; NF-E2;
NFE2L2
nuclear factor, erythroid 2-like 2
NFE2L2; nuclear factor, erythroid 2-like 2; NRF2; nuclear factor erythroid 2-related factor 2; HEBP1; NFE2-related factor 2; NF-E2-related factor 2; nuclear factor erythroid-derived 2-like 2; nuclear factor (erythroid-derived 2)-like 2; nuclear factor, erythroid derived 2, like 2;
NGFRAP1
nerve growth factor receptor (TNFRSF16) associated protein 1
NGFRAP1; nerve growth factor receptor (TNFRSF16) associated protein 1; protein BEX3; Bex; BEX3; brain expressed; X linked 3; DXS6984E; HGR74; NADE; brain expressed, X-linked 3; brain-expressed X-linked protein 3; ovarian granulosa cell protein (13kD); p75NTR-associated cell death executor; ovarian granulosa cell 13.0 kDa protein HGR74; nerve growth factor receptor-associated protein 1;
NODAL
nodal growth differentiation factor
NODAL; nodal growth differentiation factor; HTX5; nodal homolog;
OTX1
orthodenticle homeobox 1
OTX1; orthodenticle homeobox 1; homeobox protein OTX1; FLJ38361; Homeobox protein OTX 1; MGC15736; Orthodenticle 1; Orthodenticle homolog 1; Orthodenticle1; Otx 1; OTX1_HUMAN; OTX1X;
OTX2
orthodenticle homeobox 2
OTX2; orthodenticle homeobox 2; orthodenticle homolog 2 (Drosophila); homeobox protein OTX2; orthodenticle homolog 2; CPHD6; MCOPS5; MGC45000;
PAPSS2
3-phosphoadenosine 5-phosphosulfate synthase 2
PAPSS2; 3-phosphoadenosine 5-phosphosulfate synthase 2; bifunctional 3-phosphoadenosine 5-phosphosulfate synthase 2; ATPSK2; SK 2; PAPSS 2; PAPS synthase 2; PAPS synthetase 2; ATP sulfurylase/APS kinase 2; ATP sulfurylase/adenosine 5-phosphosulfate kinase;
PDCD11
programmed cell death 11
PDCD11; programmed cell death 11; protein RRP5 homolog; ALG 4; KIAA0185; RRP5; apoptosis-linked gene 4; NF-kappa-B-binding protein; programmed cell death protein 11; ALG4; NFBP; ALG-4;
PDCD2L
programmed cell death 2-like
PDCD2L; programmed cell death 2-like; programmed cell death protein 2-like; MGC13096; MGC144595; Programmed cell death 2 like; Programmed cell death protein 2 like;
PDCD7
programmed cell death 7
PDCD7; programmed cell death 7; programmed cell death protein 7; ES18; HES18; U11/U12 snRNP 59K; apoptosis-related protein ES18; FLJ54213; MGC22015;
PIGO
phosphatidylinositol glycan anchor biosynthesis, class O
PIGO; phosphatidylinositol glycan anchor biosynthesis, class O; phosphatidylinositol glycan, class O; GPI ethanolamine phosphate transferase 3; DKFZp434M222; FLJ00135; MGC20536; MGC3079; FLJ00350; mFLJ00350; OTTHUMP00000021324; OTTHUMP00000021325; OTTMUSP00000007085; Phosphatidylinositol glycan anchor biosynthesis class O; Phosphatidylinositol glycan biosynthesis class O protein; Phosphatidylinositol glycan class O; PIG O; RP11-182N22.4; RP23-124L1.7; PIG-O; phosphatidylinositol-glycan biosynthesis class O protein;
PLEKHG5
pleckstrin homology domain containing, family G (with RhoGef domain) member 5
PLEKHG5; pleckstrin homology domain containing, family G (with RhoGef domain) member 5; pleckstrin homology domain-containing family G member 5; KIAA0720; NFkB activating protein; novel PH domain-containing protein; PH domain-containing family G member 5;
PLEKHM1
pleckstrin homology domain containing, family M (with RUN domain) member 1
PLEKHM1; pleckstrin homology domain containing, family M (with RUN domain) member 1; pleckstrin homology domain-containing family M member 1; KIAA0356; 162 kDa adapter protein; AP162; PH domain-containing family M member 1; PKHM1_HUMAN; B2; OPTB6;
POGK
pogo transposable element with KRAB domain
POGK; pogo transposable element with KRAB domain; BASS2; KIAA15131; KRAB box domain containing 2; KRBOX2; LST003; BASS 2; KIAA1513; OTTHUMP00000032214; OTTHUMP00000032215;
PRDM1
PR domain containing 1, with ZNF domain
PRDM1; PR domain containing 1, with ZNF domain; PR domain zinc finger protein 1; PR domain-containing protein 1; B lymphocyte induced maturation protein; B lymphocyte-induced maturation protein 1; beta-interferon gene positive regulatory domain I-binding factor; Blimp1; Blimp-1; PRDI-BF1; ZNFPR1A1;
PROCR
protein C receptor, endothelial
PROCR; protein C receptor, endothelial; CCCA; EPCR; CCD41; endothelial protein C receptor; APC receptor; centrocyclin; CD201 antigen; activated protein C receptor; cell cycle, centrosome-associated protein;
PRPS2
phosphoribosyl pyrophosphate synthetase 2
PRPS2; phosphoribosyl pyrophosphate synthetase 2; ribose-phosphate pyrophosphokinase 2; PRS II; ribose phosphate diphosphokinase 2; EC 2.7.6.1; Phosphoribosyl pyrophosphate synthetase II; PPRibP; Ribose phosphate pyrophosphokinase II; PRS-II; PPRibP synthetase; OTTHUMP00000022921; OTTHUMP00000214964; OTTHUMP00000214965; ribose-phosphate diphosphokinase 2; phosphoribosyl pyrophosphate synthase II; PRSII;
QARS
glutaminyl-tRNA synthetase
QARS; glutaminyl-tRNA synthetase; glutamine--tRNA ligase; glutamine tRNA ligase; glutamine-tRNA synthetase; GLNRS; PRO2195;
RALGPS2
Ral GEF with PH domain and SH3 binding motif 2
RALGPS2; Ral GEF with PH domain and SH3 binding motif 2; ras-specific guanine nucleotide-releasing factor RalGPS2; FLJ10244; FLJ25604; KIAA0351; dJ595C2.1; Ral A exchange factor RalGPS2; RALGPS 2; OTTHUMP00000033050; OTTHUMP00000038515; ralA exchange factor RalGPS2; Ral-A exchange factor RalGPS2; ral GEF with PH domain and SH3-binding motif 2;
RARS
arginyl-tRNA synthetase
RARS; arginyl-tRNA synthetase; arginine--tRNA ligase, cytoplasmic; arginine tRNA ligase 1; cytoplasmic; DALRD1; arginine tRNA ligase 1, cytoplasmic; arginyl-tRNA synthetase, cytoplasmic; ArgRS; MGC8641;
RIT2
Ras-like without CAAX 2
RIT2; Ras-like without CAAX 2; Ric (Drosophila) like, expressed in neurons , RIN; GTP-binding protein Rit2; RIBA; GTP binding protein Rit2; GTP binding protein Roc2; Ras like protein expressed in neurons; Ras like without CAAX 2; Ras like without CAAX protein 2; Ras-like protein expressed in neurons; Ras-like without CAAX protein 2; Ric (Drosophila) like; Ric like; RIN; RIT2_HUMAN; ROC2; OTTHUMP00000163445; GTP-binding protein Roc2; Ric-like, expressed in neurons;
RNASEL
ribonuclease L (2,5-oligoisoadenylate synthetase-dependent)
RNASEL; ribonuclease L (2,5-oligoisoadenylate synthetase-dependent); PRCA1, prostate cancer 1 , RNS4; 2-5A-dependent ribonuclease; 2 5A dependent ribonuclease; 2 5 oligoisoadenylate synthetase dependent; 2-5A-dependent RNase; DKFZp781D08126; Interferon induced 2 5A dependent RNase; MGC104972; MGC133329; PRCA 1; PRCA1; Ribonuclease 4; Ribonuclease L (2 5-oligoisoadenylate synthetase dependent); Ribonuclease L; Ribonuclease4; RibonucleaseL; RNS 4; RNS4; RNase L; OTTHUMP00000033148; interferon-induced 2-5A-dependent RNase; 2,5-oligoisoadenylate synthetase-dependent;
RNMT
RNA (guanine-7-) methyltransferase
RNMT; RNA (guanine-7-) methyltransferase; mRNA cap guanine-N7 methyltransferase; RG7MT1; hMet; hCMT1; hcm1p; mRNA cap methyltransferase; mRNA (guanine-7-)methyltransferase; mRNA (guanine-N(7)-)-methyltransferase; MET; hCMT1c; KIAA0398; DKFZp686H1252;
SFMBT1
Scm-like with four mbt domains 1
SFMBT1; Scm-like with four mbt domains 1; scm-like with four MBT domains protein 1; DKFZp434L243; RU1; SFMBT; renal ubiquitous protein 1; Scm-related gene containing four mbt domains; Scm-related gene product containing four mbt domains;
SHMT1
serine hydroxymethyltransferase 1 (soluble)
SHMT1; serine hydroxymethyltransferase 1 (soluble); serine hydroxymethyltransferase, cytosolic; 14 kDa protein; CSHMT; cytoplasmic serine hydroxymethyltransferase; MGC15229; MGC24556; SHMT; serine methylase; glycine hydroxymethyltransferase;
SLC19A2
solute carrier family 19 (thiamine transporter), member 2
SLC19A2; solute carrier family 19 (thiamine transporter), member 2; TRMA; thiamine transporter 1; THTR1; S19A2_HUMAN; Solute carrier family 19 member 2; TC1; Thiamine carrier 1; THT1; ThTr 1; ThTr-1; OTTHUMP00000033497; OTTHUMP00000033498; OTTHUMP00000033499; high affinity thiamine transporter; reduced folate carrier protein (RFC) like;
SLC4A1
solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)
SLC4A1; solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group); AE1, DI, EPB3, Waldner blood group , WD; band 3 anion transport protein; CD233; FR; Froese blood group; RTA1A; SW; Swann blood group; WR; Wright blood group; Solute carrier family 4 anion exchanger member 1; Solute carrier family 4 member 1; AE 1; AE1; Anion exchange protein 1; Anion exchanger 1; B3AT_HUMAN; BND3; DI; Diego blood group; EMPB3; EPB3; Erythrocyte membrane protein band 3; Erythroid anion exchange protein; Waldner blood group; WD; WD1; OTTHUMP00000210781; solute carrier fa;
SMO
smoothened, frizzled class receptor
SMO; smoothened, frizzled class receptor; Gx; SMOH; FZD11; smoothened homolog; protein Gx; frizzled family member 11; seven transmembrane helix receptor; smoothened, frizzled family receptor; smoothened, seven transmembrane spanning receptor;
SMS
spermine synthase
SMS; spermine synthase; Snyder Robinson X linked mental retardation syndrome , SRS; MRSR; SPMSY; SpS; Spermidine aminopropyltransferase; Snyder Robinson X linked mental retardation syndrome; SPSY_HUMAN; SRS; Snyder-Robinson X-linked mental retardation syndrome;
STEAP1
six transmembrane epithelial antigen of the prostate 1
STEAP1; six transmembrane epithelial antigen of the prostate 1; six transmembrane epithelial antigen of the prostate , STEAP; metalloreductase STEAP1; PRSS24; six-transmembrane epithelial antigen of prostate 1; STEAP; MGC19484;
STK17B
serine/threonine kinase 17b
STK17B; serine/threonine kinase 17b; DRAK2; serine/threonine-protein kinase 17B; death-associated protein kinase-related 2; DAP kinase-related apoptosis-inducing protein kinase 2;
STK32A
serine/threonine kinase 32A
STK32A; serine/threonine kinase 32A; serine/threonine-protein kinase 32A; MGC22688; YANK1; A930015B13Rik; Serine/threonine protein kinase 32A; STK 32A; YANK 1; OTTHUMP00000223848; OTTHUMP00000223877;
STK38
serine/threonine kinase 38
STK38; serine/threonine kinase 38; serine/threonine-protein kinase 38; NDR; NDR1 protein kinase; nuclear Dbf2-related 1; nuclear Dbf2-related kinase 1; Ndr Ser/Thr kinase-like protein; serine threonine protein kinase; NDR1;
STK40
serine/threonine kinase 40
STK40; serine/threonine kinase 40; serine/threonine-protein kinase 40; MGC4796; SgK495; 2310004N11Rik; sugen kinase 495; Ser/Thr-like kinase; SINK-homologous serine/threonine-protein kinase; SHIK; RP11-268J15.4;
STON1-GTF2A1L
STON1-GTF2A1L readthrough
STON1-GTF2A1L; STON1-GTF2A1L readthrough; STON1-GTF2A1L protein; SALF; stoned B/TFIIA alpha/beta like factor; SBLF; STN 1; Stoned B like factor; Stonin 1; OTTHUMP00000159452; OTTHUMP00000200508; OTTHUMP00000201180; stoned B/TFIIA-alpha/beta-like factor;
STT3A
STT3, subunit of the oligosaccharyltransferase complex, homolog A
STT3A; STT3, subunit of the oligosaccharyltransferase complex, homolog A (S. cerevisiae); integral membrane protein 1 , ITM1; dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A; MGC9042; STT3 A; TMC; B5; transmembrane conserved;
STYK1
serine/threonine/tyrosine kinase 1
STYK1; serine/threonine/tyrosine kinase 1; tyrosine-protein kinase STYK1; DKFZp761P1010; NOK; SuRTK106; Novel oncogene with kinase domain; Protein kinase STYK1; Protein PK unique; Protein PK-unique; Styk 1; STYK1_HUMAN; SuRTK 106; Tyrosine protein kinase STYK1; OTTHUMP00000238727;
TGFB1I1
transforming growth factor beta 1 induced transcript 1
TGFB1I1; transforming growth factor beta 1 induced transcript 1; HIC5; ARA55; HIC-5; TSC-5; transforming growth factor beta-1-induced transcript 1 protein; androgen receptor coactivator ARA55; hydrogen peroxide-inducible clone 5 protein; androgen receptor coactivator 55 kDa protein; androgen receptor-associated protein of 55 kDa;
TGS1
trimethylguanosine synthase 1
TGS1; trimethylguanosine synthase 1; NCOA6IP, nuclear receptor coactivator 6 interacting protein , trimethylguanosine synthase homolog (S. cerevisiae); trimethylguanosine synthase; PIMT; Cap specific guanine N2 methyltransferase; CLL associated antigen KW 2; DKFZp762A163; FLJ22995; HCA137; Hepatocellular carcinoma associated antigen 137; NCOA6IP; Nuclear receptor coactivator 6 interacting protein; PIPMT; PRIP interacting protein PIPMT; PRIP interacting protein with methyltransferase domain; PRIP interacting protein with methyltransferase motif; SEREX defined; TGS 1; Trimethylguanosine synthase homolog (S. cerevisiae); Trimethylguanosine synthase homolog; SEREX-defined; CLL-associated antigen KW-2; PRIP-interacting protein PIPMT; cap-specific guanine-N2 methyltransferase; hepatocellular carcinoma-associated antigen 137; nuclear receptor coactivator 6-interacting protein; PRIP-interacting protein with methyltransferase motif; PRIP-interacting protein with methyltransferase domain;
THAP1
THAP domain containing, apoptosis associated protein 1
THAP1; THAP domain containing, apoptosis associated protein 1; dystonia 6, torsion (autosomal dominant) , DYT6; 4833431A01Rik; FLJ10477;
THOC6
THO complex 6 homolog
THOC6; THO complex 6 homolog (Drosophila); WD repeat domain 58 , WDR58; THO complex subunit 6 homolog; fSAP35; functional spliceosome associated protein 35; MGC2655; WD repeat domain 58; WD repeat-containing protein 58; functional spliceosome-associated p;
THUMPD1
THUMP domain containing 1
THUMPD1; THUMP domain containing 1; THUMP domain-containing protein 1; FLJ20274; DKFZp686C1054;
TK1
thymidine kinase 1, soluble
TK1; thymidine kinase 1, soluble; thymidine kinase, cytosolic; thymidine kinase-1; thymidine kinase 1 soluble isoform; TK2;
TMEFF2
transmembrane protein with EGF-like and two follistatin-like domains 2
TMEFF2; transmembrane protein with EGF-like and two follistatin-like domains 2;
TMSB4X
thymosin beta 4, X-linked
TMSB4X; FX; PTMB4; TB4X; TMSB4; thymosin beta 4, X-linked; OTTHUMP00000022927; prothymosin beta-4; thymosin, beta 4, X chromosome; thymosin beta-4; T beta-4; THYB4; Thymosin Beat 4;
TRADD
TNFRSF1A-associated via death domain
TRADD; TNFRSF1A-associated via death domain; tumor necrosis factor receptor type 1-associated DEATH domain protein; Hs.89862; TNFR1-associated death domain protein; tumor necrosis factor receptor-1-associated protein; tumor necrosis factor receptor type 1 associated death domain protein; MGC11078;
TRIP6
thyroid hormone receptor interactor 6
TRIP6; thyroid hormone receptor interactor 6; thyroid receptor-interacting protein 6; MGC3837; MGC4423; MGC10556; MGC10558; MGC29959; OIP1; ZRP 1; OIP-1; OPA interacting protein 1; OPA-interacting protein 1; Thyroid receptor interacting protein 6; TR-interacting protein 6; TRI6; TRIP 6; TRIP-6; TRIP6_HUMAN; ZRP-1; ZRP1; Zyxin related protein 1; Zyxin-related protein 1; OTTHUMP00000211326; thyroid hormone receptor interacting protein 6; TRIP6i2;
TRMT112
tRNA methyltransferase 11-2 homolog (S. cerevisiae)
TRMT112; tRNA methyltransferase 11-2 homolog (S. cerevisiae); TRM112; HSPC152; HSPC170; TRMT11-2; tRNA methyltransferase 112 homolog; OTTHUMP00000237051; OTTHUMP00000237052; OTTHUMP00000237053; OTTHUMP00000237320; TRM112-like protein;
TXNDC3
thioredoxin domain containing 3 (spermatozoa)
TXNDC3; thioredoxin domain containing 3 (spermatozoa); thioredoxin domain-containing protein 3; CILD6; NME8; sperm specific thioredoxin 2; SPTRX2; NM23 H8; Spermatid specific thioredoxin 2; Sptrx 2; Thioredoxin domain containing protein 3; OTTHUMP00000128304; OTTHUMP00000207133; sperm-specific thioredoxin 2; spermatid-specific thioredoxin-2; NM23-H8; sptrx-2;
TXNL4A
thioredoxin-like 4A
TXNL4A; thioredoxin-like 4A; thioredoxin like 4 , TXNL4; thioredoxin-like protein 4A; DIB1; DIM1; HsT161; similar to S. pombe dim1+; U5 15kD; DIB 1; DIM 1; DIM1 protein homolog; Spliceosomal U5 snRNP specific 15 kDa protein; Thioredoxin like 4; Thioredoxin like 4A; Thioredoxin like protein 4A; Thioredoxin like U5 snRNP protein U5 15kD; TXNL 4; TXNL 4A; TXNL4; thioredoxin-like 4; thioredoxin-like U5 snRNP protein U5-15kD; spliceosomal U5 snRNP-specific 15 kDa protein; U5-15kD;
TXNRD2
thioredoxin reductase 2
TXNRD2; thioredoxin reductase 2; thioredoxin reductase 2, mitochondrial; selenoprotein Z; thioredoxin reductase beta; TR; TR3; TRXR2; thioredoxin reductase 3; thioredoxin reductase TR3; SELZ; TR-BETA;
UBRF2
Ubiquitin-like With PHD And Ring Finger Domains 2
UHRF2; DKFZp434B0920; DKFZp686G0837; E3 ubiquitin-protein ligase UHRF2; EC 6.3.2.; MGC33463; NIRF; Np95/ICBP90-like RING finger protein; np95/ICBP90-like RING finger protein; Np95-like ring finger protein; Nuclear protein 97; nuclear protein 97; Nuclear zinc finger protein Np97; nuclear zinc finger protein NP97; OTTHUMP00000021047; RING finger protein 107; RNF107; RP11-472F14.2; Ubiquitin-like PHD and RING finger domain-containing protein 2; ubiquitin-like PHD and RING finger domain-containing protein 2; ubiquitin-like with PHD and ring finger domains 2; ubiquitin-like, containing PHD and RING finger domains, 2; ubiquitin-like-containing PHD and RING finger domains protein 2; Ubiquitin-like-containing PHD and RING finger domains protein 2; URF2;
UMPS
uridine monophosphate synthetase
UMPS; uridine monophosphate synthetase; uridine 5-monophosphate synthase; orotate phosphoribosyl transferase and orotidine 5 decarboxylase; OMPdecase; OPRT; OPRtase; Orotate phosphoribosyltransferase phosphoribosyltransferase; Orotidine 5 phosphate decarboxylase; UMP synthase; Uridine 5 monophosphate synthase; OTTHUMP00000215261; orotate phosphoribosyltransferase; orotidine 5-phosphate decarboxylase;
MRI1
methylthioribose-1-phosphate isomerase 1
MTNA; MGC3207; Ypr118w; methylthioribose-1-phosphate isomerase; M1Pi; MTR-1-P isomerase; mediator of RhoA-dependent invasion; S-methyl-5-thioribose-1-phosphate isomerase; translation initiation factor eIF-2B subunit alpha/beta/delta-like protein; MRI1; methylthioribose-1-phosphate isomerase 1;
PIGL
phosphatidylinositol glycan anchor biosynthesis, class L
PIGL; phosphatidylinositol glycan anchor biosynthesis, class L; phosphatidylinositol glycan, class L; N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase; N acetylglucosaminylphosphatidylinositol deacetylase; Phosphatidylinositol glycan anchor biosynthesis class L; Phosphatidylinositol glycan class L; Phosphatidylinositol-glycan biosynthesis class L protein; PIG-L; PIGL_HUMAN; N-acetylglucosaminylphosphatidylinositol deacetylase;
PIGS
phosphatidylinositol glycan anchor biosynthesis, class S
PIGS; phosphatidylinositol glycan anchor biosynthesis, class S; GPI transamidase component PIG-S; DKFZp686K20216; FLJ45226; GPI transamidase subunit; Phosphatidylinositol glycan anchor biosynthesis class S; Phosphatidylinositol glycan class S; Phosphatidylinositol-glycan biosynthesis class S protein; PIGS_HUMAN; phosphatidylinositol glycan, class S homolog; Gm393; Gm689; BC058979;
GPX4
glutathione peroxidase 4
GPX4; glutathione peroxidase 4; MCSP; GPx-4; PHGPx; snGPx; GSHPx-4; snPHGPx; phospholipid hydroperoxide glutathione peroxidase, mitochondrial; phospholipid hydroperoxidase; sperm nucleus glutathione peroxidase;
RIPK1
receptor (TNFRSF)-interacting serine-threonine kinase 1
RIPK1; receptor (TNFRSF)-interacting serine-threonine kinase 1; receptor-interacting serine/threonine-protein kinase 1; RIP; RIP-1; cell death protein RIP; receptor interacting protein; receptor-interacting protein 1; serine/threonine-protein kinase RIP;
GPX1
glutathione peroxidase 1
GPX1; glutathione peroxidase 1; GPx-1; GSHPx-1; cellular glutathione peroxidase; GPXD; GSHPX1; MGC14399; MGC88245;
GYS1
glycogen synthase 1 (muscle)
GYS1; glycogen synthase 1 (muscle); GYS; glycogen [starch] synthase, muscle; GSY;
GST
Glutathione-S-Transferase
GST; Glutathione-S-Transferase; Glutathione S alkyltransferase A1; Glutathione S aralkyltransferase A1; Glutathione S aryltransferase A1; Glutathione S transferase 2; Glutathione S transferase A1; Glutathione S-transferase A1; GST 2; GST class alpha; GST class alpha 1; GST class alpha member 1; GST class-alpha member 1; GST epsilon; GST HA subunit 1; GST-epsilon; GST2; GSTA 1; GSTA1 1; GSTA1; GSTA1 protein; GSTA1-1; GSTA1_HUMAN; GTH 1; GTH1; HA subunit 1; MGC131939; S (hydroxyalkyl) glutathione lyase A1; Glutathione S Transferase ; Glutathione S transferase Mu 1 ; Glutathione S-transferase class-mu 26 kDa isozyme ; Gluthatione s transferase ; GST 26 ; GST ; GST class mu 1 ; GST1 ; GSTM1 1 ; GSTM1a 1a ; GSTM1b 1b ; GTH4 ; GTM1 ; H B ; HB subunit 4 ; MGC26563 ; MU 1 ; MU ; SJ26 antigen ; SjGST ;
THOP1
thimet oligopeptidase 1
THOP1; thimet oligopeptidase 1; thimet oligopeptidase; EC 3.4.24.15; Endopeptidase 24.15; EP24.15; MEPD_HUMAN; MP78; THOP1_HUMAN; TOP;
ACOT12
acyl-CoA thioesterase 12
ACOT12; acyl-CoA thioesterase 12; acyl-coenzyme A thioesterase 12; Cach; StAR related lipid transfer (START) domain containing 15; STARD15; THEAL; hCACH-1; cytosolic acetyl-CoA hydrolase; acyl-CoA thioester hydrolase 12; START domain-containing protein 15;
IFIT3
interferon-induced protein with tetratricopeptide repeats 3
IFIT3; interferon-induced protein with tetratricopeptide repeats 3; IFIT4, interferon induced protein with tetratricopeptide repeats 4; CIG 49; GARG 49; IFI60; IRG2; ISG60; RIG G; RP11-149I23.4; CIG49; IFI-60K; IFI60K; IFIT-3; IFIT-4; IFIT3_HUMAN; IFIT4; Interferon induced 60 kDa protein; Interferon induced protein with tetratricopeptide repeats 3; Interferon-induced 60 kDa protein; Interferon-induced protein with tetratricopeptide repeats 4; ISG-60; Retinoic acid induced gene G protein; Retinoic acid-induced gene G protein; RIG-G; RIGG; CIG-49; GARG-49;
GSTA4
glutathione S-transferase alpha 4
GSTA4; glutathione S-transferase alpha 4; glutathione S transferase A4; glutathione S-transferase A4; DKFZp686D21185; Glutathione S alkyltransferase A4; Glutathione S aralkyltransferase A4; Glutathione S aryltransferase A4; Glutathione S transferase A4 4; Glutathione S transferase alpha 4; Glutathione S-transferase A4-4; Glutathione transferase A4 4; GST class alpha member 4; GST class-alpha member 4; GSTA4 4; GSTA4_HUMAN; GTA4; OTTHUMP00000016624; OTTHUMP00000016625; S (hydroxyalkyl)glutathione lyase A4; glutathione transferase A4-4; glutathione S-aryltransferase A4; glutathione S-alkyltransferase A4; glutathione S-aralkyltransferase A4; S-(hydroxyalkyl)glutathione lyase A4; GSTA4-4;
FAM84B
family with sequence similarity 84, member B
FAM84B; family with sequence similarity 84, member B; protein FAM84B; BCMP101; breast cancer membrane associated protein 101; neurological/sensory 2; NSE2; BF642811; D330050I23Rik; Breast cancer membrane protein 101; Breast cancer membrane-associated protein 101; FA84B_HUMAN; Family with sequence similarity 84 member B; OTTHUMP00000228215; Protein NSE2; RGD1562236;
GSTT2
glutathione S-transferase, theta 2
GSTT2; glutathione S-transferase, theta 2; glutathione S-transferase theta-2; EC 2.5.1.18; Glutathione S transferase 12; Glutathione S transferase Yrs Yrs; Glutathione S-transferase theta-2B; GST 12 12; GST class theta 2; GST class-theta-2; GST T2; GSTT 2; GSTT2 protein; GSTT2_HUMAN; GSTT2B; MGC182032; OTTHUMP00000198491; OTTHUMP00000198492; Yrs; mGSTT2; AI266894;
LCMT1
leucine carboxyl methyltransferase 1
LCMT1; leucine carboxyl methyltransferase 1; Lcmt; LCMT-1; AL033290; MGC11807;
PRPSAP2
phosphoribosyl pyrophosphate synthetase-associated protein 2
PRPSAP2; phosphoribosyl pyrophosphate synthetase-associated protein 2; phosphoribosyl pyrophosphate synthase-associated protein 2; PAP41; 41 kDa phosphoribosypyrophosphate synthetase associated protein; 41 kDa phosphoribosypyrophosphate synthetase-associated protein; KPRB; KPRB_HUMAN; MGC117304; MGC126719; MGC126721; Phosphoribosyl pyrophosphate synthetase associated protein 2; PRPP synthase-associated protein 2; PRPP synthetase associated protein 2;
PKMYT1
protein kinase, membrane associated tyrosine/threonine 1
PKMYT1; protein kinase, membrane associated tyrosine/threonine 1; membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase; membrane associated tyrosine and threonine specific cdc2 inhibitory kinase; MYT1; myt1 kinase; FLJ20093; DKFZp5;
MMAA
methylmalonic aciduria (cobalamin deficiency) cblA type
MMAA; methylmalonic aciduria (cobalamin deficiency) cblA type; methylmalonic aciduria (cobalamin deficiency) type A; methylmalonic aciduria type A protein, mitochondrial; cblA; mitochondrial; Methylmalonic aciduria type A protein; Methylmalonic aciduria type A protein mitochondrial; MGC120010; MGC120011; MGC120012; MGC120013; MMAA_HUMAN; OTTHUMP00000220105; OTTHUMP00000220104;
ILVBL
ilvB (bacterial acetolactate synthase)-like
ILVBL; ilvB (bacterial acetolactate synthase)-like; acetolactate synthase-like protein; 209L8; acetolactate synthase homolog; AHAS; FLJ39061; ILV2H; MGC1269; MGC19535; Acetolactate synthase like protein; IlvB (bacterial acetolactate synthase) like; IlvB like protein; IlvB-like protein; ILVBL_HUMAN;
PAICS
phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase
PAICS; phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase; PAIS; multifunctional protein ADE2; ADE2H1; AIRC; ADE2; AIR carboxylase; DKFZp781N1372; MGC1343; MGC5024; Phosphoribosylaminoimidazole carboxylase; PUR6_HUMAN; SAICAR synthetase; multifunctional protein ADE2H1;
TBXAS1
thromboxane A synthase 1 (platelet)
TBXAS1; thromboxane A synthase 1 (platelet); thromboxane A synthase 1 (platelet, cytochrome P450, subfamily V); thromboxane-A synthase; CYP5; CYP5A1; cytochrome P450; family 5; subfamily A; polypeptide 1; THAS; TS; TXAS; TXS; Cytochrome P450 5A1; FLJ52771; GHOSAL; THAS_HUMAN; Thromboxane A synthase 1 platelet cytochrome P450 subfamily V; TXA synthase; OTTHUMP00000211927; OTTHUMP00000211928; OTTHUMP00000211929; OTTHUMP00000211930; OTTHUMP00000211931; platelet, cytochrome P450, subfamily V; cytochrome P450, family 5, subfamily A, polypeptide 1; thromboxane; BDPLT14;
IGF2BP2
Insulin-like growth factor 2 mRNA binding protein 2
RP23-50H13.1; C330012H03Rik; IMP-2; Imp2; Neilsen; IGF-II mRNA-binding protein 2; IGF2 mRNA-binding protein 2; VICKZ family member 2; insulin-like growth factor 2 mRNA-binding protein 2; insulin-like growth factor 2, binding protein 2;
PANK2
pantothenate kinase 2
PANK2; pantothenate kinase 2; pantothenate kinase 2 (Hallervorden-Spatz syndrome); AI642621; 4933409I19Rik; MGC118448;
PANK3
pantothenate kinase 3
PANK3; pantothenate kinase 3; FLJ12899; hPanK3; pantothenic acid kinase 3; MGC16863; DKFZp686O22247;
STK39
serine threonine kinase 39
STK39; serine threonine kinase 39; STE20/SPS1-related proline-alanine-rich protein kinase; DCHT; SPAK; STE20/SPS1 homolog (yeast); STE20/SPS1 homolog; ste-20-related kinase; Ste20-like protein kinase; small intestine SPAK-like kinase; serine/threonine-pro;
ATP5B
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide
ATP5B; ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide; ATPSB; ATP synthase subunit beta, mitochondrial; mitochondrial; ATP 5B; ATP synthase subunit beta; ATP synthase subunit beta mitochondrial; ATPB; ATPB_HUMAN; ATPMB; Mitochondrial ATP Synthase Subunit Beta; Mitochondrial ATP synthetase beta subunit; OTTHUMP00000243448; OTTHUMP00000243449; OTTHUMP00000243452; mitochondrial ATP synthase beta subunit; mitochondrial ATP synthetase, beta subunit;
TASP1
taspase, threonine aspartase, 1
TASP1; taspase, threonine aspartase, 1; C20orf13, chromosome 20 open reading frame 13; threonine aspartase 1; dJ585I14.2; FLJ20212; taspase 1; taspase-1; C20orf13; MGC39159;
TIPRL
TIP41, TOR signaling pathway regulator-like
TIPRL; TIP41, TOR signaling pathway regulator-like (S. cerevisiae); TIP41, TOR signalling pathway regulator like (S. cerevisiae); TIP41-like protein; dJ69E11.3; MGC3794; TIP41; type 2A-interacting protein; putative MAPK activating protein; putative MAPK-a;
IFIT1
interferon-induced protein with tetratricopeptide repeats 1
IFIT1; interferon-induced protein with tetratricopeptide repeats 1; G10P1, IFI56, IFNAI1; GARG 16; IFI 56; IFI56; IFNAI1; C56; G10P1; GARG16; IFI 56K; IFI-56K; IFIT-1; IFIT1_HUMAN; Interferon alpha inducible protein (MW 56kD); Interferon induced 56 kDa protein; Interferon induced protein 56; Interferon-induced 56 kDa protein; ISG56; OTTHUMP00000020062; RNM561; interferon-induced protein 56; Interferon, alpha-inducible protein (MW 56kD); IFI-56; GARG-16;
PUS7
pseudouridylate synthase 7 homolog
PUS7; pseudouridylate synthase 7 homolog (S. cerevisiae); pseudouridylate synthase 7 homolog; FLJ20485; KIAA1897; MGC17720;
GADD45GIP1
growth arrest and DNA-damage-inducible, gamma interacting protein 1
GADD45GIP1; growth arrest and DNA-damage-inducible, gamma interacting protein 1; growth arrest and DNA damage-inducible proteins-interacting protein 1; CKBBP2; CKII beta binding protein 2; CR6 interacting factor 1; CRIF1; MGC4667; MGC4758; p53 responsive gene 6; papillomavirus L2 interacting nuclear protein 1; PLINP 1; Plinp1; PRG6; CKII beta associating protein; CKII beta-associating protein; CR6-interacting factor 1; G45IP_HUMAN; growth arrest and DNA damage inducible, gamma interacting protein 1; p53 responsive gene 6 protein; p53-responsive gene 6 protein; Papillomavirus L2-interacting nuclear protein 1; PLINP-1;
FAM3B
family with sequence similarity 3, member B
FAM3B; family with sequence similarity 3, member B; C21orf11, chromosome 21 open reading frame 11; protein FAM3B; 2 21; C21orf76; D21M16SJHU19e; ORF9; PRED44; pancreatic derived factor; pancreatic-derived factor; cytokine-like protein 2-21; 2-21; PANDER;
ILKAP
integrin-linked kinase-associated serine/threonine phosphatase
ILKAP; integrin-linked kinase-associated serine/threonine phosphatase; integrin linked kinase associated serine/threonine phosphatase 2C; integrin-linked kinase-associated serine/threonine phosphatase 2C; DKFZP434J2031; FLJ10181; protein phosphatase 2c, d;
ECE1
endothelin converting enzyme 1
ECE1; endothelin converting enzyme 1; ECE; endothelin-converting enzyme 1; ECE-1;
FAM3D
family with sequence similarity 3, member D
FAM3D; family with sequence similarity 3, member D; protein FAM3D; EF7; OIT1; Cytokine-like protein EF-7; Protein FAM3D precursor;
TXNL4B
thioredoxin-like 4B
TXNL4B; thioredoxin-like 4B; thioredoxin-like protein 4B; Dim2; DLP; FLJ20511; AI595343; D530025J19Rik; Dim1 like protein; Dim1-like protein; MGC109322; RGD1305127; Thioredoxin like 4B; Thioredoxin like protein 4B; TXN4B_HUMAN;
ACOT7
acyl-CoA thioesterase 7
ACOT7; acyl-CoA thioesterase 7; cytosolic acyl coenzyme A thioester hydrolase; ACH1; ACT; BACH; brain acyl CoA hydrolase; CTE II; hBACH; LACH1; MGC1126; CTE-IIa; acyl-CoA thioesterase 2; brain acyl-CoA hydrolase; acyl-CoA thioesterase, long chain; long ch;
ACOT8
acyl-CoA thioesterase 8
ACOT8; acyl-CoA thioesterase 8; peroxisomal acyl CoA thioesterase , peroxisomal acyl CoA thioesterase 1 , PTE1; acyl-coenzyme A thioesterase 8; choloyl CoA hydrolase; hACTE III; hTE; PTE 2; ACTEIII; ACOT8_HUMAN; acyl CoA thioesterase 8; Choloyl coenzyme A thioesterase; Choloyl-coenzyme A thioesterase; hACTE-III; hACTEIII; HIV Nef associated acyl CoA thioesterase; HIV-Nef-associated acyl-CoA thioesterase; HNAACTE; Long chain fatty acyl CoA hydrolase; Palmitoyl CoA hydrolase; Peroxisomal acyl CoA thioesterase 1; Peroxisomal acyl coenzyme A thioester hydrolase 1; Peroxisomal acyl-coenzyme A thioester hydrolase 1; Peroxisomal long chain acyl CoA thioesterase 1; Peroxisomal long-chain acyl-CoA thioesterase 1; PTE 1; PTE-1; PTE-2; PTE1; PTE2; Thioesterase II; thioesterase III; OTTHUMP00000031675; OTTHUMP00000214962; choloyl-CoA hydrolase; palmitoyl-CoA hydrolase; long-chain fatty-acyl-CoA hydrolase; peroxisomal acyl-CoA thioesterase 1; HIV;
ACSL5
acyl-CoA synthetase long-chain family member 5
ACSL5; acyl-CoA synthetase long-chain family member 5; FACL5, fatty acid Coenzyme A ligase, long chain 5; long-chain-fatty-acid--CoA ligase 5; ACS2; ACS5; FACL5 for fatty acid coenzyme A ligase 5; fatty acid Coenzyme A ligase; long chain 5; long chain ac;
ACSS1
acyl-CoA synthetase short-chain family member 1
ACSS1; acyl-CoA synthetase short-chain family member 1; ACAS2L, acetyl Coenzyme A synthetase 2 (AMP forming) like; acetyl-coenzyme A synthetase 2-like, mitochondrial; AceCS2L; dJ568C11.3; MGC33843; acetate--CoA ligase 2; ACAS2L; ACECS1; FLJ45659;
ACSS2
acyl-CoA synthetase short-chain family member 2
ACSS2; acyl-CoA synthetase short-chain family member 2; ACAS2, acetyl Coenzyme A synthetase 2 (ADP forming); acetyl-coenzyme A synthetase, cytoplasmic; AceCS; ACS; ACSA; dJ1161H23.1; cytoplasmic; ACAS2; Acetate CoA ligase; Acetate thiokinase; Acetate--CoA ligase; Acetyl CoA synthetase; Acetyl Coenzyme A synthetase 2 (ADP forming); Acetyl coenzyme A synthetase cytoplasmic; Acetyl-CoA synthetase; Acetyl-coenzyme A synthetase; ACSA_HUMAN; Acyl activating enzyme; Acyl CoA synthetase short chain family member 2; Acyl-activating enzyme; Cytoplasmic acetyl coenzyme A synthetase; MYH7B; acetate-CoA ligase; cytoplasmic acetyl-coenzyme A synthetase; acetyl-Coenzyme A synthetase 2 (ADP forming);
ADSSL1
adenylosuccinate synthase like 1
ADSSL1; adenylosuccinate synthase like 1; adenylosuccinate synthetase isozyme 1; FLJ38602; basic isozyme; muscle isozyme; Adenylosuccinate synthetase; AdSS 1; ADSS1; AMPSase 1; IMP aspartate ligase 1; IMP--aspartate ligase 1; M-type adenylosuccinate synthetase; PURA1_HUMAN; OTTHUMP00000244483; OTTHUMP00000244484; adenylosuccinate synthetase, basic isozyme; adenylosuccinate synthetase, muscle isozyme;
ANK1
ankyrin 1, erythrocytic
ANK1; ankyrin 1, erythrocytic; ANK; ankyrin-1; SPH1; ANK-1; ANK1_HUMAN; Ankyrin 1; Ankyrin R; Ankyrin-R; Erythrocyte ankyrin; SPH2;
ANTXR1
anthrax toxin receptor 1
ANTXR1; anthrax toxin receptor 1; anthrax toxin receptor; ATR; FLJ10601; FLJ21776; TEM8; tumor endothelial marker 8 precursor; 2310008J16Rik; 2810405N18Rik; tumor endothelial marker 8; FLJ11298;
AOF1
KDM1B lysine (K)-specific demethylase 1B
AOF1; LSD2; C6orf193; FLJ33898; FLJ34109; FLJ43328; bA204B7.3; dJ298J15.2; DKFZp686I0412; lysine-specific histone demethylase 1B; OTTHUMP00000179124; OTTHUMP00000179125; amine oxidase, flavin containing 1; lysine-specific histone demethylase 2; amine oxidase (flavin containing) domain 1; flavin-containing amine oxidase domain-containing protein 1;
AOF2
KDM1A lysine (K)-specific demethylase 1A
AOF2; KDM1; LSD1; BHC110; KIAA0601; lysine-specific histone demethylase 1A; OTTHUMP00000003255; OTTHUMP00000003256; lysine (K)-specific demethylase 1; BRAF35-HDAC complex protein BHC110; amine oxidase (flavin containing) domain 2; FAD-binding protein BRAF35-HDAC complex, 110 kDa subunit; flavin-containing amine oxidase domain-containing protein 2;
ARAP1
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1
ARAP1; ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1; centaurin, delta 2 , CENTD2; arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1; ANK repeat and PH domain-containing protein 1; mKIAA0782; 2410002L19Rik; ARAP 1; ARAP1_HUMAN; Arf GAPRho GAP ankyrin repeat and pleckstrin homology domains containing protein 1; Arf GAP Rho GAP ankyrin repeat and pleckstrin homology domain containing protein 1; Arf-GAP with Rho-GAP domain; CENT D2; Centaurin delta 2; Centaurin delta2; Centaurin-delta-2; CENTD 2; CENTD2; Cnt d2; Cnt-d2; Cntd2; KIAA0782; MGC176140; OTTHUMP00000211458; OTTHUMP00000211459; OTTHUMP00000211460; OTTHUMP00000211461; OTTHUMP00000211462; OTTHUMP00000211463; centaurin, delta 2; ARF-GAP, RHO-GAP, anky;
ARAP3
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3
ARAP3; ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3; centaurin, delta 3 , CENTD3; arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3; DRAG1; FLJ21065; Ankyrin repeat and plekstrin homology domains containing protein 3; ARAP 3; ARF GAP; ARF-GAP RHO-GAP ankyrin repeat and plekstrin homology domains containing protein 3; Phosphoinositide binding protein; PtdIns 3 4 5 P3 binding protein; RHO GAP; cnt-d3; centaurin-delta-3; centaurin, delta 3; PtdIns(3,4,5)P3-binding protein; Arf and Rho GAP adapter protein 3; ARF-GAP, RHO-GAP, ankyrin repeat and plekstrin homology domains-containing protein 3; CENTD3;
ASMT
acetylserotonin O-methyltransferase
ASMT;acetylserotonin O-methyltransferase;ASMTY;HIOMT;HIOMTY;hydroxyindole O-methyltransferase;acetylserotonin N-methyltransferase;acetylserotonin methyltransferase (Y chromosome);
ATP5I
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E
ATP5I;ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E;ATP synthase, H+ transporting, mitochondrial F0 complex, subunit e, ATP synthase, H+ transporting, mitochondrial F0 complex, subunit E;ATP synthase subunit e, mitochondrial;ATPase subunit e;ATP synthase e chain, mitochondrial;F1F0-ATP synthase, murine e subunit;ATP synthase, H+ transporting, mitochondrial F0 complex, subunit E;ATP5K;MGC12532;
ATP5J
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6
ATP5J; ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6; ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F6 , ATP5, ATP5A, ATPM; ATP synthase-coupling factor 6, mitochondrial; CF6; coupling factor 6; mitochondrial; ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F6; ATP synthase-coupling factor 6; ATP5; ATP5A; ATP5J_HUMAN; ATPase subunit F6; ATPM; F6; MS508; OTTHUMP00000096106; OTTHUMP00000096107; OTTHUMP00000096108; OTTHUMP00000096110; OTTHUMP00000096111; OTTHUMP00000096112; proliferation-inducing protein 36; mitochondrial ATP synthas;
ATPAF2
ATP synthase mitochondrial F1 complex assembly factor 2
ATPAF2; ATP synthase mitochondrial F1 complex assembly factor 2; ATP12; Atp12p; LP3663; MGC29736; ATP12 homolog; OTTHUMP00000065658; OTTHUMP00000065659; OTTHUMP00000065660; MC5DN1;
BAG4
BCL2-associated athanogene 4
BAG4; BCL2-associated athanogene 4; BAG family molecular chaperone regulator 4; silencer of death domains; SODD; bcl-2-associated athanogene 4; BAG-family molecular chaperone regulator-4; BAG-4; DKFZp586O2022;
BAT3
BAG6 BCL2-associated athanogene 6
G3; BAT3; BAG-6; D6S52E; large proline-rich protein BAG6; scythe; protein G3; protein Scythe; OTTHUMP00000029237; OTTHUMP00000029238; OTTHUMP00000029239; HLA-B associated transcript 3; HLA-B associated transcript-3; HLA-B-associated transcript 3; large proline-rich protein BAT3; BAG family molecular chaperone regulator 6;
BHMT2
betaine--homocysteine S-methyltransferase 2
BHMT2; betaine--homocysteine S-methyltransferase 2; Betaine homocysteine S methyltransferase 2; EC 2.1.1.5; FLJ20001; betaine-homocysteine methyltransferase 2;
BLID
BH3-like motif containing, cell death inducer
BLID; BH3-like motif containing, cell death inducer; BH3-like motif-containing cell death inducer; BRCC2; breast cancer cell 2; OTTHUMP00000231802; breast cancer cell protein 2;
BSND
Bartter syndrome, infantile, with sensorineural deafness (Barttin)
BSND; Bartter syndrome, infantile, with sensorineural deafness (Barttin); deafness, autosomal recessive 73 , DFNB73; barttin; BART; deafness, autosomal recessive 73; DFNB73; MGC119283; MGC119284; MGC119285;
C7orf38
FAM200A family with sequence similarity 200, member A
C7orf38; FLJ36794; DKFZp727G131; hypothetical protein LOC221786; OTTHUMP00000210467;
CDS1
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1
CDS1; CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1; phosphatidate cytidylyltransferase 1; CDP DAG synthase 1; CDP DG synthetase 1; CDP diacylglycerol synthase (phosphatidate cytidylyltransferase) 1; CDP diacylglycerol synthase 1; CDP diglyceride pyrophosphorylase 1; CDP diglyceride synthetase 1; CDP-DAG synthase 1; CDP-DG synthase 1; CDP-diacylglycerol synthase 1; CDP-diglyceride pyrophosphorylase 1; CDP-diglyceride synthase 1; CDS 1; CDS; CDS1_HUMAN; CTP:phosphatidate cytidylyltransferase 1; CDP-DG synthetase 1; CDP-diglyceride synthetase 1; CTP:phosphatidate cytidylyltransf;
CIDEA
cell death-inducing DFFA-like effector a
CIDEA; cell death-inducing DFFA-like effector a; cell death activator CIDE-A; CIDE A; CIDE-A;
CIDEC
cell death-inducing DFFA-like effector c
cell death-inducing DFFA-like effector c; CIDEC; FSP27; CIDE-3; FLJ20871; cell death activator CIDE-3; OTTHUMP00000158645; OTTHUMP00000207602; fat specific protein 27; Cell Death Inducing DFFA Like Effector C; Cell death inducing DFFA like effector protein C; Cell death-inducing DFFA-like effector protein C; CIDE3; CIDEC_HUMAN; Fat-specific protein FSP27 homolog; CIDEX;
CIR
1 corepressor interacting with RBPJ, 1
CIR; corepressor interacting with RBPJ 1; recepin; OTTHUMP00000163177; OTTHUMP00000205180; CBF1 interacting corepressor; CBF1-interacting corepressor;
CLTA
clathrin, light chain A
CLTA;clathrin, light chain A;clathrin, light polypeptide (Lca);clathrin light chain A;Lca;LCA;
CLTC
clathrin, heavy chain (Hc)
CLTC; clathrin, heavy chain (Hc); Hc; CHC; CHC17; CLH-17; CLTCL2; clathrin heavy chain 1; clathrin, heavy polypeptide (Hc); clathrin, heavy polypeptide-like 2; clathrin heavy chain on chromosome 17;
COQ3
coenzyme Q3 homolog, methyltransferase
COQ3; coenzyme Q3 homolog, methyltransferase (S. cerevisiae); coenzyme Q3 homolog, methyltransferase (yeast); hexaprenyldihydroxybenzoate methyltransferase, mitochondrial; bA9819.1; polyprenyldihydroxybenzoate methyltransferase; DHHB-MT; DHHB-MTase; DHHB;
CRELD2
cysteine-rich with EGF-like domains 2
CRELD2; cysteine-rich with EGF-like domains 2; cysteine-rich with EGF-like domain protein 2; MGC11256; CREL2_HUMAN; CRELD 2; Cysteine rich with EGF like domain protein 2; Cysteine rich with EGF like domains 2; DKFZp667O055;
CTPS
CTP synthase
CTPS; CTP synthase; CTP synthase , CTPS; CTP synthase 1; CTP synthetase 1; UTP--ammonia ligase 1; cytidine 5-triphosphate synthetase; cytidine 5-prime triphosphate synthetase;
DAP
death-associated protein
DAP; death-associated protein; death-associated protein 1; DAP-1; MGC99796;
DAP3
death associated protein 3
DAP3; death associated protein 3; 28S ribosomal protein S29, mitochondrial; bMRP 10; DAP 3; DKFZp686G12159; MGC126058; MGC126059; mitochondrial 28S ribosomal protein S29; MRP S29; MRPS29; S29mt; death-associated protein 3; ionizing radiation resistance co;
DARS
aspartyl-tRNA synthetase
DARS; aspartyl-tRNA synthetase; aspartate--tRNA ligase, cytoplasmic; aspartate tRNA ligase 1; cytoplasmic; aspRS; aspartate tRNA ligase 1, cytoplasmic; aspartyl-tRNA synthetase, cytoplasmic; cell proliferation-inducing protein 40; cell proliferation-induc;
DDAH2
Dimethylarginine Dimethylaminohydrolase 2
N(G),N(G)-dimethylarginine dimethylaminohydrolase 2; dime-thylarginine dimethylaminohydrolase 2; DDAH-2; DDAH; DDAH2; protein G6a; S-phase protein; dimethylargininase-2; NG30; G6a; dimethylarginine dimethylaminohydrolase II; NG-dimethylarginine dimethylamino hydrolase homolog; dimethylarginine dimethylaminohydrolase 2; OT-THUMP00000029307; OTTHUMP00000029308; OT-THUMP00000029310; OTTHUMP00000174406; OT-THUMP00000174488; OTTHUMP00000174489; EC 3.5.3.18; alternative name: NG30, G6a;
DIDO1
death inducer-obliterator 1
DIDO1; death inducer-obliterator 1; C20orf158, chromosome 20 open reading frame 158 , DATF1, death associated transcription factor 1; death-inducer obliterator 1; BYE1; DIO 1; DIO1; dJ885L7.8; FLJ11265; KIAA0333; death-associated transcription factor 1;
DIO1
deiodinase, iodothyronine, type I
DIO1;deiodinase, iodothyronine, type I;TXDI1;type I iodothyronine deiodinase;DIOI;type 1 DI;type-I 5-deiodinase;thyroxine deiodinase type I (selenoprotein);5DI;MGC130050;MGC130051;
DMAP1
DNA methyltransferase 1 associated protein 1
DMAP1; DNA methyltransferase 1 associated protein 1; EAF2; SWC4; MEAF2; DNMAP1; DNMTAP1; DNA methyltransferase 1-associated protein 1; DNMT1 associated protein 1; DNMT1-associated protein 1;
DNMT3L
DNA (cytosine-5-)-methyltransferase 3-like
DNMT3L; DNA (cytosine-5-)-methyltransferase 3-like; DNA (cytosine-5)-methyltransferase 3-like; cytosine 5 methyltransferase 3 like protein; human cytosine 5 methyltransferase 3 like protein; MGC1090; cytosine-5-methyltransferase 3-like protein; human cyto;
EDNRA
endothelin receptor type A
EDNRA; endothelin receptor type A; ETA; ET-A; ETAR; ETRA; ETA-R; hET-AR; endothelin-1 receptor; G protein-coupled receptor; endothelin receptor subtype A; endothelin-1-specific receptor;
EPB41L1
erythrocyte membrane protein band 4.1-like 1
EPB41L1; erythrocyte membrane protein band 4.1-like 1; band 4.1-like protein 1; KIAA0338; neuronal protein 4.1; neuron-type nonerythroid protein 4.1; 4.1N; MRD11; MGC11072; DKFZp686H17242;
EPB42
erythrocyte membrane protein band 4.2
EPB42; erythrocyte membrane protein band 4.2; Erythrocyte surface protein band 4.2; MGC116735; MGC116737; PA; EPB42_HUMAN; Erythrocyte protein 4.2; P4.2; SPH5; OTTHUMP00000161294;
ETNK1
ethanolamine kinase 1
ETNK1; ethanolamine kinase 1; EKI; EKI1; EKI 1; putative protein product of Nbla10396; Nbla10396;
F2R
Coagulation factor II (thrombin) receptor
Coagulation factor II receptor; CF2R; Coagulation factor II (thrombin) receptor; F2R; HTR; PAR 1; PAR-1; PAR1; Protease activated receptor 1; Proteinase activated receptor 1; Proteinase-activated receptor 1; Thrombin receptor; TR;
FARSA
phenylalanyl-tRNA synthetase, alpha subunit
FARSA; phenylalanyl-tRNA synthetase, alpha subunit; FARSL, FARSLA, phenylalanine tRNA synthetase like , phenylalanyl tRNA synthetase like, alpha subunit; phenylalanyl-tRNA synthetase alpha chain; CML33; phenylalanine tRNA ligase 1; alpha; cytoplasmic; CML 33; FARS; FARSL; FRSA; PheHA; Phenylalanine tRNA ligase 1 alpha cytoplasmic; Phenylalanine tRNA ligase alpha chain; Phenylalanine tRNA synthetase alpha subunit; Phenylalanine tRNA synthetase like alpha subunit; Phenylalanyl tRNA synthetase alpha chain; Phenylalanyl tRNA synthetase alpha subunit; Phenylalanyl tRNA synthetase like alpha subunit; PheRS; phenylalanine--tRNA ligase alpha chain; phenylalanine-tRNA synthetase alpha-subunit; phenylalanine tRNA ligase 1, alpha, cytoplasmic; phenylalanyl-tRNA synthetase-like, alpha subunit; phenylalanine-tRNA synthetas; FARSLA;
FARSB
phenylalanyl-tRNA synthetase, beta subunit
FARSB; phenylalanyl-tRNA synthetase, beta subunit; FARSLB, phenylalanyl tRNA synthetase like, beta subunit; phenylalanine--tRNA ligase beta subunit; FRSB; PheHB; phenylalanine tRNA ligase 1; beta; cytoplasmic; phenylalanine-tRNA ligase beta chain; phenyl; PheRS; FARSLB; HSPC173; phenylalanyl-tRNA synthetase beta chain; OTTHUMP00000164205; phenylalanine--tRNA ligase beta chain; phenylalanyl-tRNA synthetase beta-subunit; phenylalanine tRNA ligase 1, beta, cytoplasmic; phenylalanyl-tRNA synthetase-like, beta subunit; phenylalanine-tRNA synthetase-like, beta subunit;
FASN
fatty acid synthase
FASN; fatty acid synthase; FAS; SDR27X1; short chain dehydrogenase/reductase family 27X; member 1; short chain dehydrogenase/reductase family 27X, member 1; OA-519; MGC14367; MGC15706;
FBXL10
KDM2B lysine (K)-specific demethylase 2B
CXXC2; Fbl10; PCCX2; FBXL10; JHDM1B; lysine-specific demethylase 2B; OTTHUMP00000240026; OTTHUMP00000240027; F-box protein FBL10; F-box/LRR-repeat protein 10; CXXC-type zinc finger protein 2; protein containing CXXC domain 2; protein-containing CXXC domain 2; [Histone-H3]-lysine-36 demethylase 1B; F-box and leucine-rich repeat protein 10; jumonji C domain-containing histone demethylase 1B; jmjC domain-containing histone demethylation protein 1B; JEMMA (Jumonji domain, EMSY-interactor, methyltransferase motif) protein; jumonji domain-containing EMSY-interactor methyltransferase motif protein;
FRAP1
MTOR mechanistic target of rapamycin (serine/threonine kinase)
FRAP; FRAP1; FRAP2; RAFT1; RAPT1; FLJ44809; serine/threonine-protein kinase mTOR; OTTHUMP00000001983; rapamycin target protein 1; mammalian target of rapamycin; rapamycin and FKBP12 target 1; FKBP-rapamycin associated protein; rapamycin associated protein FRAP2; FKBP12-rapamycin complex-associated protein 1; FK506 binding protein 12-rapamycin associated protein 1; FK506 binding protein 12-rapamycin associated protein 2; FK506-binding protein 12-rapamycin complex-associated protein 1;
GPX5
glutathione peroxidase 5 (epididymal androgen-related protein)
GPX5;glutathione peroxidase 5 (epididymal androgen-related protein);epididymal secretory glutathione peroxidase;EGLP;GPx-5;GSHPx-5;epididymal androgen-related protein;epididymis-specific glutathione peroxidase-like protein;
GPX6
glutathione peroxidase 6 (olfactory)
GPX6; glutathione peroxidase 6 (olfactory); glutathione peroxidase pseudogene 3 , GPXP3;
GRB7
growth factor receptor-bound protein 7
GRB7; growth factor receptor-bound protein 7; B47; Epidermal growth factor receptor GRB 7; Epidermal growth factor receptor GRB-7; GRB7 adapter protein; GRB7_HUMAN; Growth factor receptor bound protein 7; OTTHUMP00000164349; OTTHUMP00000164350; OTTHUMP00000164351; OTTHUMP00000164352;
GRINL1A
glutamate receptor, ionotropic, N-methyl D-aspartate-like 1A
glutamate receptor, ionotropic, N-methyl D-aspartate-like 1A; Glutamate receptor-like protein 1A; DKFZp586F1918; GRINL1A downstream protein Gdown4; protein GRINL1A; protein GRINL1A, isoforms 4/5; OTTHUMP00000163345; OTTHUMP00000163421;
GSTA2
glutathione S-transferase alpha 2
GSTA2; glutathione S-transferase alpha 2; glutathione S transferase A2 , GST2; glutathione S-transferase A2; EC 2.5.1.18; Glutathione S transferase 2; Glutathione S transferase A2; Glutathione S-alkyltransferase A2; Glutathione S-aralkyltransferase A2; Glutathione S-aryltransferase A2; Glutathione S-transferase GT41A; Glutathione S-transferase Ya-2; Glutathione S-transferase, alpha 2 (Yc2); GST 1b-1b; GST A2-2; GST class alpha member 2; GST gamma; GST Ya2; GST, class alpha, 2; GST2; Gst2-2; GSTA2 2; GSTA2-2; Gstc-2; Gstc2; GTA2; GTH2; HA subunit 2; Liver GST2; MGC10525; OTTHUMP00000017883; S-(hydroxyalkyl)glutathione lyase A2; GST-gamma; GST HA subunit 2; GST class-alpha member 2;
GSTM3
glutathione S-transferase mu 3 (brain)
GSTM3; glutathione S-transferase mu 3 (brain); glutathione S transferase M3 (brain); glutathione S-transferase Mu 3; GST5; brain GST; brain type mu glutathione S transferase; glutathione S alkyltransferase M3; glutathione S aryltransferase M3; glutathione S transferase M3; Glutathione S transferase Mu 3; glutathione S transferase, Mu 3; GST class mu 3; GST class-mu 3; GSTB; GSTM3-3; GSTM3_HUMAN; GTM3; hGSTM3-3; MGC3310; MGC3704; S (hydroxyalkyl)glutathione lyase M3; glutathione S-transferase, Mu-3; glutathione S-aryltransferase M3; glutathione S-alkyltransferase M3; glutathione S-aralkyltransferase M3; S-(hydroxyalkyl)glutathione lyase M3; glutathione S-transferase M3 (brain); brain type mu-glutathione S-transferase;
GYS2
glycogen synthase 2 (liver)
GYS2; glycogen synthase 2 (liver); glycogen [starch] synthase, liver; Glycogen starch synthase liver; EC 2.4.1.11; Glycogen synthase 2 liver;
HAAO
3-hydroxyanthranilate 3,4-dioxygenase
HAAO; 3-hydroxyanthranilate 3,4-dioxygenase; HAD; 3-hydroxyanthranilate oxygenase; 3-hydroxyanthranilic acid dioxygenase; HAO; 3-HAO;
HCCS
holocytochrome c synthase
HCCS; holocytochrome c synthase; holocytochrome c synthase (cytochrome c heme lyase); cytochrome c-type heme lyase; CCHL; cytochrome c heme lyase; OTTHUMP00000022904; OTTHUMP00000022905; DKFZp779I1858; EC 4.4.1.17; Holocytochrome c type synthase; MCOPS7; OTTHUMP00000022903; OTTMUSP00000021173; OTTMUSP00000021174; RGD1563855; RP23-37L2.1; cytochrome c heme-lyase; holocytochrome c-type synthase;
HEY2
hes-related family bHLH transcription factor with YRPW motif 2
HEY2; hes-related family bHLH transcription factor with YRPW motif 2; GRL; CHF1; HRT2; HERP1; HESR2; bHLHb32; GRIDLOCK; hairy/enhancer-of-split related with YRPW motif protein 2; HRT-2; hCHF1; hHRT2; HESR-2; protein gridlock homolog; HES-related repressor protein 1; HES-related repressor protein 2; hairy-related transcription factor 2; cardiovascular helix-loop-helix factor 1; class B basic helix-loop-helix protein 32; hairy and enhancer of split-related protein 2; cardiovascular basic helix-loop-helix factor 1; hairy/enhancer-of-split related with YRPW motif 2;
HMBS
hydroxymethylbilane synthase
HMBS; hydroxymethylbilane synthase; PBGD, PORC, porphobilinogen deaminase , porphyria, acute; Chester type , UPS, uroporphyrinogen I synthase; porphobilinogen deaminase; HEM3_HUMAN; PBG D; PBG-D; PBGD; Pre uroporphyrinogen synthase; Pre-uroporphyrinogen synthase; UPS; Uroporphyrinogen I synthase; Uroporphyrinogen I synthetase; OTTHUMP00000238530; OTTHUMP00000238532; OTTHUMP00000238533; OTTHUMP00000238534; OTTHUMP00000238537; OTTHUMP00000238539; OTTHUMP00000238540; OTTHUMP00000238541; OTTHUMP00000238580; PORC; EC 2.5.1.61;
HMGCS2
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial)
HMGCS2;3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial);3 hydroxy 3 methylglutaryl Coenzyme A synthase 2 (mitochondrial);hydroxymethylglutaryl-CoA synthase, mitochondrial;HMG-CoA synthase;3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (mitochondrial);
HOOK2
hook microtubule-tethering protein 2
HOOK2; hook microtubule-tethering protein 2; HK2; protein Hook homolog 2; hHK2; h-hook2; hook homolog 2;
IARS
isoleucyl-tRNA synthetase
IARS; isoleucyl-tRNA synthetase; isoleucyl-tRNA synthetase, cytoplasmic; IARS1; ILRS; isoleucine tRNA ligase 1; cytoplasmic; FLJ20736; IleRS; IRS; Isoleucine tRNA ligase; Isoleucine tRNA synthetase; Isoleucyl tRNA synthetase; PRO0785; OTTHUMP00000021636; isoleucine--tRNA ligase; isoleucine tRNA ligase 1, cytoplasmic;
IFIH1
interferon induced with helicase C domain 1
IFIH1; interferon induced with helicase C domain 1; Hlcd; MDA5; MDA-5; IDDM19; MGC133047; interferon-induced helicase C domain-containing protein 1; helicard; OTTHUMP00000162935; CADM-140 autoantigen; helicase with 2 CARD domains; RNA helicase-DEAD box protein 116; murabutide down-regulated protein; DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide; melanoma differentiation associated protein-5; melanoma differentiation-associated protein 5; interferon-induced with helicase C domain protein 1; clinically amyopathic dermatomyositis autoantigen 140 kDa;
IGF2BP3
insulin-like growth factor 2 mRNA binding protein 3
IGF2BP3; insulin-like growth factor 2 mRNA binding protein 3; insulin-like growth factor 2 mRNA-binding protein 3; cancer/testis antigen 98; CT98; IGF II mRNA binding protein 3; IMP 3; hKOC; VICKZ family member 3; IGF2 mRNA-binding protein 3; IGF-II mRNA-binding protein 3; KH domain containing protein overexpressed in cancer; KH domain-containing protein overexpressed in cancer; IMP3; KOC1; IMP-3; VICKZ3; DKFZp686F1078; OTTHUMP00000158561; VICKZ3.;
ING2
inhibitor of growth family, member 2
ING2; inhibitor of growth family, member 2; ING1L, inhibitor of growth family, member 1 like; inhibitor of growth protein 2; p33ING2; p32; ING1Lp; inhibitor of growth 1-like protein; ING1L;
JARID1A
KDM5A lysine (K)-specific demethylase 5A
RBP2; RBBP2; RBBP-2; JARID1A; lysine-specific demethylase 5A; OTTHUMP00000237742; histone demethylase JARID1A; retinoblastoma binding protein 2; retinoblastoma-binding protein 2; jumonji/ARID domain-containing protein 1A; Jumonji, AT rich interactive domain 1A (RBP2-like); Jumonji, AT rich interactive domain 1A (RBBP2-like);
JARID1B
KDM5B lysine (K)-specific demethylase 5B
CT31; PLU1; PUT1; PLU-1; JARID1B; FLJ10538; FLJ12459; FLJ12491; FLJ16281; FLJ23670; RBBP2H1A; lysine-specific demethylase 5B; RBP2-H1; OTTHUMP00000038815; OTTHUMP00000038816; OTTHUMP00000197658; cancer/testis antigen 31; histone demethylase JARID1B; putative DNA/chromatin binding motif; jumonji, AT rich interactive domain 1B; jumonji/ARID domain-containing protein 1B; retinoblastoma-binding protein 2 homolog 1; retinoblastoma-binding protein 2, homolog 1A;
JMJD1A
KDM3A lysine (K)-specific demethylase 3A
TSGA; JMJD1; JHDM2A; JHMD2A; JMJD1A; KIAA0742; DKFZp686A24246; DKFZp686P07111; lysine-specific demethylase 3A; OTTHUMP00000160707; OTTHUMP00000203309; testis-specific protein A; jumonji domain containing 1; jumonji domain containing 1A; jumonji domain-containing protein 1A; jumonji C domain-containing histone demethylase 2A; jmjC domain-containing histone demethylation protein 2A;
JMJD7-PLA2G4B
JMJD7-PLA2G4B readthrough
JMJD7-PLA2G4B;JMJD7-PLA2G4B readthrough;JMJD7-PLA2G4B protein;jumonji domain containing 7-phospholipase A2, group IVB (cytosolic) read-through;HsT16992;cPLA2-beta;
KCNA1
potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
KCNA1; potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia); EA1; MK1; AEMK; HBK1; HUK1; MBK1; RBK1; KV1.1; potassium voltage-gated channel subfamily A member 1; voltage-gated K(+) channel HuKI; voltage-gated potassium channel HBK1; voltage-gated potassium channel subunit Kv1.1;
LANCL1
LanC lantibiotic synthetase component C-like 1 (bacterial)
LANCL1; LanC lantibiotic synthetase component C-like 1 (bacterial); GPR69A, LanC (bacterial lantibiotic synthetase component C) like 1; lanC-like protein 1; p40; 40 kDa erythrocyte membrane protein; GPR69A; OTTHUMP00000163940; OTTHUMP00000206535; OTTHUMP00000206536; OTTHUMP00000206537; OTTHUMP00000206538; G protein-coupled receptor 69A; LanC (bacterial lantibiotic synthetase component); LanC (bacterial lantibi;
LARS2
leucyl-tRNA synthetase 2, mitochondrial
LARS2; leucyl-tRNA synthetase 2, mitochondrial; probable leucyl-tRNA synthetase, mitochondrial; KIAA0028; leucine tRNA ligase 2; mitocondrial; LEURS; MGC26121; mitochondrial; LARS 2; Leucine translase; Leucine tRNA ligase 2 mitocondrial; Leucine tRNA ligase; Leucine--tRNA ligase; Leucyl tRNA synthetase 2; Leucyl tRNA synthetase 2 mitochondrial; Probable leucyl-tRNA synthetase; SYLM_HUMAN; OTTHUMP00000164232; OTTHUMP00000210279; OTTHUMP00000210280; leucine tRNA ligase 2, mitocondrial;
LASS1
LAG1 homolog, ceramide synthase 1
LAG1 homolog, ceramide synthase 1; Protein UOG-1; UOG1; LAG1 longevity assurance homolog 1 (S. cerevisiae); LAG1; MGC90349; CerS1; LAG1 longevity assurance homolog 1; longevity assurance (LAG1, S. cerevisiae) homolog 1; upstream of GDF1; Longevity assurance gene 1 protein homolog 1; LASS1;
LIAS
lipoic acid synthetase
LIAS; lipoic acid synthetase; lipoyl synthase, mitochondrial; LAS; lip-syn; lipoate synthase; LS; LIP1; PDHLD; HUSSY-01; MGC23245;
LILRA2
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2
LILRA2; leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2; leukocyte immunoglobulin-like receptor subfamily A member 2; CD85h; ILT1; LIR 7; LIR7; CD85 antigen-like family member H; ILT-1; Immunoglobulin like transcript 1; Immunoglobulin-like transcript 1; Leukocyte immunoglobulin like receptor 7; Leukocyte immunoglobulin like receptor subfamily A member 2; Leukocyte immunoglobulin-like receptor 7; LIR-7; LIRA2_HUMAN; OTTHUMP00000068394; OTTHUMP00000068395; OTTHUMP00000068396; OTTHUMP00000068397; leuko;
LLGL1
lethal giant larvae homolog 1
LLGL1 + LLGL2; DLG4; HGL; HUGL; HUGL 1; HUGL1; Human homolog to the D lgl gene protein; lethal giant larvae homolog 1; lethal giant larvae homolog 2; Lethal(2) giant larvae protein homolog 1; Lethal(2) giant larvae protein homolog 2; LGL2; LLGL;
LLGL2
lethal giant larvae homolog 2
LLGL2; lethal giant larvae homolog 2 (Drosophila); lethal giant larvae (Drosophila) homolog 2; lethal(2) giant larvae protein homolog 2; HGL; human giant larvae homolog; LGL2;
LMOD1
leiomodin 1 (smooth muscle)
LMOD1; leiomodin 1 (smooth muscle); leiomodin-1; 1D; 64kD; D1; 64 kDa autoantigen 1D3; SM LMOD; SMLMOD; Smooth muscle leiomodin; Thyroid associated ophthalmopathy autoantigen; 64 kDa autoantigen 1D; 64 kDa autoantigen D1; leiomodin, muscle form; leimodin 1 (smooth muscle); thyroid and eye muscle autoantigen D1 (64kD); thyroid-associated ophthalmopathy autoantigen; SM-LMOD;
LSS
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)
LSS; lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase); lanosterol synthase; OSC; hOSC; oxidosqualene--lanosterol cyclase; 2,3-epoxysqualene-lanosterol cyclase; 2,3-epoxysqualene--lanosterol cyclase; FLJ25486; FLJ35015; FLJ39450; FLJ46393;
MAST2
microtubule associated serine/threonine kinase 2
MAST2; microtubule associated serine/threonine kinase 2; microtubule-associated serine/threonine-protein kinase 2; KIAA0807; MAST205; EC 2.7.11.1 3; FLJ39200; MAST 2; MAST 205; Microtubule associated testis specific serine/threonine protein kinase; MTSSK; OTTHUMP00000009697 2; OTTHUMP00000046616; RP4 533D7.1; RP4-533D7.1 2; OTTHUMP00000009697; RP4-533D7.1;
MBD3
methyl-CpG binding domain protein 3
MBD3; methyl-CpG binding domain protein 3; methyl-CpG-binding domain protein 3;
MBD3L1
methyl-CpG binding domain protein 3-like 1
MBD3L1; methyl-CpG binding domain protein 3-like 1; MBD3L, methyl CpG binding domain protein 3 like; methyl-CpG-binding domain protein 3-like 1; MBD3-like protein 1; MBD3L; MGC138263; MGC138269;
MBD5
methyl-CpG binding domain protein 5
MBD5; methyl-CpG binding domain protein 5; methyl-CpG-binding domain protein 5; FLJ11113; KIAA1461; methyl-CpG-binding protein MBD5; MRD1; FLJ30517;
MCCC2
methylcrotonoyl-CoA carboxylase 2 (beta)
MCCC2; methylcrotonoyl-CoA carboxylase 2 (beta); methylcrotonoyl Coenzyme A carboxylase 2 (beta); methylcrotonoyl-CoA carboxylase beta chain, mitochondrial; MCCB; biotin carboxylase; MCCase subunit beta; 3-methylcrotonyl-CoA carboxylase 2; methylcrotonoyl;
MECP2
methyl CpG binding protein 2 (Rett syndrome)
MECP2; methyl CpG binding protein 2 (Rett syndrome); RS; RTS; RTT; PPMX; MRX16; MRX79; MRXSL; AUTSX3; MRXS13; methyl-CpG-binding protein 2; meCp-2 protein;
METTL2B
methyltransferase like 2B
METTL2B; methyltransferase like 2B; methyltransferase like 2 , METTL2; methyltransferase-like protein 2B; FLJ11350; METL; methyltransferase like 2; METTL2; METTL2A; PSENIP1;
MGC3207
MRI1 methylthioribose-1-phosphate isomerase homolog (S. cerevisiae)
MTNA; MGC3207; Ypr118w; methylthioribose-1-phosphate isomerase; M1Pi; MTR-1-P isomerase; mediator of RhoA-dependent invasion; S-methyl-5-thioribose-1-phosphate isomerase; translation initiation factor eIF-2B subunit alpha/beta/delta-like protein;
MGST2
microsomal glutathione S-transferase 2
MGST2; microsomal glutathione S-transferase 2; MGST II; FLJ27438; GST 2; GST2; MGC14097; MGST 2; MGSTII; Microsomal glutathione S transferase 2; Microsomal GST 2; Microsomal GST II; microsomal GST-2; microsomal GST-II; MGST-II;
MGST3
microsomal glutathione S-transferase 3
MGST3; microsomal glutathione S-transferase 3; GST III; microsomal glutathione S transferase III; microsomal GST 3; microsomal GST III; MGST3_HUMAN; Microsomal glutathione S transferase 3; Microsomal GST-3; Microsomal GST-III; Microsomal GST3; Microsomal GSTIII; microsomal glutathione S-transferase III; GST-III;
MLLT1
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog); translocated to, 1
MLLT1; myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1; myeloid/lymphoid or mixed lineage leukemia (trithorax (Drosophila) homolog); protein ENL; ENL; LTG19; YEATS1; ENL/MLL fusion; MLLT1/;
MLLT3
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)
MLLT3; myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3; AF9; YEATS3; protein AF-9; YEATS domain-containing protein 3; ALL1-fused gene from chromosome 9 protein; myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein; myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog); translocated to, 3;
MOCS2
molybdenum cofactor synthesis 2
MOCS2;molybdenum cofactor synthesis 2;molybdopterin synthase catalytic subunit;MOCO1;MOCO1-A;MOCO1-B;MPT synthase large subunit;sulfur carrier protein MOCS2A;molybdopterin-synthase large subunit;molybdopterin-synthase small subunit;molybdenum cofactor synthesis protein 2A;molybdenum cofactor synthesis protein 2B;molybdenum cofactor biosynthesis protein E;molybdopterin synthase sulfur carrier subunit;molybdenum cofactor synthesis protein 2 large subunit;molybdenum cofactor synthesis protein 2 small subunit;MPTS;MCBPE;MOCS2A;MOCS2B;
MT2A
metallothionein 2A
MT2A;metallothionein 2A;MT2;metallothionein-2;MT-2;MT-II;metallothionein-2A;metallothionein-II;
MT3
metallothionein 3
MT3; metallothionein 3; metallothionein 3 (growth inhibitory factor (neurotrophic)); metallothionein-3; GIF; GIFB; GRIF; Metallothionein III; Growth inhibitory factor; Metallothionein-III; Mt 3; MT III; MT-3; MT-III; MT3_HUMAN; OTTHUMP00000164383;
MTHFR
methylenetetrahydrofolate reductase (NAD(P)H)
MTHFR; methylenetetrahydrofolate reductase (NAD(P)H); 5,10 methylenetetrahydrofolate reductase (NADPH); methylenetetrahydrofolate reductase; 5,10-methylenetetrahydrofolate reductase (NADPH);
MTL5
metallothionein-like 5, testis-specific (tesmin)
MTL5; metallothionein-like 5, testis-specific (tesmin); tesmin; CXC domain containing 2; CXCDC2; Metallothionein-like 5, testis-specific; OTTHUMP00000237193; OTTHUMP00000237194; OTTHUMP00000237195; testis-specific metallothionein-like protein; MTLT;
MTRR
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
MTRR; 5-methyltetrahydrofolate-homocysteine methyltransferase reductase; methionine synthase reductase; cblE; [methionine synthase] cobalamin methyltransferase (cob(II)alamin reducing); 5 methyltetrahydrofolate homocysteine methyltransferase reductase; Methionine synthase reductase, mitochondrial; MGC129643; MSR; OTTHUMP00000115546; OTTHUMP00000220821; [methionine synthase]-cobalamin methyltransferase (cob(II)alamin reducing);
MYH11
myosin, heavy chain 11, smooth muscle
MYH11; myosin, heavy chain 11, smooth muscle; myosin, heavy polypeptide 11, smooth muscle; myosin-11; SMHC; SMMHC; myosin heavy chain 11; myosin heavy chain, smooth muscle isoform; AAT4; FAA4; FLJ35232; MGC32963; MGC126726; DKFZp686D10126; DKFZp686D19237;
N6AMT1
N-6 adenine-specific DNA methyltransferase 1 (putative)
N6AMT1; N-6 adenine-specific DNA methyltransferase 1 (putative); C21orf127, chromosome 21 open reading frame 127 , HemK methyltransferase family member 2 , HEMK2; hemK methyltransferase family member 2; MTQ2; N6AMT; PRED28; C21orf127; Chromosome 21 open reading frame 127; EC 2.1.1.-; HemK2; M.HsaHemK2P; MGC19995; N-6 adenine-specific DNA methyltransferase 1; N6-DNA-methyltransferase; OTTHUMP00000096393; OTTHUMP00000096394; OTTHUMP00000096395; n(6)-adenine-specific DNA methyltransferase 1;
NARS
asparaginyl-tRNA synthetase
NARS; asparaginyl-tRNA synthetase; asparaginyl-tRNA synthetase, cytoplasmic; asparagine tRNA ligase 1; cytoplasmic; NARS1; 3010001M15Rik; AA960128; ASNRS; ASNS; Asparagine tRNA ligase 1, cytoplasmic; Asparagine tRNA ligase; Asparagine--tRNA ligase; Asparaginyl tRNA synthetase; C78150; EC 6.1.1.22; LRRGT00113; MGC116236; NRS; SYNC_HUMAN;
NCKIPSD
NCK interacting protein with SH3 domain
NCKIPSD; NCK interacting protein with SH3 domain; NCK-interacting protein with SH3 domain; AF3P21; dia interacting protein; diaphanous protein interacting protein; DIP1; ORF1; SH3 protein interacting with Nck; 90 kDa; SPIN90; WASLBP; WISH; DIP; SH3 protein interacting with Nck90 kDa; VIP54; DIP-1; OTTHUMP00000164823; OTTHUMP00000210186; dia-interacting protein 1; SH3 adapter protein SPIN90; 54 kDa VacA-interacting protein; 54 kDa vimentin-interacting protein; WASP-interacting SH3;
NPHP4
nephronophthisis 4
NPHP4; nephronophthisis 4; nephrocystin-4; KIAA0673; nephrocystin 4; nephroretinin; POC10; POC10 centriolar protein homolog (Chlamydomonas); SLSN4; NPHP4_HUMAN; POC10 centriolar protein homolog;
OPA3
optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia)
OPA3; optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia); optic atrophy 3 protein; FLJ22187; MGA3; FLJ25932; Iraqi Jewish optic atrophy plus (3 methylglutaconicaciduria type 3); MGC75494; OPA 3; OPA3 protein; Optic atrophy 3 (Iraqi Jewish optic atrophy plus); Optic atrophy 3; Optic atrophy 3 (Iraqi-Jewish optic atrophy plus);
PAG1
phosphoprotein associated with glycosphingolipid microdomains 1
PAG1; phosphoprotein associated with glycosphingolipid microdomains 1; phosphoprotein associated with glycosphingolipid-enriched microdomains 1; CBP; Csk binding protein; PAG; transmembrane adaptor protein PAG; Csk-binding protein; transmembrane phosphoprotein Cbp; transmembrane adapter protein PAG; FLJ37858; MGC138364;
PANK4
pantothenate kinase 4
PANK4; pantothenate kinase 4; FLJ10782; hPanK4; pantothenic acid kinase 4; DKFZp547M242;
PAPSS1
3-phosphoadenosine 5-phosphosulfate synthase 1
PAPSS1; 3-phosphoadenosine 5-phosphosulfate synthase 1; bifunctional 3-phosphoadenosine 5-phosphosulfate synthase 1; ATPSK1; PAPSS; SK 1; PAPSS 1; PAPS synthase 1; sulfurylase kinase 1; 3-prime-phosphoadenosine 5-prime-phosphosulfate synthase 1; SK1;
PAXIP1
PAX interacting (with transcription-activation domain) protein 1
PAXIP1; PAX interacting (with transcription-activation domain) protein 1; PTIP; TNRC2; CAGF28; CAGF29; PACIP1; PAXIP1L; PAX-interacting protein 1; protein encoded by CAG trinucleotide repeats; PAX transcription activation domain interacting protein 1 like;
PDCD10
programmed cell death 10
PDCD10; programmed cell death 10; CCM3, cerebral cavernous malformations 3; programmed cell death protein 10; TFAR15; apoptosis-related protein 15; TF-1 cell apoptosis-related protein 15; cerebral cavernous malformations 3 protein; CCM3; MGC1212; MGC2447;
PIGB
phosphatidylinositol glycan anchor biosynthesis, class B
PIGB;phosphatidylinositol glycan anchor biosynthesis, class B;phosphatidylinositol glycan, class B;GPI mannosyltransferase 3;PIG-B;GPI-MT-III;GPI mannosyltransferase III;phosphatidylinositol-glycan biosynthesis class B protein;MGC21236;
PIGC
phosphatidylinositol glycan anchor biosynthesis, class C
PIGC; phosphatidylinositol glycan anchor biosynthesis, class C; phosphatidylinositol glycan, class C; phosphatidylinositol N-acetylglucosaminyltransferase subunit C; GPI2; Phosphatidylinositol glycan biosynthesis class C protein; Phosphatidylinositol N acetylglucosaminyltransferase subunit C; PIG-C; OTTHUMP00000032652; phosphatidylinositol-glycan biosynthesis class C protein; phosphatidylinositol-glycan biosynthesis, class C protein;
PIGH
phosphatidylinositol glycan anchor biosynthesis, class H
PIGH; phosphatidylinositol glycan anchor biosynthesis, class H; phosphatidylinositol glycan, class H; phosphatidylinositol N-acetylglucosaminyltransferase subunit H; GPI H; GPIH; Phosphatidylinositol glycan anchor biosynthesis class H; Phosphatidylinositol glycan biosynthesis class H protein; Phosphatidylinositol glycan class H; Phosphatidylinositol N acetylglucosaminyltransferase subunit H; Phosphatidylinositol-glycan biosynthesis class H protein; PIG H; PIG-H; PIGH_HUMAN; OTTHUMP00000246879; phosphatidylinositol-glycan biosynthesis, class H protein; GPI-H;
PIGP
phosphatidylinositol glycan anchor biosynthesis, class P
PIGP; phosphatidylinositol glycan anchor biosynthesis, class P; Down syndrome critical region gene 5 , DSCR5, phosphatidylinositol glycan, class P; phosphatidylinositol N-acetylglucosaminyltransferase subunit P; DCRC; DSRC; phosphatidylinositol n acetylglucosaminyltranferase subunit; DCRC S; Down syndrome critical region gene 5; Down syndrome critical region protein 5; Down syndrome critical region protein C; DSCR 5; DSCR5; DSCRC; Phosphatidylinositol glycan anchor biosynthesis class P; Phosphatidylinositol glycan biosynthesis class P; Phosphatidylinositol glycan biosynthesis class P protein; Phosphatidylinositol glycan class P; Phosphatidylinositol N acetylglucosaminyltransferase subunit P; PIG-P; OTTHUMP00000109075; OTTHUMP00000109076; OTTHUMP00000109077; OTTHUMP00000109078; OTTHUMP00000109079; phosphatidylinositol glycan, class P; Down syndrome cri; DCRC-S;
PIGQ
phosphatidylinositol glycan anchor biosynthesis, class Q
PIGQ; phosphatidylinositol glycan anchor biosynthesis, class Q; phosphatidylinositol glycan, class Q; phosphatidylinositol N-acetylglucosaminyltransferase subunit Q; GPI1; hGPI1; PIG-Q; N-acetylglucosamyl transferase component GPI1; N-acetylglucosaminyl t;
PIP5K3
likely ortholog of mouse phosphatidylinositol-4-phosphate 5-kinase, type III
PIP5K3; likely ortholog of mouse phosphatidylinositol-4-phosphate 5-kinase, type III; p235; PIP5K; KIAA0981;
PLUNC
palate, lung and nasal epithelium associated
palate, lung and nasal epithelium associated; Von Ebner protein Hl; LUNX; NASG; SPURT; bA49G10.5; palate, lung and nasal epithelium carcinoma associated; Lung-specific protein X; Nasopharyngeal carcinoma-related protein; ligand-binding protein RYA3; Palate lung and nasal epithelium clone protein; Secretory protein in upper respiratory tracts; tracheal epithelium enriched protein; Tracheal epithelium-enriched protein; LPLUNC3; SPLUNC1; protein Plunc; OTTHUMP00000030625; OTTHUMP00000030626; OTTHUMP00000030627; PLUNC; palate, lung and nasal epithelium associated;
POLQ
polymerase (DNA directed), theta
POLQ; polymerase (DNA directed), theta; DNA polymerase theta; POLH; DNA polymerase eta; PRO0327; DKFZp781A0112;
PRMT2
protein arginine methyltransferase 2
PRMT2; protein arginine methyltransferase 2; HMT1 (hnRNP methyltransferase, S. cerevisiae) like 1 , HMT1 hnRNP methyltransferase like 1 (S. cerevisiae) , HRMT1L1; protein arginine N-methyltransferase 2; MGC111373; PRMT2 beta; PRMT2 alpha; PRMT2 gamma; HM;
PROSC
proline synthetase co-transcribed homolog (bacterial)
PROSC; proline synthetase co-transcribed homolog (bacterial); proline synthetase co transcribed (bacterial homolog); proline synthase co-transcribed bacterial homolog protein; FLJ11861; Proline synthetase co transcribed bacterial homolog; Proline synthetase co transcribed homolog (bacterial); proline synthetase co-transcribed (bacterial homolog); proline synthetase co-transcribed bacterial homolog protein;
PSTPIP1
proline-serine-threonine phosphatase interacting protein 1
PSTPIP1; proline-serine-threonine phosphatase interacting protein 1; proline-serine-threonine phosphatase-interacting protein 1; CD2 antigen binding protein 1; CD2 cytoplasmic tail binding protein; CD2BP1; CD2BP1L; CD2BP1S; H PIP; PAPAS; PEST phosphatase interacting protein 1; PSTPIP; CD2 binding protein 1; HPIP; Proline serine threonine phosphatase interacting protein 1; CD2-binding protein 1; CD2 antigen-binding protein 1; CD2 cytoplasmic tail-binding protein; PEST phosphatase-interacting protein 1; H-PIP;
PTGIS
prostaglandin I2 (prostacyclin) synthase
PTGIS; prostaglandin I2 (prostacyclin) synthase; prostacyclin synthase; Cyp8; Pgis; Cyp8a1;
PUS1
pseudouridine synthase 1
PUS1; pseudouridine synthase 1; tRNA pseudouridine synthase A, mitochondrial; A730013B20Rik; DOBI; MGC112655; MGC11268; MLASA; mPus1p; Pseudouridylate synthase 1; tRNA pseudouridine(38-40) synthase; tRNA pseudouridylate synthase I; tRNA uridine isomerase I; tRNA-uridine isomerase I; TRUA_HUMAN; OTTMUSP00000027965; OTTMUSP00000027966; OTTMUSP00000027967; OTTMUSP00000027968; MPUS1;
PXK
PX domain containing serine/threonine kinase
PXK; PX domain containing serine/threonine kinase; PX domain-containing protein kinase-like protein; FLJ20335; K-ATPase; Modulator of Na; Modulator of Na K ATPase; Modulator of Na K ATPase long form; MONaKA; PX domain containing protein kinase like protein; PX ser/thr kinase v2; PX serine/threonine kinase; PXK_HUMAN; OTTHUMP00000214170; OTTHUMP00000214171; OTTHUMP00000214173; OTTHUMP00000214175; OTTHUMP00000214179; modulator of Na,K-ATPase long form;
RABEPK
Rab9 effector protein with kelch motifs
RABEPK; Rab9 effector protein with kelch motifs; bA65N13.1; RAB9P40; 8430412M01Rik; AV073337; C87311; 9530020d24rik; DKFZp686P1077; OTTHUMP00000022126; OTTMUSP00000012898; OTTMUSP00000012899; OTTMUSP00000041318; RAB9 effector p40; RABEPK protein; RGD1310612; RP11 65N13.1; RP23-446N16.2; 40 kDa Rab9 effector protein; p40;
RASD1
RAS, dexamethasone-induced 1
RASD1; RAS, dexamethasone-induced 1; dexamethasone-induced Ras-related protein 1; activator of G protein signaling; AGS1; dexamethasone induced ras related protein 1; DEXRAS1; ras related protein; ras-related protein; activator of G-protein signaling 1; M;
RBPMS
RNA binding protein with multiple splicing
RBPMS; RNA binding protein with multiple splicing; RNA-binding protein with multiple splicing; HERMES; RBP MS; RNA binding protein gene with multiple splicing; RBP-MS; heart and RRM expressed sequence;
RIPK3
receptor-interacting serine-threonine kinase 3
RIPK3; receptor-interacting serine-threonine kinase 3; receptor-interacting serine/threonine-protein kinase 3; RIP3; RIP-3; RIP-like protein kinase 3; receptor interacting protein 3; receptor-interacting protein 3;
RIPK4
receptor-interacting serine-threonine kinase 4
RIPK4; receptor-interacting serine-threonine kinase 4; ANKRD3, ankyrin repeat domain 3; receptor-interacting serine/threonine-protein kinase 4; ANKK2; DIK; PKC delta interacting protein kinase; PKK; protein kinase C associated kinase; RIP4; protein kinas;
RP6-213H19.1
MST4 serine/threonine protein kinase MST4
MASK; serine/threonine-protein kinase MST4; OTTHUMP00000024034; OTTHUMP00000215131; OTTHUMP00000215132; OTTHUMP00000215133; OTTHUMP00000215134; STE20-like kinase MST4; mammalian sterile 20-like 4; Mst3 and SOK1-related kinase; serine/threonine-protein kinase MASK; mammalian Ste20-like protein kinase 4;
SARS
seryl-tRNA synthetase
SARS; seryl-tRNA synthetase; serine--tRNA ligase, cytoplasmic; serine tRNA ligase 1; cytoplasmic; SERS; Seryl-tRNA Ser/Sec synthetase; seryl-tRNA(Ser/Sec) synthetase; serine tRNA ligase 1, cytoplasmic; seryl-tRNA synthetase, cytoplasmic; SERRS; FLJ36399;
SEPHS1
selenophosphate synthetase 1
SEPHS1; selenophosphate synthetase 1; selenide, water dikinase 1; SPS; SPS1; selenium donor protein 1; selenophosphate synthase 1; selenophosphate synthetase 1 +E9; selenophosphate synthetase 1 +E9a; selenophosphate synthetase 1 major; selenophosphate syn;
SEPHS2
selenophosphate synthetase 2
SEPHS2; selenophosphate synthetase 2; selenide, water dikinase 2; SPS2; selenium donor protein 2; selenophosphate synthase 2;
SGMS2
sphingomyelin synthase 2
SGMS2; sphingomyelin synthase 2; phosphatidylcholine:ceramide cholinephosphotransferase 2; MGC26963; SMS2; SGMS 2; SM synthase; SMS 2; SMS2_HUMAN;
SIT1
signaling threshold regulating transmembrane adaptor 1
SIT1; signaling threshold regulating transmembrane adaptor 1; suppression inducing transmembrane adaptor 1; signaling threshold-regulating transmembrane adapter 1; SHP2 interacting transmembrane adaptor; SIT; gp30/40; suppression-inducing transmembrane ad;
SLC22A4
solute carrier family 22 (organic cation/ergothioneine transporter), member 4
SLC22A4; solute carrier family 22 (organic cation/ergothioneine transporter), member 4; solute carrier family 22 member 4; MGC34546; OCTN1; LSTP Like 2; MGC40524; Ergothioneine transporter; ET transporter; Organic cation transporter 1; Organic cation/carnitine transporter 1; RP23-354D12.1; S22A4_HUMAN; Solute carrier family (organic cation transporter), member 4; integral membrane transport protein;
SPTB
spectrin, beta, erythrocytic
SPTB; spectrin, beta, erythrocytic; spectrin beta chain, erythrocyte; spherocytosis; clinical type I; beta-I spectrin; membrane cytoskeletal protein; EL3; HS2; SPH2; HSPTB1;
SPTBN2
spectrin, beta, non-erythrocytic 2
SPTBN2; spectrin, beta, non-erythrocytic 2; SCA5, spinocerebellar ataxia 5; spectrin beta chain, brain 2; beta-III spectrin; spectrin, non-erythroid beta chain 2; glutamate transporter EAAT4-associated protein 41; SCA5; GTRAP41;
STK11
serine/threonine kinase 11
STK11; serine/threonine kinase 11; PJS; LKB1; hLKB1; serine/threonine-protein kinase STK11; liver kinase B1; polarization-related protein LKB1; renal carcinoma antigen NY-REN-19; serine/threonine-protein kinase 11; serine/threonine-protein kinase LKB1;
STK17A
serine/threonine kinase 17a
STK17A; serine/threonine kinase 17a; DRAK1; serine/threonine-protein kinase 17A; death-associated protein kinase-related 1; serine/threonine kinase 17a (apoptosis-inducing); DAP kinase-related apoptosis-inducing protein kinase 1;
STK19
serine/threonine kinase 19
STK19; serine/threonine kinase 19; serine/threonine-protein kinase 19; D6S60; G11; RP1; MHC class III HLA-RP1; nuclear serine/threonine protein kinase; D6S60E; HLA-RP1; MGC117388;
STK31
serine/threonine kinase 31
STK31; serine/threonine kinase 31; serine/threonine-protein kinase 31; SgK396; TDRD8; sugen kinase 396; tudor domain containing 8; serine/threonine-protein kinase NYD-SPK; FLJ16102;
STK32C
serine/threonine kinase 32C
STK32C; serine/threonine kinase 32C; serine/threonine-protein kinase 32C; MGC23665; PKE; YANK3; PKE protein kinase; protein kinase (PKE); RP11-140A10.1;
STK38L
serine/threonine kinase 38 like
STK38L; serine/threonine kinase 38 like; serine/threonine-protein kinase 38-like; KIAA0965; NDR2; nuclear Dbf2 related 2; NDR2 protein kinase; nuclear Dbf2-related 2; nuclear Dbf2-related kinase 2;
TH1L
TH1-like
TH1L; TH1-like (Drosophila); TH1 like (Drosophila homolog); negative elongation factor C/D; HSPC130; NELF C; NELF D; TH1; trihydrophobin 1; NELF-C/D; TH1-like protein; TH1 drosophila homolog; negative elongation factor proteins C and D; NELF-C; NELF-D;
THAP11
THAP domain containing 11
THAP11; THAP domain containing 11; THAP domain-containing protein 11; CTG B43a; CTG B45d; HRIHFB2206; RONIN; THA11_HUMAN; THAP 11; OTTHUMP00000174850; CTG-B43a; CTG-B45d;
THOC1
THO complex 1
THOC1; THO complex 1; THO complex subunit 1; HPR1; P84; tho1; hTREX84; nuclear matrix protein p84; P84N5;
THOC3
THO complex 3
THOC3; THO complex 3; THO complex subunit 3; MGC5469; TEX1; TEX1 homolog; Tho3; hTREX45;
THRSP
thyroid hormone responsive
THRSP; thyroid hormone responsive; lipogenic protein 1 , LPGP1, thyroid hormone responsive SPOT14 (rat) homolog; thyroid hormone-inducible hepatic protein; Lpgp; S14; SPOT14; SPOT14 homolog (rat); SPOT14 homolog; spot 14 protein; lipogenic protein 1; thy;
TMSB10
thymosin beta 10
TMSB10; thymosin beta 10; migration-inducing protein 12; TB10; thymosin beta-10; MIG12; PTMB10; migration-inducing gene 12; THYB10;
TMSB4Y
thymosin beta 4, Y-linked
TMSB4Y;thymosin beta 4, Y-linked;thymosin, beta 4, Y chromosome;thymosin beta-4, Y-chromosomal;TB4Y;thymosin beta-4, Y isoform;MGC26307;
TPTE
transmembrane phosphatase with tensin homology
TPTE; transmembrane phosphatase with tensin homology; putative tyrosine-protein phosphatase TPTE; cancer/testis antigen 44; CT44; PTEN related tyrosine phosphatase; PTEN2; EC=3.1.3.48; HGNC:12023; Putative protein Tyrosine Phosphatase; Putative tyrosine protein phosphatase; Tensin; TPTE_HUMAN; Tumor antigen BJ HCC 5; Tumor antigen BJ-HCC-5; OTTHUMP00000082789; OTTHUMP00000082790; OTTHUMP00000082791; PTEN-related tyrosine phosphatase; tensin, putative protein-tyrosine phosphatase;
TREX1
three prime repair exonuclease 1
TREX1; three prime repair exonuclease 1; AGS1, Aicardi Goutieres syndrome 1; DRN3; DNase III; 3 repair exonuclease 1; 3-5 exonuclease TREX1; CRV; AGS1; HERNS; DKFZp434J0310;
TRIP10
thyroid hormone receptor interactor 10
TRIP10; thyroid hormone receptor interactor 10; salt tolerator , STOT; cdc42-interacting protein 4; Cdc42 interacting protein; CIP4; HSTP; STP; Cdc42 interacting protein 4; Cdc42 interaction protein 4 long isoform; CG11341; CG15015 PA; Cip 4; CIP4_HUMAN; DCIP4; Protein Felic; Salt tolerant protein; Salt tolerator; STOT; Thyroid receptor interacting protein 10; Thyroid receptor-interacting protein 10; TR-interacting protein 10; TRIP 10; TRIP-10; Truncated Cdc42 interaction protein 4; OTTHUMP00000196789; OTTHUMP00000196790; OTTHUMP00000196791;
TRIP11
thyroid hormone receptor interactor 11
TRIP11; thyroid hormone receptor interactor 11; thyroid receptor-interacting protein 11; CEV14; GMAP 210; Trip230; TR-interacting protein 11; Golgi-microtubule-associated protein of 210 kDa; golgi-associated microtubule-binding protein 210; clonal evoluti;
TSHR
thyroid stimulating hormone receptor
TSHR; thyroid stimulating hormone receptor; thyrotropin receptor; LGR3; TSH-R; thyrotropin receptor-I, hTSHR-I; seven transmembrane helix receptor; thyroid-stimulating hormone receptor; thyroid stimulating hormone receptor, isoform 2; CHNG1; hTSHR-I; MGC7;
TYW1
tRNA-yW synthesizing protein 1 homolog (S. cerevisiae)
TYW1; tRNA-yW synthesizing protein 1 homolog (S. cerevisiae); radical S adenosyl methionine and flavodoxin domains 1 , RSAFD1; tRNA wybutosine-synthesizing protein 1 homolog; FLJ10900; MGC23001; MGC60291; tRNA yW synthesizing protein 1 homolog A (S. cerevisiae); TYW1A; YPL207W; GC23001; Radical S-adenosyl methionine and flavodoxin domain-containing protein 1; RSAFD1; tRNA-yW-synthesizing protein; TYW1_HUMAN; OTTHUMP00000160137; tRNA-yW synthesizing protein 1 homolog A; radical S-adenosyl methionine and flavodoxin domains 1;
UHRF2
ubiquitin-like with PHD and ring finger domains 2, E3 ubiquitin protein ligase
UHRF2; ubiquitin-like with PHD and ring finger domains 2, E3 ubiquitin protein ligase; ubiquitin like with PHD and ring finger domains 2; E3 ubiquitin-protein ligase UHRF2; MGC33463; NIRF; Np95 like ring finger protein; RNF107; URF2; nuclear protein 97; R;
UTX
KDM6A lysine (K)-specific demethylase 6A
UTX; MGC141941; bA386N14.2; DKFZp686A03225; lysine-specific demethylase 6A; OTTHUMP00000023175; histone demethylase UTX; ubiquitously-transcribed TPR gene on the X chromosome; ubiquitously transcribed TPR protein on the X chromosome; ubiquitously-transcribed TPR protein on the X chromosome; ubiquitously transcribed tetratricopeptide repeat protein X-linked; ubiquitously transcribed X chromosome tetratricopeptide repeat protein; ubiquitously-transcribed X chromosome tetratricopeptide repeat protein; bA386N14.2 (ubiquitously transcribed X chromosome tetratricopeptide repeat protein (UTX));
VARS
valyl-tRNA synthetase
VARS; valyl-tRNA synthetase; valyl tRNA synthetase 2 , VARS2; valine tRNA ligase 1; cytoplasmic; Bat 6; Bat6; D17H6S56E; EC 6.1.1.9; G7A; Protein G7a; SYVC_HUMAN; Valine tRNA ligase; Valine--tRNA ligase; ValRS; VALYL tRNA SYNTHETASE 1; valyl tRNA synthetase 2; Vars1; VARS2; OTTHUMP00000029422; valyl-tRNA synthetase 2; valine tRNA ligase 1, cytoplasmic;
WARS2
tryptophanyl tRNA synthetase 2, mitochondrial
WARS2; tryptophanyl tRNA synthetase 2, mitochondrial; tryptophanyl-tRNA synthetase, mitochondrial; TrpRS; tryptophan tRNA ligase 2; mitochondrial; (Mt)TrpRS; Mitochondrial tryptophanyl tRNA synthetase 2; Tryptophanyl tRNA synthetase 2; tryptophan-tRNA ligase; tryptophan--tRNA ligase; tryptophan tRNA ligase 2, mitochondrial;
ZIC2
zinc finger protein of the cerebellum 2
Zic2; zinc finger protein of the cerebellum 2; Ku; HPE5; zinc finger protein ZIC 2; kumba; GENA 29; OTTMUSP00000022013; odd-paired homolog; Zic family member 2 (odd-paired homolog, Drosophila); Zinc Finger Protein of Cerebellum 2;
ZKSCAN1
zinc finger with KRAB and SCAN domains 1
ZKSCAN1; zinc finger with KRAB and SCAN domains 1; zinc finger protein 36 (KOX 18) , ZNF36, ZNF139; zinc finger protein with KRAB and SCAN domains 1; KOX18; PHZ 37; MGC138429; MGC63357; Zinc finger protein 139; Zinc finger protein 36 (KOX 18); Zinc finger protein 36; Zinc finger protein KOX18; ZKSC1_HUMAN; ZNF139; ZNF36; PHZ-37; 9130423L19Rik;
ZKSCAN5
zinc finger with KRAB and SCAN domains 5
ZKSCAN5; zinc finger with KRAB and SCAN domains 5; ZFP95, zinc finger protein 95 homolog (mouse) , zinc finger protein homologous to Zfp95 in mouse; zinc finger protein with KRAB and SCAN domains 5; ZNF914; FLJ39233; HGNC:12867; KIAA1015; MGC33710; Zfp 95; ZFP95; Zinc finger protein 95 homolog; zfp-95; zinc finger protein homologous to Zfp95 in mouse;
AC0T7
Acyl-CoA Thioesterase 7
ACOT7; acyl-CoA thioesterase 7; ACT; ACH1; BACH; LACH; LACH1; hBACH; CTE-II; MGC1126; cytosolic acyl coenzyme A thioester hydrolase; CTE-IIa; OTTHUMP00000001410; OTTHUMP00000001413; OTTHUMP00000001414; OTTHUMP00000001415; OTTHUMP00000200492; OTTHUMP00000200493; acyl-CoA thioesterase 2; brain acyl CoA hydrolase; brain acyl-CoA hydrolase; acyl-CoA thioesterase, long chain; long chain acyl-CoA thioester hydrolase; NP_009205.3; EC 3.1.2.2;
CTSG
cathepsin G
cathepsin G; CTSG; CG; CATG; MGC23078; OTTHUMP00000178752; CATG_HUMAN; Cathepsin G precursor; CTSG protein; EC 3.4.21.20; EC 3.4.21;
GPX2
glutathione peroxidase 2 (gastrointestinal)
GPX2; glutathione peroxidase 2 (gastrointestinal); glutathione peroxidase 2; GSHPX GI; Gastrointestinal glutathione peroxidase; GI GPx; Glutathione peroxidase gastrointestinal; Glutathione peroxidase related protein 2; Glutathione peroxidase-gastrointestinal; Glutathione peroxidase-related protein 2; GPRP; GPRP-2; GPx 2; GPx-2; GPx-GI; GPX2_HUMAN; GSHPx 2; GSHPx-2; GSHPx-GI; gastrointestinal glutathione peroxidase 2; GI-GPx;
KDM1A
lysine (K)-specific demethylase 1A
KDM1A; lysine (K)-specific demethylase 1A; AOF2; KDM1; LSD1; BHC110; lysine-specific histone demethylase 1A; lysine (K)-specific demethylase 1; BRAF35-HDAC complex protein BHC110; lysine-specific histone demethylase 1; amine oxidase (flavin containing) domain 2; FAD-binding protein BRAF35-HDAC complex, 110 kDa subunit; flavin-containing amine oxidase domain-containing protein 2;
KDM5C
lysine (K)-specific demethylase 5C
KDM5C; lysine (K)-specific demethylase 5C; MRXJ; SMCX; MRX13; MRXSJ; XE169; MRXSCJ; JARID1C; DXS1272E; lysine-specific demethylase 5C; protein SmcX; selected cDNA on X; Smcy homolog, X-linked; Smcx homolog, X chromosome; histone demethylase JARID1C; mental retardation, X-linked 13; JmjC domain-containing protein SMCX; Jumonji/ARID domain-containing protein 1C; Jumonji, AT rich interactive domain 1C (RBP2-like);
PCYT2
phosphate cytidylyltransferase 2, ethanolamine
PCYT2; phosphate cytidylyltransferase 2, ethanolamine; ET; ethanolamine-phosphate cytidylyltransferase; phosphorylethanolamine transferase; CTP:phosphoethanolamine cytidylyltransferase;
STK25
serine/threonine kinase 25
STK25; serine/threonine kinase 25; serine/threonine kinase 25 (Ste20, yeast homolog); serine/threonine-protein kinase 25; SOK1; YSK1; SOK-1; ste20-like kinase; Ste20, yeast homolog; ste20/oxidant stress response kinase 1; sterile 20/oxidant stress-respons;
STK32B
serine/threonine kinase 32B
STK32B; serine/threonine kinase 32B; serine/threonine-protein kinase 32B; HSA250839; STK32; STKG6; YANK2; gene for serine/threonine protein kinase;
MT
Metallothionein
CES 1; CES1; Metallothionein 1A; Metallothionein 1S; Metallothionein 2; Metallothionein 2A; Metallothionein IA; Metallothionein II; Metallothionein2; MGC32848; MT 1A; MT 2; MT 2A; MT IA; MT II; MT1; MT1A; MT1S; MT2; MT2A; MTC; MT; Metallothionein; Metallothioneins; MTs;
T3
Triiodothyronine
Triiodothyronine; T3; (2S)-2-amino-3- [4-(4-hydroxy-3-iodo-phenoxy)- 3,5-diiodo-phenyl]propanoic acid; triiodothyronine; 3,3',5-triiodo-L-thyronine;
Tox
thymocyte selection-associated high mobility group box
TOX; thymocyte selection-associated high mobility group box; thymocyte selection-associated high mobility group box protein TOX; KIAA0808; TOX1; Thymus high mobility group box protein TOX; TOX 1;
CGRRF1
cell growth regulator with ring finger domain 1
CGRRF1; cell growth regulator with ring finger domain 1; cell growth regulator with RING finger domain protein 1; CGR19; RNF197; Cell growth regulatory gene 19 protein; Cell Growth Regulatory with Ring Finger Domain; CGRRF 1; RING finger protein 197;
DMRTB1
DMRT-like family B with proline-rich C-terminal, 1
DMRTB1; DMRT-like family B with proline-rich C-terminal, 1; doublesex- and mab-3-related transcription factor B1; DMRT B 1; DMRT like family B with proline rich C terminal 1; DMRTB_HUMAN; FLJ32711; FLJ40434; HGNC:13913;
FAM175A
family with sequence similarity 175, member A
FAM175A; family with sequence similarity 175, member A; ABRA1; CCDC98; BRCA1-A complex subunit Abraxas; abraxas protein; coiled-coil domain containing 98; coiled-coil domain-containing protein 98;
HSPC152
TRMT112 tRNA methyltransferase 11-2 homolog (S. cerevisiae)
TRM112; HSPC152; HSPC170; TRMT11-2; tRNA methyltransferase 112 homolog; OTTHUMP00000237051; OTTHUMP00000237052; OTTHUMP00000237053; OTTHUMP00000237320; TRM112-like protein;
KIR3DX1
killer cell immunoglobulin-like receptor, three domains, X1
killer cell immunoglobulin-like receptor, three domains, X1; FLJ00060; KIR3DL0; LENG12; leukocyte receptor cluster (LRC) member 12; Leukocyte receptor cluster member 12; KIR3DX1;
MLLT6
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6
MLLT6; myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6; myeloid/lymphoid or mixed lineage leukemia (trithorax (Drosophila) homolog); protein AF-17; AF17; FLJ23480; Myeloid/lymphoid or mixe;
MSL2
male-specific lethal 2 homolog
MSL2; male-specific lethal 2 homolog (Drosophila); male specific lethal 2 like 1 (Drosophila) , MSL2L1, ring finger protein 184 , RNF184; male-specific lethal 2 homolog; FLJ10546; KIAA1585; male specific lethal 2 homolog (Drosophila); msl 2; MSL2-like 1;
OSGIN2
oxidative stress induced growth inhibitor family member 2
OSGIN2; oxidative stress induced growth inhibitor family member 2; C8orf1, chromosome 8 open reading frame 1; oxidative stress-induced growth inhibitor 2; hT41; C230027H09Rik; BC010311; C8orf1; MGC11786; OSGIN 2; OTTMUSP00000004957; RGD1306323; RP23-386N10.2;
PLEKHH3
pleckstrin homology domain containing, family H (with MyTH4 domain) member 3
PLEKHH3;pleckstrin homology domain containing, family H (with MyTH4 domain) member 3;pleckstrin homology domain-containing family H member 3;FLJ21019;PH domain-containing family H member 3;
RSAD2
radical S-adenosyl methionine domain containing 2
RSAD2;radical S-adenosyl methionine domain containing 2;radical S-adenosyl methionine domain-containing protein 2;cig5;vig1;viperin;cytomegalovirus-induced gene 5 protein;virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible;cig33;2510004L01Rik;
TMEFF1
transmembrane protein with EGF-like and two follistatin-like domains 1
TMEFF1; transmembrane protein with EGF-like and two follistatin-like domains 1; TR-1; H7365; C9orf2; CT120.1; tomoregulin-1; cancer/testis antigen family 120, member 1; transmembrane protein with EGF-like and one follistatin-like domain;
TRMT2A
TRM2 tRNA methyltransferase 2 homolog A (S. cerevisiae)
TRMT2A;TRM2 tRNA methyltransferase 2 homolog A (S. cerevisiae);tRNA (uracil-5-)-methyltransferase homolog A;HpaII tiny fragments locus 9C;HTF9C;tRNA methyltransferase 2 homolog A;hpaII tiny fragments locus 9c protein;MGC102728;
ZKSCAN3
zinc finger with KRAB and SCAN domains 3
ZKSCAN3; zinc finger with KRAB and SCAN domains 3; zinc finger protein 306 , zinc finger protein 309 , ZNF306, ZNF309; zinc finger protein with KRAB and SCAN domains 3; dJ874C20.1; ZF47; Zfp47; mszf35; SCAN-KRAB-zinc finger protein; Skz1; Zfp-47; ZFP306; Zfp307; Zinc finger and SCAN domain containing protein 13; Zinc finger and SCAN domain-containing protein 13; Zinc finger protein 306; Zinc finger protein 306, isoform CRA_a; Zinc finger protein 307; Zinc finger protein 309; Zinc finger protein 47 homolog; Zinc finger protein with KRAB and SCAN domains3; Zinc finger protein zfp47; ZKSC3_HUMAN; ZNF309; ZSCAN13; OTTHUMP00000016204; ZNF306; dJ874C20.1.;
ZKSCAN4
zinc finger with KRAB and SCAN domains 4
ZKSCAN4; zinc finger with KRAB and SCAN domains 4; zinc finger protein 307 , zinc finger protein 427 , ZNF307, ZNF427; zinc finger protein with KRAB and SCAN domains 4; FLJ32136; P1P373C6; p373c6.1; p373c6.1 (novel C2H2 type zinc finger protein); Zinc finger protein 307; Zinc finger protein 427; ZKSC4_HUMAN; ZNF307; ZNF427;
AARSD1
alanyl-tRNA synthetase domain containing 1
AARSD1; alanyl-tRNA synthetase domain containing 1; alanyl-tRNA editing protein Aarsd1; MGC2744; alanyl-tRNA synthetase domain-containing protein 1;
ADAP1
ArfGAP with dual PH domains 1
ADAP1; ArfGAP with dual PH domains 1; arf-GAP with dual PH domain-containing protein 1; CENTA1; Centaurin, alpha 1; GCS1L; p42IP4; Putative MAPK activating protein PM25; inositol(1,3,4,5)tetrakisphosphate receptor;
B3GNT6
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)
B3GNT6; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase); UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6; B3Gn T6; beta 1,3 Gn T6; beta 1,3 N acetylglucosaminyltransferase 6; beta 1,3 N acetylglucosaminyltransferase 6 protein; beta3Gn T6; core 3 synthase; UDP GlcNAc:betaGal beta 1,3 N acetylglucosaminyltransferase 6; BGnT-6; beta3Gn-T6; beta-1,3-Gn-T6; OTTHUMP00000229266; beta-1,3-N-acetylglucosaminyltransferase 6; beta-1,3-N-acetylglucosaminyltransferase protein; B3Gn-T6; IMAGE:4907098;
CERS1
ceramide synthase 1
LAG1 homolog, ceramide synthase 1; Protein UOG-1; UOG1; LAG1 longevity assurance homolog 1 (S. cerevisiae); LAG1; MGC90349; CerS1; LAG1 longevity assurance homolog 1; longevity assurance (LAG1, S. cerevisiae) homolog 1; upstream of GDF1; Longevity assurance gene 1 protein homolog 1; LASS1; CERS1;
CERS2
ceramide synthase 2
LAG1 homolog, ceramide synthase 2; LAG1 longevity assurance homolog 2 (S. cerevisiae); SP260; MGC987; CerS2; OTTHUMP00000033029; FLJ10243; OTTHUMP00000033030; L3; OTTHUMP00000033031; longevity assurance (LAG1, S. cerevisiae) homolog 2; ceramide synthase 2; Tumor metastasis-suppressor gene 1 protein; LAG1 longevity assurance 2; TMSG1; LAG1 longevity assurance homolog 2; LASS2; OTTHUMP00000033028; CERS2 ceramide synthase 2;
CERS6
ceramide synthase 6
LAG1 homolog, ceramide synthase 6; MGC129950; CerS6; LAG1 longevity assurance homolog 6; LAG1 longevity assurance homolog 6 (S. cerevisiae); longevity assurance homolog 6; MGC129949; LASS6; OTTHUMP00000163046; OTTHUMP00000163047;
CEV1
cellulose synthase A catalytic subunit 3 [UDP-forming]
CEV1; cellulose synthase A catalytic subunit 3 [UDP-forming]; ATCESA3; ATH B; ATHB; AtRSW5; Cellulose synthase 3; Cellulose synthase A catalytic subunit 3 [UDP forming]; Cellulose synthase A catalytic subunit 3; Cellulose synthase/ transferase transferring glycosyl groups; Constitutive expression of VSP1; Constitutive expression of VSP1 protein 1; ELI1; Isoxaben resistant 1; Isoxaben resistant protein 1; IXR1; K2A11.4; K2A11_4; Protein ECTOPIC LIGNIN 1; Protein RADIALLY SWOLLEN 5; RSW5; Cellulose synthase family protein CONSTITUTIVE EXPRESSION OF VSP 1 (CEV1); FUNCTIONS IN: cellulose synthase activity, transferase activity, transferring glycosyl groups; INVOLVED IN: primary cell wall biogenesis, cellulose biosynthetic process, defense re; ATH-B; CESA3; CONSTITUTIVE EXPRESSION OF VSP 1;
ECs2841
perosamine synthetase
ECs2841; perosamine synthetase; Escherichia coli O157:H7 str. Sakai; similar to Per [Escherichia coli O157:H7 C664-1992] gi|3435175|gb|AAC32343.1|;
EPAS1
endothelial PAS domain protein 1
EPAS1; endothelial PAS domain protein 1; endothelial PAS domain-containing protein 1; mHLF; EPAS-1; HIF2-alpha; HIF-2-alpha; Hif like protein; HIF-related factor; HIF1alpha-like factor; HIF1 alpha-like factor; HIF-1-alpha-like factor; HLF (HIF1alpha-like;
FGF11
fibroblast growth factor 11
FGF11; fibroblast growth factor 11; FHF3; fibroblast growth factor homologous factor 3; FLJ16061; MGC45269; MGC102953; FGF 11; FGF-11; FGF11_HUMAN; FHF 3; FHF-3; OTTHUMP00000135275;
FGF3
fibroblast growth factor 3
FGF3; fibroblast growth factor 3; fibroblast growth factor 3 (murine mammary tumor virus integration site (v int 2) oncogene homolog) , INT2; HBGF 3; INT 2 proto oncogene protein; murine mammary tumor virus integration site 2; mouse; oncogene INT2; V INT2;
FGFBP1
fibroblast growth factor binding protein 1
FGFBP1; fibroblast growth factor binding protein 1; fibroblast growth factor-binding protein 1; FGFBP; HBP17; 17 kDa heparin binding growth factor binding protein; FGF binding protein 1; FGF BP; FGF BP1; Fibroblast growth factor binding protein 1 precursor; FGF-binding protein 1; 17 kDa HBGF-binding protein; heparin-binding growth factor binding protein; 17 kDa heparin-binding growth factor-binding protein; FGF-BP; FGF-BP1; FGFBP-1;
HADHA
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit
HADHA; hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit; GBP; ECHA; HADH; LCEH; MTPA; LCHAD; TP-ALPHA; trifunctional enzyme subunit alpha, mitochondrial; 3-oxoacyl-CoA thiolase; gastrin-binding protein; 78 kDa gastrin-binding protein; long-chain 2-enoyl-CoA hydratase; long-chain-3-hydroxyacyl-CoA dehydrogenase; mitochondrial trifunctional enzyme, alpha subunit; mitochondrial trifunctional protein, alpha subunit; 3-ketoacyl-Coenzyme A (CoA) thiolase, alpha subunit; mitochondrial long-chain 2-enoyl-Coenzyme A (CoA) hydratase, alpha subunit; mitochondrial long-chain L-3-hydroxyacyl-Coenzyme A (CoA) dehydrogenase, alpha subunit; hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit;
HADHB
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit
HADHB; hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit; hydroxyacyl Coenzyme A dehydrogenase/3 ketoacyl Coenzyme A thiolase/enoyl Coenzyme A hydratase (trifunctional protein), beta subunit; trifunctional enzyme subunit beta, mitochondrial; mitochondrial trifunctional protein; beta subunit; MTPB; 2 enoyl Coenzyme A (CoA) hydratase beta subunit; 3 ketoacyl Coenzyme A (CoA) thiolase of mitochondrial trifunctional protein beta subunit; 3 ketoacyl Coenzyme A thiolase; 3 ketoacyl Coenzyme A thiolase of mitochondrial trifunctional protein beta subunit; 3-ketoacyl-CoA thiolase; Acetyl CoA acyltransferase; Acetyl-CoA acyltransferase; Beta ketothiolase; Beta-ketothiolase; ECHB; ECHB_HUMAN; HADH; Hydroxyacyl Coenzyme A (CoA) dehydrogenase beta subunit; Hydroxyacyl Coenzyme A dehydrogenase; Hydroxyacyl Coenzyme A dehydrogenase beta subunit; Hydroxyacyl Coenzyme A dehydrogenase/3 ketoacyl Coenzyme A thiolase/enoyl Coenzyme A hydratase (trifunctional protein) beta subunit; MGC87480; Mitochondrial trifunctional enzyme beta subunit; Mitochondrial trifunctional protein beta subunit; MS733; MSTP 029; MSTP029; TP beta; TP-beta; TPbeta; Trifunctional enzyme subunit beta; Trifunctional enzyme subunit beta mitochondrial; Trifunctional protein; OTTHUMP00000122456; OTTHUMP00000200808; 2-enoyl-Coenzyme A (CoA) hydratase, beta subunit; mitochondrial trifunctional enzyme, beta subunit; mitochondrial trifunction;
HAS1
hyaluronan synthase 1
HA synthase 1; HAS; HAS1; HAS1_HUMAN; HuHAS1; Hyaluronan synthase 1; Hyaluronate synthase 1; Hyaluronic acid synthase 1;
KDM3A
lysine (K)-specific demethylase 3A
KDM3A; lysine (K)-specific demethylase 3A; TSGA; JMJD1; JHDM2A; JHMD2A; JMJD1A; KIAA0742; DKFZp686A24246; DKFZp686P07111; lysine-specific demethylase 3A; OTTHUMP00000160707; OTTHUMP00000203309; testis-specific protein A; jumonji domain containing 1; jumonji domain containing 1A; jumonji domain-containing protein 1A; jumonji C domain-containing histone demethylase 2A; jmjC domain-containing histone demethylation protein 2A;
KDM3B
lysine (K)-specific demethylase 3B
KDM3B; lysine (K)-specific demethylase 3B; 5qNCA; NET22; C5orf7; JMJD1B; lysine-specific demethylase 3B; nuclear protein 5qNCA; jumonji domain containing 1B; jumonji domain-containing protein 1B; jmjC domain-containing histone demethylation protein 2B; KIAA1082; OTTHUMP00000224009;
KDM4A
lysine (K)-specific demethylase 4A
KDM4A; lysine (K)-specific demethylase 4A; JMJD2, JMJD2A, jumonji domain containing 2 , jumonji domain containing 2A; lysine-specific demethylase 4A; JHDM3A; jumonji C domain containing histone demethylase 3A; KIAA0677; jumonji domain containing 2; jumo;
KDM6A
lysine (K)-specific demethylase 6A
KDM6A; lysine (K)-specific demethylase 6A; UTX; KABUK2; bA386N14.2; lysine-specific demethylase 6A; histone demethylase UTX; ubiquitously-transcribed TPR gene on the X chromosome; ubiquitously-transcribed TPR protein on the X chromosome; ubiquitously transcribed tetratricopeptide repeat protein X-linked; bA386N14.2 (ubiquitously transcribed X chromosome tetratricopeptide repeat protein (UTX));
LILRA4
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4
LILRA4; leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4; leukocyte immunoglobulin-like receptor subfamily A member 4; CD85g; ILT7; ILT-7; OTTHUMP00000067952; immunoglobulin-like transcript 7; CD85 antigen-like family member G; leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 4;
LOC442228
similar to dJ22I17.2 (novel protein with EGF-like and laminin G domains)
LOC442228; similar to dJ22I17.2 (novel protein with EGF-like and laminin G domains); similar to dJ22I17.2 (novel protein with EGF-like and laminin G; dJ22I17.2;
LOC649853
hypothetical protein LOC649853
LOC649853; hypothetical protein LOC649853; Aw 19; HLA class I histocompatibility antigen A-29 alpha chain; HLA-A; major histocompatibility complex class I HLA-A29.1; MHC class I antigen A 29;
LTBP1
latent transforming growth factor beta binding protein 1
LTBP1; latent transforming growth factor beta binding protein 1; latent-transforming growth factor beta-binding protein 1; LTBP-1; TGF-beta1-BP-1; transforming growth factor beta-1-binding protein 1;
MAEA
macrophage erythroblast attacher
MAEA; macrophage erythroblast attacher; EMP; 1110030D19Rik; Cell proliferation inducing gene 5 protein; Cell proliferation-inducing gene 5 protein; Erythroblast macrophage protein; HLC 10; HLC-10; HLC10; Human lung cancer oncogene 10 protein; Lung cancer related protein 10; MAEA_HUMAN; MGC93683; PIG5; OTTHUMP00000217706; OTTHUMP00000217707; OTTHUMP00000217708; OTTHUMP00000217709; OTTHUMP00000217710; OTTHUMP00000217711; OTTHUMP00000217716; OTTHUMP00000217718; proliferation-inducing gene 5; lung cancer-related protein 10; erythrobl; EMLP;
MAST1
microtubule associated serine/threonine kinase 1
MAST1; microtubule associated serine/threonine kinase 1; microtubule-associated serine/threonine-protein kinase 1; KIAA0973; SAST; syntrophin associated serine/threonine kinase; syntrophin-associated serine/threonine-protein kinase; SAST170;
MBD2
methyl-CpG binding domain protein 2
MBD2; methyl-CpG binding domain protein 2; methyl-CpG-binding domain protein 2; demethylase; DMTase; NY-CO-41; DKFZp586O0821;
MEF2BNB-MEF2B
MEF2BNB-MEF2B readthrough
MEF2BNB-MEF2B; MEF2BNB-MEF2B readthrough; myocyte enhancer factor 2B; PRDM3; MADS box transcription enhancer factor 2; MDS1 EVI1; Mef2b; MEF2B_HUMAN; Myocyte specific enhancer factor 2B; Myocyte-specific enhancer factor 2B; RSRFR2; Serum response factor like protein 2; Serum response factor-like protein 2; XMEF2; LOC729991-MEF2B readthrough; LOC729991-MEF2B;
MLLT10
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10
MLLT10; myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10; myeloid/lymphoid or mixed lineage leukemia (trithorax (Drosophila) homolog); protein AF-10; AF10; type I AF10 protein; type IV AF;
NET1
neuroepithelial cell transforming 1
NET1; neuroepithelial cell transforming 1; neuroepithelial cell-transforming gene 1 protein; ARHGEF8; NET1A; proto-oncogene p65 Net1; p65 Net1 proto-oncogene protein; small GTP-binding protein regulator; neuroepithelioma transforming gene 1; neuroepitheli;
PICK1
protein interacting with PRKCA 1
PICK1; protein interacting with PRKCA 1; PRKCABP, protein interacting with PRKCA , protein kinase C, alpha binding protein; PRKCA-binding protein; dJ1039K5; MGC15204; OTTHUMP00000028509; PICK 1; PICK1_HUMAN; PRKCA binding protein; PRKCABP; Protein interacting with C kinase 1; Protein interacting with PRKCA; Protein kinase C alpha binding protein; Protein kinase C-alpha-binding protein; Protein that interacts with C kinase 1; OTTHUMP00000199277; OTTHUMP00000199289; OTTHUMP00000199291; PICK;
PTGS1
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
PTGS1; prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase); COX1; COX3; PHS1; PCOX1; PES-1; PGHS1; PTGHS; PGG/HS; PGHS-1; prostaglandin G/H synthase 1; PGH synthase 1; cyclooxygenase-1; prostaglandin H2 synthase 1;
PTH1R
parathyroid hormone 1 receptor
PTH1R; parathyroid hormone 1 receptor; parathyroid hormone receptor 1 , PTHR, PTHR1; parathyroid hormone/parathyroid hormone-related peptide receptor; PTH1 receptor; PTH/PTHr receptor; PTH/PTHrP type I receptor; parathyroid hormone receptor 1; seven trans;
REL
v-rel reticuloendotheliosis viral oncogene homolog
REL; C-Rel; proto-oncogene c-Rel; OTTHUMP00000159786; OTTHUMP00000201246; C-Rel proto-oncogene protein; oncogene REL, avian reticuloendotheliosis; v-rel avian reticuloendotheliosis viral; oncogene homolog; NFkB, c-Rel subunit;
THOC4
THO complex 4
THOC4; THO complex 4; THO complex subunit 4; ALY; ALY/REF; BEF; REF; Ally of AML1 and LEF1; bZIP enhancing factor; THOC 4; THOC-4; Transcriptional coactivator; tho4; OTTHUMP00000218275; ally of AML-1 and LEF-1; bZIP-enhancing factor BEF; transcriptional coactivator Aly/REF;
TMPO
thymopoietin
TMPO; thymopoietin; LAP2; LEM domain containing 4; LEMD4; TP; Lamina associated polypeptide 2; LAP 2; Thymopoietin isoform alpha; Thymopoietin related peptide isoform alpha; Thymopoietin related peptide isoforms beta/gamma; Thymopoietin, isoforms beta/gamma; TP alpha; TP beta/gamma; TPRP isoform alpha; TPRP isoforms beta/gamma; lamina-associated polypeptide 2; thymopoietin-related peptide isoform alpha; thymopoietin-related peptide isoforms beta/gamma; CMD1T; PRO0868;
TRMT61A
tRNA methyltransferase 61 homolog A (S. cerevisiae)
TRMT61A; tRNA methyltransferase 61 homolog A (S. cerevisiae); C14orf172, chromosome 14 open reading frame 172; tRNA (adenine-N(1)-)-methyltransferase catalytic subunit TRMT61A; FLJ40452; GCD14; Gcd14p; hTRM61; Adenine N; C14orf172; Chromosome 14 open reading frame 172; TRM61; tRNA; tRNA (adenine N (1) ) m1A58methyltransferase subunit TRM61; tRNA (adenine-N(1)-)-methyltransferase catalytic subunit TRM61; tRNA (m1A58)MTase subunit TRM61; tRNA (m1A58T) methyltransferase subunit TRM61; tRNA(m1A58)-methyltransferase subunit TRM61; tRNA(m1A58)-methyltransferase subunit TRMT61A; tRNA(m1A58)MTase subunit TRMT61A; OTTHUMP00000246784; tRNA(m1A58)MTase subunit TRM61; tRNA (adenine-N(1;
NTHL1
nth endonuclease III-like 1 (E. coli)
NTHL1; nth endonuclease III-like 1 (E. coli); nth (E.coli endonuclease III) like 1; endonuclease III-like protein 1; NTH1; OCTS3; Endonuclease III like protein 1; NTH 1; NTH endonuclease III Like 1; NTHL 1; NTHL1_HUMAN; OCTS 3; OTTHUMP00000158939;
ING4
inhibitor of growth family, member 4
ING4; inhibitor of growth family, member 4; inhibitor of growth protein 4; my036; p29ING4; brain my036 protein; candidate tumor suppressor p33 ING1 homolog; MGC12557;
SLC1A1
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
SLC1A1; solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1; excitatory amino acid transporter 3; EAAC1; EAAT3; excitatory amino acid carrier 1; solute carrier family 1 member 1; neuronal and epithelial;
RPE65
retinal pigment epithelium-specific protein 65kDa
RPE65; retinal pigment epithelium-specific protein 65kDa; LCA2; RP20; rd12; mRPE65; sRPE65; retinoid isomerohydrolase; p63; retinol isomerase; RBP-binding membrane protein; all-trans-retinyl-palmitate hydrolase; retinitis pigmentosa 20 (autosomal recessive); retinal pigment epithelium-specific 65 kDa protein;
EGR2
early growth response 2
EGR2; early growth response 2; AT591; CMT1D; CMT4E; KROX20; E3 SUMO-protein ligase EGR2; zinc finger protein Krox-20; early growth response protein 2; KROX-20, Drosophila, homolog (early growth response-2);
RAPSN
receptor-associated protein of the synapse
RAPSN; receptor-associated protein of the synapse; 43 kDa receptor-associated protein of the synapse; 43 kD receptor associated protein of the synapse; 43 kda postsynaptic protein; Acetylcholine receptor associated 43 kda protein; acetylcholine receptor-associated 43 kda protein; CMS1D; CMS1E; MGC3597; RAPSN_HUMAN; RAPsyn; Receptor associated protein of the synapse 43kD; Receptor associated protein of the synapse; receptor-associated protein of the synapse 43kD; RING finger protein 205; RNF 205; RNF205; receptor-associated protein of the synapse, 43kD;
ACSL3
acyl-CoA synthetase long-chain family member 3
ACSL3; acyl-CoA synthetase long-chain family member 3; FACL3, fatty acid Coenzyme A ligase, long chain 3; long-chain-fatty-acid--CoA ligase 3; ACS3; PRO2194; LACS 3; lignoceroyl-CoA synthase; long-chain acyl-CoA synthetase 3; fatty-acid-Coenzyme A ligase;
AGAP1
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1
AGAP1; ArfGAP with GTPase domain, ankyrin repeat and PH domain 1; centaurin, gamma 2 , CENTG2; arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1; GGAP1; KIAA1099; AGAP 1; AGAP-1; AGAP1_HUMAN; Arf GAP with GTP binding proteinlike ANK repeat and PH domains 1; ArfGAP with GTPase domain ankyrin repeat and PH domain 1; Centaurin gamma 2; Centaurin-gamma-2; CENTG2; Cnt-g2; GGAP 1; GTP binding and GTPase activating protein 1; GTP-binding and GTPase-activating protein 1; MGC71657; centaurin, gamma 2; Arf GAP with GTP-binding protein-like, ANK repeat and PH domains 1;
BRSK1
BR serine/threonine kinase 1
BRSK1; BR serine/threonine kinase 1; serine/threonine-protein kinase BRSK1; KIAA1811; SAD1 kinase; SAD1 homolog; protein kinase SAD1A; brain-selective kinase 1; SadB kinase short isoform; BR serine/threonine-protein kinase 1; serine/threonine-protein kina;
EDNRB
endothelin receptor type B
EDNRB; endothelin receptor type B; ETB; ET-B; ETBR; ETRB; HSCR; WS4A; ABCDS; ET-BR; HSCR2; endothelin B receptor; endothelin receptor non-selective type;
ENOX1
ecto-NOX disulfide-thiol exchanger 1
ENOX1; ecto-NOX disulfide-thiol exchanger 1; cCNOX; CNOX; FLJ10094; PIG38; bA64J21.1; Candidate growth related and time keeping constitutive hydroquinone [NADH] oxidase; Cell proliferation inducing gene 38 protein; Constitutive Ecto NOX; Ecto NOX disulfide thiol exchanger 1; OTTHUMP00000018332; Proliferation inducing protein 38; constitutive Ecto-NOX; cell proliferation-inducing gene 38 protein; candidate growth-related and time keeping constitutive hydroquinone (NADH) oxidase; candidate growth-related and time keeping constitutive hydroquinone [NADH] oxidase;
ETHE1
ethylmalonic encephalopathy 1
ETHE1; ethylmalonic encephalopathy 1; protein ETHE1, mitochondrial; HSCO; YF13H12; ethylmalonic encephalopathy protein 1; hepatoma subtracted clone one protein;
FAM20C
family with sequence similarity 20, member C
FAM20C; family with sequence similarity 20, member C; dentin matrix protein 4; DKFZp547D065; DMP4; IMAGE:4942737; RNS; DMP-4; DKFZp547C074;
FGF13
fibroblast growth factor 13
FGF13; fibroblast growth factor 13; FGF2; FHF2; fibroblast growth factor homologous factor 2; FGF 13; FGF 2; FGF-13; FGF13_HUMAN; FHF 2; FHF-2; OTTHUMP00000024143; OTTHUMP00000024144;
GARS
glycyl-tRNA synthetase
GARS; glycyl-tRNA synthetase; Charcot Marie Tooth neuropathy 2D , CMT2D; glycine--tRNA ligase; DSMAV; glycine tRNA ligase; GlyRS; SMAD1; AP-4-A synthetase; Charcot-Marie-Tooth neuropathy 2D; diadenosine tetraphosphate synthetase; Charcot-Marie-Tooth neuro;
GFER
growth factor, augmenter of liver regeneration
GFER; growth factor, augmenter of liver regeneration; ALR; HPO; HSS; ERV1; HPO1; HPO2; HERV1; FAD-linked sulfhydryl oxidase ALR; ERV1 homolog; hepatopoietin protein; erv1-like growth factor; hepatic regenerative stimulation substance;
GHRHR
growth hormone releasing hormone receptor
GHRHR; growth hormone releasing hormone receptor; growth hormone-releasing hormone receptor; GHRFR; GHRH R; GHRH receptor; GHRHR_HUMAN; GHRHRpsv; GRF R; GRF receptor; GRFR; Growth hormone releasing factor receptor; Growth hormone-releasing factor receptor; IGHD1B;
GHSR
growth hormone secretagogue receptor
GHSR; growth hormone secretagogue receptor; growth hormone secretagogue receptor type 1; GH releasing peptide receptor; GH-releasing peptide receptor; Ghrelin receptor; GHRP; GHRPR; GHS-R; GHSR_HUMAN; Growth hormone secretagogue receptor 1; growth hormone secretatgogue receptor;
GPRIN1
G protein regulated inducer of neurite outgrowth 1
GPRIN1; G protein regulated inducer of neurite outgrowth 1; G protein-regulated inducer of neurite outgrowth 1; GRIN1; KIAA1893;
GPX7
glutathione peroxidase 7
GPX7; glutathione peroxidase 7; FLJ14777; GPX6; NPGPx; CL683; GPx-7; GPX7_HUMAN; GSHPx-7; glutathione peroxidase 6; non-selenocysteine containing phospholipid hydroperoxide glutathione peroxidase;
HMGCS1
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble)
HMGCS1; 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble); 3 hydroxy 3 methylglutaryl Coenzyme A synthase 1 (soluble) , HMGCS; hydroxymethylglutaryl-CoA synthase, cytoplasmic; 3 hydroxy 3 methylglutaryl coenzyme A (HMG CoA) synthase; cytoplasmic; 3 hydroxy 3 methylglutaryl Coenzyme A synthase 1 (soluble); 3-hydroxy-3-methylglutaryl coenzyme A synthase; EC 2.3.3.10; HMCS1_HUMAN; HMG CoA synthase; HMG-CoA synthase; HMGCS; Hydroxymethylglutaryl CoA synthase, cytoplasmic; Hydroxymethylglutaryl-CoA synthase; MGC90332; 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) synthase; 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble);
HPGDS
hematopoietic prostaglandin D synthase
HPGDS; hematopoietic prostaglandin D synthase; glutathione S transferase sigma; GSTS; H PGDS; PGDS; GST class-sigma; prostaglandin-H2 D-isomerase; glutathione S-transferase sigma; glutathione-dependent PGD synthase; glutathione-dependent PGD synthetase; h;
ING5
inhibitor of growth family, member 5
ING5; inhibitor of growth family, member 5; inhibitor of growth protein 5; FLJ23842; p28ING5; 1700001C14Rik; 1700027H23Rik; 1810018M11Rik; ING 5; ING-5; Inhibitor of growth family member 5; p28 ING 5; p28 ING-5; p28 ING5;
MGST1
microsomal glutathione S-transferase 1
MGST1; microsomal glutathione S-transferase 1; GST12; MGST I; Glutathione S transferase 12; MGST 1; MGST; MGST1_HUMAN; Microsomal GST 1; Microsomal GST-1; Microsomal GST-I; glutathione S-transferase 12; MGST-I;
MTHFD1
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase
MTHFD1; methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase; MTHFC, MTHFD; C-1-tetrahydrofolate synthase, cytoplasmic; 5,10 methylenetetrahydrofolate dehydrogenase 5,10 methylenetetrahydrofolate cyclohydrolase,10 formyltetrahydrofolate synthetase; C1 tetrahydrofolate synthase cytoplasmic; C1 THF synthase; C1-THF synthase; C1TC; C1TC_HUMAN; Cytoplasmic C 1 tetrahydrofolate synthase; Formyltetrahydrofolate synthetase; Methenyltetrahydrofolate cyclohydrolase; Methylenetetrahydrofolate dehydrogenase (NADP+ dependent)methenyltetrahydrofolate cyclohydrolase formyltetrahydrofolate synthetase; Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 methenyltetrahydrofolate cyclohydrolase formyltetrahydrofolate synthetase; Methylenetetrahydrofolate dehydrogenase; MTHFC; MTHFD; NADP dependent cyclohydrolase formyltetrahydrofolate synthetase; OTTHUMP00000180657; OTTHUMP00000245366; cytoplasmic C-1-tetrahydrofolate synthase; 5,10-methylenetetrahydrofolate dehydrogenase, 5,10-methylenetetrahydrofolate cyclohydrolase, 10-formyltetrahydrofolate synthetase;
MUT
methylmalonyl CoA mutase
MUT; methylmalonyl CoA mutase; methylmalonyl Coenzyme A mutase; methylmalonyl-CoA mutase, mitochondrial; mitochondrial; MCM; Methylmalonyl CoA isomerase; Methylmalonyl CoA mutase mitochondrial; Methylmalonyl-CoA isomerase; Methylmalonyl-CoA mutase; MUTA_HUMAN;
OGFR
opioid growth factor receptor
OGFR; opioid growth factor receptor; 7 60; 7-60 protein; protein 7-60; zeta-type opioid receptor;
PPT1
palmitoyl-protein thioesterase 1
PPT1; palmitoyl-protein thioesterase 1; PPT; ceroid lipofuscinosis; neuronal 1; infantile; CLN1; INCL; PPT-1; palmitoyl-protein hydrolase 1; ceroid-palmitoyl-palmitoyl-protein thioesterase 1;
RPUSD1
RNA pseudouridylate synthase domain containing 1
RPUSD1; RNA pseudouridylate synthase domain containing 1; C16orf40, chromosome 16 open reading frame 40; RNA pseudouridylate synthase domain-containing protein 1; MGC19600; RLUCL; C16orf40; Ribosomal large subunit pseudouridine synthase C like protein; RNA pseudouridylate synthase domain containing protein 1; RPUSD 1; ribosomal large subunit pseudouridine synthase C like; ribosomal large subunit pseudouridine synthase C-like protein;
RRAD
Ras-related associated with diabetes
RRAD; Ras-related associated with diabetes; RAD; RAD1; REM3; GTP-binding protein RAD; ras associated with diabetes; RAS (RAD and GEM) like GTP binding 3;
SHMT2
serine hydroxymethyltransferase 2 (mitochondrial)
SHMT2; serine hydroxymethyltransferase 2 (mitochondrial); SHMT; serine hydroxymethyltransferase, mitochondrial; GLYA; Glycine hydroxymethyltransferase; Serine hydroxymethyltransferase mitochondrial; Serine methylase; SHMT 2; GLY A+; serine aldolase; threonine aldolase; serine hydroxymethylase; glycine auxotroph A, human complement for hamster;
SPTBN1
spectrin, beta, non-erythrocytic 1
SPTBN1; spectrin, beta, non-erythrocytic 1; spectrin beta chain, brain 1; beta-fodrin; beta-G spectrin; beta-spectrin 2; beta-II spectrin; beta-spectrin II; fodrin beta chain; embryonic liver beta-fodrin; spectrin, non-erythroid beta chain 1; ELF; SPTB2;
TARS2
threonyl-tRNA synthetase 2, mitochondrial (putative)
TARS2; threonyl-tRNA synthetase 2, mitochondrial (putative); TARSL1, threonyl tRNA synthetase like 1; threonyl-tRNA synthetase, mitochondrial; FLJ12528; threonine tRNA ligase 2; mitochondrial; Threonine tRNA ligase; ThrRS; TARS 2; TARSL1; Threonyl tRNA synthetase 2, mitochondrial; Threonyl tRNA synthetase like 1; threonine--tRNA ligase; threonyl-tRNA synthetase-like 1; threonine tRNA ligase 2, mitochondrial;
TBRG4
transforming growth factor beta regulator 4
TBRG4; transforming growth factor beta regulator 4; protein TBRG4; cell cycle progression 2 protein; Cpr2; FAST kinase domains 4; FASTKD4; H_TD2522F11.8; KIAA0948; Cell cycle progression protein 2; Cell cycle progression restoration protein 2; FAST kinase domain containing protein 4; FAST kinase domain-containing protein 4;
THAP4
THAP domain containing 4
THAP4; THAP domain containing 4; THAP domain-containing protein 4; CGI 36; 2010320B01Rik; CGI-36; MGC93755; PP238; THAP4_HUMAN;
TXNDC5
thioredoxin domain containing 5 (endoplasmic reticulum)
TXNDC5; thioredoxin domain containing 5 (endoplasmic reticulum); thioredoxin domain containing 5; thioredoxin domain-containing protein 5; EndoPDI; ERp46; FLJ21353; FLJ90810; Hcc 2; MGC3178; PDIA15; protein disulfide isomerase family A; member 15; ER prot;
ADAMTS3
ADAM metallopeptidase with thrombospondin type 1 motif, 3
ADAMTS3; ADAM metallopeptidase with thrombospondin type 1 motif, 3; ADAMTS-4; A disintegrin and metalloproteinase with thrombospondin motifs 3; ADAM-TS3; ADAMTS-3; PC II-NP; ADAM-TS 3; zinc metalloendopeptidase; procollagen II N-proteinase; procollagen II amino propeptide-processing enzyme; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 3;
AGAP2
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
AGAP2; ArfGAP with GTPase domain, ankyrin repeat and PH domain 2; centaurin, gamma 1 , CENTG1; arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2; cnt-g1; centaurin, gamma 1; phosphoinositide 3-kinase enhancer; phosphatidylinositol 3-kinas;
C8orf44-SGK3
C8orf44-SGK3 readthrough
C8ORF44-SGK3;C8orf44-SGK3 readthrough;serine/threonine-protein kinase Sgk3;cytokine-independent survival kinase;serum/glucocorticoid-regulated kinase 3;DKFZp779G0825;
CCT8
chaperonin containing TCP1, subunit 8 (theta)
CCT8; chaperonin containing TCP1, subunit 8 (theta); C21orf112, chromosome 21 open reading frame 112; T-complex protein 1 subunit theta; Cctq; PRED71; C21orf112; CCT 8; CCT theta; Chaperonin containing TCP1 subunit 8 (theta); Chaperonin subunit 8 (Theta) (Predicted), isoform CRA_a; Chaperonin subunit 8 (theta); Chromosome 21 open reading frame 112; D21S246; KIAA0002; Renal carcinoma antigen NY REN 15; T complex protein 1 subunit theta; T complex protein 1 theta subunit; TCP 1 theta; Tcpq; CCT-theta; TCP-1-theta; renal carcinoma antigen NY-REN-15; T-complex protein 1, theta subunit;
DEDD2
death effector domain containing 2
DEDD2; death effector domain containing 2; FLAME-3; DNA-binding death effector domain-containing protein 2; DED-containing protein FLAME-3; FADD-like anti-apoptotic molecule 3; death effector domain-containing DNA binding protein 2;
KLRC4-KLRK1
KLRC4-KLRK1 readthrough
KLRC4-KLRK1;KLRC4-KLRK1 readthrough;NKG2-D type II integral membrane protein;NK cell receptor D;NKG2-D-activating NK receptor;killer cell lectin-like receptor subfamily K member 1;FLJ17759;FLJ78582;
LOC100009097
hypothetical protein LOC100009097
Iggc; hypothetical protein LOC100009097; Ig gamma H-chain; immunoglobulin gamma1 constant region;
MADD
MAP-kinase activating death domain
MADD; MAP-kinase activating death domain; MAP kinase-activating death domain protein; DENN; KIAA0358; RAB3GEP; Rab3 GDP/GTP exchange factor; insulinoma glucagonoma clone 20; differentially expressed in normal and neoplastic cells; IG20; FLJ35600; FLJ36300;
MTR
5-methyltetrahydrofolate-homocysteine methyltransferase
MTR; 5-methyltetrahydrofolate-homocysteine methyltransferase; MS; HMAG; cblG; methionine synthase; cobalamin-dependent methionine synthase; vitamin-B12 dependent methionine synthase; 5-methyltetrahydrofolate-homocysteine methyltransferase 1;
NOL3
nucleolar protein 3 (apoptosis repressor with CARD domain)
NOL3; nucleolar protein 3 (apoptosis repressor with CARD domain); ARC; FCM; MYP; NOP; NOP30; nucleolar protein 3; nucleolar protein of 30 kDa; muscle-enriched cytoplasmic protein;
Nsf
N-ethylmaleimide-sensitive factor
NSF; N-ethylmaleimide-sensitive factor; vesicle-fusing ATPase; N ethylmaleimide sensitive factor like protein; SKD2; NEM-sensitive fusion protein; vesicular-fusion protein NSF; N-ethylmaleimide-sensitive fusion protein; N-ethylmaleimide-sensitive factor-l;
PTH2R
parathyroid hormone 2 receptor
PTH2R; parathyroid hormone 2 receptor; parathyroid hormone receptor 2 , PTHR2; Parathyroid hormone receptor precursor; PTH 2 receptor; PTH2 receptor; PTH2R_HUMAN; Pthr 2; Pthr2; parathyroid hormone receptor 2;
TMX1
thioredoxin-related transmembrane protein 1
TMX1; thioredoxin-related transmembrane protein 1; thioredoxin domain containing , thioredoxin domain containing 1 , thioredoxin domain containing , TXNDC, TXNDC1; PDIA11; protein disulfide isomerase family A; member 11; thioredoxin related transmembrane protein; TMX; Thioredoxin domain containing; Thioredoxin domain-containing protein 1; TMX1_HUMAN; Transmembrane Trx-related protein; TXNDC; TXNDC1; thioredoxin domain containing 1; protein disulfide isomerase family A, member 11;
TRHR
thyrotropin-releasing hormone receptor
TRHR; thyrotropin-releasing hormone receptor; thyroliberin receptor; TRH-R; MGC141920;
AASS
aminoadipate-semialdehyde synthase
AASS; aminoadipate-semialdehyde synthase; alpha-aminoadipic semialdehyde synthase, mitochondrial; LKRSDH; LORSDH; lysine-2-oxoglutarate reductase; aminoadipic semialdehyde synthase; alpha-aminoadipate semialdehyde synthase; lysine-ketoglutarate reductase;
FAM164C
family with sequence similarity 164, member C
FAM164C; family with sequence similarity 164, member C; C14orf140, chromosome 14 open reading frame 140; protein FAM164C; chromosome 14 open reading frame 140; family with sequence similarity 164 member C; FLJ23093; UPF0418 protein FAM164C; C14orf140;
ANTXR2
anthrax toxin receptor 2
ANTXR2; anthrax toxin receptor 2; capillary morphogenesis protein 2; CMG 2; CMG2; FLJ31074; ISH; JHF; MGC111533; MGC45856; 2310046B19Rik; ANTR2_HUMAN; AW561899; Capillary morphogenesis gene 2 protein; CMG-2;
ADAMTS14
ADAM metallopeptidase with thrombospondin type 1 motif, 14
ADAMTS14; ADAM metallopeptidase with thrombospondin type 1 motif, 14; A disintegrin and metalloproteinase with thrombospondin motifs 14; ADAM-TS14; ADAMTS-14; ADAM-TS 14; metalloprotease-disintegrin protease; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 14;
ADAMTS15
ADAM metallopeptidase with thrombospondin type 1 motif, 15
ADAMTS15; ADAM metallopeptidase with thrombospondin type 1 motif, 15; A disintegrin and metalloproteinase with thrombospondin motifs 15; ADAM-TS15; ADAMTS-15; ADAM-TS 15; metalloprotease disintegrin 15 with thrombospondin domains; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 15, preproprotein;
AMIGO2
adhesion molecule with Ig like domain 2
AMIGO2; adhesion molecule with Ig like domain 2; amphoterin-induced protein 2; ALI 1; ALI1; Alivin 1; Alivin1; AMIGO 2; Amphoterin Induced Gene 2; Amphoterin induced protein 2; DEGA; Differentially expressed in gastric adenocarcinoma; Differentially expressed in gastric adenocarcinomas; Transmembrane protein AMIGO 2; Transmembrane protein AMIGO2; AMIGO-2; alivin-1;
AMIGO3
adhesion molecule with Ig-like domain 3
AMIGO3; adhesion molecule with Ig-like domain 3; amphoterin-induced protein 3; amphoterin induced gene and open reading frame 3; Adhesion molecule with Ig like domain 3; ALI3; Alivin 3; AMIGO 3; Amphoterin induced gene and ORF 3; Amphoterin induced protein 3 precursor; alivin-3; amphoterin-induced gene and ORF 3; AMIGO-3;
AGAP4
ArfGAP with GTPase domain, ankyrin repeat and PH domain 4
AGAP4; ArfGAP with GTPase domain, ankyrin repeat and PH domain 4; centaurin, gamma like family, member 1 , CTGLF1; arf-GAP with GTPase, ANK repeat and PH domain-containing protein 4; Em:AC012044.1; MRIP2; ANK repeat and PH domain-containing protein 4; AGAP-4; AGAP4_HUMAN; Arf-GAP with GTPase; ArfGAP with GTPase domain, ankyrin repeat and PH domain 4provided; Centaurin-gamma-like family member 1; CTGLF1; ARF GTPase-activating protein; centaurin, gamma-like family, member 1;
AGAP8
ArfGAP with GTPase domain, ankyrin repeat and PH domain 8
AGAP8; ArfGAP with GTPase domain, ankyrin repeat and PH domain 8; centaurin, gamma like family, member 5 , CTGLF5; arf-GAP with GTPase, ANK repeat and PH domain-containing protein 8; ANK repeat and PH domain-containing protein 8; AGAP 8; AGAP-8; AGAP8_HUMAN; Arf GAP with GTPase ANK repeat and PH domain containing protein 8; Arf-GAP with GTPase; Centaurin gamma like family member 5; Centaurin-gamma-like family member 5; CTGLF5; centaurin, gamma-like family, member 5;
AGAP9
ArfGAP with GTPase domain, ankyrin repeat and PH domain 9
AGAP9; ArfGAP with GTPase domain, ankyrin repeat and PH domain 9; centaurin, gamma like family, member 6 , CTGLF6; arf-GAP with GTPase, ANK repeat and PH domain-containing protein 9; bA301J7.2; FLJ00312; AGAP 9; centaurin-gamma-like family member 6; CTGLF6; centaurin, gamma-like family, member 6; AGAP-9;
ASMTL
acetylserotonin O-methyltransferase-like
ASMTL; acetylserotonin O-methyltransferase-like; N-acetylserotonin O-methyltransferase-like protein; Acetylserotonin N methyltransferase like; Acetylserotonin O methyltransferase like; ASMTLX; ASMTLY; ASTML; N acetylserotonin O methyltransferase like protein; acetylserotonin N-methyltransferase-like;
ARMS2
age-related maculopathy susceptibility 2
ARMS2; age-related maculopathy susceptibility 2; age-related maculopathy susceptibility protein 2; Age related maculopathy susceptibility 2; Age related maculopathy susceptibility protein 2 mitochondrial; ARMD8; ARMS2 age related maculopathy susceptibility 2; LOC387715; Macular degeneration age related 8; PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE;
ADO
2-aminoethanethiol (cysteamine) dioxygenase
ADO; 2-aminoethanethiol (cysteamine) dioxygenase; C10orf22, chromosome 10 open reading frame 22; 2-aminoethanethiol dioxygenase; cysteamine dioxygenase; FLJ14547; cysteamine (2-aminoethanethiol) dioxygenase (ADO); C10orf22; DKFZp564C046;
FAM129C
family with sequence similarity 129, member C
FAM129C; family with sequence similarity 129, member C; niban-like protein 2; B cell novel protein 1; BCNP1; FLJ39802; B-cell novel protein 1;
ACSBG2
acyl-CoA synthetase bubblegum family member 2
ACSBG2; acyl-CoA synthetase bubblegum family member 2; long-chain-fatty-acid--CoA ligase ACSBG2; BGR; bubblegum related protein; DKFZp434K1635; PRTD NY3; ACSBG 2; Acyl CoA synthetase bubblegum family member 2; BGR like; BRGL; Bubblegum related acyl CoA synthetase 2; Long chain fatty acid CoA ligase; Long chain fatty acid CoA ligase ACSBG2; MGC111089; PRTDNY3; bubblegum-related protein; PRTD-NY3;
ACSF2
acyl-CoA synthetase family member 2
ACSF2; acyl-CoA synthetase family member 2; acyl-CoA synthetase family member 2, mitochondrial; ACSMW; FLJ20920; mitochondrial; ACSF 2; ACSF2_HUMAN; Acyl CoA synthetase family member 2; Acyl CoA synthetase family member 2 mitochondrial; AVYV493; PPARG binding long chain fatty acid acyl Co A ligase like; Putative uncharacterized protein FLJ20920; PPARG binding, long chain fatty acid acyl Co-A ligase like;
ASAP3
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3
ASAP3; ArfGAP with SH3 domain, ankyrin repeat and PH domain 3; DDEFL1, development and differentiation enhancing factor like 1; arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3; centaurin; beta 6; CENTB6; FLJ20199; UPLC1; centaurin,;
ACOT1
acyl-CoA thioesterase 1
ACOT1; acyl-CoA thioesterase 1; acyl-coenzyme A thioesterase 1; ACH2; CTE 1; LACH2; Acyl CoA thioesterase 1, cytosolic; Acyl coenzyme A thioesterase 1; CTE I; CTE Ib; Cte1; Cytosolic acyl CoA thioesterase 1; D12Ucla1; Inducible cytosolic acyl-coenzyme A thioester hydrolase; Long chain acyl CoA hydrolase; Long chain acyl CoA thioester hydrolase; CTE-I; CTE-Ib; long chain acyl-CoA hydrolase; long chain acyl-CoA thioester hydrolase; CTE-1;
ACSF3
acyl-CoA synthetase family member 3
ACSF3; acyl-CoA synthetase family member 3; acyl-CoA synthetase family member 3, mitochondrial; Acyl CoA synthetase family member 3; Acyl CoA synthetase family member 3 mitochondrial; FLJ39242; Hypothetical protein LOC197322;
ACSL6
acyl-CoA synthetase long-chain family member 6
ACSL6; acyl-CoA synthetase long-chain family member 6; FACL6, fatty acid Coenzyme A ligase, long chain 6; long-chain-fatty-acid--CoA ligase 6; ACS2; KIAA0837; LACS2; LACS5; long fatty acyl-CoA synthetase 2; fatty-acid-Coenzyme A ligase, long-chain 6; FAC;
AGFG1
ArfGAP with FG repeats 1
AGFG1; ArfGAP with FG repeats 1; HIV 1 Rev binding protein , HRB; arf-GAP domain and FG repeats-containing protein 1; RAB; RIP; D730048C23Rik; HIV 1 Rev binding protein; MGC116375; MGC116938; MGC116940; Rev/Rex activation domain-binding protein; AGFG1_HUMAN; AU045498; C130049H11Rik; C85612; DKFZp686I15205; HIV-1 Rev-binding protein; HRB; Nucleoporin like protein RIP; Nucleoporin-like protein RIP; Rev interacting protein; Rev-interacting protein; HIV-1 Rev binding protein; hRIP, Rev interacting protein; Rab, Rev/Rex activation domain-binding protein;
AGFG2
ArfGAP with FG repeats 2
AGFG2; ArfGAP with FG repeats 2; HIV 1 Rev binding protein like , HRBL; arf-GAP domain and FG repeats-containing protein 2; RABR; AGFG2_HUMAN; Arf GAP domain and FG repeats containing protein 2; HIV-1 Rev-binding protein-like protein; HIV1 Rev binding protein like protein; HRBL; Nucleoporin; RAB-R; Rev/Rex activation domain-binding protein related; OTTHUMP00000209085; Rev/Rex activation domain binding protein-related;
BANK1
B-cell scaffold protein with ankyrin repeats 1
BANK1; B-cell scaffold protein with ankyrin repeats 1; B-cell scaffold protein with ankyrin repeats; BANK; FLJ20706; FLJ34204;
AARS2
alanyl-tRNA synthetase 2, mitochondrial (putative)
AARS2; alanyl-tRNA synthetase 2, mitochondrial (putative); AARSL, alanyl tRNA synthetase like; alanyl-tRNA synthetase, mitochondrial; alanine tRNA ligase 2; mitochondrial (putative); bA444E17.1; KIAA1270; AARSL; Gm89; MT ALARS; MTALARS; AARS 2; Alanine tRNA ligase 2 mitochondrial; Alanine tRNA ligase; Alanyl tRNA synthetase 2 mitochondrial; Alanyl tRNA synthetase like; AlaRS; MGC69820; Probable alanyl tRNA synthetase mitochondrial; RP11-444E17.1; alanine--tRNA ligase; alanyl-tRNA synthetase like; probable alanyl-tRNA synthetase, mitochondrial; alanine tRNA ligase 2, mitochondrial (putative); COXPD8; MT-ALARS;
ACAP3
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3
ACAP3; ArfGAP with coiled-coil, ankyrin repeat and PH domains 3; centaurin, beta 5 , CENTB5; arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3; KIAA1716; Centaurin, beta 5; Centaurin-beta-5; CENTB5; Cnt-b5; OTTHUMP00000002288;
ACCSL
1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional)-like
ACCSL; 1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional)-like; 1-aminocyclopropane-1-carboxylate synthase-like protein 2; 1 aminocyclopropane 1 carboxylate synthase homolog (Arabidopsis)(non functional) like; 1 aminocyclopropane 1 carboxylate synthase like protein 2; 1A1L2_HUMAN; ACC synthase like protein 2; ACC synthase-like protein 2;
ADAMTS9
ADAM metallopeptidase with thrombospondin type 1 motif, 9
ADAMTS9; ADAM metallopeptidase with thrombospondin type 1 motif, 9; A disintegrin and metalloproteinase with thrombospondin motifs 9; ADAM-TS9; ADAMTS-9; ADAM-TS 9; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 9;
PLEKHF1
pleckstrin homology domain containing, family F (with FYVE domain) member 1
PLEKHF1; pleckstrin homology domain containing, family F (with FYVE domain) member 1; pleckstrin homology domain-containing family F member 1; APPD; MGC4090; PHAFIN1; ZFYVE15; phafin 1; phafin-1; apoptosis-inducing protein D; PH domain-containing family F;
ASNSD1
asparagine synthetase domain containing 1
ASNSD1; asparagine synthetase domain containing 1; asparagine synthetase domain-containing protein 1; FLJ20752; NBLA00058; NS3TP1; ASNSD 1; HCV NS3 transactivated protein 1; HCV NS3-transactivated protein 1;
ACSM2B
acyl-CoA synthetase medium-chain family member 2B
ACSM2B; acyl-CoA synthetase medium-chain family member 2B; ACSM2, acyl CoA synthetase medium chain family member 2; acyl-coenzyme A synthetase ACSM2B, mitochondrial; HXMA; HYST1046; xenobiotic/medium chain fatty acid:CoA ligase; ACSM2; Acyl CoA synthetase medium chain family member 2; Acyl CoA synthetase medium chain family member 2B; Acyl coenzyme A synthetase ACSM2B, mitochondrial; Butyrate CoA ligase 2B; Butyryl coenzyme A synthetase 2B; Middle chain acyl CoA synthetase 2B; Xenobiotic/medium chain fatty acid CoA ligase HXM A; butyrate--CoA ligase 2B; butyryl-coenzyme A synthetase 2B; middle-chain acyl-CoA synthetase 2B; xenobiotic/medium-chain fatty acid:CoA ligase; acyl-CoA synthetase medium-chain family member 2; xenobiotic/medium-chain fatty acid-CoA ligase HXM-A;
ACSM3
acyl-CoA synthetase medium-chain family member 3
ACSM3; acyl-CoA synthetase medium-chain family member 3; SA (rat hypertension associated) homolog , SA hypertension associated homolog (rat) , SAH; acyl-coenzyme A synthetase ACSM3, mitochondrial; SA; Butyryl coenzyme A synthetase 3; mitochondrial; ACSM3_HUMAN; Acyl CoA synthetase medium chain family member 3; Acyl-coenzyme A synthetase ACSM3; Butyrate CoA ligase 3; Butyrate--CoA ligase 3; Butyryl-coenzyme A synthetase 3; Middle chain acyl CoA synthetase 3; Middle-chain acyl-CoA synthetase 3; Protein SA homolog; SA (rat hypertension associated) homolog; SA hypertension associated homolog; SA, rat, homolog of; SAH; OTTHUMP00000162290; SA hypertension-associated homolog; SA (rat hypertension-associated) homolog;
ACSM4
acyl-CoA synthetase medium-chain family member 4
ACSM4; acyl-CoA synthetase medium-chain family member 4; acyl-coenzyme A synthetase ACSM4, mitochondrial; similar to olfactory specific medium chain acyl CoA synthetase;
ACSM5
acyl-CoA synthetase medium-chain family member 5
ACSM5; acyl-CoA synthetase medium-chain family member 5; acyl-coenzyme A synthetase ACSM5, mitochondrial; FLJ20581; Acyl CoA synthetase medium chain family member 5; Acyl coenzyme A synthetase ACSM5, mitochondrial; MACS3;
FAM203A
family with sequence similarity 203, member A
FAM203A; family with sequence similarity 203, member A; C8orf30A, chromosome 8 open reading frame 30A; protein FAM203A; brain protein 16; FLJ40907; LOC51236; BRP16; chromosome 8 open reading frame 30A; D15Ertd741e; MGC94185; MNCb-5873; C8orf30A;
ADAMTS10
ADAM metallopeptidase with thrombospondin type 1 motif, 10
ADAMTS10; ADAM metallopeptidase with thrombospondin type 1 motif, 10; WMS; WMS1; ADAM-TS10; ADAMTS-10; A disintegrin and metalloproteinase with thrombospondin motifs 10; ADAM-TS 10; zinc metalloendopeptidase; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 10;
ADAMTS12
ADAM metallopeptidase with thrombospondin type 1 motif, 12
ADAMTS12; ADAM metallopeptidase with thrombospondin type 1 motif, 12; PRO4389; A disintegrin and metalloproteinase with thrombospondin motifs 12; ADAM-TS12; ADAMTS-12; ADAM-TS 12; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 12;
ADAMTS16
ADAM metallopeptidase with thrombospondin type 1 motif, 16
ADAMTS16; ADAM metallopeptidase with thrombospondin type 1 motif, 16; ADAMTS16s; A disintegrin and metalloproteinase with thrombospondin motifs 16; ADAM-TS16; ADAMTS-16; ADAM-TS 16; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 16;
ADAMTS18
ADAM metallopeptidase with thrombospondin type 1 motif, 18
ADAMTS18; ADAM metallopeptidase with thrombospondin type 1 motif, 18; a disintegrin like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 18 , ADAMTS21; A disintegrin and metalloproteinase with thrombospondin motifs 18; ADAMTS 18; ADAMTS21; EC 3.4.24.; ADAM-TS18; ADAMTS-18; ADAM-TS 18; disintegrin and metalloprotease-like protein; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 18; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 21; KNO2;
ADAMTS19
ADAM metallopeptidase with thrombospondin type 1 motif, 19
ADAMTS19; ADAM metallopeptidase with thrombospondin type 1 motif, 19; A disintegrin and metalloproteinase with thrombospondin motifs 19; ADAM-TS19; ADAMTS-19; ADAM-TS 19; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 19;
ADAMTS20
ADAM metallopeptidase with thrombospondin type 1 motif, 20
ADAMTS20; ADAM metallopeptidase with thrombospondin type 1 motif, 20; GON-1; ADAM-TS20; ADAMTS-20; A disintegrin and metalloproteinase with thrombospondin motifs 20; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 20;
ADAMTS6
ADAM metallopeptidase with thrombospondin type 1 motif, 6
ADAMTS6; ADAM metallopeptidase with thrombospondin type 1 motif, 6; ADAM-TS6; ADAMTS-6; ADAM-TS 6; A disintegrin and metalloproteinase with thrombospondin motifs 6; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 6;
ADAMTS7
ADAM metallopeptidase with thrombospondin type 1 motif, 7
ADAMTS7; ADAM metallopeptidase with thrombospondin type 1 motif, 7; ADAM-TS7; ADAMTS-7; ADAM-TS 7; A disintegrin and metalloproteinase with thrombospondin motifs 7; COMPase; a disintegrin and metalloprotease with thrombospondin motifs-7 preproprotein; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 7;
AIMP2
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2
AIMP2; aminoacyl tRNA synthetase complex-interacting multifunctional protein 2; aminoacyl tRNA synthase complex-interacting multifunctional protein 2; JTV 1; JTV1; p38; PRO0992; protein JTV-1; ARS-interacting multi-functional protein 2; multisynthase comp;
atpA
ATP synthase CF1 alpha chain
atpA; ATP synthase CF1 alpha chain; ATP synthase CF1 alpha subunit; ATP synthase subunit alpha; ATPase subunit alpha; F ATPase subunit alpha;
ATPAF1
ATP synthase mitochondrial F1 complex assembly factor 1
ATPAF1; ATP synthase mitochondrial F1 complex assembly factor 1; ATP11; Atp11p; FLJ22351; ATP11 homolog; ATPAF 1; ATPF1_HUMAN; Homolog of yeast ATP11; MGC88060; OTTHUMP00000009681; OTTHUMP00000231564; OTTHUMP00000231566; OTTHUMP00000231567; OTTHUMP00000231568;
IGFALS
insulin-like growth factor binding protein, acid labile subunit
IGFALS; insulin-like growth factor binding protein, acid labile subunit; insulin-like growth factor-binding protein complex acid labile subunit; ALS; insulin-like growth factor binding protein complex acid labile chain;
AMT
aminomethyltransferase
AMT; aminomethyltransferase; aminomethyltransferase (glycine cleavage system protein T); aminomethyltransferase, mitochondrial; GCST; glycine cleavage system protein T; NKH; GCE; GCVT; glycine cleavage system T protein;
MSMO1
methylsterol monooxygenase 1
MSMO1; methylsterol monooxygenase 1; SC4MOL, sterol C4 methyl oxidase like; DESP4; ERG25; MGC104344; 1500001G16Rik; C 4 methyl sterol; C-4 methylsterol oxidase; C78600; ERG25_HUMAN; Methylsterol monooxygenase; OTTHUMP00000219757; OTTHUMP00000219758; OTTHUMP00000219759; OTTHUMP00000219760; SC4MOL; sterol C4 methyl oxidase like; C-4 methyl sterol;
SC4MOL
sterol-C4-methyl oxidase-like
SC4MOL; sterol-C4-methyl oxidase-like; methylsterol monooxygenase 1; ERG25; MGC104344; 1500001G16Rik; C 4 methyl sterol; C-4 methylsterol oxidase; C78600; DESP4; ERG25_HUMAN; Methylsterol monooxygenase; OTTHUMP00000219757; OTTHUMP00000219758; OTTHUMP00000219759; OTTHUMP00000219760; sterol C4 methyl oxidase like; Msmo1;
BAG6
BCL2-associated athanogene 6
BAG6; BCL2-associated athanogene 6; BAT3, HLA B associated transcript 3; large proline-rich protein BAG6; D6S52E; G3; scythe; protein G3; protein Scythe; HLA-B associated transcript 3; HLA-B associated transcript-3; HLA-B-associated transcript 3; large p;
COQ5
coenzyme Q5 homolog, methyltransferase (S. cerevisiae)
COQ5; coenzyme Q5 homolog, methyltransferase (S. cerevisiae); coenzyme Q5 homolog, methyltransferase (yeast); 2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial; 2 methoxy 6 polyprenyl 1; 4 benzoquinol methylase; MGC4767; Ubiquinone biosynthesis methyltransferase COQ5, mitochondrial;
TRIP4
thyroid hormone receptor interactor 4
TRIP4; thyroid hormone receptor interactor 4; activating signal cointegrator 1; HsT17391; TRIP-4; TR-interacting protein 4; thyroid receptor interacting protein 4; thyroid receptor-interacting protein 4; ASC1; ASC-1;
ATPC
chloroplast ATP synthase gamma chain
ATPC; chloroplast ATP synthase gamma chain; ATP synthase gamma chain, chlorop; ATPC chloroplast ATP synthase gamma chain; ATP synthase gamma chain, chloroplast precursor, gi:114638, PMID: 2904436, PMID: 8349573, PMID: 8543042;
ATP5C1
ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1
ATP5C1; ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1; ATP5C, ATP5CL1; ATP synthase subunit gamma, mitochondrial; ATP synthase gamma chain, mitochondrial; ATP synthase, H+ transporting, mitochondrial F1 complex, gamma subunit; ATP5C 1; ATP5C; ATP5CL1; F ATPase gamma subunit; Mitochondrial ATP synthase, gamma subunit 1; F-ATPase gamma subunit;
ATHL1
ATH1, acid trehalase-like 1
ATHL1; ATH1, acid trehalase-like 1 (yeast); acid trehalase-like protein 1; FLJ22635; MGC129858; MGC129859;
ATP5A1
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle
ATP5A1; ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle; ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit, isoform 1, cardiac muscle , ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit, isoform 2, non cardiac muscle like 2 , ATP5AL2, ATPM; ATP synthase subunit alpha, mitochondrial; ATP5A; hATP1; OMR; ORM; mitochondrial; ATP synthase alpha chain, mitochondrial; ATP synthase subunit alpha; ATP synthase subunit alpha mitochondrial; ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit, isoform 1, cardiac muscle; ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit, isoform 2, non-cardiac muscle-like 2; ATP sythase (F1 ATPase) alpha subunit; ATP5AL2; ATPA_HUMAN; ATPM; Mitochondrial ATP synthetase oligomycin resistant; MOM2; MS502; OTTHUMP00000163475; ATP sythase (F1-ATPase) alpha subunit; mitochondrial ATP synthetase, oligomycin-resistant;
ATP5F1
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1
ATP5F1; ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1; ATP synthase, H+ transporting, mitochondrial F0 complex, subunit b, isoform 1 , ATP synthase, H+ transporting, mitochondrial F0 complex, subunit B1; ATP synthase subunit b, mitochondrial; mitochondrial; AT5F1_HUMAN; ATP synthase B chain mitochondrial; ATP synthase subunit b; ATP synthase, H+ transporting, mitochondrial F0 complex, subunit b,; ATP synthase, H+ transporting, mitochondrial F0 complex, subunit B1; ATPase subunit b; Cell proliferation inducing protein 47; H+ ATP synthase subunit b; MGC24431; PIG47; H+-ATP synthase subunit b; ATP synthase B chain, mitochondrial; cell proliferation-inducing protein 47; ATP synthase, H+ transporting, mitochondrial F0 complex, subunit b, isoform 1;
ATP5H
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d
ATP5H; ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d; ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d; ATP synthase subunit d, mitochondrial; ATP5JD; ATPQ; mitochondrial; ATP synthase subunit d; ATP5H_HUMAN; ATPase subunit d; MS504; My032 protein; ATP synthase D chain, mitochondrial; ATP synthase, H+ transporting, mitochondrial F1F0, subunit d;
ATP5J2
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2
ATP5J2; ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2; ATP synthase, H+ transporting, mitochondrial F0 complex, subunit f, isoform 2 , ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F2; ATP synthase subunit f, mitochondrial; ATP synthase f chain; mitochondrial; ATP5JL; F1Fo ATP synthase complex Fo membrane domain f subunit; F1Fo ATPase; F1Fo ATPase synthase f subunit; ATP synthase f chain, mitochondrial; ATP synthase, H+ transporting, mitochondrial F0 complex, subunit f, isoform 2; F1F0-type ATPase subunit f; F1Fo-ATP synthase complex Fo membrane domain f subunit; F1Fo-ATPase synthase f subunit;
FAM207A
family with sequence similarity 207, member A
FAM207A; family with sequence similarity 207, member A; C21orf70, chromosome 21 open reading frame 70; protein FAM207A; PRED56; C21orf70; Chromosome 21 open reading frame 70; CU070_HUMAN; Hypothetical protein LOC85395; Uncharacterized protein C21orf70;
FAM188A
family with sequence similarity 188, member A
FAM188A; family with sequence similarity 188, member A; C10orf97, chromosome 10 open reading frame 97; protein FAM188A; CARD containing protein; CARP; caspase recruitment domain containing pro apoptotic protein; DERP5; FLJ13397; my042; Dermal papilla derived protein 5; Chromosome 10 open reading frame 97; MST126; CARD-containing protein; dermal papilla-derived protein 5; caspase recruitment domain containing pro-apoptotic protein; MSTP126; C10orf97; RP11-394I23.1;
FAM110B
family with sequence similarity 110, member B
FAM110B; family with sequence similarity 110, member B; C8orf72, chromosome 8 open reading frame 72; protein FAM110B; MGC39325; Chromosome 8 open reading frame 72; Family with sequence similarity 110 member B; C8orf72;
CATHL3
cathelicidin antimicrobial peptide
CATHL3; cathelicidin antimicrobial peptide; cathelicidin-1; 18 kDa cationic antimicrobial protein; Antibacterial protein FALL-39; Antibacterial protein LL-37; CAMP; CAMP_HUMAN; CAP 18; CAP-18; CAP18; Cathelin-like protein; Cathelin-related antimicrobial peptide; Cationic antimicrobial protein, 18-KD; CLP; Cnlp; Cramp; CRAMP, mouse, homolog of; FALL 39; FALL-39 peptide antibiotic; FALL39; hCAP 18; hCAP-18; hCAP18; HSD26; LL37; MCLP; Peptide antibiotic, PR-39, porcine, homolog of; CATH-1; CATH-3; fowlicidin 1; fowlicidin-1; fowlicidin-3; cathelicidin-3; CATHL1;
CARS
cysteinyl-tRNA synthetase
CARS; cysteinyl-tRNA synthetase; cysteinyl-tRNA synthetase, cytoplasmic; CARS1; cysteine tRNA ligase 1; cytoplasmic; Cysteine tRNA ligase; CysRS; Cysteinyl tRNA synthetase, cytoplasmic; MGC:11246; cysteine translase; cysteine--tRNA ligase; cysteine tRNA ligase 1, cytoplasmic;
MMADHC
methylmalonic aciduria (cobalamin deficiency) cblD type, with homocystinuria
MMADHC; methylmalonic aciduria (cobalamin deficiency) cblD type, with homocystinuria; C2orf25, chromosome 2 open reading frame 25; methylmalonic aciduria and homocystinuria type D protein, mitochondrial; cblD; CL25022; protein C2orf25, mitochondrial; C2o;
TYW5
tRNA-yW synthesizing protein 5
TYW5; tRNA-yW synthesizing protein 5; C2orf60, chromosome 2 open reading frame 60; tRNA wybutosine-synthesizing protein 5; FLJ37953; Chromosome 2 open reading frame 60; Hypothetical protein LOC129450; JmjC domain containing protein C2orf60; MGC70509; tRNA yW-synthesizing enzyme 5; jmjC domain-containing protein C2orf60; hTYW5; C2orf60;
CLN8
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation)
CLN8; ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation); C8orf61, chromosome 8 open reading frame 61 , EPMR; protein CLN8; FLJ39417; EPMR; C8orf61;
CAMKMT
calmodulin-lysine N-methyltransferase
CAMKMT; calmodulin-lysine N-methyltransferase; C2orf34, chromosome 2 open reading frame 34; CaM KMT; CLNMT; CLNMT_HUMAN; calmodulin methyltransferase; Cam; KMT; C2orf34;
FAM189B
family with sequence similarity 189, member B
FAM189B; family with sequence similarity 189, member B; C1orf2, chromosome 1 open reading frame 2; protein FAM189B; cote1; C1orf2; Chromosome 1 open reading frame 2; Family with sequence similarity 189 member B; Hypothetical protein LOC10712;
TRMT1L
TRM1 tRNA methyltransferase 1-like
TRMT1L; TRM1 tRNA methyltransferase 1-like; C1orf25, chromosome 1 open reading frame 25; TRMT1-like protein; TRM1 like; bG120K12.3; Chromosome 1 open reading frame 25; Hypothetical protein FLJ90512; MST070; MSTP070; N2; N2 dimethylguanosine tRNA methyltransferase like; TRM1-like protein; TRM1L; C1orf25;
FAM163A
family with sequence similarity 163, member A
FAM163A; family with sequence similarity 163, member A; C1orf76, chromosome 1 open reading frame 76; protein FAM163A; MGC16664; cebelin; neuroblastoma derived secretory protein; neuroblastoma-derived secretory protein; NDSP; C1orf76; RP11-12M5.2;
FAM206A
family with sequence similarity 206, member A
FAM206A; family with sequence similarity 206, member A; C9orf6, chromosome 9 open reading frame 6; protein FAM206A; CG 8; FLJ20457; CG8; Hypothetical protein LOC54942; UPF0436 protein C9orf6; CG-8; C9orf6;
CARS2
cysteinyl-tRNA synthetase 2, mitochondrial (putative)
CARS2; cysteinyl-tRNA synthetase 2, mitochondrial (putative); probable cysteinyl-tRNA synthetase, mitochondrial; cysteine tRNA ligase 2; mitochondrial (putative); FLJ12118; CARS 2; CysRS; Cysteine tRNA ligase 2 mitochondrial (putative); Cysteine tRNA ligase 2 mitochondrial; Cysteine tRNA ligase; Cysteinyl tRNA synthetase 2; Cysteinyl tRNA synthetase 2 mitochondrial (putative); Cysteinyl tRNA synthetase 2 mitochondrial; DKFZp667A2315; DKFZp686G08243; OTTHUMP00000018707; Probable cysteinyl tRNA synthetase mitochondrial; cysteine--tRNA ligase; cysteine tRNA ligase 2, mitochondrial (putative);
CERCAM
cerebral endothelial cell adhesion molecule
CERCAM; cerebral endothelial cell adhesion molecule; CEECAM1, cerebral cell adhesion molecule; glycosyltransferase 25 family member 3; GLT25D3; glycosyltransferase 25 domain containing 3; CEECAM1; Cerebral endothelial cell adhesion molecule 1; Glycosyltransferase 25 family member 3 precursor; cerebral cell adhesion molecule;
CEPT1
choline/ethanolamine phosphotransferase 1
CEPT1; choline/ethanolamine phosphotransferase 1; choline/ethanolaminephosphotransferase 1; CEPT1_HUMAN; DKFZp313G0615; hCEPT1; MGC45223; choline/ethanolaminephosphotransferase;
ACAP1
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1
ACAP1; ArfGAP with coiled-coil, ankyrin repeat and PH domains 1; centaurin, beta 1 , CENTB1; arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1; KIAA0050; ANK repeat and PH domain-containing protein 1; ACAP 1; ACAP1_HUMAN; Arf GAP with coiled coil ANK repeat and PH domains 1; Arf GAP with coiled coil, ankyrin repeat, and pleckstrin homology domains 1; Arf-GAP with coiled-coil; CENT B1; Centaurin beta 1; Centaurin-beta-1; CENTB 1; Cnt b1; Cnt-b1; Cntb1; centaurin, beta 1; OTTHUMP00000128386; Arf GAP with coiled coil, ANK repeat and PH domains 1; CENTB1;
ARAP2
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2
ARAP2; ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2; centaurin, delta 1 , CENTD1; arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2; PARX; cnt-d1; centaurin-delta-1; centaurin, delta 1; Arf and Rho GAP adapter protein;
CIR1
corepressor interacting with RBPJ, 1
CIR; corepressor interacting with RBPJ 1; recepin; OTTHUMP00000163177; OTTHUMP00000205180; CBF1 interacting corepressor; CBF1-interacting corepressor;
CHSY1
chondroitin sulfate synthase 1
CHSY1; chondroitin sulfate synthase 1; Chondroitin glucuronyltransferase 1; Chondroitin synthase 1; CHSS1_HUMAN; ChSy-1; Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1; N-acetylgalactosaminyltransferase 1; OTTHUMP00000194839; N-acetylgalactosaminyltransferase II; chondroitin glucuronyltransferase II; CHSY; CSS1; TPBS;
CS
citrate synthase
CS; citrate synthase; citrate synthase, mitochondrial; mitochondrial; CISY_HUMAN; citrate synthetase;
EPS8
epidermal growth factor receptor pathway substrate 8
EPS8; epidermal growth factor receptor pathway substrate 8; epidermal growth factor receptor kinase substrate 8;
ADAP2
ArfGAP with dual PH domains 2
ADAP2; ArfGAP with dual PH domains 2; CENTA2; cent-b; HSA272195; arf-GAP with dual PH domain-containing protein 2; cnt-a2; centaurin beta; centaurin-alpha-2; centaurin, alpha 2; centaurin-alpha 2 protein;
CESA1
cellulose synthase A catalytic subunit 1 [UDP-forming]
CESA1; cellulose synthase A catalytic subunit 1 [UDP-forming]; F8B4_110; RSW1; Cellulose synthase 1; F8B4.110; Radially Swollen 1; cellulose synthase 1 (CESA1); FUNCTIONS IN: cellulose synthase activity, transferase activity, transferring glycosyl groups; INVOLVED IN: primary cell wall biogenesis, cellulose biosynthetic process, plant-type cell wall biogenesis, hyperosmotic salinity response; LOCATED IN: Golgi apparatus, plasma membrane; EXPRESSED IN: 26 plant structures; EXPRESSED DURING: 16 growth stages; CONTAINS InterPro DOMAIN/s: Cellulose synthase (InterPro:IPR005150), Zinc finger, RING-type (InterPro:IPR001841); BEST Arabidopsis thaliana protein match is: cellulose synthase 10 (TAIR:AT2G25540.1); Has 1807 Blast hits to 1807 proteins in 277 species: Archae - 0; Bacteria - 0; Metazoa - 736; Fungi - 347; Plants - 385; Viruses - 0; Other Eukaryotes - 339 (source: NCBI BLink).; AtCESA1;
FAM164A
family with sequence similarity 164, member A
FAM164A; family with sequence similarity 164, member A; C8orf70, chromosome 8 open reading frame 70; protein FAM164A; CGI 62; C8orf70; Chromosome 8 open reading frame 70; Hypothetical protein C8orf70; hypothetical protein LOC51101; OTTHUMP00000227042; CGI-62;
CHRFAM7A
CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion
CHRFAM7A; CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion; CHRNA7-FAM7A fusion protein; CHRNA7 DR1; D 10; Alpha 7 neuronal nicotinic acetylcholine receptor FAM7A hybrid; CHRNA7 (cholinergic receptor nicotinic alpha 7 exons 5 10) and FAM7A (family with sequence similarity 7A exons A E) fusion; CHRNA7; CHRNA7 FAM7A fusion; CHRNA7 FAM7A fusion protein; D10; HGNC:15781; MGC120482; MGC120483; alpha-7 nicotinic cholinergic receptor subunit; alpha 7 neuronal nicotinic acetylcholine receptor-FAM7A hybrid; CHRNA7 (cholinergic receptor, nicotinic, alpha polypeptide 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion; D-10; CHRNA7-DR1;
CIT
citron (rho-interacting, serine/threonine kinase 21)
CIT; citron (rho-interacting, serine/threonine kinase 21); citron Rho-interacting kinase; CRIK; KIAA0949; STK21; serine/threonine-protein kinase 21;
FAM127A
family with sequence similarity 127, member A
FAM127A; family with sequence similarity 127, member A; CAAX box 1 , CXX1; protein FAM127A; Mar8; MAR8C; Mart8; Mammalian retrotransposon derived protein 8C; CAAX box protein 1; Cerebral protein 5; CXX 1; MART8C; CAAX box 1; CXX1;
DGKQ
diacylglycerol kinase, theta 110kDa
DGKQ; diacylglycerol kinase, theta 110kDa; DAGK4, diacylglycerol kinase, theta (110kD); diacylglycerol kinase theta; DAGK; DAGK7; DGK-theta; DAG kinase theta; diglyceride kinase theta; DAGK4;
ICMT
isoprenylcysteine carboxyl methyltransferase
ICMT; isoprenylcysteine carboxyl methyltransferase; protein-S-isoprenylcysteine O-methyltransferase; HSTE14; PCCMT; PPMT; protein S isoprenylcysteine O methyltransferase; 1700008E11Rik; C80758; fcmt; Gm13095; MGC118506; OTTMUSG00000010406; ICMT_HUMAN; Isoprenylcysteine carboxylmethyltransferase; MGC39955; MGC95322; MST098; MSTP098; PCMT; Prenylated protein carboxyl methyltransferase; Prenylcysteine carboxyl methyltransferase; RP23-421E12.4; STE14; protein-S isoprenylcysteine O-methyltransferase;
CMYA5
cardiomyopathy associated 5
CMYA5; cardiomyopathy associated 5; C5orf10, chromosome 5 open reading frame 10; cardiomyopathy-associated protein 5; DKFZp451G223; genethonin 3; myospryn; SPRYD2; TRIM76; tripartite motif containing 76; Tripartite motif containing protein 76; C5orf10; SPRY domain containing protein 2; 2310076E16Rik; Cardiomyopathy associated protein 5; Chromosome 5 open reading frame 10; CMYA 5; CMYA5_HUMAN; DKFZp451G182; DTNBP2; Dystrobrevin binding protein 2; Dystrobrevin-binding protein 2; Genethonin-3; SPRY domain-containing protein 2; Tripartite motif-containing protein 76; tripartite motif-containing 76;
FAM32A
family with sequence similarity 32, member A
FAM32A; family with sequence similarity 32, member A; protein FAM32A; DKFZP586O0120; CGI 144; Family with sequence similarity 32 member A; Hypothetical protein LOC26017; ovarian tumor associated gene-12; OTAG12;
FAM35A
family with sequence similarity 35, member A
FAM35A; family with sequence similarity 35, member A; protein FAM35A; bA163M19.1; FAM35A1; MGC5560; FA35A_HUMAN; Family with sequence similarity 35 member A; Hypothetical protein LOC54537;
FAM36A
family with sequence similarity 36, member A
FAM36A; family with sequence similarity 36, member A; protein FAM36A; FLJ43269; FAM 36A; Family with sequence similarity 36 member A; Hypothetical protein LOC116228; OTTHUMP00000038200;
COMTD1
catechol-O-methyltransferase domain containing 1
COMTD1; catechol-O-methyltransferase domain containing 1; catechol O-methyltransferase domain-containing protein 1; FLJ23841; catechol O methyltransferase domain containing 1;
FAM107A
family with sequence similarity 107, member A
FAM107A; family with sequence similarity 107, member A; protein FAM107A; DRR1; TU3A; Down regulated in renal cell carcinoma 1; Down-regulated in renal cell carcinoma 1; Downregulated in renal cell carcinoma; F107A_HUMAN; FLJ30158; FLJ45473; Protein TU3A; family with sequence similarity 107 member A transcript;
FAM108A1
family with sequence similarity 108, member A1
FAM108A1; family with sequence similarity 108, member A1; C19orf27, chromosome 19 open reading frame 27; abhydrolase domain-containing protein FAM108A1; MGC5244; C19orf27;
FAM108B1
family with sequence similarity 108, member B1
FAM108B1; family with sequence similarity 108, member B1; C9orf77, chromosome 9 open reading frame 77; abhydrolase domain-containing protein FAM108B1; CGI 67; Abhydrolase domain containing protein FAM108B1; C9orf77; OTTHUMP00000021455; CGI-67; RP11-409O11.2;
FAM109A
family with sequence similarity 109, member A
FAM109A; family with sequence similarity 109, member A; sesquipedalian-1; FLJ32356; A230106M15Rik; AU017694; Family with sequence similarity 109 member A; FLJ3235; Protein FAM109A; Ses1; 27 kDa inositol polyphosphate phosphatase-interacting protein A; IPIP27A;
FAM109B
family with sequence similarity 109, member B
FAM109B; family with sequence similarity 109, member B; sesquipedalian-2; DKFZp686J07229; 27 kDa inositol polyphosphate phosphatase interacting protein B; Ses2; IPIP27B; MGC125831; MGC125832;
FAM111A
family with sequence similarity 111, member A
FAM111A; family with sequence similarity 111, member A; protein FAM111A; FLJ22794; KIAA1895; Family with sequence similarity 111 member A; Hypothetical protein LOC63901; RGD1560913;
FAM122B
family with sequence similarity 122B
FAM122B; family with sequence similarity 122B; protein FAM122B; DKFZp686L20116; RP11 308B5.5; synoviocyte proliferation associated in collagen-induced arthritis 2; SPACIA2; RP11-308B5.5; MGC131814;
DIMT1
DIM1 dimethyladenosine transferase 1 homolog (S. cerevisiae)
DIMT1; DIM1 dimethyladenosine transferase 1 homolog (S. cerevisiae); DIM1 dimethyladenosine transferase 1 like (S. cerevisiae) , DIMT1L; probable dimethyladenosine transferase; HSA9761; 18S rRNA dimethylase; DIM1 dimethyladenosine transferase 1 like; Dimethyladenosine transferase; S adenosylmethionine 6 N,N adenosyl(rRNA) dimethyltransferase; OTTHUMP00000161884; OTTHUMP00000221860; probable 18S rRNA dimethylase; S-adenosylmethionine-6-N,N-adenosyl(rRNA) dimethyltransferase; 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase; probable S-adenosylmethionine-6-N,N-adenosyl(rRNA) dimethyltransferase; probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase; DIM1; DIMT1L; HUSSY5;
DIO2
deiodinase, iodothyronine, type II
DIO2; deiodinase, iodothyronine, type II; type II iodothyronine deiodinase; type 2 DI; type-II 5 deiodinase; type-II 5-deiodinase; iodothyronine type II deiodinase; 5DII; DIOII; AI324267;
DIO3
deiodinase, iodothyronine, type III
DIO3; deiodinase, iodothyronine, type III; TXDI3; type III iodothyronine deiodinase; Type 3 DI; D3; 5DIII; Deiodinase iodothyronine type 3; Deiodinase iodothyronine type III; Dio 3; DIOIII; MGC124117; MGC124118; type-III 5 deiodinase; type-III 5-deiodinase; type 3 iodothyronine selenodeiodinase; iodothyronine deiodinase, placental type; thyroxine deiodinase type III (selenoprotein);
CRLS1
cardiolipin synthase 1
CRLS1; cardiolipin synthase 1; C20orf155, chromosome 20 open reading frame 155; cardiolipin synthase; CLS1; dJ967N21.6; GCD10; GCD10 homolog (S. cerevisiae); 4930557M15Rik; 5730490M08; 0610009I22Rik; C20orf155; CLS; CRLS1_HUMAN; OTTMUSP00000016677; Protein GCD10 homolog; RGD1311037; RP23-77H16.4;
CTPS2
CTP synthase II
CTPS2; CTP synthase II; CTP synthase 2; CTP synthetase 2; CYTIDINE 5 PRIME TRIPHOSPHATE SYNTHETASE 2; FLJ43358; MGC32997; PYRG2_HUMAN; UTP--ammonia ligase 2; UTP-ammonia ligase; CTP synthetase type 2; CTP synthetase isoform; cytidine 5-triphosphate synthetase 2;
AS3MT
arsenic (+3 oxidation state) methyltransferase
AS3MT; arsenic (+3 oxidation state) methyltransferase; arsenite methyltransferase; CYT19; methyltransferase cyt19; methylarsonite methyltransferase; S-adenosylmethionine:arsenic (III) methyltransferase; S-adenosyl-L-methionine:arsenic(III) methyltransfera;
DARS2
aspartyl-tRNA synthetase 2, mitochondrial
DARS2; aspartyl-tRNA synthetase 2, mitochondrial; aspartyl-tRNA synthetase, mitochondrial; aspartate tRNA ligase 2; mitochondrial; FLJ10514; Aspartate tRNA ligase; Aspartyl tRNA synthetase 2 (mitochondrial); AspRS; LBSL; MT ASPRS; RP3 383J4.2; aspartate tRNA ligase 2, mitochondrial; MT-ASPRS; RP3-383J4.2;
FAM13B
family with sequence similarity 13, member B
FAM13B; family with sequence similarity 13, member B; C5orf5, chromosome 5 open reading frame 5 , FAM13B1, family with sequence similarity 13, member B1; protein FAM13B; ARHGAP49; KHCHP; N61; C5orf5; FA13B_HUMAN; FAM13B1; Family with sequence similarity 13, member B1; GAP-like protein N61;
FAM13C
family with sequence similarity 13, member C
FAM13C; family with sequence similarity 13, member C; FAM13C1, family with sequence similarity 13, member C1; protein FAM13C; Family with sequence similarity 13 member C1; Hypothetical protein LOC220965; MGC33233; RGD1310149; OTTHUMP00000019640; OTTHUMP00000019641; OTTHUMP00000019642; OTTHUMP00000217375; OTTHUMP00000217376; OTTHUMP00000217377; OTTHUMP00000237978; family with sequence similarity 13, member C1; FAM13C1;
FAM170A
family with sequence similarity 170, member A
FAM170A; family with sequence similarity 170, member A; protein FAM170A; F170A_HUMAN; Family with sequence similarity 170 member A; MGC149385; Zinc finger domain-containing protein; Zinc finger protein ZNFD; Znf domain containing protein; ZNFD;
FAM171A1
family with sequence similarity 171, member A1
FAM171A1; family with sequence similarity 171, member A1; C10orf38, chromosome 10 open reading frame 38; protein FAM171A1; FLJ12884; Astroprincin; C10orf38; chromosome 10 open reading frame 38; hypothetical protein LOC221061; MGC130014; MGC130015; OTTHUMP00000019205;
FAM173B
family with sequence similarity 173, member B
FAM173B; family with sequence similarity 173, member B; protein FAM173B; FAM173 B; FLJ20667; Hypothetical protein LOC134145; LOC134145;
FAM175B
family with sequence similarity 175, member B
FAM175B; family with sequence similarity 175, member B; KIAA0157; BRISC complex subunit Abro1; Abraxas brother; ABRO1; Em:AC068896.4; ABRO 1; C430003P19Rik; AA589499; Abraxas brother 1; ABRO; AI853413; FLJ22338; hypothetical protein LOC23172; OTTHUMP00000020697; RGD1308918; abraxas brother protein 1;
ACSS3
acyl-CoA synthetase short-chain family member 3
ACSS3; acyl-CoA synthetase short-chain family member 3; acyl-CoA synthetase short-chain family member 3, mitochondrial; FLJ21963; Acyl CoA synthetase short chain family member 3, mitochondrial; AMP-binding enzyme, 33217;
FAM78B
family with sequence similarity 78, member B
FAM78B; family with sequence similarity 78, member B; protein FAM78B; C030014K22Rik; C030020L09Rik; FA78B_HUMAN; Hypothetical protein LOC149297; MGC131653; RP11-375H19.1; OTTHUMP00000032614;
FAM81B
family with sequence similarity 81, member B
FAM81B; family with sequence similarity 81, member B; protein FAM81B; FLJ25333; FA81B_HUMAN; Hypothetical protein LOC153643; OTTHUMP00000222798;
DH11.4
hypothetical protein DH11.4
DH11.4; hypothetical protein; Hypothetical protein DH11.4; putative nuclear protein family member (2I285C); synaptotagmin XII;
FAM101A
family with sequence similarity 101, member A
FAM101A; family with sequence similarity 101, member A; protein FAM101A; FLJ44614; cfm; 3110032G18Rik; cfm2; F101A_HUMAN; Hypothetical protein LOC73121;
FAM102A
family with sequence similarity 102, member A
FAM102A; family with sequence similarity 102, member A; C9orf132, chromosome 9 open reading frame 132; protein FAM102A; bA203J24.7; Eeig1; C230093N12Rik; early estrogen-induced gene 1 protein; C9orf132; MGC50853;
FAM102B
family with sequence similarity 102, member B
FAM102B; family with sequence similarity 102, member B; protein FAM102B; DKFZp779B126; DKFZp686N01110;
FAM104B
family with sequence similarity 104, member B
FAM104B; family with sequence similarity 104, member B; chromosome X open reading frame 44 , CXorf44; protein FAM104B; FLJ20434; CXorf44; F104B_HUMAN; FLJ18375;
DHDDS
dehydrodolichyl diphosphate synthase
DHDDS; dehydrodolichyl diphosphate synthase; DS; FLJ13102; HDS; Dedol PP synthase; dedol-PP synthase; cis-prenyl transferase; cis-isoprenyltransferase; CIT; CPT; RP59;
EPB49
erythrocyte membrane protein band 4.9 (dematin)
EPB49; erythrocyte membrane protein band 4.9 (dematin); dematin; DMT; FLJ78462; FLJ98848;
EPS15
epidermal growth factor receptor pathway substrate 15
EPS15; epidermal growth factor receptor pathway substrate 15; epidermal growth factor receptor substrate 15; AF 1P; MLLT5; protein AF-1p; ALL1 fused gene from chromosome 1; AF1P; AF-1P;
DUS1L
dihydrouridine synthase 1-like (S. cerevisiae)
DUS1L; dihydrouridine synthase 1-like (S. cerevisiae); tRNA-dihydrouridine synthase 1-like; DUS1; PP3111; PP3111 protein; 1110032N12Rik; dihydrouridine synthase 1 like (S. cerevisiae); RP23-99M13.5;
EPB41L4A
erythrocyte membrane protein band 4.1 like 4A
EPB41L4A; erythrocyte membrane protein band 4.1 like 4A; band 4.1-like protein 4A; NBL4; Band 4.1 like protein 4A; EPB41L4; FLJ38738; erythrocyte protein band 4.1-like 4;
EPB41L5
erythrocyte membrane protein band 4.1 like 5
EPB41L5; erythrocyte membrane protein band 4.1 like 5; band 4.1-like protein 5; BE37; FLJ12957; KIAA1548; YMO1;
EPB41L2
erythrocyte membrane protein band 4.1-like 2
EPB41L2; erythrocyte membrane protein band 4.1-like 2; band 4.1-like protein 2; 4.1 G; D10Ertd398e; NBL2; OTTHUMP00000040262; 4.1G; AW555191; Band 4.1 like protein 2; DKFZp781D1972; DKFZp781H1755; E41L2_HUMAN; Erythrocyte membrane protein band 4.1 like 2; Erythrocyte membrane protein band 4.1 like protein 2; Generally expressed protein 4.1; OTTHUMP00000017197; OTTHUMP00000233453; OTTHUMP00000233454; OTTHUMP00000233488; OTTHUMP00000233489; OTTHUMP00000233490; OTTHUMP00000233519; OTTHUMP00000233520; OTTHUMP00000233521; OTTHUMP00000233522; OTTHUMP00000233653; erythrocyte membrane protein band 4.1 like-protein 2; 4.1-G;
FAM178B
family with sequence similarity 178, member B
FAM178B; family with sequence similarity 178, member B; protein FAM178B; LOC51252;
FAM180A
family with sequence similarity 180, member A
FAM180A; family with sequence similarity 180, member A; protein FAM180A; HWKM1940; UNQ1940;
FAM181B
family with sequence similarity 181, member B
FAM181B; family with sequence similarity 181, member B; protein FAM181B; LOC220382; MGC33846; F181B_HUMAN;
FAM185A
family with sequence similarity 185, member A
FAM185A; family with sequence similarity 185, member A; protein FAM185A; MGC35361;
FAM188B2
family with sequence similarity 188, member B2
FAM188B2; family with sequence similarity 188, member B2; C3orf76, chromosome 3 open reading frame 76; C3orf76; CLRN1; F1882_HUMAN; LOC646951; Protein FAM188B2; Putative UPF0526 protein B; UPF0526 protein B like;
PDSS1
prenyl (decaprenyl) diphosphate synthase, subunit 1
PDSS1; prenyl (decaprenyl) diphosphate synthase, subunit 1; TPRT, trans prenyltransferase; decaprenyl-diphosphate synthase subunit 1; coenzyme Q1 homolog (yeast); COQ1; TPT; coenzyme Q1 homolog; trans-prenyltransferase 1; trans-prenyltransferase (TPT); p;
ECT2
epithelial cell transforming sequence 2 oncogene
ECT2; epithelial cell transforming sequence 2 oncogene; protein ECT2; ARHGEF31; ECT 2; ECT2 protein; Epithelial Cell Transforming Sequence 2; Epithelial cell transforming sequence 2 oncogene protein; FLJ10461; MGC138291; OTTHUMP00000210539; OTTHUMP00000210684; OTTHUMP00000210685; OTTHUMP00000210686; epithelial cell-transforming sequence 2 oncogene;
TXNDC12
thioredoxin domain containing 12 (endoplasmic reticulum)
TXNDC12; thioredoxin domain containing 12 (endoplasmic reticulum); thioredoxin domain-containing protein 12; AGR1; anterior gradient homolog 1 (Xenopus laevis); endoplasmic reticulum thioredoxin superfamily member; 18 kDa; ERP18; ERP19; hAG 1; PDIA16; pro;
FAM22G
family with sequence similarity 22, member G
FAM22G; family with sequence similarity 22, member G; protein FAM22G; FA22G_HUMAN; Family with sequence similarity 22 member G; Family with sequence similarity 22 pseudogene; Hypothetical protein LOC441457; family with sequence similarity 22, pseudogene;
FAM26D
family with sequence similarity 26, member D
FAM26D; family with sequence similarity 26, member D; C6orf78, chromosome 6 open reading frame 78; protein FAM26D; FLJ32239; C6orf78;
FAM26F
family with sequence similarity 26, member F
FAM26F; family with sequence similarity 26, member F; C6orf187, chromosome 6 open reading frame 187; protein FAM26F; dJ93H18.5; OTTHUMP00000017061; OTTHUMP00000017062; RP1 93H18.5; C6orf187; RP1-93H18.5;
FAM59A
family with sequence similarity 59, member A
FAM59A; family with sequence similarity 59, member A; C18orf11, chromosome 18 open reading frame 11; protein FAM59A; FLJ21610; GAREM; Grb2 associated and regulator of Erk/MAPK; FA59A_HUMAN; Gm944; Grb2-associated and regulator of Erk/MAPK; C18orf11;
FAM5C
family with sequence similarity 5, member C
FAM5C; family with sequence similarity 5, member C; protein FAM5C; DBCCR1L; DBCCR1L1; RP11-445K1.1; B830045N13Rik; BMP/retinoic acid inducible neural specific protein 3; BRINP3; DBCCR1 like protein 1; MGC107461; MGC40674; OTTMUSP00000028549; RP23-212I24.1; DBCCR1-like protein 1;
ACSL4
acyl-CoA synthetase long-chain family member 4
ACSL4; acyl-CoA synthetase long-chain family member 4; FACL4, fatty acid Coenzyme A ligase, long chain 4 , mental retardation, X linked 63 , mental retardation, X linked 68 , MRX63, MRX68; long-chain-fatty-acid--CoA ligase 4; long chain fatty acid Coen;
DUS2L
dihydrouridine synthase 2-like, SMM1 homolog
DUS2L; dihydrouridine synthase 2-like, SMM1 homolog (S. cerevisiae); dihydrouridine synthase 2 like (SMM1, S. cerevisiae); tRNA-dihydrouridine(20) synthase [NAD(P)+]-like; DUS2; FLJ20399; SMM1; hDUS2; up-regulated in lung cancer 8; up-regulated in lung ca;
DUS3L
dihydrouridine synthase 3-like (S. cerevisiae)
DUS3L; dihydrouridine synthase 3-like (S. cerevisiae); tRNA-dihydrouridine synthase 3-like; DUS3; FLJ13896;
DUS4L
dihydrouridine synthase 4-like (S. cerevisiae)
DUS4L; dihydrouridine synthase 4-like (S. cerevisiae); tRNA-dihydrouridine synthase 4-like; DUS4; PP35; protein similar to E.coli yhdg and R. capsulatus nifR3; 2700089B10Rik; MGC130363; MGC133233; 2310069P03Rik; AI482040; DUS4L_HUMAN; RGD1311445;
FAM134B
family with sequence similarity 134, member B
FAM134B; family with sequence similarity 134, member B; protein FAM134B; FLJ20152; F134B_HUMAN; JK1; JK-1;
FAM135B
family with sequence similarity 135, member B
FAM135B; family with sequence similarity 135, member B; protein FAM135B; C8ORFK32; MGC33221; MGC126009; MGC126010;
FAM136A
family with sequence similarity 136, member A
FAM136A; family with sequence similarity 136, member A; protein FAM136A; FLJ14668; hypothetical protein FLJ14668;
FAM161A
family with sequence similarity 161, member A
FAM161A; family with sequence similarity 161, member A; retinitis pigmentosa 28 (autosomal recessive) , RP28; protein FAM161A; FLJ13305; retinitis pigmentosa 28 (autosomal recessive); RP28; MGC129982; MGC129983;
FAM161B
family with sequence similarity 161, member B
FAM161B; family with sequence similarity 161, member B; C14orf44, chromosome 14 open reading frame 44; protein FAM161B; FLJ31697; C14orf44; c14_5547;
FAM19A4
family with sequence similarity 19 (chemokine (C-C motif)-like), member A4
FAM19A4; family with sequence similarity 19 (chemokine (C-C motif)-like), member A4; protein FAM19A4; TAFA 4; Chemokine like protein TAFA 4; Family with sequence similarity 19 (chemokine (C C motif) like) member A4; Family with sequence similarity 19 member A4; FLJ25161; TAFA4; chemokine-like protein TAFA-4; TAFA-4;
FAM21C
family with sequence similarity 21, member C
FAM21C; family with sequence similarity 21, member C; WASH complex subunit FAM21C; Em:AC012044.3; KIAA0592; FAM21A; Family with sequence similarity 21 member C; Hypothetical protein LOC253725; Protein FAM21C; vaccinia virus penetration factor; VPEF;
FOXE1
forkhead box E1 (thyroid transcription factor 2)
FOXE1; forkhead box E1 (thyroid transcription factor 2); TTF2; FOXE2; HFKH4; HFKL5; TITF2; TTF-2; FKHL15; forkhead box protein E1; forkhead box E2; forkhead box protein E2; HNF-3/fork head-like protein 5; thyroid transcription factor 2; forkhead-related protein FKHL15; forkhead, drosophila, homolog-like 15;
TRMT2B
TRM2 tRNA methyltransferase 2 homolog B (S. cerevisiae)
TRMT2B; TRM2 tRNA methyltransferase 2 homolog B (S. cerevisiae); chromosome X open reading frame 34 , CXorf34; tRNA (uracil-5-)-methyltransferase homolog; FLJ12687; dJ341D10.3; Chromosome X open reading frame 34; CXorf34; Putative methyltransferase CXorf34; tRNA (uracil 5 )methyltransferase homolog; TRM2 homolog;
FAM40B
family with sequence similarity 40, member B
FAM40B; family with sequence similarity 40, member B; protein FAM40B; KIAA1170; homolog of yeast FAR11 protein 2;
FAM83D
family with sequence similarity 83, member D
FAM83D; family with sequence similarity 83, member D; C20orf129, chromosome 20 open reading frame 129; protein FAM83D; dJ616B8.3; 2310007D09Rik; CHICA; BB104611; C20orf129; FA83D_HUMAN; FLJ38341; MGC92947; RGD1565583; RP23-119H5.1; Spindle protein CHICA;
FAM155A
family with sequence similarity 155, member A
FAM155A; family with sequence similarity 155, member A; transmembrane protein FAM155A;
FAM156A
family with sequence similarity 156, member A
FAM156A; family with sequence similarity 156, member A; TMEM29, transmembrane protein 29; protein FAM156A; PRO0659; FAM156B; PP12994; TMEM29; TMEM29B; Transmembrane protein 29;
FAM160B1
family with sequence similarity 160, member B1
FAM160B1; family with sequence similarity 160, member B1; KIAA1600; protein FAM160B1; bA106M7.3; RP11-106M7.3; DKFZp686D10123;
FYTTD1
forty-two-three domain containing 1
FYTTD1; forty-two-three domain containing 1; UAP56-interacting factor; DKFZp761B1514; UAP56 interacting factor; UIF; Forty two three domain containing 1; Forty two three domain containing protein 1; Forty-two-three domain-containing protein 1; FYTTD 1; OTTHUMP00000208028; OTTHUMP00000208031; OTTHUMP00000208032; Protein 40 2 3; Protein 40-2-3; UIF_HUMAN;
FAM89B
family with sequence similarity 89, member B
FAM89B; family with sequence similarity 89, member B; mammary tumor virus receptor 2; Family with sequence similarity 89 member B; Mammary turmor virus receptor homolog 1; MMTVR; MMTVR2; MTVR1; Protein FAM89B; MMTV; Mtvr2; 1110021A21Rik;
ENTHD1
ENTH domain containing 1
ENTHD1; ENTH domain containing 1; ENTH domain-containing protein 1; FLJ25421; epsin-2B; dJ370M22.3 (EPSIN 2B); CACNA1I; dJ370M22.3;
ETNK2
ethanolamine kinase 2
ETNK2; ethanolamine kinase 2; EKI2; FLJ10761; AI197444; HMFT1716; RP11 74C13.2; Tuc1; 4933417N20Rik; EC 2.7.1.82; EKI 2; EKI2_HUMAN; Ethanolamine kinase like protein; Ethanolamine kinase-like protein; ETNK 2; OTTHUMP00000034313; OTTHUMP00000034314; RP11-74C13.2;
KDM2A
lysine (K)-specific demethylase 2A
KDM2A; lysine (K)-specific demethylase 2A; FBL7; CXXC8; FBL11; FBXL11; JHDM1A; LILINA; lysine-specific demethylase 2A; F-box/LRR-repeat protein 11; CXXC-type zinc finger protein 8; [Histone-H3]-lysine-36 demethylase 1A; F-box and leucine-rich repeat protein 11; jumonji C domain-containing histone demethylase 1A; jmjC domain-containing histone demethylation protein 1A;
FAM105A
family with sequence similarity 105, member A
FAM105A; family with sequence similarity 105, member A; protein FAM105A; FLJ11127; NET20; F105A_HUMAN; Family with sequence similarity 105 member A; FLJ43660; Hypothetical protein LOC54491;
FAM123B
family with sequence similarity 123B
FAM123B; family with sequence similarity 123B; APC membrane recruitment protein 1; adenomatous polyposis coli membrane recruitment 1; AMER1; FLJ39827; RP11 403E24.2; Wilms Tumor on the X; WTX; protein FAM123B; Wilms tumor gene on the;
FAM124A
family with sequence similarity 124A
FAM124A; family with sequence similarity 124A; protein FAM124A; FLJ30707; family with sequence similarity 124, member A; hypothetical protein LOC220108;
FAM125B
family with sequence similarity 125, member B
FAM125B; family with sequence similarity 125, member B; C9orf28, chromosome 9 open reading frame 28; multivesicular body subunit 12B; FLJ00001; C9orf28; Chromosome 9 open reading frame 28; ESCRT-I complex subunit MVB12B; F125B_HUMAN; Family with sequence similarity 125 member B; Protein FAM125B; MVB12B;
FAM126A
family with sequence similarity 126, member A
FAM126A; family with sequence similarity 126, member A; hyccin; down regulated by Ctnnb1; a; DRCTNNB1A; HCC; HYCC1; Down regulated by Ctnnb1 a; Down regulated by CTNNB1 protein A; Down-regulated by CTNNB1 protein A; Family with sequence similarity 126 member A; HLD5; HYCCI_HUMAN; Protein FAM126A; down regulated by Ctnnb1, a;
FAM18B1
family with sequence similarity 18, member B1
FAM18B1; family with sequence similarity 18, member B1; FAM18B, family with sequence similarity 18, member B; protein FAM18B1; CGI 148; YDR084C; family with sequence similarity 18, member B; FAM18B; NPD008; CGI-148; FLJ46240;
FAM190A
family with sequence similarity 190, member A
FAM190A; family with sequence similarity 190, member A; protein FAM190A; KIAA1680; 6230405M12Rik; Hypothetical protein LOC232035; C130092O11Rik; F190A_HUMAN; KIAA1680 protein; MGC130404; MGC130405; MGC48628; RGD1565731;
FAM194B
family with sequence similarity 194, member B
FAM194B; family with sequence similarity 194, member B; protein FAM194B; FLJ32682; F194B_HUMAN; Hypothetical protein LOC220081; OTTHUMP00000018353;
FAM196A
family with sequence similarity 196, member A
FAM196A; family with sequence similarity 196, member A; C10orf141, chromosome 10 open reading frame 141; protein FAM196A; FLJ45557; C10orf141; F196A_HUMAN; Hypothetical protein LOC642938;
FAM46A
family with sequence similarity 46, member A
FAM46A; family with sequence similarity 46, member A; C6orf37, chromosome 6 open reading frame 37; protein FAM46A; FLJ20037; C6orf37; Chromosome 6 open reading frame 37; D930050G01Rik; FA46A_HUMAN; FLJ31495; HBV X-transactivated gene 11 protein; HBV XAg-transactivated protein 11; Hypothetical protein LOC55603; OTTHUMP00000016782; Retinal expressed gene C6orf37; RGD1311381; XTP11;
FAM46C
family with sequence similarity 46, member C
FAM46C; family with sequence similarity 46, member C; protein FAM46C; FLJ20202; Family with sequence similarity 46 member C;
FAM46D
family with sequence similarity 46, member D
FAM46D; family with sequence similarity 46, member D; protein FAM46D; cancer/testis antigen 112; CT1.26; CT112; MGC26999; Hypothetical protein LOC169966; OTTHUMP00000023605;
FAM47A
family with sequence similarity 47, member A
FAM47A; family with sequence similarity 47, member A; protein FAM47A; MGC27003; similar to hypothetical protein FLJ35782;
FAM47B
family with sequence similarity 47, member B
FAM47B; family with sequence similarity 47, member B; protein FAM47B; FLJ35782; FA47B_HUMAN;
FAM50B
family with sequence similarity 50, member B
FAM50B; family with sequence similarity 50, member B; protein FAM50B; D6S2654E; X5L; D0H6S2654E; DNA segment, human D6S2654E; FA50B_HUMAN; Protein XAP 5 like; Protein XAP-5-like;
FAM53A
family with sequence similarity 53, member A
FAM53A; family with sequence similarity 53, member A; protein FAM53A; DNTNP; dorsal neural-tube nuclear protein;
FAM53B
family with sequence similarity 53, member B
FAM53B; family with sequence similarity 53, member B; KIAA0140; protein FAM53B; bA12J10.2; RP11-12J10.2; FLJ13019;
FAM53C
family with sequence similarity 53, member C
FAM53C; family with sequence similarity 53, member C; C5orf6, chromosome 5 open reading frame 6; protein FAM53C; putative nuclear protein; C5orf6;
FAM54A
family with sequence similarity 54, member A
FAM54A; family with sequence similarity 54, member A; DUF729 domain containing 1 , DUFD1; protein FAM54A; DUF729 domain containing 1; DUF729 domain-containing protein 1; DUFD1;
FAM54B
family with sequence similarity 54, member B
FAM54B; family with sequence similarity 54, member B; protein FAM54B; MST116; MSTP116; HYST1888;
FAM78A
family with sequence similarity 78, member A
FAM78A; family with sequence similarity 78, member A; C9orf59, chromosome 9 open reading frame 59; protein FAM78A; FLJ00024; C9orf59; RP11-544A12.6;
FAM82A2
family with sequence similarity 82, member A2
FAM82A2; family with sequence similarity 82, member A2; FAM82C; regulator of microtubule dynamics protein 3; FLJ10579; PTPIP51; Cerebral protein 10; Family with sequence similarity 82 member C; hRMD 3; Microtubule associated protein; Protein FAM82A2; Protein FAM82C; Protein tyrosine phosphatase interacting protein 51; Regulator of microtubule dynamics 3; RMD 3; RMD3; TCPTP interacting protein 51; RMD-3; TCPTP-interacting protein 51; microtubule-associated protein; family with sequence similarity 82, member C; protein tyrosine phosphatase-interacting protein 51; hRMD-3;
FAM82B
family with sequence similarity 82, member B
FAM82B; family with sequence similarity 82, member B; regulator of microtubule dynamics protein 1; CGI 90; FLJ20665; CGI90; hRMD 1; hRMD1; Microtubule associated protein; Regulator of microtubule dynamics 1; RMD 1; RMD1; hRMD-1; microtubule-associated protein; RMD-1; CGI-90;
FAM83E
family with sequence similarity 83, member E
FAM83E; family with sequence similarity 83, member E; protein FAM83E; FLJ20200; FA83E_HUMAN; hypothetical protein LOC54854; MGC138175; MGC138177;
FAM83F
family with sequence similarity 83, member F
FAM83F; family with sequence similarity 83, member F; protein FAM83F; Family with sequence similarity 83 member F; Hypothetical protein LOC113828; RP3 496C20.4; OTTHUMP00000198255;
FLAD1
flavin adenine dinucleotide synthetase homolog
FLAD1; FAD1 flavin adenine dinucleotide synthetase homolog (S. cerevisiae); Fad1, flavin adenine dinucleotide synthetase, homolog (yeast); FAD synthase; FAD1; PP591; FAD synthetase; FAD-synthetase; FAD pyrophosphorylase; FMN adenylyltransferase; flavin ad;
ETS2
v-ets erythroblastosis virus E26 oncogene homolog 2 (avian)
ETS2; v-ets erythroblastosis virus E26 oncogene homolog 2 (avian); v ets avian erythroblastosis virus E26 oncogene homolog 2; protein C-ets-2; C ets 2 protein; ETS2_HUMAN; ETS2IT1; Oncogene ETS2; v ets avian erythroblastosis virus E2 oncogene homolog 2; V ets erythroblastosis virus E26 oncogene homolog 2; oncogene ETS-2; v-ets avian erythroblastosis virus E2 oncogene homolog 2; v-ets avian erythroblastosis virus E26 oncogene homolog 2;
PLEKHD1
pleckstrin homology domain containing, family D (with coiled-coil domains) member 1
PLEKHD1; pleckstrin homology domain containing, family D (with coiled-coil domains) member 1; pleckstrin homology domain containing, family D (with M protein repeats) member 1; UPF0639 protein; UPF0639;
GLIPR1L1
GLI pathogenesis-related 1 like 1
GLIPR1L1; GLI pathogenesis-related 1 like 1; GLIPR1-like protein 1; MGC26856; ALKN2972; PRO7434; UNQ2972/PRO7434;
GSTO2
glutathione S-transferase omega 2
GSTO2; glutathione S-transferase omega 2; glutathione S-transferase omega-2; bA127L20.1; Glutathione S transferase like protein; Glutathione S transferase omega 2; GSTO 2; GSTO-2; GSTO2_HUMAN; glutathione-S-transferase-like protein; bA127L20.1 (novel glutathione-S-transferase);
FAM20A
family with sequence similarity 20, member A
FAM20A; family with sequence similarity 20, member A; protein FAM20A; DKFZp434F2322; FP2747; AIGFS;
EPRS
glutamyl-prolyl-tRNA synthetase
EPRS; glutamyl-prolyl-tRNA synthetase; QARS, QPRS; bifunctional glutamate/proline--tRNA ligase; EARS; GLUPRORS; glutamate tRNA ligase; PARS; proline tRNA ligase; proline-tRNA ligase; prolyl-tRNA synthetase; glutaminyl-tRNA synthetase; proliferation-induci;
FAM166A
family with sequence similarity 166, member A
FAM166A; family with sequence similarity 166, member A; protein FAM166A; HSD46; FLJ40100;
FAM167A
family with sequence similarity 167, member A
FAM167A; family with sequence similarity 167, member A; C8orf13, chromosome 8 open reading frame 13; protein FAM167A; D8S265; C8orf13; MGC120649; MGC120650; MGC120651; DKFZp761G151;
FAM168A
family with sequence similarity 168, member A
FAM168A; family with sequence similarity 168, member A; KIAA0280; protein FAM168A; TCRP1; tongue cancer chemotherapy resistance associated protein 1; tongue cancer chemotherapy resistance-associated protein 1;
FAM168B
family with sequence similarity 168, member B
FAM168B; family with sequence similarity 168, member B; protein FAM168B; KIAA0280L; p20; myelin-associated neurite-outgrowth inhibitor; MANI; MGC87527;
FAM169A
family with sequence similarity 169, member A
FAM169A; family with sequence similarity 169, member A; protein FAM169A; KIAA0888;
FAM198B
family with sequence similarity 198, member B
FAM198B; family with sequence similarity 198, member B; C4orf18, chromosome 4 open reading frame 18; protein FAM198B; DKFZp434L142; FLJ38155; AD021; AD036; C4orf18; Expressed in nerve and epithelium during development; F198B_HUMAN; FLJ23966; OTTHUMP00000220346; OTTHUMP00000220347; OTTHUMP00000220349; Protein ENED;
GPRIN2
G protein regulated inducer of neurite outgrowth 2
GPRIN2; G protein regulated inducer of neurite outgrowth 2; KIAA0514; G protein-regulated inducer of neurite outgrowth 2; MGC15171; Gm286; C130040D06Rik; C230073P13; GRIN2; GRIN2_HUMAN; mKIAA0514; RGD1308922;
GAS2L1
growth arrest-specific 2 like 1
GAS2L1; growth arrest-specific 2 like 1; GAS2-like protein 1; GAR22; GA2L1_HUMAN; GAR 22; GAS2 like protein 1; GAS2 related protein on chromosome 22; GAS2-related protein on chromosome 22; Growth arrest specific 2 like 1; Growth arrest specific protein 2 like 1; Growth arrest-specific protein 2-like 1; MGC17243;
FTSJD1
FtsJ methyltransferase domain containing 1
FTSJD1; FtsJ methyltransferase domain containing 1; ftsJ methyltransferase domain-containing protein 1; adrift homolog (Drosophila); AFT; FLJ11171; FtsJ methyltransferase domain containing protein 1; FTSJ1_HUMAN; Protein adrift homolog; adrift homolog;
FTSJD2
FtsJ methyltransferase domain containing 2
FTSJD2; FtsJ methyltransferase domain containing 2; KIAA0082; cap-specific mRNA (nucleoside-2-O-)-methyltransferase 1; FLJ22156; FTSJD 2; OTTHUMP00000016324; Uncharacterized protein KIAA0082; ISG95; cap1 2O-ribose methyltransferase 1; interferon-stimulated gene 95 kDa protein; ftsJ methyltransferase domain-containing protein 2; S-adenosyl-L-methionine-dependent methyltransferase FTSJD2; MTr1; hMTr1;
GAS8
growth arrest-specific 8
GAS8; growth arrest-specific 8; GAS11, growth arrest specific 11; growth arrest-specific protein 8; Growth arrest specific protein 8; MGC138326; GAS 11; GAS 8; GAS11; Growth arrest specific 11; Growth arrest specific 8; Growth arrest specific protein 11; GAS-8; GAS-11; growth arrest-specific 11; growth arrest-specific protein 11;
FAM111B
family with sequence similarity 111, member B
FAM111B; family with sequence similarity 111, member B; protein FAM111B; CANP; cancer-associated nucleoprotein;
FAM117A
family with sequence similarity 117, member A
FAM117A; family with sequence similarity 117, member A; protein FAM117A; C/EBP induced protein; C/EBP-induced protein; F117A_HUMAN; OTTHUMP00000220571;
FAM118A
family with sequence similarity 118, member A
FAM118A; family with sequence similarity 118, member A; C22orf8, chromosome 22 open reading frame 8; protein FAM118A; bK268H5.C22.4; FLJ20635; C22orf8;
FAM118B
family with sequence similarity 118, member B
FAM118B; family with sequence similarity 118, member B; protein FAM118B; FLJ21103;
METTL21A
methyltransferase like 21A
METTL21A; methyltransferase like 21A; FAM119A, family with sequence similarity 119, member A; methyltransferase-like protein 21A; HCA557b; Hepatocellular carcinoma associated antigen 557b; LOC151194; family with sequence similarity 119, member A; hepatoc;
FAM120A
family with sequence similarity 120A
FAM120A; family with sequence similarity 120A; C9orf10, chromosome 9 open reading frame 10; constitutive coactivator of PPAR-gamma-like protein 1; DNA polymerase transactivated protein 1; DNAPTP1; KIAA0183; DNA polymerase-transactivated protein 1; DNA po;
FAM120AOS
family with sequence similarity 120A opposite strand
FAM120AOS; family with sequence similarity 120A opposite strand; C9orf10OS, chromosome 9 open reading frame 10 opposite strand; putative FAM120A opposite strand protein; C9orf10OS; F120S_HUMAN; FLJ31534;
FAM120C
family with sequence similarity 120C
FAM120C; family with sequence similarity 120C; chromosome X open reading frame 17 , CXorf17; constitutive coactivator of PPAR-gamma-like protein 2; FLJ20506; ORF34; BJ HCC 21 tumor antigen; Constitutive coactivator of PPAR gamma like protein 2; CXorf17; F120C_HUMAN; FLJ43676; Hypothetical protein LOC54954; LOC54954; Protein FAM120C; Tumor antigen BJ-HCC-21; OTTHUMP00000023368; OTTHUMP00000214810; OTTHUMP00000214811;
FAM122A
family with sequence similarity 122A
FAM122A; family with sequence similarity 122A; C9orf42, chromosome 9 open reading frame 42; protein FAM122A; MGC17347; 116224; C9orf42; F122A_HUMAN;
FAM150A
family with sequence similarity 150, member A
FAM150A; family with sequence similarity 150, member A; protein FAM150A; UNQ9433; RPLK9433; MGC163513; MGC163515;
FAM151A
family with sequence similarity 151, member A
FAM151A; family with sequence similarity 151, member A; C1orf179, chromosome 1 open reading frame 179; protein FAM151A; MGC27169; MGC37700; 2010309H15Rik; C1orf179; Hypothetical protein LOC313430; MGC94145; OTTMUSP00000008558; RP23-97O7.7; OTTHUMP00000011521; OTTHUMP00000011522; hyporthetical protein MGC27169;
FAM153B
family with sequence similarity 153, member B
FAM153B; family with sequence similarity 153, member B; protein FAM153B; OTTHUMP00000223259; OTTHUMP00000223260; OTTHUMP00000223262; DKFZp434D115; F153B_HUMAN; Hypothetical protein LOC202134; OTTHUMP00000223257;
FAM154A
family with sequence similarity 154, member A
FAM154A; family with sequence similarity 154, member A; C9orf138, chromosome 9 open reading frame 138; protein FAM154A; MGC35182; 4930500O09Rik; C9orf138; FLJ35283;
FAM70A
family with sequence similarity 70, member A
FAM70A; family with sequence similarity 70, member A; protein FAM70A; FLJ20716; hypothetical protein LOC55026; RP3 525N14.6; RP3-525N14.6;
FAM71A
family with sequence similarity 71, member A
FAM71A; family with sequence similarity 71, member A; protein FAM71A; FLJ32796; RP11-338C15.4;
FAM71B
family with sequence similarity 71, member B
FAM71B; family with sequence similarity 71, member B; protein FAM71B; MGC26988; HSD 51; HSD51;
FAM71D
family with sequence similarity 71, member D
FAM71D; family with sequence similarity 71, member D; C14orf54, chromosome 14 open reading frame 54; protein FAM71D; 4921509E07Rik; 4930516C23Rik; C14orf54; Chromosome 14 open reading frame 54; FLJ36130; GARI-L2; Golgi-associated Rab2B interactor-like 2; Hypothetical protein LOC161142; RIKEN cDNA 4921509E07, isoform CRA_b;
FAM90A1
family with sequence similarity 90, member A1
FAM90A1; family with sequence similarity 90, member A1; protein FAM90A1; FLJ10408; Hypothetical protein LOC55138;
FAM91A1
family with sequence similarity 91, member A1
FAM91A1; family with sequence similarity 91, member A1; protein FAM91A1; FLJ23790; skeletal muscle cells re-entry induced; DKFZp666B104;
FAM92A1
family with sequence similarity 92, member A1
FAM92A1; family with sequence similarity 92, member A1; protein FAM92A1; FLJ38979;
FAM92B
family with sequence similarity 92, member B
FAM92B; family with sequence similarity 92, member B; protein FAM92B; FLJ44299; MGC138149;
FAM96B
family with sequence similarity 96, member B
FAM96B; family with sequence similarity 96, member B; mitotic spindle-associated MMXD complex subunit MIP18; CGI 128; MSS19-interacting protein of 18 kDa; MIP18; CGI-128;
FAM98A
family with sequence similarity 98, member A
FAM98A; family with sequence similarity 98, member A; protein FAM98A; DKFZP564F0522; DKFZp686O03192; FAM 98A; Family with sequence similarity 98 member A; Hypothetical protein LOC25940; LOC25940;
FAM98B
family with sequence similarity 98, member B
FAM98B; family with sequence similarity 98, member B; protein FAM98B; FLJ38426;
SGK494
uncharacterized serine/threonine-protein kinase SgK494
SGK494; uncharacterized serine/threonine-protein kinase SgK494; MGC39533; Sugen kinase 494; Uncharacterized serine/threonine protein kinase SgK494;
GFI1B
growth factor independent 1B transcription repressor
GFI1B; growth factor independent 1B transcription repressor; growth factor independent 1B (potential regulator of CDKN1A, translocated in CML); zinc finger protein Gfi-1b; growth factor independent protein 1B; potential regulator of CDKN1A translocated in;
GAS1
growth arrest-specific 1
GAS1; growth arrest-specific 1; growth arrest-specific protein 1; GAS-1; Growth arrest-specific gene-1;
FGF14
fibroblast growth factor 14
FGF14; fibroblast growth factor 14; FHF4; SCA27; MGC119129; MGC129319; bA397O8.2; FHF 4; Fibroblast growth factor homologous factor 4; mFHF-4(1B); MGC129318; RP11-397O8.6; FHF-4; FGF-14;
FGFBP2
fibroblast growth factor binding protein 2
FGFBP2; fibroblast growth factor binding protein 2; fibroblast growth factor-binding protein 2; killer specific secretory protein of 37 kDa; KSP37; FGF-BP2; FGFBP-2; HBp17-RP; FGF-binding protein 2; HBp17-related protein; 37 kDa killer-specific secretory;
FPGS
folylpolyglutamate synthase
FPGS; folylpolyglutamate synthase; folylpolyglutamate synthase, mitochondrial; tetrahydrofolate synthase; folylpoly-gamma-glutamate synthetase; tetrahydrofolylpolyglutamate synthase;
GCN1L1
GCN1 general control of amino-acid synthesis 1-like 1
GCN1L1; GCN1 general control of amino-acid synthesis 1-like 1 (yeast); GCN1 (general control of amino acid synthesis 1, yeast) like 1; translational activator GCN1; GCN1; GCN1L; KIAA0219; hsGCN1; GCN1-like protein 1; GCN1 (general control of amino-acid sy;
HARS2
histidyl-tRNA synthetase 2, mitochondrial (putative)
HARS2; histidyl-tRNA synthetase 2, mitochondrial (putative); HARSL, histidyl tRNA synthetase like; probable histidyl-tRNA synthetase, mitochondrial; HARSR; histidine tRNA ligase 2; mitochondrial (putative); HO3; Harsl; 4631412B19Rik; AI593507; HARS 2; HARS related; HisRS; Histidine translase; Histidine tRNA ligase; Histidine tRNA ligase homolog; Histidine tRNA ligase like; Histidyl tRNA synthetase 2 mitochondrial; Histidyl tRNA synthetase like; Probable histidyl tRNA synthetase mitochondrial; HARS-related; histidine-tRNA ligase homolog; histidine tRNA ligase 2, mitochondrial (putative);
GPR37
G protein-coupled receptor 37 (endothelin receptor type B-like)
GPR37; G protein-coupled receptor 37 (endothelin receptor type B-like); probable G-protein coupled receptor 37; EDNRBL; hET(B)R LP; PAELR; ETBR-LP-1; endothelin B receptor-like protein 1; Parkin-associated endothelin receptor-like receptor; hET(B)R-LP;
GREB1
growth regulation
GREB1; growth regulation; protein GREB1; gene regulated in breast cancer 1 protein; gene regulated by estrogen in breast cancer;
HEXIM2
hexamethylene bis-acetamide inducible 2
HEXIM2; hexamethylene bis-acetamide inducible 2; protein HEXIM2; FLJ32384; MAQ1 paralog; hexamthylene bis-acetamide inducible 2; hexamethylene bis-acetamide-inducible protein 2; hexamethylene-bis-acetamide-inducible transcript 2; L3;
GRINA
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding)
GRINA; glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding); NMDARA1; protein lifeguard 1; HNRGW; LFG1; TMBIM3; transmembrane BAX inhibitor motif containing 3; putative MAPK-activating protein PM02; NMDA receptor g;
HR
hair growth associated
HR; hair growth associated; AU; MUHH; ALUNC; MUHH1; HSA277165; protein hairless; hairless homolog;
HIC2
hypermethylated in cancer 2
HIC2; hypermethylated in cancer 2; hypermethylated in cancer 2 protein; HRG22; KIAA1020; ZBTB30; ZNF907; HIC1-related gene on chromosome 22; Hic3; Zinc finger and BTB domain-containing protein 30; hic-2; hic-3; HIC1-related gene on chromosome 22 protein;
KDM5D
lysine (K)-specific demethylase 5D
KDM5D; lysine (K)-specific demethylase 5D; HY, HYA, JARID1D, jumonji, AT rich interactive domain 1D , Jumonji, AT rich interactive domain 1D (RBP2 like) , SMCY, Smcy homolog, Y linked (mouse); lysine-specific demethylase 5D; KIAA0234; H-Y; Histocompatibility Y antigen; HY; HYA; JAD1D; Jumonji/ARID domain-containing protein 1D; protein SmcY; Smcy homolog, Y-linked; SMC homolog, Y chromosome; Smcy homolog, Y chromosome; histone demethylase JARID1D; selected mouse cDNA on Y, human homolog of; Jumonji, AT rich interactive domain 1D (RBP2-like); SMCY; JARID1D;
KDM6B
lysine (K)-specific demethylase 6B
KDM6B; lysine (K)-specific demethylase 6B; JMJD3; lysine-specific demethylase 6B; lysine demethylase 6B; jmjC domain-containing protein 3; jumonji domain-containing protein 3; jumonji domain containing 3, histone lysine demethylase;
METTL20
methyltransferase like 20
METTL20; methyltransferase like 20; C12orf72, chromosome 12 open reading frame 72; methyltransferase-like protein 20; DKFZp451L235; MGC50559; C12orf72; Chromosome 12 open reading frame 72; UPF0516 protein C12orf72;
GPX8
glutathione peroxidase 8 (putative)
GPX8; glutathione peroxidase 8 (putative); probable glutathione peroxidase 8; EPLA847; UNQ847; Glutathione peroxidase 8; GPX 8; GPx-8; GSHPx-8;
GRTP1
growth hormone regulated TBC protein 1
GRTP1; growth hormone regulated TBC protein 1; growth hormone-regulated TBC protein 1; FLJ22474; TBC1D6; GRTP1_HUMAN; MGC138328; MGC138330; OTTHUMP00000018752; TBC1 domain family member 6; TBC1 domain family, member 6;
GSTA5
glutathione S-transferase alpha 5
GSTA5; glutathione S-transferase alpha 5; glutathione S transferase A5; glutathione S-transferase A5; glutathione S transferase alpha 5; glutathione S transferase Yc 2; Glutathione S-transferase A5-5; GST A5 5; GST class-alpha member 5; GST Yc2; Gsta5 glutathione S transferase Yc2 subunit; GSTA5_HUMAN; glutathione transferase A5;
GSTCD
glutathione S-transferase, C-terminal domain containing
GSTCD; glutathione S-transferase, C-terminal domain containing; Glutathione S transferase, C terminal domain containing; glutathione S-transferase C-terminal domain-containing protein; FLJ13273; 4933434L15Rik; DKFZp686I10174; MGC74393; OTTMUSP00000027240; OTTMUSP00000027241; RGD1311822;
HLCS
holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase)
HLCS; holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase); holocarboxylase synthetase (biotin (proprionyl Coenzyme A carboxylase (ATP hydrolysing)) ligase) , holocarboxylase synthetase (biotin [proprionyl Coenzyme A carboxylase (ATP hydrolysing)] ligase); biotin--protein ligase; HCS; Biotin [acetyl CoA carboxylase] ligase; Biotin [methylcrotonoyl CoA carboxylase] ligase; Biotin [methylmalonyl CoA carboxytransferase] ligase; Biotin [propionyl CoA carboxylase [ATP hydrolyzing]] ligase; Biotin apo protein ligase; Biotin apo-protein ligase; Biotin protein ligase; Biotin--[acetyl-CoA-carboxylase] ligase; BPL1_HUMAN; EC 6.3.4.-; Holocarboxylase synthetase; Holocarboxylase synthetase, EC 6.3.4; biotin--[methylcrotonoyl-CoA-carboxylase] ligase; biotin--[methylmalonyl-CoA-carboxytransferase] ligase; holocarboxylase synthetase (biotin-(proprionyl-Coenzyme A-carboxylase (ATP-hydrolysing)) ligase);
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
HMGCR; 3-hydroxy-3-methylglutaryl-CoA reductase; 3 hydroxy 3 methylglutaryl Coenzyme A reductase; 3-hydroxy-3-methylglutaryl-Coenzyme A reductase; 3 hydroxy 3 methylglutaryl CoA reductase (NADPH); hydroxymethylglutaryl CoA reductase; 3H3M; MGC103269; HMDH_HUMAN; HMG CoA reductase; HMG CoAR; HMG-CoA reductase; Red; hydroxymethylglutaryl-CoA reductase; 3-hydroxy-3-methylglutaryl CoA reductase (NADPH); LDLCQ3;
MTHFD2L
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like
MTHFD2L; methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like; probable bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase 2; MGC72244; MTHFD2-like; NADP-dependent methylenetetrahydrofolate dehydrogenase 2-like protein; FLJ131;
MTHFSD
methenyltetrahydrofolate synthetase domain containing
MTHFSD; methenyltetrahydrofolate synthetase domain containing; methenyltetrahydrofolate synthase domain-containing protein; FLJ12998; methenyltetrahydrofolate synthetase domain-containing protein; FLJ13893; MGC138262; MGC138264; MGC177233;
HEMK1
HemK methyltransferase family member 1
HEMK1; HemK methyltransferase family member 1; MTQ1; HEMK; M.HsaHemKP; HEMK homolog 7kb;
LRTOMT
leucine rich transmembrane and 0-methyltransferase domain containing
LRTOMT; leucine rich transmembrane and 0-methyltransferase domain containing; deafness, autosomal recessive 63 , DFNB63, leucine rich repeat containing 51 , LRRC51; leucine-rich repeat-containing protein 51; transmembrane O-methyltransferase; COMT2; tran;
HDGFRP2
hepatoma-derived growth factor, related protein 2
HDGFRP2; hepatoma-derived growth factor, related protein 2; hepatoma-derived growth factor-related protein 2; HDGF-2; HDGR2_HUMAN; Hepatoma-derived growth factor 2; Hepatoma-derived growth factor; heptoma derived growth factor related protein 2; HRP-2;
JHDM1D
jumonji C domain containing histone demethylase 1 homolog D
JHDM1D; jumonji C domain containing histone demethylase 1 homolog D (S. cerevisiae); lysine-specific demethylase 7; KIAA1718; histone lysine demethylase JHDM1D; jmjC domain-containing histone demethylation protein 1D; jumonji C domain-containing histone d;
RRP8
ribosomal RNA processing 8, methyltransferase, homolog (yeast)
RRP8; ribosomal RNA processing 8, methyltransferase, homolog (yeast); KIAA0409; ribosomal RNA-processing protein 8; RRP8 methyltransferase homolog (S. cerevisiae); Cerebral protein 1; hypothetical protein LOC23378; Nucleomethylin; Ribosomal RNA processing 8 methyltransferase homolog; Ribosomal RNA processing protein 8; RRP 8; RRP8 methyltransferase homolog;
LRRD1
leucine-rich repeats and death domain containing 1
LRRD1; leucine-rich repeats and death domain containing 1; leucine-rich repeat and death domain-containing protein 1; IMAGE:4798971; Leucine-rich repeat and death domain-containing protein LOC401387; YG015_HUMAN;
IARS2
isoleucyl-tRNA synthetase 2, mitochondrial
IARS2; isoleucyl-tRNA synthetase 2, mitochondrial; isoleucine--tRNA ligase, mitochondrial; FLJ10326; isoleucine tRNA ligase 2; mitochondrial; isoleucine tRNA ligase 2, mitochondrial; isoleucyl-tRNA synthetase, mitochondrial; mitochondrial isoleucine tRNA;
IFIT2
interferon-induced protein with tetratricopeptide repeats 2
IFIT2; interferon-induced protein with tetratricopeptide repeats 2; cig42; G10P2; GARG 39; Glucocorticoid attenuated response gene 39; IFI 54; IFI 54K; IFI-54K; IFI54; IFIT 2; IFIT-2; IFIT2_HUMAN; Interferon induced 54 kDa protein; Interferon induced protein 54; Interferon induced protein with tetratricopeptide repeats 2; Interferon, alpha inducible protein (MW 54kD); Interferon-induced 54 kDa protein; ISG 54 K; ISG 54K; ISG-54 K; ISG54; GARG-39; glucocorticoid-attenuated response gene 39 protein; AV302338;
IFIT5
interferon-induced protein with tetratricopeptide repeats 5
IFIT5; interferon-induced protein with tetratricopeptide repeats 5; retinoic acid and interferon inducible protein (58kD); RI58; FLJ53857; FLJ92678; IFIT-5; IFIT5_HUMAN; Interferon induced protein with tetratricopeptide repeats 5; Retinoic acid and interferon inducible 58 kDa protein; Retinoic acid- and interferon-inducible 58 kDa protein; retinoic acid- and interferon-inducible protein (58kD);
IGF2BP1
insulin-like growth factor 2 mRNA binding protein 1
IGF2BP1; insulin-like growth factor 2 mRNA binding protein 1; insulin-like growth factor 2 mRNA-binding protein 1; IGF II mRNA binding protein 1; IMP 1; ZBP-1; VICKZ family member 1; zipcode-binding protein 1; IGF2 mRNA-binding protein 1; IGF-II mRNA-bind;
FAM174B
family with sequence similarity 174, member B
FAM174B; family with sequence similarity 174, member B; membrane protein FAM174B; LOC400451; MGC102891;
INMT
indolethylamine N-methyltransferase
INMT; indolethylamine N-methyltransferase; Amine N methyltransferase; Amine N-methyltransferase; Aromatic alkylamine N methyltransferase; Aromatic alkylamine N-methyltransferase; Arylamine N methyltransferase; Arylamine N-methyltransferase; Indolamine N-methyltransferase; Indolethylamine N methyltransferase; INMT_HUMAN; nicotine N methyltransferase; thioester S methyltransferase like; nicotine N-methyltransferase;
KDM4B
lysine (K)-specific demethylase 4B
KDM4B; lysine (K)-specific demethylase 4B; JMJD2B; TDRD14B; lysine-specific demethylase 4B; tudor domain containing 14B; jumonji domain containing 2B; jumonji domain-containing protein 2B; jmjC domain-containing histone demethylation protein 3B;
ISM1
isthmin 1 homolog (zebrafish)
ISM1; isthmin 1 homolog (zebrafish); C20orf82, chromosome 20 open reading frame 82; isthmin-1; bA149I18.1; C20orf82; Chromosome 20 open reading frame 82; dJ1077I2.1; ISM; Isthmin 1; Isthmin; OTTHUMP00000030295;
ISPD
isoprenoid synthase domain containing
ISPD; isoprenoid synthase domain containing; 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein; 4 diphosphocytidyl 2C methyl D erythritol synthase homolog (Arabidopsis); hCG_1745121; Nip; notch1 induced protein; Isoprenoid synthase domain-containing protein; ISPD_HUMAN; notch1-induced protein; 4-diphosphocytidyl-2C-methyl-D-erythritol synthase homolog;
KDM4D
lysine (K)-specific demethylase 4D
KDM4D; lysine (K)-specific demethylase 4D; JMJD2D; lysine-specific demethylase 4D; jumonji domain containing 2D; jumonji domain-containing protein 2D; jmjC domain-containing histone demethylation protein 3D;
KDM1B
lysine (K)-specific demethylase 1B
KDM1B; lysine (K)-specific demethylase 1B; AOF1; LSD2; C6orf193; bA204B7.3; dJ298J15.2; lysine-specific histone demethylase 1B; amine oxidase, flavin containing 1; lysine-specific histone demethylase 2; amine oxidase (flavin containing) domain 1; flavin-containing amine oxidase domain-containing protein 1;
LILRA5
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5
LILRA5; leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5; LILRB7; leukocyte immunoglobulin-like receptor subfamily A member 5; CD85; CD85f; ILT11; LIR9; CD85 antigen-like family member F; ILT-11; Immunoglobulin like transcript 11 protein; Immunoglobulin-like transcript 11; Leukocyte Ig like receptor 9; Leukocyte immunoglobulin like receptor subfamily A (with TM domain) member 5; Leukocyte immunoglobulin-like receptor 9; Leukocyte immunoglobulin-like receptor subfamily B (with TM and ITIM domains) member 7; LIR-9; LIRA5_HUMAN; leukocyte Ig-like receptor 9; immunoglobulin-like transcript 11 protein; leukocyte immunoglobulin-like receptor subfamily A member 5 soluble; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 7;
EARS2
glutamyl-tRNA synthetase 2, mitochondrial (putative)
EARS2; glutamyl-tRNA synthetase 2, mitochondrial (putative); probable glutamyl-tRNA synthetase, mitochondrial; glutamate tRNA ligase 2; mitochondrial (putative); KIAA1970; MSE1; AL024049; mKIAA1970; 3230401I01Rik; EARS 2; GluRS; Glutamate--tRNA ligase; Probable glutamyl tRNA synthetase, mitochondrial; RGD1307904; glutamate tRNA ligase 2, mitochondrial;
SPECC1
sperm antigen with calponin homology and coiled-coil domains 1
SPECC1; sperm antigen with calponin homology and coiled-coil domains 1; cytospin-B; cytokinesis and spindle organization B; cytospin B; CYTSB; FLJ36955; HCMOGT 1; NSP; sperm antigen HCMOGT 1; NSP5; sperm antigen HCMOGT-1; structure protein NSP5a3a; struct;
METTL13
methyltransferase like 13
METTL13; methyltransferase like 13; KIAA0859; methyltransferase-like protein 13; CGI 01; antiapoptotic protein FEAT; feat; CGI-01; 5630401D24Rik;
FAM184B
family with sequence similarity 184, member B
FAM184B; family with sequence similarity 184, member B; protein FAM184B; KIAA1276;
KIR3DL2
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
KIR3DL2; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2; killer cell immunoglobulin-like receptor 3DL2; CD158K; cl 5; nkat4; nkat4a; nkat4b; CD158 antigen like family member K; CD158 antigen-like family member K; KI3L2_HUMAN; Killer cell immunoglobulin like receptor 3DL2; killer cell immunoglobulin like receptor KIR3DL2; Killer cell immunoglobulin like receptor, three domains, long cytoplasmic tail, 2; KIR antigen 3DL2; Kirl2; MHC class I NK cell receptor; Natural killer associated transcript 4; natural killer cell inhibitory receptor; Natural killer-associated transcript 4; NK associated transcript 4; NK associated transcript 4A, included; NK associated transcript 4B, included; NKAT-4; p140; p70 natural killer cell receptor clone CL 5; p70 natural killer cell receptor clone CL-5; p70 NK receptor CL 5; p70 NK receptor CL-5; killer Ig receptor; p70 killer cell inhibitory receptor; killer cell immunoglobulin-like receptor KIR3DL2;
LOC727787
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like
LOC727787; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like; Killer cell immunoglobulin like receptor three domains long cytoplasmic tail 2 like; LOC727787|-|-;
MAST4
microtubule associated serine/threonine kinase family member 4
MAST4; microtubule associated serine/threonine kinase family member 4; microtubule-associated serine/threonine-protein kinase 4; KIAA0303; Microtubule associated serine/threonine protein kinase member 4;
LANCL2
LanC lantibiotic synthetase component C-like 2 (bacterial)
LANCL2; LanC lantibiotic synthetase component C-like 2 (bacterial); GPR69B, LanC (bacterial lantibiotic synthetase component C) like 2; lanC-like protein 2; G protein coupled receptor 69B; TASP; testis specific adriamycin sensitivity protein; LanC (bacterial lantibiotic synthetase component C) like 2; G protein-coupled receptor 69B; testis-specific adriamycin sensitivity protein; LanC (bacterial lantibiotic synthetase component C)-like 2; GPR69B;
CERS3
ceramide synthase 3
CERS3; ceramide synthase 3; LAG1 homolog, ceramide synthase 3 , LAG1 longevity assurance homolog 3 (S. cerevisiae) , LASS3; MGC27091; LAG1 longevity assurance homolog 3; LAG1 homolog, ceramide synthase 3; LASS 3; MGC 27091; LASS3;
CERS4
ceramide synthase 4
CERS4; ceramide synthase 4; LAG1 homolog, ceramide synthase 4 , LAG1 longevity assurance homolog 4 (S. cerevisiae) , LASS4; FLJ12089; Trh1; LAG1 homolog ceramide synthase 4; LAG1 longevity assurance homolog 4; LASS 4; LASS4; LASS4 LAG1 homolog ceramide synthase 4; LASS4_HUMAN; Trh 1; LAG1 homolog, ceramide synthase 4;
CERS5
ceramide synthase 5
CERS5; ceramide synthase 5; LAG1 homolog, ceramide synthase 5 , LAG1 longevity assurance homolog 5 (S. cerevisiae) , LASS5; FLJ25304; MGC45411; Trh4; LAG1 homolog, ceramide synthase 5; LAG1 longevity assurance homolog 5; LASS5;
LCMT2
leucine carboxyl methyltransferase 2
LCMT2; leucine carboxyl methyltransferase 2; KIAA0547; MGC9534; PPM2; tRNA yW synthesizing protein 4; TYW4; tRNA-yW synthesizing protein 4; tRNA-Wybutosine-synthesizing protein 4; p21WAF1/CIP1 promoter-interacting protein; FLJ51321;
MAST3
microtubule associated serine/threonine kinase 3
MAST3; microtubule associated serine/threonine kinase 3; microtubule-associated serine/threonine-protein kinase 3; KIAA0561;
SLC16A2
solute carrier family 16, member 2 (thyroid hormone transporter)
SLC16A2; solute carrier family 16, member 2 (thyroid hormone transporter); AHDS, Allan Herndon Dudley syndrome , DXS128, mental retardation, X linked 22 , MRX22, solute carrier family 16 (monocarboxylic acid transporters), member 2 , solute carrier fa;
LARS
leucyl-tRNA synthetase
LARS; leucyl-tRNA synthetase; leucyl-tRNA synthetase, cytoplasmic; FLJ10595; FLJ21788; HSPC192; LARS1; leucine tRNA ligase 1; cytoplasmic; LEUS; RNTLS; Leucine tRNA ligase; Cytoplasmic leucyl tRNA synthetase; Cytosolic leucyl tRNA synthetase; hr025Cl; HSPC 192; KIAA1352; LARS 1; Leucine translase; Leucyl tRNA synthetase cytoplasmic; LeuRS; LRS; PIG 44; PIG44; Proliferation inducing gene 44; OTTHUMP00000223912; OTTHUMP00000223913; leucine-tRNA ligase; leucine--tRNA ligase; proliferation-inducing gene 44; cytosolic leucyl-tRNA synthetase; cytoplasmic leucyl-tRNA synthetase; leucine tRNA ligase 1, cytoplasmic;
MBD3L2
methyl-CpG binding domain protein 3-like 2
MBD3L2; methyl-CpG binding domain protein 3-like 2; methyl-CpG-binding domain protein 3-like 2; MBD3-like protein 2;
MBD3L3
methyl-CpG binding domain protein 3-like 3
MBD3L3; methyl-CpG binding domain protein 3-like 3; putative methyl-CpG-binding domain protein 3-like 3; MB3L3_HUMAN; MBD3 like 3; MBD3 like protein 3; MBD3-like protein 3; putative methyl CpG binding domain protein 3 like 3; MBD3-like 3;
MBD3L5
methyl-CpG binding domain protein 3-like 5
MBD3L5; methyl-CpG binding domain protein 3-like 5; putative methyl-CpG-binding domain protein 3-like 5; MB3L5_HUMAN; MBD3-like protein 5; MBD3-like 5;
MBD4
methyl-CpG binding domain protein 4
MBD4; methyl-CpG binding domain protein 4; methyl-CpG-binding domain protein 4; MED1; G/T mismatch glycosylase; G/U mismatch glycosylase; methyl-CpG-binding protein MBD4; 3,N(4)-ethenocytosine glycosylase; methyl-CpG-binding endonuclease 1; mismatch-speci;
MBD6
methyl-CpG binding domain protein 6
MBD6; methyl-CpG binding domain protein 6; methyl-CpG-binding domain protein 6; methyl-CpG-binding protein MBD6;
CMBL
carboxymethylenebutenolidase homolog (Pseudomonas)
CMBL; carboxymethylenebutenolidase homolog (Pseudomonas); carboxymethylenebutenolidase like (Pseudomonas); carboxymethylenebutenolidase homolog; FLJ23617; CMBL_HUMAN; carboxymethylenebutenolidase-like (Pseudomonas);
LOC389833
similar to hypothetical protein MGC27019
LOC389833; similar to hypothetical protein MGC27019; FLJ35473;
PIDD
p53-induced death domain protein
PIDD; p53-induced death domain protein; leucine rich repeats and death domain containing , LRDD; p53-induced protein with a death domain; DKFZp434D229; MGC16925; leucine-rich repeats and death domain containing; leucine-rich repeat and death domain-contai;
GLIPR1L2
GLI pathogenesis-related 1 like 2
GLIPR1L2; GLI pathogenesis-related 1 like 2; GLIPR1-like protein 2; MGC39497; GLI pathogenesis related 1 like 2; GLIPR1L 2; GRPL2_HUMAN;
AGPAT9
1-acylglycerol-3-phosphate O-acyltransferase 9
AGPAT9; 1-acylglycerol-3-phosphate O-acyltransferase 9; 1 acylglycerol 3 phosphate O acyltransferase 9 (lysophosphatidic acid acyltransferase, theta); glycerol-3-phosphate acyltransferase 3; HMFN0839; LPAAT theta; lysophosphatidic acid acyltransferase; th;
METAP1D
methionyl aminopeptidase type 1D (mitochondrial)
METAP1D; methionyl aminopeptidase type 1D (mitochondrial); methionine aminopeptidase 1D, mitochondrial; MAP1D; Metap1l; methionine aminopeptidase 1D; mitochondrial; AMP1D_HUMAN; CDS of metAP 3 within PCR fragment; CDS of metAP-3 within PCR fragment; methionyl aminopeptidase type 1D, mitochondrial;
METTL5
methyltransferase like 5
METTL5; methyltransferase like 5; methyltransferase-like protein 5; HSPC133; OTTHUMP00000205108; OTTHUMP00000205109; RGD1566062; 2810410A08Rik; DC3; FLJ10459; mCG_12967; Methyltransferase like protein 5; METTL 5; MGC187943; OTTHUMP00000205107; OTTMUSP00000040951;
METTL6
methyltransferase like 6
METTL6; methyltransferase like 6; methyltransferase-like protein 6; MGC24132; Methyltransferase like protein 6;
METTL10
methyltransferase like 10
METTL10; methyltransferase like 10; C10orf138, chromosome 10 open reading frame 138; methyltransferase-like protein 10; Em:AC068896.3; LOC399818; C10orf138;
MSL1
male-specific lethal 1 homolog
MSL1; male-specific lethal 1 homolog (Drosophila); male-specific lethal 1 homolog; DKFZp686P24239; hMSL1; MSL 1; MSL1-like 1; male-specific lethal 1-like 1; male-specific lethal-1 homolog 1; MSL-1; MGC141861; DKFZp686J17211;
NFAM1
NFAT activating protein with ITAM motif 1
NFAM1; NFAT activating protein with ITAM motif 1; NFAT activation molecule 1; CNAIP; NFAT activation molecule 1 precursor; Calcinerin/NFAT activating ITAM containing protein; NFAT-activating protein with ITAM motif 1; calcinerin/NFAT-activating ITAM-containing protein; calcineurin/NFAT-activating ITAM-containing protein; bK126B4.4;
METTL7B
methyltransferase like 7B
METTL7B; methyltransferase like 7B; methyltransferase-like protein 7B; MGC17301;
MMACHC
methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria
MMACHC; methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria; methylmalonic aciduria and homocystinuria type C protein; cblC; DKFZP564I122; 1810037K07Rik; BOS_3654; FLJ25671; Methylmalonic aciduria (cobalamin deficiency) cblC type with homocystinuria; Methylmalonic aciduria and homocystinuria type C protein homolog; MGC134307; OTTHUMP00000009243; RP11 291L19.3; RP23-177C18.3; RP11-291L19.3;
MEPCE
methylphosphate capping enzyme
MEPCE; methylphosphate capping enzyme; BCDIN3, bin3, bicoid interacting 3, homolog (Drosophila); 7SK snRNA methylphosphate capping enzyme; FLJ20257; BCDIN3; Bicoid interacting protein 3 homolog; Bin3 bicoid interacting 3; Bin3 bicoid interacting 3 homolog (Drosophila); Bin3 bicoid interacting 3 homolog; Bin3 homolog; bin3, bicoid-interacting 3, homolog; bicoid-interacting protein 3 homolog;
METTL16
methyltransferase like 16
METTL16; methyltransferase like 16; methyltransferase 10 domain containing , METT10D; methyltransferase-like protein 16; MGC3329; putative methyltransferase METT10D; methyltransferase 10 domain containing; methyltransferase 10 domain-containing protein; M;
METTL17
methyltransferase like 17
METTL17; methyltransferase like 17; methyltransferase 11 domain containing 1 , METT11D1; methyltransferase-like protein 17, mitochondrial; FLJ20859; false p73 target gene protein; protein RSM22 homolog, mitochondrial; methyltransferase 11 domain containin;
METTL15
methyltransferase like 15
METTL15; methyltransferase like 15; methyltransferase 5 domain containing 1 , METT5D1; probable methyltransferase-like protein 15; FLJ33979; Methyltransferase 5 domain containing 1; METT5D 1; methyltransferase 5 domain-containing protein 1; probable S-adenosyl-L-methionine-dependent methyltransferase METT5D1; putative S-adenosyl-L-methionine-dependent methyltransferase METT5D1; METT5D1;
METTL11B
methyltransferase like 11B
METTL11B; methyltransferase like 11B; C1orf184, chromosome 1 open reading frame 184; alpha N-terminal protein methyltransferase 1B; C1orf184; Chromosome 1 open reading frame 184; Gm207,; Methyltransferase-like protein 11B; NTM1B; NTM1B_HUMAN; X-Pro-Lys N-terminal protein methyltransferase 1B; OTTHUMP00000034162;
METTL21C
methyltransferase like 21C
METTL21C; methyltransferase like 21C; C13orf39, chromosome 13 open reading frame 39; methyltransferase-like protein 21C; LOC196541; C13orf39; MT21C_HUMAN; UPF0567 protein C13orf39;
METTL2A
methyltransferase like 2A
METTL2A; methyltransferase like 2A; methyltransferase-like protein 2A; FLJ12760; METTL2;
METTL4
methyltransferase like 4
METTL4; methyltransferase like 4; methyltransferase-like protein 4; FLJ23017; HsT661; METL4_HUMAN; METTL 4;
METTL7A
methyltransferase like 7A
METTL7A; methyltransferase like 7A; methyltransferase-like protein 7A; DKFZP586A0522; protein AAM-B; AAM-B;
FAM192A
family with sequence similarity 192, member A
FAM192A; family with sequence similarity 192, member A; C16orf94, chromosome 16 open reading frame 94; protein FAM192A; NEFA interacting nuclear protein NIP30; NIP30; LOC80011; CDA10; NEFA interacting nuclear protein; NIP 30; NEFA-interacting nuclear protein NIP30; CDA018; C16orf94;
MT-ATP6
mitochondrially encoded ATP synthase 6
MT-ATP6; mitochondrially encoded ATP synthase 6; ATP synthase 6 , MTATP6, RP, spicular retinitis pigmentosa with dementia, seizures, ataxia, proximal muscle weakness and sensory deficit; ATP synthase F0 subunit 6; ATP6; ATPase 6; Su6m; ATP synthase subunit a; ATP6_HUMAN; ATPASE6; F-ATPase protein 6; MTATP6; ATP synthase 6; ATPase subunit 6;
MRM1
mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae)
MRM1; mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae); rRNA methyltransferase 1, mitochondrial; FLJ22578; ENSMUSG00000054212; RP23-293L24.6; A530065E19Rik; Mitochondrial large ribosomal RNA ribose methylase; MRM1_HUMAN; OTTMUSP00000008034; RGD1566232;
FAM114A1
family with sequence similarity 114, member A1
FAM114A1; family with sequence similarity 114, member A1; protein Noxp20; 9130005N14Rik; RGD1560201; 1190001N04Rik,; Hypothetical protein LOC92689; MGC117924; Nervous system over-expressed protein 20; Noxp20; OTTMUSP00000027384; 1190001N04Rik;
NOSIP
nitric oxide synthase interacting protein
NOSIP; nitric oxide synthase interacting protein; nitric oxide synthase-interacting protein; CGI 25; CGI25; CGI25 protein; eNOS interacting protein; eNOS-interacting protein; CGI-25;
NOSTRIN
nitric oxide synthase trafficker
NOSTRIN; nitric oxide synthase trafficker; MGC20702; BM247; BM247 homolog; DaIP2; eNOS-trafficking inducer; mDaIP2; Nitric oxide synthase traffic inducer; NOSTN_HUMAN; RP23-431D4.2; ENOS traffic inducer; nitric oxide synthase trafficking; endothelial nitric oxide synthase traffic inducer; ortholog of mouse disabled 2 interacting proein 2;
ASAP2
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2
ASAP2; ArfGAP with SH3 domain, ankyrin repeat and PH domain 2; DDEF2, development and differentiation enhancing factor 2; arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2; centaurin; beta 3; CENTB3; KIAA0400; PAP; SHAG1; centaurin,;
MTFMT
mitochondrial methionyl-tRNA formyltransferase
MTFMT; mitochondrial methionyl-tRNA formyltransferase; methionyl-tRNA formyltransferase, mitochondrial; FMT1; mitochondrial; FMT; FMT_HUMAN; Methionyl tRNA formyltransferase, mitochondrial; Methionyl-tRNA formyltransferase; mitochondrial methionyl tRNA formyltransferase;
PLEKHG6
pleckstrin homology domain containing, family G (with RhoGef domain) member 6
PLEKHG6; pleckstrin homology domain containing, family G (with RhoGef domain) member 6; pleckstrin homology domain-containing family G member 6; FLJ10665; PH domain-containing family G member 6; myosin interacting guanine nucleotide exchange factor; myosi;
NARS2
asparaginyl-tRNA synthetase 2, mitochondrial (putative)
NARS2; asparaginyl-tRNA synthetase 2, mitochondrial (putative); probable asparaginyl-tRNA synthetase, mitochondrial; asparagine tRNA ligase 2; mitochondrial (putative); FLJ23441; SLM5; MGC125113; RGD1305145; AI875199; AsnRS; Asparagine tRNA ligase 2 mitochondrial; Asparagine tRNA ligase; Asparaginyl tRNA synthetase 2; Asparaginyl tRNA synthetase 2 mitochondrial; MGC41336; NARS 2; Probable asparaginyl tRNA synthetase; Probable asparaginyl tRNA synthetase mitochondrial; asparagine--tRNA ligase; asparagine tRNA ligase 2, mitochondrial (putative);
NRADD
neurotrophin receptor associated death domain
NRADD; neurotrophin receptor associated death domain; death domain containing membrane protein NRADD; PLAIDD; NRDD; BB104149; 2610311B09Rik;
NPHP1
nephronophthisis 1 (juvenile) homolog (human)
NPHP1; nephronophthisis 1 (juvenile) homolog (human); nephrocystin-1; JBTS4; Juvenile nephronophthisis 1 protein; Nephrocystin 1; NPH1; SLSN1;
NOM1
nucleolar protein with MIF4G domain 1
NOM1; nucleolar protein with MIF4G domain 1; C7orf3, chromosome 7 open reading frame 3; nucleolar MIF4G domain-containing protein 1; SGD1; C7orf3; FLJ16401; NOM1_HUMAN; SGD1 homolog;
GRIN3A
glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
GRIN3A; glutamate receptor, ionotropic, N-methyl-D-aspartate 3A; glutamate [NMDA] receptor subunit 3A; GluN3A; NMDAR3A; N-methyl-D-aspartate receptor subtype 3A; NR3A; NMDAR-L; FLJ45414;
GRIN3B
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B
GRIN3B; glutamate receptor, ionotropic, N-methyl-D-aspartate 3B; NR3B; GluN3B; glutamate receptor ionotropic, NMDA 3B; NMDAR3B; NMDA receptor subunit 3B; glutamate [NMDA] receptor subunit 3B; N-methyl-D-aspartate receptor subtype 3B; NMDA type glutamate receptor subunit NR3B;
NFE2L3
nuclear factor (erythroid-derived 2)-like 3
NFE2L3; nuclear factor (erythroid-derived 2)-like 3; nuclear factor erythroid 2-related factor 3; Nrf3; erythroid derived 2; like 3; NF-E2-related factor 3; NF2L3_HUMAN; NFE2-related factor 3; Nuclear factor; nuclear factor, erythroid derived 2, like 3; nuclear factor-erythroid 2-related factor 3; nuclear factor-erythroid 2 p45-related factor 3;
OAS3
2-5-oligoadenylate synthetase 3, 100kDa
OAS3; 2-5-oligoadenylate synthetase 3, 100kDa; 2 5 oligoadenylate synthetase 3 (100 kD); 2-5-oligoadenylate synthase 3; p100OAS; p100 OAS; 2-5A synthase 3; 2-5A synthetase 3; (2-5)oligo(A) synthase 3; (2-5)oligo(A) synthetase 3; 2-5oligoadenylate syntheta;
OASL
2-5-oligoadenylate synthetase-like
OASL; 2-5-oligoadenylate synthetase-like; 59 kDa 2-5-oligoadenylate synthase-like protein; p59OASL; TRIP14; TRIP-14; p59 OASL; TR-interacting protein 14; thyroid receptor-interacting protein 14; 59 kDa 2-5-oligoadenylate synthetase-like protein;
OASL1
2-5 oligoadenylate synthetase-like 1
OASL1; 2-5 oligoadenylate synthetase-like 1; 59 kDa 2-5-oligoadenylate synthase-like protein; 2,5-oligoadenylate synthetase-like 9; 7530414C13Rik; oasl9;
OAZ1
ornithine decarboxylase antizyme 1
OAZ1; ornithine decarboxylase antizyme 1; OAZ; antizyme 1; AZI; MGC138338; ODC-Az;
OAS2
2-5-oligoadenylate synthetase 2, 69/71kDa
OAS2; 2-5-oligoadenylate synthetase 2, 69/71kDa; 2 5 oligoadenylate synthetase 2 (69 71 kD); 2-5-oligoadenylate synthase 2; (2-5)oligo(A) synthetase 2; 2-5-oligoadenylate synthetase 2; 2-5A synthetase 2; MGC78578; p69 OAS / p71 OAS; p69OAS / p71OAS; 2-5A synthase 2;
PAMR1
peptidase domain containing associated with muscle regeneration 1
PAMR1; peptidase domain containing associated with muscle regeneration 1; inactive serine protease PAMR1; DKFZP586H2123; RAMP; regeneration associated muscle protease; FP938; Inactive serine protease; Inactive serine protease RAMP; PAMR 1; Regeneration associated muscle protease homolog; OTTHUMP00000232625; OTTHUMP00000232626; OTTHUMP00000232627; OTTHUMP00000232628; regeneration-associated muscle protease homolog; peptidase domain-containing protein associated with muscle regeneration 1;
ITGBL1
integrin, beta-like 1 (with EGF-like repeat domains)
ITGBL1; integrin, beta-like 1 (with EGF-like repeat domains); integrin beta-like protein 1; integrin beta like 1; OSCP; ten integrin EGF like repeat domains protein; TIED; osteoblast-specific cysteine-rich protein; ten integrin EGF-like repeat domains pro;
FAM132A
family with sequence similarity 132, member A
FAM132A; family with sequence similarity 132, member A; C1q domain containing 2 , C1QDC2; protein FAM132A; adipolin; adipose derived insulin sensitizing factor; C1QTNF12; CTRP12; MGC105127; C1q domain containing 2; C1q/TNF-related protein 12; adipose-deri;
FAM160B2
family with sequence similarity 160, member B2
FAM160B2; family with sequence similarity 160, member B2; RAI16, retinoic acid induced 16; protein FAM160B2; FLJ21801; retinoic acid induced 16; retinoic acid-induced protein 16; RAI16; FLJ11125; MGC138352;
PRPSAP1
phosphoribosyl pyrophosphate synthetase-associated protein 1
PRPSAP1; phosphoribosyl pyrophosphate synthetase-associated protein 1; phosphoribosyl pyrophosphate synthase-associated protein 1; PAP39; 39 kDa phosphoribosypyrophosphate synthase associated protein; 39 kDa phosphoribosypyrophosphate synthase-associated protein; KPRA_HUMAN; Phosphoribosyl pyrophosphate synthase associated protein 1; Phosphoribosyl pyrophosphate synthetase associated protein 1; PRPP synthase associated protein 1; PRPP synthase-associated protein 1;
PEBP4
phosphatidylethanolamine-binding protein 4
PEBP4; phosphatidylethanolamine-binding protein 4; CORK1; cousin of RKIP 1 protein; hPEBP4; MGC22776; cousin-of-RKIP 1 protein; protein cousin-of-RKIP 1; CORK-1; PEBP-4; PRO4408; GWTM1933;
TKV
thickveins
TKV; thickveins; CG14026 gene product from transcript CG14026-RA; Thick veins protein; thickveins, isoform A; CG14026-PA; tkv-PA; Thick-vein; Activin-A-receptor-25D; DPP receptor; BMP receptor kinase 25D; thickvein; thick veins; slater; thickveins, isoform C; CG14026-PC; tkv-PC; thickveins, isoform B; CG14026-PB; tkv-PB; thickveins, isoform D; CG14026-PD; tkv-PD; Atkv; Atr25D; Brk25D; Brk25D1; Brk25D2; CG14026; Dmel\CG14026; dtfr; kv; l(2)04415; l(2)25Da; STK-A; str; tkv1;
PCMTD2
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2
PCMTD2; protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2; C20orf36, chromosome 20 open reading frame 36; protein-L-isoaspartate O-methyltransferase domain-containing protein 2; FLJ10883; C20orf36; KIAA0835; KIAA1050; protein L isoaspartate (D aspartate) O methyltransferase domain containing 2;
PDSS2
prenyl (decaprenyl) diphosphate synthase, subunit 2
PDSS2; prenyl (decaprenyl) diphosphate synthase, subunit 2; C6orf210, chromosome 6 open reading frame 210; decaprenyl-diphosphate synthase subunit 2; bA59I9.3; C6orf210; Candidate tumor suppressor protein; chromosome 6 open reading frame 210; decaprenyl pyrophosphate synthetase subunit 2; DLP1; hDLP1; subunit 2 of decaprenyl diphosphate synthase; decaprenyl pyrophosphate synthase subunit 2; all-trans-decaprenyl-diphosphate synthase subunit 2;
QRSL1
glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1
QRSL1; glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1; glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial; DKFZP564C1278; FLJ10989; FLJ12189; FLJ13447; GatA; 2700038P16Rik; C80053; Glutaminyl tRNA synthase (glutamine hydrolyzing) like 1; Glutaminyl tRNA synthase like protein 1; MGC105526; OTTMUSP00000026615; glu-AdT subunit A; glutaminyl-tRNA synthase-like protein 1; glutamyl-tRNA(Gln) amidotransferase subunit A homolog;
OTC
ornithine carbamoyltransferase
OTC; ornithine carbamoyltransferase; ornithine carbamoyltransferase, mitochondrial; OTCase; ornithine transcarbamylase; OCTD; MGC129967; MGC129968; MGC138856;
PANK1
pantothenate kinase 1
PANK1; EC 2.7.1.33 protein; hPanK protein; hPanK1 protein; MGC24596 protein; PANK protein; PANK1a protein; PANK1b protein; pantothenate kinase 1 protein; pantothenate kinase protein; Pantothenic acid kinase 1 protein;
PARS2
prolyl-tRNA synthetase 2, mitochondrial (putative)
PARS2; prolyl-tRNA synthetase 2, mitochondrial (putative); probable proline--tRNA ligase, mitochondrial; DKFZp727A071; proline tRNA ligase 2; mitochondrial (putative); proRS; proline--tRNA ligase; proline tRNA ligase 2, mitochondrial (putative); MT-PRORS;
PRMT7
protein arginine methyltransferase 7
PRMT7; protein arginine methyltransferase 7; protein arginine N-methyltransferase 7; FLJ10640; KIAA1933; histone-arginine N-methyltransferase PRMT7; myelin basic protein-arginine N-methyltransferase; [Myelin basic protein]-arginine N-methyltransferase PRM;
PRMT8
protein arginine methyltransferase 8
PRMT8; protein arginine methyltransferase 8; HRMT1L3; HRMT1L4; protein arginine N-methyltransferase 8; HMT1 hnRNP methyltransferase-like 3; protein arginine N-methyltransferase 4; heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 4;
RRH
retinal pigment epithelium-derived rhodopsin homolog
RRH; retinal pigment epithelium-derived rhodopsin homolog; visual pigment-like receptor peropsin; peropsin;
PDGFRL
platelet-derived growth factor receptor-like
PDGFRL; platelet-derived growth factor receptor-like; platelet-derived growth factor receptor-like protein; PRLTS; PDGFR-like protein; PDGF receptor beta-like tumor suppressor; platelet-derived growth factor-beta-like tumor suppressor; PDGRL;
PIGK
phosphatidylinositol glycan anchor biosynthesis, class K
PIGK; phosphatidylinositol glycan anchor biosynthesis, class K; phosphatidylinositol glycan, class K; GPI-anchor transamidase; GPI transamidase subunit; GPI8; hGPI8; PIG-K; GPI8 homolog; phosphatidylinositol-glycan biosynthesis class K protein; MGC22559;
PIGN
phosphatidylinositol glycan anchor biosynthesis, class N
PIGN; phosphatidylinositol glycan anchor biosynthesis, class N; phosphatidylinositol glycan, class N; GPI ethanolamine phosphate transferase 1; MDC4; PIG N; MCD4 homolog; phosphatidylinositol-glycan biosynthesis class N protein; MCD4; MCAHS; PIG-N; MCAHS1;
PUS10
pseudouridylate synthase 10
PUS10; pseudouridylate synthase 10; CCDC139, coiled coil domain containing 139; putative tRNA pseudouridine synthase Pus10; FLJ32312; CCDC139; Coiled coil domain containing protein 139; DOBI; MGC126729; tRNA pseudouridine 55 synthase; tRNA uridine isomerase; psi55 synthase; tRNA-uridine isomerase; pseudouridine synthase 10; tRNA pseudouridylate synthase; coiled-coil domain containing 139; coiled-coil domain-containing protein 139;
PUS3
pseudouridylate synthase 3
PUS3; pseudouridylate synthase 3; tRNA pseudouridine synthase 3; FKSG32; PUS3_HUMAN; tRNA pseudouridylate synthase 3; tRNA-uridine isomerase 3; 2610020J05Rik;
PUS7L
pseudouridylate synthase 7 homolog (S. cerevisiae)-like
PUS7L; pseudouridylate synthase 7 homolog (S. cerevisiae)-like; pseudouridylate synthase 7 homolog-like protein; DKFZP434G1415; DKFZp781B2386; FLJ34711; FLJ40012; Pseudouridylate synthase 7 homolog;
PUSL1
pseudouridylate synthase-like 1
PUSL1; pseudouridylate synthase-like 1; tRNA pseudouridine synthase-like 1; FLJ90811; tRNA-uridine isomerase-like 1; tRNA pseudouridylate synthase-like 1;
PIGA
phosphatidylinositol glycan anchor biosynthesis, class A
PIGA; phosphatidylinositol glycan anchor biosynthesis, class A; GPI3; PIG-A; MCAHS2; phosphatidylinositol N-acetylglucosaminyltransferase subunit A; GPI anchor biosynthesis; GLCNAC-PI synthesis protein; class A GlcNAc-inositol phospholipid assembly protein; phosphatidylinositol-glycan biosynthesis, class A protein;
recA
DNA strand exchange and recombination protein with protease and nuclease activity
recA; DNA strand exchange and recombination protein with protease and nuclease activity; lexB; Protein recA; RecA protein; RecA1; RecA2; recaLP; recH; Recombinase A; DNA strand exchange and renaturation, DNA-dependent ATPase, DNA- and ATP-dependent coprotease; ECK2694; JW2669; rnmB; srf; tif; umuB; umuR; zab;
PFAS
phosphoribosylformylglycinamidine synthase
PFAS; phosphoribosylformylglycinamidine synthase; FGAR amidotransferase; FGARAT; KIAA0361; PURL; FGAM synthase; formylglycinamide ribotide synthetase; formylglycinamide ribotide amidotransferase; FGAMS;
PGS1
phosphatidylglycerophosphate synthase 1
PGS1; phosphatidylglycerophosphate synthase 1; CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial; DKFZP762M186; HCG1642326, isoform CRA_b; PGS1 protein Fragment; PGP synthase 1;
PLEKHF2
pleckstrin homology domain containing, family F (with FYVE domain) member 2
PLEKHF2; pleckstrin homology domain containing, family F (with FYVE domain) member 2; pleckstrin homology domain-containing family F member 2; FLJ13187; PHAFIN2; ZFYVE18; PH and FYVE domain containing protein 2; PH domain containing family F member 2; Phafin 2; Zinc finger FYVE domain containing protein 18; PH domain-containing family F member 2; PH and FYVE domain-containing protein 2; zinc finger FYVE domain-containing protein 18;
F2RL2
coagulation factor II (thrombin) receptor-like 2
F2RL2; coagulation factor II (thrombin) receptor-like 2; PAR3; PAR-3; proteinase-activated receptor 3; thrombin receptor-like 2; protease-activated receptor 3; proteinase-activated receptor-3; Coagulation factor II receptor-like 2 (protease-actovated receptor 3);
PIGX
phosphatidylinositol glycan anchor biosynthesis, class X
PIGX; phosphatidylinositol glycan anchor biosynthesis, class X; phosphatidylinositol glycan, class X; phosphatidylinositol-glycan biosynthesis class X protein; FLJ20522; PIG-X; GPI-mannosyltransferase subunit;
PIGY
phosphatidylinositol glycan anchor biosynthesis, class Y
PIGY; phosphatidylinositol glycan anchor biosynthesis, class Y; phosphatidylinositol glycan, class Y; protein preY, mitochondrial; MGC14156; phosphatidylinositol-glycan biosynthesis class Y protein; phosphatidylinositol N-acetylglucosaminyltransferase sub;
PLEKHG2
pleckstrin homology domain containing, family G (with RhoGef domain) member 2
PLEKHG2; pleckstrin homology domain containing, family G (with RhoGef domain) member 2; pleckstrin homology domain-containing family G member 2; ARHGEF42; CLG; FLJ00018; FLJ22458; Pleckstrin homology domain containing family G member 2; PH domain-containing family G member 2; common-site lymphoma/leukemia guanine nucleotide exchange factor;
PLEKHG3
pleckstrin homology domain containing, family G (with RhoGef domain) member 3
PLEKHG3; pleckstrin homology domain containing, family G (with RhoGef domain) member 3; KIAA0599; pleckstrin homology domain-containing family G member 3; ARHGEF43; BC030417; MGC156299; MGC156300; MGC40768; PH domain-containing family G member 3; PKHG3_HUMAN; Pleckstrin homology domain containing family G (with RhoGef domain) member 3; RGD1308089; pleckstrin homology domain containing, family G, member 3;
PLEKHG4
pleckstrin homology domain containing, family G (with RhoGef domain) member 4
PLEKHG4; pleckstrin homology domain containing, family G (with RhoGef domain) member 4; SCA4, spinocerebellar ataxia 4; puratrophin-1; ARHGEF44; DKFZP434I216; puratrophin 1; Pleckstrin homology domain containing family G (with RhoGef domain) member 4; Pleckstrin homology domain containing family G member 4; PLEKHG 4; PRTPHN 1; PRTPHN1; Puratrophin1; Purkinje cell atrophy associated protein 1; SCA 4; SCA4; PH domain-containing family G member 4; Purkinje cell atrophy-associated protein 1; pleckstrin homology domain-containing family G member 4;
POGZ
pogo transposable element with ZNF domain
POGZ; pogo transposable element with ZNF domain; KIAA0461; putative protein product of Nbla00003; SUHW5; suppressor of hairy wing homolog 5; zinc finger protein 280E; ZNF280E; ZNF635m; MGC71543; POGZ_HUMAN; suppressor of hairy wing homolog; Zinc finger protein 635; ZNF635;
PSTPIP2
proline-serine-threonine phosphatase interacting protein 2
PSTPIP2; proline-serine-threonine phosphatase interacting protein 2; proline-serine-threonine phosphatase-interacting protein 2; Macrophage actin associated tyrosine phosphorylated protein; Macrophage actin-associated tyrosine-phosphorylated protein; MAYP; Proline serine threonine phosphatase interacting protein 2; OTTHUMP00000202182; OTTHUMP00000202254; PEST phosphatase-interacting protein 2;
RALY
RNA binding protein, autoantigenic (hnRNP-associated with lethal yellow homolog (mouse))
RALY; RNA binding protein, autoantigenic (hnRNP-associated with lethal yellow homolog (mouse)); RNA binding protein (autoantigenic, hnRNP associated with lethal yellow); RNA-binding protein Raly; HNRPCL2; P542; Autoantigen p542; Heterogeneous nuclear ribonucleoprotein C-like 2; hnRNP associated with lethal yellow protein homolog; hnRNP core protein C-like 2; MGC117312; RALY_HUMAN; RNA binding protein (autoantigenic hnRNP associated with lethal yellow); RNA binding protein (autoantigenic); RNA binding protein autoantigenic (hnRNP associated with lethal yellow homolog (mouse)); RNA-binding protein (autoantigenic); RNA-binding protein (autoantigenic, hnRNP-associated with lethal yellow);
PPT2
palmitoyl-protein thioesterase 2
PPT2; palmitoyl-protein thioesterase 2; lysosomal thioesterase PPT2; C6orf8; Palmitoyl protein hydrolase 2; Palmitoyl protein thioesterase 2; PPT 2; S thioesterase G14; VE statin2; VE-statin2; S-thioesterase G14; palmitoyl-protein hydrolase 2; G14; PPT-2;
eba-165
erythrocyte binding antigen-165
eba-165; erythrocyte binding antigen-165; erythrocyte binding antigen putative;
RSAD1
radical S-adenosyl methionine domain containing 1
RSAD1; radical S-adenosyl methionine domain containing 1; radical S-adenosyl methionine domain-containing protein 1, mitochondrial; FLJ11164; oxygen-independent coproporphyrinogen-III oxidase-like protein RSAD1; FLJ20975;
RG9MTD2
RNA (guanine-9-) methyltransferase domain containing 2
RG9MTD2; RNA (guanine-9-) methyltransferase domain containing 2; RNA (guanine-9-)-methyltransferase domain-containing protein 2; MGC27034; TRM10; RNA (guanine-9-)methyltransferase domain containing protein 2; FLJ20325; RG9MTD 2;
RG9MTD3
RNA (guanine-9-) methyltransferase domain containing 3
RG9MTD3; RNA (guanine-9-) methyltransferase domain containing 3; RNA (guanine-9-)-methyltransferase domain-containing protein 3; bA3J10.9; FLJ31455; EC 2.1.1; OTTHUMP00000021393; RG9D3; RNA (guanine 9 ) methyltransferase domain containing 3; RP11 3J10.9; RP11-3J10.9;
scpA
hypothetical protein scpA
scpA; hypothetical protein; sspB2; sspP; Staphopain A; Staphylococcal cysteine proteinase A; Staphylopain A; identified by similarity to EGAD:14314; match to protein family HMM PF02616;
PROCA1
protein interacting with cyclin A1
PROCA1; protein interacting with cyclin A1; protein PROCA1; MGC39650; proline rich cyclin A1 interacting protein; 4933404M19Rik; MGC116192; proline-rich cyclin A1-interacting protein; RP23-185A18.6;
PRSS16
protease, serine, 16 (thymus)
PRSS16; protease, serine, 16 (thymus); thymus-specific serine protease; TSSP; serine protease 16; thymus specific serine peptidase; FLJ36271; FLJ40714; FLJ44172;
PTDSS1
phosphatidylserine synthase 1
PTDSS1; phosphatidylserine synthase 1; KIAA0024; PSS1; PSSA; PtdSer synthase 1; Serine exchange enzyme I; PSS-1; serine-exchange enzyme I;
PTDSS2
phosphatidylserine synthase 2
PTDSS2; phosphatidylserine synthase 2; PSS2; PSS-2; ptdSer synthase 2; serine-exchange enzyme II; FLJ46373;
RALGPS1
Ral GEF with PH domain and SH3 binding motif 1
RALGPS1; Ral GEF with PH domain and SH3 binding motif 1; ras-specific guanine nucleotide-releasing factor RalGPS1; KIAA0351; RALGEF2; RALGPS1A; RalA exchange factor RalGPS1; Ras specific guanine nucleotide releasing factor RalGPS1; RalGEF 2; ral guanine nucleotide exchange factor 2; ral GEF with PH domain and SH3-binding motif 1; Ral guanine nucleotide exchange factor RalGPS1A; RP13-225O21.1;
RPH3AL
rabphilin 3A-like (without C2 domains)
RPH3AL; rabphilin 3A-like (without C2 domains); rab effector Noc2; Noc2; no C2 domains protein;
RPUSD2
RNA pseudouridylate synthase domain containing 2
RPUSD2; RNA pseudouridylate synthase domain containing 2; C15orf19, chromosome 15 open reading frame 19; RNA pseudouridylate synthase domain-containing protein 2; C18B11; FLJ31409; C15orf19; C18B11 homolog; RNA pseudouridylate synthase domain containing protein 2; RPUSD 2; C18B11 homolog (44.9kD);
RPUSD3
RNA pseudouridylate synthase domain containing 3
RPUSD3; RNA pseudouridylate synthase domain containing 3; RNA pseudouridylate synthase domain-containing protein 3; MGC29784; RPUSD 3; FLJ34707;
RIBC1
RIB43A domain with coiled-coils 1
RIBC1; RIB43A domain with coiled-coils 1; RIB43A-like with coiled-coils protein 1; FLJ32783; 2610028I09Rik; MGC46233;
RIBC2
RIB43A domain with coiled-coils 2
RIBC2; RIB43A domain with coiled-coils 2; C22orf11, chromosome 22 open reading frame 11; RIB43A-like with coiled-coils protein 2; DKFZp566F0546; FLJ25720; C22orf11;
NIM1
serine/threonine-protein kinase NIM1
NIM1; serine/threonine-protein kinase NIM1; Hypothetical protein LOC167359; Hypothetical protein MGC42105; NIM1_HUMAN;
RG9MTD1
RNA (guanine-9-) methyltransferase domain containing 1
RG9MTD1; RNA (guanine-9-) methyltransferase domain containing 1; mitochondrial ribonuclease P protein 1; FLJ20432; MRPP1; 1300018J16Rik; D16Ertd454e; EC 2.1.1.-; HBV pre S2 trans regulated protein 2; MGC118020; MGC94708; Mitochondrial RNase P protein 1; NY REN 49 antigen; Renal carcinoma antigen NY REN 49; RNA (guanine 9) methyltransferase domain containing 1; RNA (guanine 9) methyltransferase domain containing protein 1 mitochondrial; Rnmtd1; NY-REN-49 antigen; renal carcinoma antigen NY-REN-49; HBV pre-S2 trans-regulated protein 2; RNA (guanine-9-)-methyltransferase domain-containing protein 1;
RIT1
Ras-like without CAAX 1
RIT1; Ras-like without CAAX 1; Ric (Drosophila) like, expressed in many tissues , RIT; GTP-binding protein Rit1; GTP binding protein Roc1; MGC125864; MGC125865; RIBB; Ric like; expressed in many tissues; ROC1; GTP-binding protein Roc1; ras-like without CAAX protein 1; Ric-like, expressed in many tissues; ras-like protein expressed in many tissues; RIT;
RNMTL1
RNA methyltransferase like 1
RNMTL1; RNA methyltransferase like 1; RNA methyltransferase-like protein 1; FLJ10581; HC90; 4833420N02Rik; AI255153; Putative RNA methyltransferase; RMTL1_HUMAN; RNA methyltransferase like protein 1; RP23-147P4.7;
SCAPER
S-phase cyclin A-associated protein in the ER
SCAPER; S-phase cyclin A-associated protein in the ER; zinc finger protein 291 , ZNF291; S phase cyclin A-associated protein in the endoplasmic reticulum; Zfp291; FLJ31533; FLJ31953; FLJ46212; KIAA1454; MSTP063; S phase cyclin A-associated protein in the ER; SCAPE_HUMAN; Zinc finger protein 291; ZNF291;
SPECC1L
sperm antigen with calponin homology and coiled-coil domains 1-like
SPECC1L; sperm antigen with calponin homology and coiled-coil domains 1-like; SPECC1 like; cytospin-A; cytokinesis and spindle organization A; cytospin A; CYTSA; KIAA0376; CYTSA_HUMAN; Renal carcinoma antigen NY-REN-22; SPECC1-like protein; OBLFC1;
SPTBN5
spectrin, beta, non-erythrocytic 5
SPTBN5; spectrin, beta, non-erythrocytic 5; spectrin beta chain, brain 4; beta V spectrin; BSPECV; HUBSPECV; HUSPECV; brain 4; non-erythroid beta chain 4; Beta-V spectrin; Spectrin; Spectrin beta chain; Spectrin, non-erythroid beta chain 4; SPTBN4; SPTN5_HUMAN;
STYXL1
serine/threonine/tyrosine interacting-like 1
STYXL1; serine/threonine/tyrosine interacting-like 1; dual specificity phosphatase 24 (putative) , DUSP24; serine/threonine/tyrosine-interacting-like protein 1; MK STYX; Dual specificity phosphatase inhibitor MK STYX; Dual specificity protein phosphatase 24; DUSP24; Map kinase phosphatase like protein MK STYX; MKSTYX; Serine/threonine/tyrosine interacting like protein 1; dual specificity phosphatase 24 (putative); map kinase phosphatase-like protein MK-STYX; dual specificity phosphatase inhibitor MK-STYX; MK-STYX;
SMCR7
Smith-Magenis syndrome chromosome region, candidate 7
SMCR7; Smith-Magenis syndrome chromosome region, candidate 7; mitochondrial dynamic protein MID49; MGC23130; MiD49; mitochondrial dynamic protein of 49 kDa; Smith-Magenis syndrome chromosomal region candidate gene 7 protein;
sars3b
hypothetical protein sars3b
sars3b; hypothetical protein sars3b; 3b; 3b protein; Hypothetical protein X2; Orf3b; ORF4;
SARS2
seryl-tRNA synthetase 2, mitochondrial
SARS2; seryl-tRNA synthetase 2, mitochondrial; SARSM, serine tRNA ligase, mitochondrial , seryl tRNA synthetase 2; seryl-tRNA synthetase, mitochondrial; FLJ20450; mtSerRS; SARS; serine tRNA ligase 2; mitochondrial; SerRSmt; SERS; SYS; SARSM; Serine tRNA ligase; Serine--tRNA ligase; SerRS; Seryl tRNA synthetase 2; Seryl-tRNA synthetase; Seryl-tRNA(Ser/Sec) synthetase; SYSM_HUMAN; serine-tRNA ligase, mitochondrial; mitochondrial seryl-tRNA synthetase; serine tRNA ligase 2, mitochondrial;
TBXA2R
thromboxane A2 receptor
TBXA2R; thromboxane A2 receptor; Prostanoid TP receptor; TP receptor; TXA2 R; TXA2R; TXA2-R; BDPLT13;
SLC25A19
solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19
SLC25A19; solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19; mitochondrial thiamine pyrophosphate carrier; solute carrier family 25 member 19; solute carrier family 25 (mitochondrial deoxynucleotide carrier), member 19; DN;
THNSL2
threonine synthase-like 2
THNSL2; threonine synthase-like 2 (S. cerevisiae); threonine synthase-like 2; FLJ10916; secreted osteoclastogenic factor of activated T cells; secreted osteoclastogenic factor of activated T-cells; THS2; TSH2; SOFAT; FLJ35504;
SMTNL2
smoothelin-like 2
SMTNL2; smoothelin-like 2; smoothelin-like protein 2; FLJ42461; MGC131847; MGC138382;
NAPB
N-ethylmaleimide-sensitive factor attachment protein, beta
NAPB; N-ethylmaleimide-sensitive factor attachment protein, beta; beta-soluble NSF attachment protein; SNAP BETA; SNAPB; Beta soluble NSF attachment protein; N ethylmaleimide sensitive factor attachment protein beta; SNAP-BETA;
TARSL2
threonyl-tRNA synthetase-like 2
TARSL2; threonyl-tRNA synthetase-like 2; probable threonyl-tRNA synthetase 2, cytoplasmic; FLJ25005; Threonine tRNA ligase; threonyl tRNA synthetase like 2; Threonyl-tRNA synthetase-like protein 2; ThrRS; OTTHUMP00000194834; threonine--tRNA ligase;
SPICT
spichthyin
SPICT; spichthyin; CG12292 gene product from transcript CG12292-RA; GM13388p; CG12292-PA; spict-PA; CG12292; Dmel\CG12292; spg6;
THEG
Theg homolog (mouse)
THEG; Theg homolog (mouse); testicular haploid expressed gene protein; cancer/testis antigen 56; CT56; MGC26138; THEG_HUMAN; testis-specific;
THEMIS
thymocyte selection associated
THEMIS; thymocyte selection associated; protein THEMIS; C6orf190; C6orf207; MGC163388; THMS1_HUMAN; Thymocyte expressed molecule involved in selection; Thymocyte selection pathway associated; Thymocyte-expressed molecule involved in selection; TSEPA; protein thylex; grb2-associating protein; thymus lymphocyte exclusively expressed; Gasp; thylex; BB160712; A430108D01; E430004N04Rik;
TET2
tet methylcytosine dioxygenase 2
TET2; tet methylcytosine dioxygenase 2; KIAA1546 , tet oncogene family member 2; methylcytosine dioxygenase TET2; FLJ20032; tet oncogene family member 2; probable methylcytosine dioxygenase TET2; MDS; KIAA1546; MGC125715;
STK11IP
serine/threonine kinase 11 interacting protein
STK11IP; serine/threonine kinase 11 interacting protein; serine/threonine-protein kinase 11-interacting protein; KIAA1898; LIP1; LKB1 interacting protein; LKB1IP; STK11IP1; LKB1 interacting protein 1; LKB1-interacting protein 1; S11IP_HUMAN; STK11 interacting protein; serine/threonine kinase 11-interacting protein;
YTHDF1
YTH domain family, member 1
YTHDF1; YTH domain family, member 1; C20orf21, YTH domain family 1; YTH domain family protein 1; FLJ20391; C20orf21; DACA 1; Dermatomyositis associated with cancer putative autoantigen 1; YTH domain family 1; YTH domain family member 1; DACA-1;
YTHDF2
YTH domain family, member 2
YTHDF2; YTH domain family, member 2; YTH domain family 2; YTH domain family protein 2; HGRG8; NY REN 2; 9430020E02Rik; CLL associated antigen KW 14; High glucose regulated protein 8; Renal carcinoma antigen NY REN 2; YTH domain family member 2; YTHDF 2; CLL-associated antigen KW-14; high-glucose-regulated protein 8; renal carcinoma antigen NY-REN-2; NY-REN-2;
YTHDF3
YTH domain family, member 3
YTHDF3; YTH domain family, member 3; YTH domain family 3; YTH domain family protein 3; FLJ31657; YTH domain family member 3; YTHDF 3;
TPK1
thiamin pyrophosphokinase 1
TPK1; thiamin pyrophosphokinase 1; HTPK1; placental protein 20; PP20; thiamine diphosphokinase; thiamine kinase; thiamine pyrophosphokinase 1; OTTHUMP00000202345; OTTHUMP00000202346; OTTHUMP00000241315;
TMSB15B
thymosin beta 15B
TMSB15B; thymosin beta 15B; thymosin beta-15B; MGC39900; NB thymosin beta; Thymosin like protein 8; Tmsb; TMSL8; TMSNB; Tbeta15b;
TMSB15A
thymosin beta 15a
TMSB15A; thymosin beta 15a; thymosin like 8 , TMSL8; thymosin beta-15A; TMSNB; NB thymosin beta; Thymosin beta identified in neuroblastoma cells; thymosin-like 8; Thymosin-like protein 8; TMSL8; Thymosin beta-15B; thymosin, beta, identified in neuroblastoma cells; Tb15; TbNB; TMSB15; TMSB15B;
THRAP3
thyroid hormone receptor associated protein 3
THRAP3; thyroid hormone receptor associated protein 3; thyroid hormone receptor-associated protein 3; TRAP150; thyroid hormone receptor-associated protein, 150 kDa subunit; thyroid hormone receptor-associated protein complex 150 kDa component; FLJ22082; M;
TEF
thyrotroph embryonic factor
TEF; thyrotroph embryonic factor; 2310028D20Rik; fb11h02; MGC64507; tefa; tefb; tefbeta; VBP; Vitellogenin gene binding protein; wu:fa12f02; wu:fb11h02; zTEF[a]; OTTMUSP00000049164; OTTMUSP00000049165; thyrotrophic embryonic factor;
STN7
serine/threonine-protein kinase SNT7
STN7; serine/threonine-protein kinase SNT7; SNT7; Stt7 homolog; STT7 HOMOLOG STN7; STT7 homolog STN7 (STN7); FUNCTIONS IN: protein kinase activity, kinase activity; INVOLVED IN: regulation of photosynthesis, light reaction, circadian rhythm; LOCATED IN: chloroplast; EXPRESSED IN: 25 plant structures; EXPRESSED DURING: 15 growth stages; CONTAINS InterPro DOMAIN/s: Protein kinase, ATP binding site (InterPro:IPR017441), Protein kinase, catalytic domain (InterPro:IPR000719), Serine/threonine-protein kinase-like domain (InterPro:IPR017442), Protein kinase-like domain (InterPro:IPR011009), Serine/threonine-protein kinase, active site (InterPro:IPR008271); BEST Arabidopsis thaliana protein match is: cyclin-dependent kinase B1; 2 (TAIR:AT2G38620.2); Has 29571 Blast hits to 29413 proteins in 1565 species: Archae - 57; Bacteria - 3753; Metazoa - 11524; Fungi - 3757; Plants - 4496; Viruses - 50; Other Eukaryotes - 5934 (source: NCBI BLink).; T6L1.2; T6L1_2;
STK35
serine/threonine kinase 35
STK35; serine/threonine kinase 35; serine/threonine-protein kinase 35; bA550O8.2; CLIK1; CLP 36 interacting kinase; CLIK-1; CLP-36 interacting kinase; CLP-36-interacting kinase 1; PDLIM1-interacting kinase 1; serine threonine kinase 35 long form; serine/t;
STK36
serine/threonine kinase 36
STK36; serine/threonine kinase 36; serine/threonine kinase 36 (fused homolog, Drosophila); serine/threonine-protein kinase 36; FU; fused homolog (Drosophila); KIAA1278; Fused homolog; Serine/threonine kinase 36, fused homolog; OTTHUMP00000164096; OTTHUMP00000164097; OTTHUMP00000206456;
STYX
serine/threonine/tyrosine interacting protein
STYX; serine/threonine/tyrosine interacting protein; serine/threonine/tyrosine-interacting protein; Protein tyrosine phosphatase like protein; protein tyrosine phosphatase-like protein;
TBRG1
transforming growth factor beta regulator 1
TBRG1; transforming growth factor beta regulator 1; FLJ14621; NIAM; nuclear interactor of ARF and MDM2; TB 5; TB-5;
YARS2
tyrosyl-tRNA synthetase 2, mitochondrial
YARS2; tyrosyl-tRNA synthetase 2, mitochondrial; tyrosyl-tRNA synthetase, mitochondrial; CGI 04; FLJ13995; mt TyrRS; tyrosine tRNA ligase 2; mitochondrial; Tyrosine tRNA ligase; Tyrosyl tRNA synthetase 2, mitochondrial; TYRRS; YARS 2; tyrosine tRNA ligase 2, mitochondrial; CGI-04; MLASA2; MT-TYRRS;
TMX4
thioredoxin-related transmembrane protein 4
TMX4; thioredoxin-related transmembrane protein 4; thioredoxin domain containing 13 , TXNDC13; DJ971N18.2; KIAA1162; PDIA14; protein disulfide isomerase family A; member 14; thioredoxin domain containing 13; thioredoxin domain-containing protein 13; prote;
PTH2
Parathyroid Hormone 2
PTH2; parathyroid hormone 2; TIP39; tuberoinfundibular peptide of 39 residues; tuberoinfundibular 39 residues; tuberoinfundibular 39 residue protein; TIPF39; TIP 39;
TBC1D9
TBC1 domain family, member 9 (with GRAM domain)
TBC1D9; TBC1 domain family, member 9 (with GRAM domain); TBC1 domain family, member 9; TBC1 domain family member 9; KIAA0882; MDR1; TBC1 domain family member 9A;
TDH
L-threonine dehydrogenase
TDH; L-threonine dehydrogenase; L-threonine 3-dehydrogenase, mitochondrial; Inactive L threonine 3 dehydrogenase mitochondrial; FLJ25033; L threonine dehydrogenase; SDR14E1P;
TIFA
TRAF-interacting protein with forkhead-associated domain
TIFA; TRAF-interacting protein with forkhead-associated domain; TRAF-interacting protein with FHA domain-containing protein A; MGC20791; T2BP; T6BP; TIFAA; TRAF2 binding protein; TRAF6 binding protein; TRAF2-binding protein; putative MAPK-activating prote;
THAP10
THAP domain containing 10
THAP10; THAP domain containing 10; THAP domain-containing protein 10; THA10_HUMAN; THAP 10;
THAP3
THAP domain containing, apoptosis associated protein 3
THAP3; THAP domain containing, apoptosis associated protein 3; THAP domain-containing protein 3; 2010013E08Rik; snoRNA MBI 15; 2210418H06Rik; MGC33488; OTTMUSP00000011101; RGD1308109; RP23-460D14.4;
THAP5
THAP domain containing 5
THAP5; THAP domain containing 5; THAP domain-containing protein 5; DKFZp313O1132;
THAP6
THAP domain containing 6
THAP6; THAP domain containing 6; THAP domain-containing protein 6; MGC30052;
THAP8
THAP domain containing 8
THAP8; THAP domain containing 8; THAP domain-containing protein 8; FLJ32891;
THOC7
THO complex 7 homolog
THOC7; THO complex 7 homolog (Drosophila); THO complex subunit 7 homolog; FLJ23445; fSAP24; functional spliceosome associated protein 24; Ngg1 interacting factor 3 like 1 binding protein 1; NIF3L1BP1; hTREX30; NIF3L1-binding protein 1; functional spliceos;
THUMPD2
THUMP domain containing 2
THUMPD2; THUMP domain containing 2; C2orf8, chromosome 2 open reading frame 8; THUMP domain-containing protein 2; MGC2454; 2810025A12Rik; C2orf8; CHROMOSOME 2 OPEN READING FRAME 8; MGC108999; SAM dependent methyltransferase; SAM-dependent methyltransferase;
THUMPD3
THUMP domain containing 3
THUMPD3; THUMP domain containing 3; THUMP domain-containing protein 3; DKFZP434F091; THUM3_HUMAN;
TRIP12
thyroid hormone receptor interactor 12
TRIP12; thyroid hormone receptor interactor 12; probable E3 ubiquitin-protein ligase TRIP12; KIAA0045; MGC138849; MGC138850; Thyroid receptor interacting protein 12; TRIP 12; TRIP-12; TR-interacting protein 12; thyroid receptor-interacting protein 12; ULF;
UACA
uveal autoantigen with coiled-coil domains and ankyrin repeats
UACA; uveal autoantigen with coiled-coil domains and ankyrin repeats; FLJ10128; KIAA1561; MGC141967; MGC141969; NUCLING; Uveal autoantigen with coiled coil domains and ankyrin repeats; nuclear membrane binding protein;
TRMT11
tRNA methyltransferase 11 homolog (S. cerevisiae)
TRMT11; tRNA methyltransferase 11 homolog (S. cerevisiae); C6orf75, chromosome 6 open reading frame 75; tRNA guanosine-2-O-methyltransferase TRM11 homolog; dJ187J11.2; MDS024; TRM11; TRMT11 1; C6orf75; chromosome 6 open reading frame 75; dJ187J11; EC 2.1.1; TRMT 11; tRNA guanosine 2 O methyltransferase TRM11; tRNA guanosine 2 O methyltransferase TRM11 homolog; tRNA methyltransferase 11 homolog; TRMT11-1;
TRMU
tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase
TRMU; tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase; TRMT, tRNA (5 methylaminomethyl 2 thiouridylate) methyltransferase; mitochondrial tRNA-specific 2-thiouridylase 1; FLJ10140; MTO2; MGC99627; Mitochondrial tRNA specific 2 thiouridylase 1; MTO 2; MTO2 homolog; MTU 1; MTU1; TRMT 1; TRMT; tRNA (5 methylaminomethyl 2 thiouridylate) methyltransferase; tRNA 5 methylaminomethyl 2 thiouridylate methyltransferase; TRNT 1; TRNT1; mitochondrial 5-methylaminomethyl-2-thiouridylate-methyltransferase; TRMT1;
TRMT12
tRNA methyltransferase 12 homolog (S. cerevisiae)
TRMT12; tRNA methyltransferase 12 homolog (S. cerevisiae); tRNA methyltranferase 12 homolog (S. cerevisiae); tRNA wybutosine-synthesizing protein 2 homolog; FLJ20772; Trm12; tRNA yW synthesizing protein 2; TYW2; Radical S-adenosyl methionine and flavodoxin domain-containing protein 2; TRM 12; TRMT 12; tRNA methyltransferase 12; tRNA-yW-synthesizing protein 2; TYW2_HUMAN; tRNA-yW synthesizing protein 2; tRNA methyltranferase 12 homolog; homolog of yeast tRNA methyltransferase; alpha-amino-alpha-carboxypropyl transferase TYW2;
TRMT5
TRM5 tRNA methyltransferase 5 homolog
TRMT5; TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae); KIAA1393; tRNA (guanine(37)-N1)-methyltransferase; TRM5; M1G-methyltransferase; tRNA-N1G37 methyltransferase; tRNA [GM37] methyltransferase; tRNA methyltransferase 5 homolog; tRNA (guanine-N(1);
TRMT6
tRNA methyltransferase 6 homolog (S. cerevisiae)
TRMT6; tRNA methyltransferase 6 homolog (S. cerevisiae); tRNA (adenine-N(1)-)-methyltransferase non-catalytic subunit TRM6; CGI 09; GCD10; Gcd10p; MGC5029; KIAA1153; Adenine N; CGI09; TRM6; TRM6_HUMAN; tRNA methyltransferase 6; tRNA(m1A58)-methyltransferase subunit TRM6; tRNA(m1A58)MTase subunit TRM6; CGI-09;
TRMT61B
tRNA methyltransferase 61 homolog B
TRMT61B; tRNA methyltransferase 61 homolog B (S. cerevisiae); potential tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61B; FLJ20628; potential tRNA (adenine-N(1)-)-methyltransferase catalytic subunit TRMT61B; DKFZp564I2178;
TRUB1
TruB pseudouridine (psi) synthase homolog 1 (E. coli)
TRUB1; TruB pseudouridine (psi) synthase homolog 1 (E. coli); probable tRNA pseudouridine synthase 1; PUS4;
TRUB2
TruB pseudouridine (psi) synthase homolog 2 (E. coli)
TRUB2; TruB pseudouridine (psi) synthase homolog 2 (E. coli); probable tRNA pseudouridine synthase 2; CLONE24922; OTTHUMP00000022257; RP11 339B21.1; TRUB 2; TruB pseudouridine (psi) synthase homolog 2; RP11-339B21.1;
USMG5
up-regulated during skeletal muscle growth 5 homolog (mouse)
USMG5; up-regulated during skeletal muscle growth 5 homolog (mouse); upregulated during skeletal muscle growth 5 , upregulated during skeletal muscle growth 5 homolog (mouse); up-regulated during skeletal muscle growth protein 5; bA792D24.4; DAPIT; MGC14697; DKFZp566D211; HCV F-transactivated protein 2; HCVFTP2; Up regulated during skeletal muscle growth 5 homolog (mouse); USMG5_HUMAN; upregulated during skeletal muscle growth 5 homolog;
TYW3
tRNA-yW synthesizing protein 3 homolog
TYW3; tRNA-yW synthesizing protein 3 homolog (S. cerevisiae); C1orf171, chromosome 1 open reading frame 171; tRNA wybutosine-synthesizing protein 3 homolog; FLJ40918; tRNA-yW-synthesizing protein 3; C1orf171;
AGGF1
angiogenic factor with G patch and FHA domains 1
AGGF1; angiogenic factor with G patch and FHA domains 1; FLJ10283; GPATC7; GPATCH7; HSU84971; VG5Q; angiogenic factor VG5Q; vasculogenesis gene on 5q protein; G patch domain-containing protein 7; HUS84971;
ZCWPW1
zinc finger, CW type with PWWP domain 1
ZCWPW1; zinc finger, CW type with PWWP domain 1; zinc finger CW-type PWWP domain protein 1; DKFZp434N0510; FLJ10057; ZCW1; ZCWPW 1; Zinc finger CW type PWWP domain protein 1; zinc finger CW type with PWWP domain 1; zinc finger, CW-type with PWWP domain 1;
TXNIP
thioredoxin interacting protein
TXNIP; thioredoxin interacting protein; THIF; VDUP1; HHCPA78; EST01027; thioredoxin-interacting protein; thioredoxin binding protein 2; thioredoxin-binding protein 2; vitamin D3 up-regulated protein 1; upregulated by 1,25-dihydroxyvitamin D-3;
UCMA
upper zone of growth plate and cartilage matrix associated
UCMA; upper zone of growth plate and cartilage matrix associated; C10orf49, chromosome 10 open reading frame 49; unique cartilage matrix-associated protein; AW121955; C10orf49; Grp; 1110017I16Rik; Gla rich protein; Gla-rich protein; OTTMUSP00000011599; RP23-272I15.1; Ucma-C; UCMA_HUMAN; Unique cartilage matrix associated protein; Unique cartilage matrix-associated protein C-terminal fragment;
FAM172A
family with sequence similarity 172, member A
FAM172A; family with sequence similarity 172, member A; C5orf21, chromosome 5 open reading frame 21; protein FAM172A; DKFZP564D172; C5orf21;
VTI1A
vesicle transport through interaction with t-SNAREs homolog 1A (yeast)
VTI1A; vesicle transport through interaction with t-SNAREs homolog 1A (yeast); vesicle transport through interaction with t-SNAREs homolog 1A; MVti1; Vti1 rp2; SNARE Vti1a beta protein; Vesicle transport through interaction with tSNAREs homolog 1A (yeast); SNARE Vti1a-beta protein; vesicle transport v-SNARE protein Vti1-like 2; VTI1RP2; Vti1-rp2;
VTI1B
vesicle transport through interaction with t-SNAREs homolog 1B (yeast)
VTI1B; vesicle transport through interaction with t-SNAREs homolog 1B (yeast); vesicle transport through interaction with t-SNAREs homolog 1B; VTI2; HGNC:17793; V SNARE; Vesicle associated soluble NSF attachment protein receptor; Vesicle transport through interaction with t SNAREs 1B; Vesicle transport through interaction with t SNAREs homolog 1B (yeast); Vesicle transport v-SNARE protein Vti1-like 1; VTI1; VTI1 like; Vti1 rp1; Vti1-rp1; VTI1B_HUMAN; VTI1L; VTI1L1; vesicle-associated soluble NSF attachment protein receptor; v-SNARE; VTI1-LIKE;
WAC
WW domain containing adaptor with coiled-coil
WAC; WW domain containing adaptor with coiled-coil; WW domain containing adaptor with coiled coil; WW domain-containing adapter protein with coiled-coil; BM 016; FLJ31290; MGC10753; PRO1741; Wwp4; 1110067P07Rik; BA48B24; BA48B24.1; KIAA1844; OTTHUMP00000019380; OTTHUMP00000019382; WAC_HUMAN; WW domain containing adapter protein with coiled coil; BM-016;
ZIK1
zinc finger protein interacting with K protein 1 homolog (mouse)
ZIK1; zinc finger protein interacting with K protein 1 homolog (mouse); zinc finger protein interacting with ribonucleoprotein K; ZNF762; ZIK1_HUMAN; Zinc finger protein 762; Zinc finger protein interacting with K protein 1;
ZGPAT
zinc finger, CCCH-type with G patch domain
ZGPAT; zinc finger, CCCH-type with G patch domain; KIAA1847; zinc finger CCCH-type with G patch domain-containing protein; dJ583P15.3; FLJ14972; GPATC6; GPATCH6; MGC44880; ZC3H9; ZC3HDC9; ZIP; g patch domain-containing protein 6; zinc finger CCCH domain-c;
ZCWPW2
zinc finger, CW type with PWWP domain 2
ZCWPW2; zinc finger, CW type with PWWP domain 2; zinc finger CW-type PWWP domain protein 2; ZCW2;
ZKSCAN2
zinc finger with KRAB and SCAN domains 2
ZKSCAN2; zinc finger with KRAB and SCAN domains 2; zinc finger protein 694 , ZNF694; zinc finger protein with KRAB and SCAN domains 2; FLJ23199; Zinc finger protein 694; ZKSC2_HUMAN; zinc finger and SCAN domain containing 31; ZNF694; ZSCAN31;
ZKSCAN14
zinc finger with KRAB and SCAN domains 14
ZKSCAN14; zinc finger with KRAB and SCAN domains 14; zinc finger protein 394; Zinc finger protein with KRAB and SCAN domains 14; ZN394_HUMAN; Znf394; zfp-94; zinc finger protein 94; zinc finger protein 99; Zfp99; 2310046C23Rik; 2810437E14Rik;
ZUFSP
zinc finger with UFM1-specific peptidase domain
ZUFSP; zinc finger with UFM1-specific peptidase domain; C6orf113, chromosome 6 open reading frame 113; zinc finger with UFM1-specific peptidase domain protein; dJ412I7.3; C6orf113; Chromosome 6 open reading frame 113; RP3-412I7.3; Zinc finger with UFM1 specific peptidase domain; Zinc finger with UFM1 specific peptidase domain protein; ZUFSP_HUMAN;
W02A11.3
hypothetical protein W02A11.3
W02A11.3; hypothetical protein; Hypothetical protein W02A11.3; ring finger protein (54.9 kD);
FAM134C
family with sequence similarity 134, member C
FAM134C; family with sequence similarity 134, member C; protein FAM134C; DKFZp686B1036; FLJ33806;
FAM76B
family with sequence similarity 76, member B
FAM76B; family with sequence similarity 76, member B; protein FAM76B; MGC33371; Family with sequence similarity 76 member B; Hypothetical protein LOC143684;
FAM81A
family with sequence similarity 81, member A
FAM81A; family with sequence similarity 81, member A; protein FAM81A; MGC26690; Hypothetical protein LOC145773 2;
BMPER
BMP binding endothelial regulator
BMPER; BMP binding endothelial regulator; BMP-binding endothelial regulator protein; CRIM3; crossveinless 2; Cv2; hCV2; crossveinless-2; BMP-binding endothelial regulator precursor protein; bone morphogenetic protein-binding endothelial cell precursor-der;
FAM131C
family with sequence similarity 131, member C
FAM131C; family with sequence similarity 131, member C; C1orf117, chromosome 1 open reading frame 117; protein FAM131C; FLJ36766; C1orf117; F131C_HUMAN; Gm693; RP11-5P18.9;
AGAP3
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3
AGAP3; ArfGAP with GTPase domain, ankyrin repeat and PH domain 3; centaurin, gamma 3 , CENTG3; arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3; ANK repeat and PH domain-containing protein 3; AGAP-3; AGAP3_HUMAN; Arf GAP with GTPase, ANK repeat and PH domain containing protein 3; Arf-GAP with GTPase; ArfGAP with GTPase domain, ankyrin repeat and PH domain; centaurin gamma 3; Centaurin-gamma-3; CENTG3; Cnt-g3; CRAG; CRAM-associated GTPase; CRMP (collapsin response mediator protein) associated; FLJ16146; FLJ34452; MR1-interacting protein; MRIP-1; MRIP1; OTTHUMP00000213333; OTTHUMP00000213334; OTTHUMP00000213335; OTTHUMP00000213336; OTTHUMP00000213337; centaurin, gamma 3;
FAM116A
family with sequence similarity 116, member A
FAM116A; family with sequence similarity 116, member A; protein FAM116A; FLJ34969; Family with sequence similarity 116 member A;
FAM19A3
family with sequence similarity 19 (chemokine (C-C motif)-like), member A3
FAM19A3; family with sequence similarity 19 (chemokine (C-C motif)-like), member A3; protein FAM19A3; TAFA 3; Chemokine like protein TAFA3; Family with sequence similarity 19 (chemokine (C C motif) like) member A3; TAFA3; chemokine-like protein TAFA-3; TAFA-3;
ZK1251.1
hypothetical protein ZK1251.1
ZK1251.1; hypothetical protein; H2a 615; H2A; H2A GL101; H2A histone family member A; H2A.1; H2A.2; H2A/a; H2A/m; H2A/O; H2A/q; H2A1B_HUMAN; H2AFA; H2AFE; H2AFL; H2AFM; H2AFO; H2AFQ; HIST1H2AE; HIST1H2AJ; HIST2H2AA; HIST2H2AA3; HIST2H2AB; HIST2H2AC; Histone 1 H2ae; Histone 2 H2aa3; Histone 2 H2ab; Histone 2 H2ac; Histone H2A type 1 B; Histone H2A type 1 C; Histone H2A type 1 E; Histone H2A type 1 J; Histone H2A type 1-B/E; Histone H2A.2; Histone H2A/a; Histone H2A/m; MGC74460;
FSIP1
fibrous sheath interacting protein 1
FSIP1; fibrous sheath interacting protein 1; fibrous sheath-interacting protein 1; FLJ35989; HSD10;
FAM76A
family with sequence similarity 76, member A
FAM76A; family with sequence similarity 76, member A; protein FAM76A; MGC34648; RP3-426I6.1; FLJ41946;
EPB41L4B
erythrocyte membrane protein band 4.1 like 4B
EPB41L4B; erythrocyte membrane protein band 4.1 like 4B; band 4.1-like protein 4B; EHM2; FERM-containing protein CG1; CG1; FLJ21596; DKFZp761N1814;
FAM59B
family with sequence similarity 59, member B
FAM59B; family with sequence similarity 59, member B; protein FAM59B; FLJ00375; KIAA2038; FA59B_HUMAN; FAM 59B; Family with sequence similarity 59 member B; HRIHFB2063;
GRB14
growth factor receptor-bound protein 14
GRB14; growth factor receptor-bound protein 14; GRB14 adapter protein; Growth factor receptorbound protein 14;
KLB
klotho beta
KLB; klotho beta; beta-klotho; betaKlotho; klotho beta like; klotho beta-like protein; BKL; MGC142213;
MSL3
male-specific lethal 3 homolog (Drosophila)
MSL3; male-specific lethal 3 homolog (Drosophila); MSL3L1; male-specific lethal 3 homolog; MSL3-like 1; male-specific lethal-3 protein-like 1;
NAPEPLD
Napepld N-acyl phosphatidylethanolamine phospholipase D
NAPEPLD; N-acyl phosphatidylethanolamine phospholipase D; N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D; NAPE-hydrolyzing phospholipase D; Metallo-beta-lactamase domain containing 1; Mbldc1; NAPE-PLD; A530089G06;
MLC1
megalencephalic leukoencephalopathy with subcortical cysts 1
MLC1; megalencephalic leukoencephalopathy with subcortical cysts 1; membrane protein MLC1; KIAA0027; LVM; MLC; VL;
NUS1
nuclear undecaprenyl pyrophosphate synthase 1 homolog
NUS1; nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae); C6orf68, chromosome 6 open reading frame 68; nogo-B receptor; MGC7199; NgBR; C6orf68; MGC:7199; MGC117249;
GHITM
growth hormone inducible transmembrane protein
GHITM; growth hormone inducible transmembrane protein; growth hormone-inducible transmembrane protein; DERP2; HSPC282; My021; PTD010; TMBIM5; transmembrane BAX inhibitor motif containing 5; dermal papilla-derived protein 2; mitochondrial morphology and cr;
GRIN2D
glutamate receptor, ionotropic, N-methyl D-aspartate 2D
GRIN2D; glutamate receptor, ionotropic, N-methyl D-aspartate 2D; EB11; NR2D; GluN2D; NMDAR2D; glutamate receptor ionotropic, NMDA 2D; estrogen receptor binding CpG island; N-methyl D-aspartate receptor subtype 2D; N-methyl-d-aspartate receptor subunit 2D; glutamate [NMDA] receptor subunit epsilon-4;
OTP
orthopedia homeobox
OTP; orthopedia homeobox; orthopedia homolog (Drosophila); homeobox protein orthopedia; orthopedia homolog; MGC3161;
RBPMS2
RNA binding protein with multiple splicing 2
RBPMS2; RNA binding protein with multiple splicing 2; RNA-binding protein with multiple splicing 2;
PIGW
phosphatidylinositol glycan anchor biosynthesis, class W
PIGW; phosphatidylinositol glycan anchor biosynthesis, class W; phosphatidylinositol glycan, class W; phosphatidylinositol-glycan biosynthesis class W protein; FLJ37433; Gwt1; PIG-W; PIGW_HUMAN;
PLEKHH2
pleckstrin homology domain containing, family H (with MyTH4 domain) member 2
PLEKHH2; pleckstrin homology domain containing, family H (with MyTH4 domain) member 2; pleckstrin homology domain-containing family H member 2; KIAA2028; PLEKHH1L; PKHH2_HUMAN; Pleckstrin homology domain containing family H member 2; PLEKHH2 pleckstrin homology domain containing, family H (with MyTH4 domain) member 2;
PLEKHM2
pleckstrin homology domain containing, family M (with RUN domain) member 2
PLEKHM2; pleckstrin homology domain containing, family M (with RUN domain) member 2; pleckstrin homology domain-containing family M member 2; KIAA0842; Novel RUN and PH domain containing protein; PH domain containing family M member 2; Pleckstrin homology domain containing family M (with RUN domain) member 2; Pleckstrin homology domain containing family M member 2; PLEKHM 2; RP11 169K16.1; Salmonella induced filaments A and kinesin interacting protein; SifA (Salmonella induced filaments A) and kinesin interacting protein; SifA and kinesin interacting protein; SKIP; sifA and kinesin-interacting protein; PH domain-containing family M member 2; novel RUN and PH domain-containing protein; salmonella-induced filaments A and kinesin-interacting protein; SifA (Salmonella-induced filaments A) and kinesin-interacting protein; RP11-169K16.1;
THEM4
thioesterase superfamily member 4
THEM4; thioesterase superfamily member 4; C terminal modulator protein; CTMP; C-terminal modulator protein; carboxyl-terminal modulator protein; FLJ27206; MGC29636;
KIR3DS1
killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1
KIR3DS1;killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1;killer cell immunoglobulin-like receptor 3DS1;nkat10;NKAT-10;killer Ig receptor;MHC class I NK cell receptor;natural killer-associated transcript 10;killer cell immunoglobulin-like receptor KIR3DS1;KIR-G1;NKAT10;CD158E2;KIR-123FM;MGC119726;MGC119728;MGC125316;
GDF1
growth differentiation factor 1
GDF1; growth differentiation factor 1; embryonic growth/differentiation factor 1; GDF-1; DORV; DTGA3;
PEAR1
platelet endothelial aggregation receptor 1
PEAR1; platelet endothelial aggregation receptor 1; MEGF12, multiple EGF like domains 12; FLJ00193; JEDI; hPEAR1; multiple EGF-like-domains 12; multiple EGF-like domains protein 12; multiple epidermal growth factor-like domains protein 12; MEGF12;
TDG
thymine-DNA glycosylase
TDG;thymine-DNA glycosylase;G/T mismatch-specific thymine DNA glycosylase;EC 3.2.2.29;003211;
anthrax PA
Bacillus anthracis protective antigen
anthrax PA; Anthrax Protective Antigen; Anthrax toxins translocating protein; Bacillus anthracis Protective Antigen; PA 83; PA; PA83; Pag; PagA; Protective antigen;
F2RL1
coagulation factor II (thrombin) receptor-like 1
F2RL1;coagulation factor II (thrombin) receptor-like 1;3538;ENSG00000164251;PAR2;GPR11;5q13;proteinase-activated receptor 2;proteinase-activated receptor 2;PAR-2;thrombin receptor-like 1;G protein-coupled receptor-11;G-protein coupled receptor 11;protease-activated receptor 2;proteinase-activated receptor-2;coagulation factor II receptor-like 1;
CRELD1
cysteine-rich with EGF-like domains 1
Creld1; AI843811; cysteine-rich with EGF-like domains 1; cysteine-rich with EGF-like domain protein 1; i11E7 protein;
MSRB1
methionine sulfoxide reductase B1
MSRB1;methionine sulfoxide reductase B1;14133;ENSG00000198736;SELR;SELX;SepR;SEPX1;HSPC270;16p13.3;MGC3344;methionine-R-sulfoxide reductase B1;methionine-R-sulfoxide reductase B1;selenoprotein R;selenoprotein X, 1;EC 1.8.4.-;
COMMD3-BMI1
COMMD3-BMI1 readthrough
COMMD3-BMI1;COMMD3-BMI1 readthrough;chromosome: 10;DKFZp434I153;COMMD3-BMI1 read-through protein;COMMD3-BMI1 read-through protein;
RECK
reversion-inducing-cysteine-rich protein with kazal motifs
RECK;reversion-inducing-cysteine-rich protein with kazal motifs;11345;ENSG00000122707;ST15;9p13.3;reversion-inducing cysteine-rich protein with Kazal motifs;reversion-inducing cysteine-rich protein with Kazal motifs;suppressor of tumorigenicity 15 protein;membrane-anchored glycoprotein (metastasis and invasion);suppression of tumorigenicity 5 (reversion-inducing-cysteine-rich protein with kazal motifs);suppression of tumorigenicity 15 (reversion-inducing-cysteine-rich protein with kazal motifs);
LILRB4
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
LILRB4;leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4;6608;ENSG00000186818;HM18;ILT3;LIR5;CD85K;LIR-5;LILRB5;19q13.4;leukocyte immunoglobulin-like receptor subfamily B member 4;leukocyte immunoglobulin-like receptor subfamily B member 4;ILT-3;immunoglobulin-like transcript 3;CD85 antigen-like family member K;monocyte inhibitory receptor HM18;leukocyte immunoglobulin-like receptor 5;leukocyte immunoglobulin-like receptor, subfamily B, member 4;leukocyte immunoglobulin-like receptor subfamily B member 4 soluble isoform;
NFE2L1
nuclear factor (erythroid-derived 2)-like 1
NFE2L1;nuclear factor (erythroid-derived 2)-like 1;7781;ENSG00000082641;NRF1;TCF11;LCR-F1;17q21.3;FLJ00380;nuclear factor erythroid 2-related factor 1;nuclear factor erythroid 2-related factor 1;TCF-11;NFE2-related factor 1;NF-E2-related factor 1;transcription factor HBZ17;transcription factor LCR-F1;locus control region-factor 1;nuclear factor, erythroid derived 2, like 1;transcription factor 11 (basic leucine zipper type);
DTHD1
death domain containing 1
DTHD1;death domain containing 1;37261;ENSG00000197057;4p14;FLJ16686, FLJ37365;death domain-containing protein 1;death domain-containing protein 1;
FAM188B
family with sequence similarity 188, member B
FAM188B;family with sequence similarity 188, member B;21916;ENSG00000106125;C7orf67;7p14.3;FLJ22374, FLJ51453, MGC44277;protein FAM188B;protein FAM188B;
FAM71F1
family with sequence similarity 71, member F1
FAM71F1;family with sequence similarity 71, member F1;30704;ENSG00000135248;FAM137A;NYD-SP18;7q32.1;protein FAM71F1;protein FAM71F1;testes development-related NYD-SP18;testis development protein NYD-SP18;family with sequence similarity 137, member A;
FAM73A
family with sequence similarity 73, member A
FAM73A;family with sequence similarity 73, member A;24741;ENSG00000180488;1p31.1;FLJ35093, DKFZp686M07166;protein FAM73A;protein FAM73A;
FAM82A1
family with sequence similarity 82, member A1
FAM82A1;family with sequence similarity 82, member A1;26567;ENSG00000115841;RMD2;RMD4;RMD-2;FAM82A;BLOCK18;PRO34163;PYST9371;2p22.2;FLJ32954, FLJ38143, MGC33318;regulator of microtubule dynamics protein 2;regulator of microtubule dynamics protein 2;microtubule-associated protein;family with sequence similarity 82, member A;
FAM83B
family with sequence similarity 83, member B
FAM83B;family with sequence similarity 83, member B;21357;ENSG00000168143;C6orf143;6p12.1;FLJ30642, MGC126677, MGC138480;protein FAM83B;protein FAM83B;
FAM83G
family with sequence similarity 83, member G
FAM83G;family with sequence similarity 83, member G;32554;ENSG00000188522;17p11.2;FLJ41564;protein FAM83G;protein FAM83G;
FAM96A
family with sequence similarity 96, member A
FAM96A;family with sequence similarity 96, member A;26235;ENSG00000166797;15q22.31;FLJ22875;MIP18 family protein FAM96A;MIP18 family protein FAM96A;
FAM98C
family with sequence similarity 98, member C
FAM98C;family with sequence similarity 98, member C;27119;ENSG00000130244;19q13.2;FLJ44669;protein FAM98C;protein FAM98C;
TMPPE
transmembrane protein with metallophosphoesterase domain
TMPPE;transmembrane protein with metallophosphoesterase domain;33865;ENSG00000188167;3p22.3;FLJ45032, FLJ46376;transmembrane protein with metallophosphoesterase domain;transmembrane protein with metallophosphoesterase domain;EC 3.1.-.-;
FAM110D
family with sequence similarity 110, member D
FAM110D;family with sequence similarity 110, member D;25860;ENSG00000197245;GRRP1;RP11-96L14.5;1p36.11;FLJ14050;protein FAM110D;protein FAM110D;glycine/arginine rich protein 1;glycine/arginine-rich protein 1;
HMGCLL1
3-hydroxymethyl-3-methylglutaryl-CoA lyase-like 1
HMGCLL1;3-hydroxymethyl-3-methylglutaryl-CoA lyase-like 1;21359;ENSG00000146151;bA418P12.1;6p12.1;DKFZp434G1411;probable 3-hydroxymethyl-3-methylglutaryl-CoA lyase 2;probable 3-hydroxymethyl-3-methylglutaryl-CoA lyase 2;3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase-like 1;3-hydroxymethyl-3-methylglutaryl-CoA lyase-like protein 1;EC 4.1.3.4;
FAM189A1
family with sequence similarity 189, member A1
FAM189A1;family with sequence similarity 189, member A1;29075;ENSG00000104059;TMEM228;15q13.1;FLJ61121, KIAA0574;protein FAM189A1;protein FAM189A1;transmembrane protein 228;
TESPA1
thymocyte expressed, positive selection associated 1
TESPA1;thymocyte expressed, positive selection associated 1;29109;ENSG00000135426;HSPC257;KIAA0748;12q13.2;KIAA0748;protein TESPA1;protein TESPA1;thymocyte-expressed positive selection-associated protein 1;
FAM190B
family with sequence similarity 190, member B
FAM190B;family with sequence similarity 190, member B;29197;ENSG00000107771;Gcap14;KIAA1128;bA486O22.1;10q23.1;FLJ14262, FLJ25809, KIAA1128;protein FAM190B;protein FAM190B;protein GCAP14 homolog;
FAM214A
family with sequence similarity 214, member A
FAM214A;family with sequence similarity 214, member A;25609;ENSG00000047346;KIAA1370;15q21.2-q21.3;FLJ10980, KIAA1370, MGC126494, MGC126495;protein FAM214A;protein FAM214A;
LILRB5
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5 [ Homo sap
LILRB5;leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5;6609;ENSG00000105609;LIR8;CD85C;LIR-8;19q13.4;leukocyte immunoglobulin-like receptor subfamily B member 5;leukocyte immunoglobulin-like receptor subfamily B member 5;CD85 antigen-like family member C;leukocyte immunoglobulin-like receptor 8;
LGSN
lengsin, lens protein with glutamine synthetase domain
LGSN;lengsin, lens protein with glutamine synthetase domain;21016;ENSG00000146166;LGS;GLULD1;6pter-q22.33;MGC163238, MGC163240;lengsin;lengsin;glutamate-ammonia ligase domain-containing protein 1;glutamate-ammonia ligase (glutamine synthase) domain containing 1;EC 1.4.1.3;
PRMT10
protein arginine methyltransferase 10 (putative)
PRMT10;protein arginine methyltransferase 10 (putative);25099;ENSG00000164169;4q31.23;FLJ46629;putative protein arginine N-methyltransferase 10;putative protein arginine N-methyltransferase 10;
NME1-NME2
NME1-NME2 readthrough
NME1-NME2;NME1-NME2 readthrough;33531;ENSG00000011052;NMELV;NM23-LV;17q21.3;FLJ93990;NME1-NME2 protein;NME1-NME2 protein;NME1-NME2 readthrough transcript;EC 2.7.4.6;
OGFRL1
opioid growth factor receptor-like 1
OGFRL1;opioid growth factor receptor-like 1;21378;ENSG00000119900;dJ331H24.1;6q13;FLJ21079, MGC102783;opioid growth factor receptor-like protein 1;opioid growth factor receptor-like protein 1;
PATL1
protein associated with topoisomerase II homolog 1 (yeast)
PATL1;protein associated with topoisomerase II homolog 1 (yeast);26721;ENSG00000166889;Pat1b;hPat1b;11q12.1;FLJ36874, MGC125671, MGC125672;protein PAT1 homolog 1;protein PAT1 homolog 1;PAT1-like protein 1;protein PAT1 homolog b;
PIGG
phosphatidylinositol glycan anchor biosynthesis, class G
PIGG;phosphatidylinositol glycan anchor biosynthesis, class G;25985;ENSG00000174227;GPI7;LAS21;PRO4405;RLGS1930;4p16.3;FLJ20265, FLJ39925, MGC131903, DKFZp434A1810, DKFZp434C1712, DKFZp434M1131;GPI ethanolamine phosphate transferase 2;GPI ethanolamine phosphate transferase 2;PIG-G;hGPI7;GPI7 homolog;phosphatidylinositol glycan, class G;phosphatidylinositol-glycan biosynthesis class G protein;
PLEKHG1
pleckstrin homology domain containing, family G (with RhoGef domain) member 1
PLEKHG1;pleckstrin homology domain containing, family G (with RhoGef domain) member 1;20884;ENSG00000120278;ARHGEF41;6q25.1;FLJ31738, KIAA1209;pleckstrin homology domain-containing family G member 1;pleckstrin homology domain-containing family G member 1;
PLEKHG4B
pleckstrin homology domain containing, family G (with RhoGef domain) member 4B
PLEKHG4B;pleckstrin homology domain containing, family G (with RhoGef domain) member 4B;29399;5p15.33;FLJ43173, KIAA1909;pleckstrin homology domain-containing family G member 4B;pleckstrin homology domain-containing family G member 4B;PH domain-containing family G member 4B;
RPUSD4
RNA pseudouridylate synthase domain containing 4
RPUSD4;RNA pseudouridylate synthase domain containing 4;25898;ENSG00000165526;11q24.2;FLJ14494;RNA pseudouridylate synthase domain-containing protein 4;RNA pseudouridylate synthase domain-containing protein 4;EC 5.4.99.12;
SCLT1
sodium channel and clathrin linker 1
SCLT1;sodium channel and clathrin linker 1;26406;ENSG00000151466;CAP1A;CAP-1A;hCAP-1A;4q28.2;FLJ30655, FLJ36042, MGC70542;sodium channel and clathrin linker 1;sodium channel and clathrin linker 1;sodium channel-associated protein 1;
SEMA5B
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and s
SEMA5B;sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B;10737;ENSG00000082684;SemG;SEMAG;3q21.1;FLJ10372, KIAA1445;semaphorin-5B;semaphorin-5B;
SFMBT2
Scm-like with four mbt domains 2
SFMBT2;Scm-like with four mbt domains 2;20256;ENSG00000198879;10p14;scm-like with four MBT domains protein 2;scm-like with four MBT domains protein 2;Scm-related gene containing four mbt domains 2;
SLC24A6
solute carrier family 24 (sodium/lithium/calcium exchanger), member 6
SLC24A6;solute carrier family 24 (sodium/lithium/calcium exchanger), member 6;26175;ENSG00000089060;NCLX;NCKX6;12q24.13;FLJ22233;sodium/potassium/calcium exchanger 6;sodium/potassium/calcium exchanger 6;solute carrier family 24 member 6;Na(+)/K(+)/Ca(2+)-exchange protein 6;solute carrier family 24 (sodium/potassium/calcium exchanger), member 6;
SLC4A2
solute carrier family 4, anion exchanger, member 2 (erythrocyte membrane protein band 3-like 1) [ H
SLC4A2;solute carrier family 4, anion exchanger, member 2 (erythrocyte membrane protein band 3-like 1);11028;ENSG00000164889;AE2;HKB3;BND3L;NBND3;EPB3L1;7q36.1;FLJ59028;anion exchange protein 2;anion exchange protein 2;AE 2;anion exchanger 2 type a;anion exchanger 2 type b1;anion exchanger 2 type b2;solute carrier family 4 member 2;non-erythroid band 3-like protein;
SLC25A26
solute carrier family 25 (S-adenosylmethionine carrier), member 26
SLC25A26;solute carrier family 25 (S-adenosylmethionine carrier), member 26;20661;ENSG00000144741;SAMC;3p14.1;FLJ77340, DKFZp434E079;S-adenosylmethionine mitochondrial carrier protein;S-adenosylmethionine mitochondrial carrier protein;solute carrier family 25, member 26;mitochondrial S-adenosylmethionine transporter;solute carrier family 25 (mitochondrial carrier;phosphate carrier), member 26;
SMCR8
Smith-Magenis syndrome chromosome region, candidate 8
SMCR8;Smith-Magenis syndrome chromosome region, candidate 8;17921;ENSG00000176994;17p11.2;FLJ34716, FLJ60657;Smith-Magenis syndrome chromosomal region candidate gene 8 protein;Smith-Magenis syndrome chromosomal region candidate gene 8 protein;
STMN4
stathmin-like 4
STMN4;stathmin-like 4;16078;ENSG00000015592;RB3;8p21.2;MGC111012;stathmin-4;stathmin-4;stathmin-like protein B3;stathmin-like-protein RB3;
STT3B
STT3, subunit of the oligosaccharyltransferase complex, homolog B (S. cerevisiae)
STT3B;STT3, subunit of the oligosaccharyltransferase complex, homolog B (S. cerevisiae);30611;ENSG00000163527;SIMP;STT3-B;3p23;FLJ90106;dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B;dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B;homolog of yeast STT3;oligosaccharyl transferase subunit STT3B;source of immunodominant MHC associated peptides;source of immunodominant MHC-associated peptides homolog;EC 2.4.1.119;
TGFBRAP1
transforming growth factor, beta receptor associated protein 1
TGFBRAP1;transforming growth factor, beta receptor associated protein 1;16836;ENSG00000135966;TRAP1;TRAP-1;2q12.1;transforming growth factor-beta receptor-associated protein 1;transforming growth factor-beta receptor-associated protein 1;TGF-beta receptor-associated protein 1;TGF beta receptor associated protein -1;
TBC1D9B
TBC1 domain family, member 9B (with GRAM domain)
TBC1D9B;TBC1 domain family, member 9B (with GRAM domain);29097;ENSG00000197226;5q35.3;FLJ41880, KIAA0676, MGC157757;TBC1 domain family member 9B;TBC1 domain family member 9B;
THADA
thyroid adenoma associated
THADA;thyroid adenoma associated;19217;ENSG00000115970;GITA;2p21;FLJ21877, FLJ44016, FLJ44876, FLJ77530, KIAA1767;thyroid adenoma-associated protein;thyroid adenoma-associated protein;death receptor-interacting protein;gene inducing thyroid adenomas protein;
THAP2
THAP domain containing, apoptosis associated protein 2
THAP2;THAP domain containing, apoptosis associated protein 2;20854;ENSG00000173451;12q21.1;DKFZp564I0422;THAP domain-containing protein 2;THAP domain-containing protein 2;
THAP7
THAP domain containing 7
THAP7;THAP domain containing 7;23190;ENSG00000184436;22q11.2;MGC10963;THAP domain-containing protein 7;THAP domain-containing protein 7;
THAP9
THAP domain containing 9
THAP9;THAP domain containing 9;23192;ENSG00000168152;4q21.22;FLJ23320, FLJ34093;THAP domain-containing protein 9;THAP domain-containing protein 9;
THBS3
thrombospondin 3
THBS3;thrombospondin 3;11787;ENSG00000169231;TSP3;1q21;MGC119564, MGC119565;thrombospondin-3;thrombospondin-3;
THSD4
thrombospondin, type I, domain containing 4
THSD4;thrombospondin, type I, domain containing 4;25835;ENSG00000187720;ADAMTSL6;FVSY9334;PRO34005;ADAMTSL-6;15q23;FLJ13710;thrombospondin type-1 domain-containing protein 4;thrombospondin type-1 domain-containing protein 4;ADAMTS-like protein 6;A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6;
TMX3
thioredoxin-related transmembrane protein 3
TMX3;thioredoxin-related transmembrane protein 3;24718;ENSG00000166479;PDIA13;TXNDC10;18q22;FLJ20793, KIAA1830;protein disulfide-isomerase TMX3;protein disulfide-isomerase TMX3;thioredoxin domain containing 10;thioredoxin domain-containing protein 10;protein disulfide isomerase family A, member 13;EC 5.3.4.1;
TXNDC11
thioredoxin domain containing 11
TXNDC11;thioredoxin domain containing 11;28030;ENSG00000153066;EFP1;16p13.13;thioredoxin domain-containing protein 11;thioredoxin domain-containing protein 11;EF-hand binding protein 1;EF-hand-binding protein 1;
TMX2
thioredoxin-related transmembrane protein 2
TMX2;thioredoxin-related transmembrane protein 2;30739;ENSG00000213593;PIG26;CGI-31;PDIA12;TXNDC14;11cen-q22.3;MGC111151, DKFZp781O2021;thioredoxin-related transmembrane protein 2;thioredoxin-related transmembrane protein 2;growth-inhibiting gene 11;thioredoxin domain-containing protein 14;cell proliferation-inducing gene 26 protein;protein disulfide isomerase family A, member 12;
TXNDC15
thioredoxin domain containing 15
TXNDC15;thioredoxin domain containing 15;20652;ENSG00000113621;UNQ335;C5orf14;5q31.1;FLJ22625;thioredoxin domain-containing protein 15;thioredoxin domain-containing protein 15;2310047H23Rik;disulfide isomerase;
TXNDC16
thioredoxin domain containing 16
TXNDC16;thioredoxin domain containing 16;19965;ENSG00000087301;KIAA1344;14q22.1;KIAA1344;thioredoxin domain-containing protein 16;thioredoxin domain-containing protein 16;
TXNDC17
thioredoxin domain containing 17
TXNDC17;thioredoxin domain containing 17;28218;ENSG00000129235;TRP14;TXNL5;17p13.1;MGC14353;thioredoxin domain-containing protein 17;thioredoxin domain-containing protein 17;protein 42-9-9;thioredoxin-like 5;thioredoxin-like protein 5;14 kDa thioredoxin-related protein;thioredoxin (Trx)-related protein, 14 kDa;
TXNDC2
thioredoxin domain containing 2 (spermatozoa)
TXNDC2;thioredoxin domain containing 2 (spermatozoa);16470;ENSG00000168454;SPTRX;SPTRX1;chromosome: 18;MGC35026, DKFZp434H0311;thioredoxin domain-containing protein 2;thioredoxin domain-containing protein 2;sptrx-1;sperm-specific thioredoxin 1;spermatid-specific thioredoxin-1;thioredoxin domain-containing 2 (spermatozoa);
TXNDC8
thioredoxin domain containing 8 (spermatozoa)
TXNDC8;thioredoxin domain containing 8 (spermatozoa);31454;ENSG00000204193;TRX6;SPTRX-3;bA427L11.2;9q31.3;thioredoxin domain-containing protein 8;thioredoxin domain-containing protein 8;thioredoxin 6;thioredoxin-6;sperm-specific thioredoxin 3;spermatid-specific thioredoxin-3;spermatocyte/spermatid-specific thioredoxin-3;
VEZF1
vascular endothelial zinc finger 1
VEZF1;vascular endothelial zinc finger 1;12949;ENSG00000136451;DB1;ZNF161;17q22;vascular endothelial zinc finger 1;vascular endothelial zinc finger 1;zinc finger protein 161;putative transcription factor DB1;
YTHDC1
YTH domain containing 1
YTHDC1;YTH domain containing 1;30626;ENSG00000083896;YT521;YT521-B;4q13.2;KIAA1966;YTH domain-containing protein 1;YTH domain-containing protein 1;splicing factor YT521-B;putative splicing factor YT521;
YTHDC2
YTH domain containing 2
YTHDC2;YTH domain containing 2;24721;ENSG00000047188;5q22.2;probable ATP-dependent RNA helicase YTHDC2;probable ATP-dependent RNA helicase YTHDC2;EC 3.6.4.13;
ZZEF1
zinc finger, ZZ-type with EF-hand domain 1
ZZEF1;zinc finger, ZZ-type with EF-hand domain 1;29027;ENSG00000074755;ZZZ4;17p13.2;FLJ10821, FLJ23789, FLJ45574, KIAA0399, MGC166929;zinc finger ZZ-type and EF-hand domain-containing protein 1;zinc finger ZZ-type and EF-hand domain-containing protein 1;zinc finger, ZZ-type with EF hand domain 1;
FAM176A
family with sequence similarity 176, member A
FAM176A;family with sequence similarity 176, member A;25816;ENSG00000115363;TMEM166;2p12;FLJ13391;protein FAM176A;protein FAM176A;transmembrane protein 166;
USE1
unconventional SNARE in the ER 1 homolog (S. cerevisiae)
USE1;unconventional SNARE in the ER 1 homolog (S. cerevisiae);30882;ENSG00000053501;P31;SLT1;MDS032;19p13.11;vesicle transport protein USE1;vesicle transport protein USE1;Q-SNARE;protein p31;USE1-like protein;putative MAPK activating protein PM26;putative MAPK-activating protein PM26;SNARE-like tail-anchored protein 1 homolog;
FAM49A
family with sequence similarity 49, member A
FAM49A;family with sequence similarity 49, member A;25373;ENSG00000197872;2p24.2;FLJ11080, FLJ33961, DKFZp566A1524;protein FAM49A;protein FAM49A;
Stk30
serine/threonine kinase 30
STK30;serine/threonine kinase 30;ENSMUSG00000056458;MOK;Rage;RAGE1;12 F1;12;MGC46883, MGC107277;MAPK/MAK/MRK overlapping kinase;MAPK/MAK/MRK overlapping kinase;T/STK 30;MOK protein kinase;renal tumor antigen;MAPK/MAK/MRK/ overlapping kinase;EC 2.7.11.22;
AGPS
alkylglycerone phosphate synthase
AGPS; alkylglycerone phosphate synthase; ADAS; ADPS; ADAP-S; ADHAPS; ALDHPSY; alkyldihydroxyacetonephosphate synthase, peroxisomal; alkyl-DHAP synthase; aging-associated protein 5; aging-associated gene 5 protein; alkylglycerone-phosphate synthase; EC 2.5.1.26;
ATP5G3
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)
ATP5G3;ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9);843;ENSG00000154518;P3;2q31.1;MGC125738;ATP synthase lipid-binding protein, mitochondrial;ATP synthase lipid-binding protein, mitochondrial;ATPase protein 9;ATPase subunit C;ATP synthase subunit 9;ATP synthase proteolipid P3;ATP synthase, mitochondrial, C subunit-3;ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C3 (subunit 9);EC 3.6.1.14;
VGF
VGF nerve growth factor inducible
VGF;VGF nerve growth factor inducible;12684;ENSG00000128564;7q22.1;neurosecretory protein VGF;neurosecretory protein VGF;neuro-endocrine specific protein VGF;
ACOT4
acyl-CoA thioesterase 4
ACOT4;acyl-CoA thioesterase 4;19748;ENSG00000177465;PTE1B;PTE2B;PTE-Ib;14q24.3;acyl-coenzyme A thioesterase 4;acyl-coenzyme A thioesterase 4;PTE-2b;peroxisomal acyl-CoA thioesterase 2B;peroxisomal long-chain acyl-CoA thioesterase Ib;peroxisomal acyl coenzyme A thioester hydrolase Ib;EC 3.1.2.2;
ACSM1
acyl-CoA synthetase medium-chain family member 1
ACSM1;acyl-CoA synthetase medium-chain family member 1;18049;ENSG00000166743;BUCS1;MACS1;16p12.3;MGC150532;acyl-coenzyme A synthetase ACSM1, mitochondrial;acyl-coenzyme A synthetase ACSM1, mitochondrial;Butyrate CoA ligase;butyrate--CoA ligase 1;lipoate-activating enzyme;butyryl Coenzyme A synthetase 1;butyryl-coenzyme A synthetase 1;medium-chain acyl-CoA synthetase;middle-chain acyl-CoA synthetase 1;EC 6.2.1.2;
ADSS
adenylosuccinate synthase
ADSS;adenylosuccinate synthase;292;ENSG00000035687;ADEH;ADSS 2;1q44;MGC20404;adenylosuccinate synthetase isozyme 2;adenylosuccinate synthetase isozyme 2;AMPSase 2;IMP--aspartate ligase 2;L-type adenylosuccinate synthetase;adenylosuccinate synthetase, liver isozyme;adenylosuccinate synthetase, acidic isozyme;adenylosuccinate synthetase (Ade(-)H-complementing);EC 6.3.4.4;
ATP5G2
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)
ATP5G2;ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9);842;ENSG00000135390;ATP5A;12q13.13;ATP synthase lipid-binding protein, mitochondrial;ATP synthase lipid-binding protein, mitochondrial;ATPase protein 9;ATPase subunit C;ATP synthase c subunit;ATP synthase proteolipid P2;mitochondrial ATP synthase, subunit C (subunit 9), isoform 2;ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C2 (subunit 9);ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (subunit 9), isoform 2;EC 3.6.1.14;
METTL21D
methyltransferase like 21D
METTL21D;methyltransferase like 21D;20352;ENSG00000100483;C14orf138;14q21.3;FLJ13920;methyltransferase-like protein 21D;methyltransferase-like protein 21D;
FAM213A
family with sequence similarity 213, member A
FAM213A;family with sequence similarity 213, member A;28651;ENSG00000122378;PAMM;C10orf58;10q23.1;MGC4248, FLJ12536, FLJ14952, FLJ44312;redox-regulatory protein FAM213A;redox-regulatory protein FAM213A;UPF0765 protein C10orf58;redox-regulatory protein PAMM;peroxiredoxin-like 2 activated in M-CSF stimulated monocytes;peroxiredoxin (PRX)-like 2 activated in M-CSF stimulated monocytes;
FAM204A
family with sequence similarity 204, member A
FAM204A;family with sequence similarity 204, member A;25794;ENSG00000165669;C10orf84;bA319I23.1;RP11-319I23.1;10q26.11;FLJ13188;protein FAM204A;protein FAM204A;
METTL25
methyltransferase like 25
METTL25;methyltransferase like 25;26228;ENSG00000127720;C12orf26;12q21.31;FLJ22789;uncharacterized protein C12orf26;uncharacterized protein C12orf26;
FAM222A
family with sequence similarity 222, member A
FAM222A;family with sequence similarity 222, member A;25915;ENSG00000139438;C12orf34;12q24.11;FLJ14721;protein FAM222A;protein FAM222A;uncharacterized protein C12orf34;
FAM216B
family with sequence similarity 216, member B
FAM216B;family with sequence similarity 216, member B;26883;ENSG00000179813;C13orf30;13q14.11;FLJ40919, MGC138442;protein FAM216B;protein FAM216B;uncharacterized protein C13orf30;
METTL22
methyltransferase like 22
METTL22;methyltransferase like 22;28368;ENSG00000067365;C16orf68;16p13.2;MGC2654, FLJ12433;methyltransferase-like protein 22;methyltransferase-like protein 22;LP8272;
FAM211A
family with sequence similarity 211, member A
FAM211A;family with sequence similarity 211, member A;32403;ENSG00000181350;C17orf76;17p11.2;FLJ35696;leucine-rich repeat-containing protein FAM211A;leucine-rich repeat-containing protein FAM211A;leucine-rich repeat-containing protein C17orf76;
METTL23
methyltransferase like 23
METTL23;methyltransferase like 23;26988;ENSG00000181038;C17orf95;17q25.1;methyltransferase-like protein 23;methyltransferase-like protein 23;
PITHD1
PITH (C-terminal proteasome-interacting domain of thioredoxin-like) domain containing 1 [ Homo sapi
PITHD1;PITH (C-terminal proteasome-interacting domain of thioredoxin-like) domain containing 1;25022;ENSG00000057757;HT014;TXNL1CL;C1orf128;RP5-886K2.4;1p36.11;PITH domain-containing protein 1;PITH domain-containing protein 1;HT014;TXNL1 C-terminal like;
METTL18
methyltransferase like 18
METTL18;methyltransferase like 18;28793;ENSG00000171806;HPM1;AsTP2;C1orf156;RP1-117P20.4;1q24.2;MGC9084;histidine protein methyltransferase 1 homolog;histidine protein methyltransferase 1 homolog;arsenic-transactivated protein 2;methyltransferase-like protein 18;
FAM212B
family with sequence similarity 212, member B
FAM212B;family with sequence similarity 212, member B;28045;ENSG00000197852;C1orf183;1p13.2;FLJ31105;protein FAM212B;protein FAM212B;uncharacterized protein C1orf183;
HENMT1
HEN1 methyltransferase homolog 1 (Arabidopsis)
HENMT1;HEN1 methyltransferase homolog 1 (Arabidopsis);26400;ENSG00000162639;HEN1;C1orf59;RP11-256E16.2;1p13.3;FLJ30525, MGC111091;small RNA 2-O-methyltransferase;small RNA 2-O-methyltransferase;EC 2.1.1.n8;
FAM213B
family with sequence similarity 213, member B
FAM213B;family with sequence similarity 213, member B;28390;ENSG00000157870;C1orf93;1p36.32;MGC26818, DKFZp547M123;prostamide/prostaglandin F synthase;prostamide/prostaglandin F synthase;prostamide/PGF synthase;prostamide/PG F synthase;EC 1.11.1.20;
FAM209A
family with sequence similarity 209, member A
FAM209A;family with sequence similarity 209, member A;16100;ENSG00000124103;C20orf106;dJ1153D9.3;20q13.31;MGC104272;protein FAM209A;protein FAM209A;uncharacterized protein C20orf106;
FAM217B
family with sequence similarity 217, member B
FAM217B;family with sequence similarity 217, member B;16170;ENSG00000196227;C20orf177;dJ551D2.5;20q13.33;protein FAM217B;protein FAM217B;uncharacterized protein C20orf177;
FAM176C
family with sequence similarity 176, member C
FAM176C;family with sequence similarity 176, member C;13239;ENSG00000166979;B18;B19;EVA1;EVA-1;SUE21;PRED34;C21orf63;C21orf64;21q22.11;protein FAM176C;protein FAM176C;eva-1 homolog;uncharacterized protein C21orf63;
FAM211B
family with sequence similarity 211, member B
FAM211B;family with sequence similarity 211, member B;33155;ENSG00000178026;C22orf36;22q11.23;MGC131773;leucine-rich repeat-containing protein FAM211B;leucine-rich repeat-containing protein FAM211B;leucine-rich repeat-containing protein C22orf36;
FAM212A
family with sequence similarity 212, member A
FAM212A;family with sequence similarity 212, member A;32480;ENSG00000185614;INKA1;C3orf54;3p21.31;MGC20416;protein FAM212A;protein FAM212A;
FAM217A
family with sequence similarity 217, member A
FAM217A;family with sequence similarity 217, member A;21362;ENSG00000145975;C6orf146;6p25.2;MGC43581;protein FAM217A;protein FAM217A;uncharacterized protein C6orf146;
METTL24
methyltransferase like 24
METTL24;methyltransferase like 24;21566;ENSG00000053328;C6orf186;dJ71D21.2;6q21;FLJ45203;methyltransferase-like protein 24;methyltransferase-like protein 24;UPF0624 protein C6orf186;
ECT2L
epithelial cell transforming sequence 2 oncogene-like
ECT2L;epithelial cell transforming sequence 2 oncogene-like;21118;ENSG00000203734;LFDH;FBXO49;C6orf91;ARHGEF32;dJ509I19.2;dJ509I19.3;dJ509I19.5;6q24.1;epithelial cell-transforming sequence 2 oncogene-like;epithelial cell-transforming sequence 2 oncogene-like;ECT2-like;F-box protein 49;putative guanine nucleotide exchange factor LFDH;lung specific F-box and DH domain containing protein;lung-specific F-box and DH domain-containing protein;
THEM6
thioesterase superfamily member 6
THEM6;thioesterase superfamily member 6;29656;ENSG00000130193;DSCD75;C8orf55;8q24.3;UPF0670 protein THEM6;UPF0670 protein THEM6;UPF0670 protein C8orf55;mesenchymal stem cell protein DSCD75;
FAM221B
family with sequence similarity 221, member B
FAM221B;family with sequence similarity 221, member B;30762;ENSG00000204930;C9orf128;9p13.3;protein FAM221B;protein FAM221B;uncharacterized protein C9orf128;
FAM205A
family with sequence similarity 205, member A
FAM205A;family with sequence similarity 205, member A;41911;ENSG00000205108;C9orf144B;9p12;FLJ58301;protein FAM205A;protein FAM205A;transmembrane protein C9orf144B;
FAM221A
family with sequence similarity 221, member A
FAM221A;family with sequence similarity 221, member A;27977;ENSG00000188732;C7orf46;7p15.3;FLJ45875, MGC72075, DKFZp686F0810;protein FAM221A;protein FAM221A;uncharacterized protein C7orf46;
FAM75E1
family with sequence similarity 75, member E1
FAM75E1;family with sequence similarity 75, member E1;26672;ENSG00000177992;C9orf79;9q22.1;FLJ35866;protein FAM75E1;protein FAM75E1;XXyac-YM21GA2.5;FAM75-like protein C9orf79;
TSTD2
thiosulfate sulfurtransferase (rhodanese)-like domain containing 2
TSTD2;thiosulfate sulfurtransferase (rhodanese)-like domain containing 2;30087;ENSG00000136925;C9orf97;RP11-244N9.5;9q22.33;FLJ36724;thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 2;thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 2;PP4189;rhodanese domain-containing protein 2;
CHSY3
chondroitin sulfate synthase 3
CHSY3;chondroitin sulfate synthase 3;24293;ENSG00000198108;CSS3;CHSY2;5q23.3;chondroitin sulfate synthase 3;chondroitin sulfate synthase 3;chSy-2;chondroitin synthase 2;chondroitin synthase-2;carbohydrate synthase 2;N-acetylgalactosaminyltransferase 3;chondroitin glucuronyltransferase 3;N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 3;glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II;EC 2.4.1.175 EC 2.4.1.226;
CLTCL1
clathrin, heavy chain-like 1
CLTCL1;clathrin, heavy chain-like 1;2093;ENSG00000070371;CLTD;CHC22;CLH22;CLTCL;22q11.21;FLJ36032;clathrin heavy chain 2;clathrin heavy chain 2;CLH-22;Clathrin, heavy polypeptide D;clathrin, heavy polypeptide-like 1;clathrin heavy chain on chromosome 22;
FAM199X
family with sequence similarity 199, X-linked
FAM199X;family with sequence similarity 199, X-linked;25195;ENSG00000123575;CXorf39;Xq22.2;protein FAM199X;protein FAM199X;
FAM100B
family with sequence similarity 100, member B
FAM100B;family with sequence similarity 100, member B;28438;ENSG00000185262;17q25.1;MGC29814, MGC71792;protein FAM100B;protein FAM100B;
FAM103A1
family with sequence similarity 103, member A1
FAM103A1;family with sequence similarity 103, member A1;31022;ENSG00000169612;RAM;C15orf18;HsT19360;15q25.2;MGC2560, MGC102778;RNMT-activating mini protein;RNMT-activating mini protein;protein FAM103A1;
FAM107B
family with sequence similarity 107, member B
FAM107B;family with sequence similarity 107, member B;23726;ENSG00000065809;C10orf45;10p13;FLJ45505, MGC11034, MGC90261;protein FAM107B;protein FAM107B;
FAM104A
family with sequence similarity 104, member A
FAM104A;family with sequence similarity 104, member A;25918;ENSG00000133193;17q25.1;FLJ14775;protein FAM104A;protein FAM104A;
FAM110C
family with sequence similarity 110, member C
FAM110C;family with sequence similarity 110, member C;33340;2p25.3;protein FAM110C;protein FAM110C;
FAM115C
family with sequence similarity 115, member C
FAM115C;family with sequence similarity 115, member C;26878;ENSG00000170379;FAM139A;7q35;FLJ40722, MGC142090;protein FAM115C;protein FAM115C;family with sequence similarity 139, member A;
FAM116B
family with sequence similarity 116, member B
FAM116B;family with sequence similarity 116, member B;32690;ENSG00000205593;22q13.33;MGC33692;protein FAM116B;protein FAM116B;
FAM117B
family with sequence similarity 117, member B
FAM117B;family with sequence similarity 117, member B;14440;ENSG00000138439;ALS2CR13;2q33.2;FLJ38771, DKFZp686H01244;protein FAM117B;protein FAM117B;amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 13;amyotrophic lateral sclerosis 2 chromosomal region candidate gene 13 protein;
FAM123A
family with sequence similarity 123A
FAM123A;family with sequence similarity 123A;26360;ENSG00000165566;13q12.13;FLJ25477;APC membrane recruitment protein 2;APC membrane recruitment protein 2;amer2;protein FAM123A;
FAM125A
family with sequence similarity 125, member A
FAM125A;family with sequence similarity 125, member A;25153;ENSG00000141971;CFBP;19p13.11;FLJ32495;multivesicular body subunit 12A;multivesicular body subunit 12A;ESCRT-I complex subunit MVB12A;CIN85/CD2AP family binding protein;CIN85/CD2AP family-binding protein;
FAM45A
family with sequence similarity 45, member A
FAM45A;family with sequence similarity 45, member A;31793;ENSG00000119979;10q25;protein FAM45A;protein FAM45A;
FAM48A
family with sequence similarity 48, member A
FAM48A;family with sequence similarity 48, member A;20596;ENSG00000102710;C13;FP757;P38IP;SPT20;C13orf19;bA421P11.4;13q13.3;protein FAM48A;protein FAM48A;p38 interacting protein;p38-interacting protein;tumor rejection antigen;transcription factor (p38 interacting protein);
FAM49B
family with sequence similarity 49, member B
FAM49B;family with sequence similarity 49, member B;25216;ENSG00000153310;L1;BM-009;8q24.21;DKFZp686B04128;protein FAM49B;protein FAM49B;
FAM123C
family with sequence similarity 123C
FAM123C;family with sequence similarity 123C;26771;ENSG00000178171;2q21.1;FLJ38377;APC membrane recruitment protein 3;APC membrane recruitment protein 3;amer3;protein FAM123C;
FAM126B
family with sequence similarity 126, member B
FAM126B;family with sequence similarity 126, member B;28593;ENSG00000155744;HYCC2;2q33.1;FLJ10981, FLJ37917, FLJ42947, MGC39518;protein FAM126B;protein FAM126B;
FAM131B
family with sequence similarity 131, member B
FAM131B;family with sequence similarity 131, member B;22202;ENSG00000159784;7q34;KIAA0773;protein FAM131B;protein FAM131B;
FAM131A
family with sequence similarity 131, member A
FAM131A;family with sequence similarity 131, member A;28308;ENSG00000175182;C3orf40;FLAT715;PRO1378;3q27.1;MGC21688;protein FAM131A;protein FAM131A;
FAM134A
family with sequence similarity 134, member A
FAM134A;family with sequence similarity 134, member A;28450;ENSG00000144567;C2orf17;2q35;MGC3035, DKFZp686C2379;protein FAM134A;protein FAM134A;
FAM135A
family with sequence similarity 135, member A
FAM135A;family with sequence similarity 135, member A;21084;ENSG00000082269;KIAA1411;6q13;FLJ13577, KIAA1411, DKFZp781H2319;protein FAM135A;protein FAM135A;
FAM149B1
family with sequence similarity 149, member B1
FAM149B1;family with sequence similarity 149, member B1;29162;ENSG00000138286;KIAA0974;10q22.2;KIAA0974;protein FAM149B1;protein FAM149B1;
FAM13A
family with sequence similarity 13, member A
FAM13A;family with sequence similarity 13, member A;19367;ENSG00000138640;FAM13A1;ARHGAP48;4q22.1;FLJ34562, MGC105131;protein FAM13A;protein FAM13A;FAM13A1_v2 protein;family with sequence similarity 13, member A1;
FAM151B
family with sequence similarity 151, member B
FAM151B;family with sequence similarity 151, member B;33716;ENSG00000152380;UNQ9217;5q14.1;protein FAM151B;protein FAM151B;AASA9217;
FAM154B
family with sequence similarity 154, member B
FAM154B;family with sequence similarity 154, member B;33727;ENSG00000188659;15q25.2;DKFZp666G057;protein FAM154B;protein FAM154B;
FAM160A1
family with sequence similarity 160, member A1
FAM160A1;family with sequence similarity 160, member A1;34237;ENSG00000164142;4q31.3;FLJ43373;protein FAM160A1;protein FAM160A1;
FAM159B
family with sequence similarity 159, member B
FAM159B;family with sequence similarity 159, member B;34236;ENSG00000145642;5q12.3;membrane protein FAM159B;membrane protein FAM159B;
FAM162B
family with sequence similarity 162, member B
FAM162B;family with sequence similarity 162, member B;21549;ENSG00000183807;C6orf189;bA86F4.2;6q22.1;protein FAM162B;protein FAM162B;
FAM162A
family with sequence similarity 162, member A
FAM162A;family with sequence similarity 162, member A;17865;ENSG00000114023;E2IG5;HGTD-P;C3orf28;3q21.1;protein FAM162A;protein FAM162A;E2-induced gene 5 protein;growth and transformation-dependent protein;HIF-1 alpha-responsive proapoptotic molecule;
FAM166B
family with sequence similarity 166, member B
FAM166B;family with sequence similarity 166, member B;34242;ENSG00000215187;9p13.3;MGC157846;protein FAM166B;protein FAM166B;
FAM167B
family with sequence similarity 167, member B
FAM167B;family with sequence similarity 167, member B;28133;ENSG00000183615;C1orf90;1p35.1;MGC10820;protein FAM167B;protein FAM167B;
FAM171B
family with sequence similarity 171, member B
FAM171B;family with sequence similarity 171, member B;29412;ENSG00000144369;KIAA1946;2q32.1;FLJ34104, KIAA1946;protein FAM171B;protein FAM171B;
FAM171A2
family with sequence similarity 171, member A2
FAM171A2;family with sequence similarity 171, member A2;30480;ENSG00000161682;17q21.31;MGC34829;protein FAM171A2;protein FAM171A2;
FAM174A
family with sequence similarity 174, member A
FAM174A;family with sequence similarity 174, member A;24943;ENSG00000174132;TMEM157;UNQ1912;5q21.1;MGC17345;membrane protein FAM174A;membrane protein FAM174A;HGS_RE408;transmembrane protein 157;HCV NS5A-transactivated protein 6;hepatitis C virus NS5A-transactivated protein 6;
FAM173A
family with sequence similarity 173, member A
FAM173A;family with sequence similarity 173, member A;14152;ENSG00000103254;C16orf24;16p13.3;MGC2494;protein FAM173A;protein FAM173A;
FAM178A
family with sequence similarity 178, member A
FAM178A;family with sequence similarity 178, member A;17814;ENSG00000119906;C10orf6;10q24.31;MGC90157;protein FAM178A;protein FAM178A;
FAM179A
family with sequence similarity 179, member A
FAM179A;family with sequence similarity 179, member A;33715;ENSG00000189350;2p23.2;protein FAM179A;protein FAM179A;
FAM181A
family with sequence similarity 181, member A
FAM181A;family with sequence similarity 181, member A;20491;ENSG00000140067;C14orf152;14q32.12;protein FAM181A;protein FAM181A;
FAM180B
family with sequence similarity 180, member B
FAM180B;family with sequence similarity 180, member B;34451;ENSG00000196666;11p11.2;protein FAM180B;protein FAM180B;hypothetical gene supported by BC065704;
FAM184A
family with sequence similarity 184, member A
FAM184A;family with sequence similarity 184, member A;20991;ENSG00000111879;C6orf60;6q22.31;FLJ13942;protein FAM184A;protein FAM184A;
FAM186A
family with sequence similarity 186, member A
FAM186A;family with sequence similarity 186, member A;26980;ENSG00000185958;12q13.12;protein FAM186A;protein FAM186A;
FAM186B
family with sequence similarity 186, member B
FAM186B;family with sequence similarity 186, member B;25296;ENSG00000135436;C12orf25;12q13.12;DKFZp434J0113, DKFZp434N2350;protein FAM186B;protein FAM186B;
FAM187B
family with sequence similarity 187, member B
FAM187B;family with sequence similarity 187, member B;26366;ENSG00000177558;TMEM162;19q13.12;FLJ25660;protein FAM187B;protein FAM187B;transmembrane protein 162;
FAM20B
family with sequence similarity 20, member B
FAM20B;family with sequence similarity 20, member B;23017;ENSG00000116199;gxk1;1q25;glycosaminoglycan xylosylkinase;glycosaminoglycan xylosylkinase;xylose kinase;EC 2.7.1.-;
FAM19A1
family with sequence similarity 19 (chemokine (C-C motif)-like), member A1
FAM19A1;family with sequence similarity 19 (chemokine (C-C motif)-like), member A1;21587;ENSG00000183662;TAFA1;TAFA-1;3p14.1;protein FAM19A1;protein FAM19A1;chemokine-like protein TAFA-1;
FAM26E
family with sequence similarity 26, member E
FAM26E;family with sequence similarity 26, member E;21568;ENSG00000178033;C6orf188;dJ493F7.3;6q22.1;MGC45451;protein FAM26E;protein FAM26E;
FAM63A
family with sequence similarity 63, member A
FAM63A;family with sequence similarity 63, member A;25648;ENSG00000143409;RP11-316M1.5;1q21.3;FLJ11280, FLJ43504;protein FAM63A;protein FAM63A;
FAM57B
family with sequence similarity 57, member B
FAM57B;family with sequence similarity 57, member B;25295;ENSG00000149926;FP1188;16p11.2;DKFZp434I2117;protein FAM57B;protein FAM57B;
FAM65A
family with sequence similarity 65, member A
FAM65A;family with sequence similarity 65, member A;25836;ENSG00000039523;16q22.1;FLJ13725, KIAA1930;protein FAM65A;protein FAM65A;
FAM69A
family with sequence similarity 69, member A
FAM69A;family with sequence similarity 69, member A;32213;ENSG00000154511;1p22.1;FLJ23493;protein FAM69A;protein FAM69A;
FAM70B
family with sequence similarity 70, member B
FAM70B;family with sequence similarity 70, member B;28297;ENSG00000184497;RP11-199F6.1;13q34;FLJ57938, MGC20579;protein FAM70B;protein FAM70B;
FAM71C
family with sequence similarity 71, member C
FAM71C;family with sequence similarity 71, member C;28594;ENSG00000180219;12q23.1;MGC39520;protein FAM71C;protein FAM71C;
FAM71F2
family with sequence similarity 71, member F2
FAM71F2;family with sequence similarity 71, member F2;27998;ENSG00000205085;FAM137B;7q32.1;protein FAM71F2;protein FAM71F2;family with sequence similarity 137, member B;
FAM73B
family with sequence similarity 73, member B
FAM73B;family with sequence similarity 73, member B;23621;ENSG00000148343;C9orf54;9q34.11;FLJ00199, FLJ14596;protein FAM73B;protein FAM73B;
PEMT
phosphatidylethanolamine N-methyltransferase
PEMT;phosphatidylethanolamine N-methyltransferase;8830;ENSG00000133027;PNMT;PEAMT;PEMPT;PEMT2;17p11.2;MGC2483;phosphatidylethanolamine N-methyltransferase;phosphatidylethanolamine N-methyltransferase;EC 2.1.1.17;
ELAVL3
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C)
ELAVL3;ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C);3314;ENSG00000196361;HUC;HUCL;PLE21;19p13.2;MGC20653, DKFZp547J036;ELAV-like protein 3;ELAV-like protein 3;Hu antigen C;hu-antigen C;paraneoplastic limbic encephalitis antigen 21;paraneoplastic cerebellar degeneration-associated antigen;
Tet1
tet methylcytosine dioxygenase 1
TET1;tet methylcytosine dioxygenase 1;ENSMUSG00000047146;LCX;Cxxc6;AA517754;BB001228;mKIAA1676;D10Ertd17e;2510010B09Rik;10 B4;10 32.0 cM;methylcytosine dioxygenase TET1;methylcytosine dioxygenase TET1;CXXC finger 6;tet oncogene 1;CXXC-type zinc finger protein 6;ten-eleven translocation 1 gene protein homolog;EC 1.14.11.n2;
WHAMM
WAS protein homolog associated with actin, golgi membranes and microtubules
WHAMM;WAS protein homolog associated with actin, golgi membranes and microtubules;30493;ENSG00000156232;WHDC1;15q25.2;KIAA1971;WASP homolog-associated protein with actin, membranes and microtubules;WASP homolog-associated protein with actin, membranes and microtubules;WH2 domain-containing protein 1;WAS protein homology region 2 domain containing 1;WAS protein homology region 2 domain-containing protein 1;
ANKDD1A
ankyrin repeat and death domain containing 1A
ANKDD1A;ankyrin repeat and death domain containing 1A;28002;ENSG00000166839;15q22.31;FLJ18078, FLJ25870, MGC120305, MGC120306, MGC120307;ankyrin repeat and death domain-containing protein 1A;ankyrin repeat and death domain-containing protein 1A;
IQCA1
IQ motif containing with AAA domain 1
IQCA1;IQ motif containing with AAA domain 1;26195;ENSG00000132321;IQCA;4930465P12Rik;2q37.3;FLJ22527, FLJ33588;IQ and AAA domain-containing protein 1;IQ and AAA domain-containing protein 1;
PCMTD1
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1
PCMTD1;protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1;30483;ENSG00000168300;8q11.23;FLJ10883;protein-L-isoaspartate O-methyltransferase domain-containing protein 1;protein-L-isoaspartate O-methyltransferase domain-containing protein 1;
OXSM
3-oxoacyl-ACP synthase, mitochondrial
OXSM;3-oxoacyl-ACP synthase, mitochondrial;26063;ENSG00000151093;KS;KASI;FASN2D;3p24.2;FLJ20604;3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial;3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial;beta-ketoacyl synthase;beta-ketoacyl-ACP synthase;3-oxoacyl-acyl-carrier-protein synthase;3-ketoacyl-acyl carrier protein synthase;type II mitochondrial beta-ketoacyl synthase;acyl-malonyl acyl carrier protein-condensing enzyme;EC 2.3.1.41;
ACSM2A
acyl-CoA synthetase medium-chain family member 2A
ACSM2A;acyl-CoA synthetase medium-chain family member 2A;32017;ENSG00000183747;ACSM2;A-923A4.1;16p12.3;FLJ34659, MGC150530;acyl-coenzyme A synthetase ACSM2A, mitochondrial;acyl-coenzyme A synthetase ACSM2A, mitochondrial;butyrate--CoA ligase 2A;butyryl-coenzyme A synthetase 2A;Homolog of rat kidney-specific (KS);middle-chain acyl-CoA synthetase 2A;EC 6.2.1.2;
AMIGO1
adhesion molecule with Ig-like domain 1
AMIGO1;adhesion molecule with Ig-like domain 1;20824;ENSG00000181754;AMIGO;AMIGO-1;1p13.3;amphoterin-induced protein 1;amphoterin-induced protein 1;alivin-2;amphoterin-induced gene and ORF;
ATP5L
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G
ATP5L; ATP5JG; ATPase sub...;
ATP5S
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit s (factor B)
ATP5S; ATPW; FB; FB...;
1700106N22Rik
calmodulin-lysine N-methyltransferase
CLNMT; CaM KMT; AI480743; AV099781; 1700106N22Rik;
ENOX2
ENOX2 ecto-NOX disulfide-thiol exchanger 2 [ Homo sapiens ]
ecto-NOX disulfide-thiol exchanger 2; 2259; Ensembl:ENSG00000165675; APK1 antigen; cytosolic ovarian carcinoma antigen 1; tumor-associated hydroquinone oxidase; APK1; tNOX; COVA1;
EDARADD
EDAR (ectodysplasin-A receptor)-associated death domain
cr; A630043P06; 1810032E07Rik; 5830469M23Rik;
EMP1
EMP1 epithelial membrane protein 1 [ Homo sapiens ]
epithelial membrane protein 1; 3333; Ensembl:ENSG00000134531; tumor-associated membrane protein; TMP; CL-20; EMP-1;
FAM176B
FAM176B family with sequence similarity 176, member B [ Homo sapiens ]
family with sequence similarity 176, member B; 25558; Ensembl:ENSG00000142694; FLJ10647; protein FAM176B; C1orf78; RP11-268J15.2;
Fam177a
family with sequence similarity 177, member A
C14orf24; Fam177a1; 1700047I17Rik; D730001C10Rik; 1700047I17Rik1;
FAM179B
family with sequence similarity 179, member B
BC062107; mKIAA0423; C130034K06; A430041B07Rik;
FAM208B
FAM208B family with sequence similarity 208, member B [ Homo sapiens ]
family with sequence similarity 208, member B; FLJ20360; C10orf18; chromosome 10 open reading frame 18; bA318E3.2; protein FAM208B; KIAA2006; uncharacterized protein C10orf18;
FAM38B
family with sequence similarity 38, member B
Piezo2; Fam38b2; 5930434P17; 9030411M15Rik; 9430028L06Rik;
FAM57A
family with sequence similarity 57, member A
Wdt3; RP23-147P4.4; 2310047D13Rik; 4932415L08Rik; 5430402E13Rik; 5430420K21Rik;
FAM71E1
family with sequence similarity 71, member E1
GARI-L5; 0610007G24Rik; 1700021N13Rik; 1700021P22Rik;
FAM72A
FAM72A family with sequence similarity 72, member A [ Homo sapiens ]
family with sequence similarity 72, member A; 24044; Ensembl:ENSG00000196550; MGC46651, MGC57827, MGC169168, MGC182081, MGC182095; protein FAM72A; Ugene; LMP1-induced protein; latent membrane protein 1-induced protein; LMPIP; RP11-312O7.1;
FAM83A
FAM83A family with sequence similarity 83, member A [ Homo sapiens ]
family with sequence similarity 83, member A; MGC14128; BJ-TSA-9; protein FAM83A; Tumor antigen BJ-TSA-9; TSGP; Tumor-specific gene expressed in prostate protein;
FSCB
FSCB fibrous sheath CABYR binding protein [ Homo sapiens ]
fibrous sheath CA; 20494; Ensembl:ENSG00000189139; DKFZp434F1017, DKFZp686A1639, DKFZp686J0539; fibrous sheath CABYR-binding protein; C14orf155;
KIR3DL3
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3
KIR44; KIRC1; CD158Z; KIR3DL7;
LILRA6
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6
ILT5; ILT8; CD85b; LILRB3; LILRB6;
Lilrb3l
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3-like
Pirb; Lilrb3; Pir-A1; Pir-A2;
KDM8
lysine (K)-specific demethylase 8
Kdm8; 3110005O21Rik; Jmjd5; lysine (K)-specific demethylase 8;
Prorsd1
prolyl-tRNA synthetase domain containing 1
Prdxdd1; Ncrna00117; RP23-92B18.3; 2010316F05Rik;
RGD1309228
similar to putative protein, with at least 9 transmembrane domains, of eukaryotic origin (43.9 kD) (2G415)
Txn1
thioredoxin 1
Txn1; ADF; Txn; Trx1; AW550880; thioredoxin 1; thioredoxin; trx; ATL-derived factor; trxA; dasC; ECK3773; fip; fipA; JW5856; tsnC;
Acot2
acyl-CoA thioesterase 2
ACOT2; MTE1; PTE2; CTE1A; PTE2A; CTE-IA; ZAP128; acyl-coenzyme A thioesterase 2, mitochondrial; long-chain acyl-CoA thioesterase 2; mitochondrial acyl-CoA thioesterase 1; acyl-coenzyme A thioester hydrolase 2a; peroxisomal long-chain acyl-coA thioesterase 2;
AGAP5
ArfGAP with GTPase domain, ankyrin repeat and PH domain 5
CTGLF2; arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5; AGAP-5; centaurin-gamma-like family member 2; centaurin, gamma-like family, member 2;
Atp5k
ATP synthase, H+ transporting, mitochondrial F1F0 complex, subunit e
Atp5i; Atp5k, Lfm-1, Lfm1; Atp5k; Atp5i...;
Ctsl
cathepsin L
CTSL; cathepsin L; MEP; CATL; CTSL1; cathepsin L1; major excreted protein; cpl-1; CathePsin L family; CathePsin L family member (cpl-1); cpl 1;
Ecel1
ECEL1 endothelin converting enzyme-like 1 [ Homo sapiens ]
endothelin converting enzyme-like 1; 3147; Ensembl:ENSG00000171551; endothelin-converting enzyme-like 1; X converting enzyme; damage induced neuronal endopeptidase; XCE; DINE; ECEX;
Fam110a
FAM110A family with sequence similarity 110, member A [ Homo sapiens ]
family with sequence similarity 110, member A; 16188; Ensembl:ENSG00000125898; MGC2450, MGC4675; protein FAM110A; F10; C20orf55; bA371L19.3;
Fam124b
FAM124B family with sequence similarity 124B [ Homo sapiens ]
family with sequence similarity 124B; 26224; Ensembl:ENSG00000124019; FLJ22746; protein FAM124B;
Fam3a
FAM3A family with sequence similarity 3, member A [ Homo sapiens ]
family with sequence similarity 3, member A; 13749; Ensembl:ENSG00000071889; protein FAM3A; cytokine-like protein 2-19; DLD; 2.19; XAP-7; DXS560S;
Fam46b
FAM46B family with sequence similarity 46, member B [ Homo sapiens ]
family with sequence similarity 46, member B; 28273; Ensembl:ENSG00000158246; MGC16491, MGC20845; protein FAM46B; RP11-344H11.8;
Fam60a
FAM60A family with sequence similarity 60, member A [ Homo sapiens ]
family with sequence similarity 60, member A; 30702; Ensembl:ENSG00000139146; protein FAM60A; tera protein homolog; L4; TERA; C12orf14;
Fgfbp3
Fibroblast Growth Factor Binding Protein 3
Fibroblast Growth Factor Binding Protein 3; FGFBP3;
LOC501110
similar to Glutathione S-transferase A1 (GTH1) (HA subunit 1) (GST-epsilon) (GSTA1-1) (GST class-alpha)
Themis2
THEMIS2 thymocyte selection associated family member 2 [ Homo sapiens ]
thymocyte selection associated family member 2; 16839; Ensembl:ENSG00000130775; protein THEMIS2; protein ICB-1; basement membrane-induced; induced by contact to basement membrane 1 protein; thymocyte-expressed molecule involved in selection protein 2; ICB-1; C1orf38;
Trmt10a
tRNA methyltransferase 10 homolog A (S. cerevisiae)
TRMT10A; TRM10; RG9MTD2; tRNA methyltransferase 10 homolog A (S. cerevisiae); tRNA methyltransferase 10 homolog A; RNA (guanine-9-) methyltransferase domain containing 2; RNA (guanine-9-)-methyltransferase domain-containing protein 2;
IGFII
insulin-like growth factor 2 (somatomedin A)
IGF-II; PP9974; C11orf43; IGF2; insulin-like growth factor 2 (somatomedin A); insulin-like growth factor II; somatomedin-A; insulin-like growth factor type 2; GF2; FLJ22066; FLJ44734;
PDGFRα
platelet-derived growth factor receptor, alpha polypeptide
CD140A; PDGFR2; PDGFR-2; RHEPDGFRA;
TGFβR2
transforming growth factor, beta receptor II (70/80kDa)
AAT3; FAA3; MFS2; RIIC; LDS1B; LDS2B; TAAD2; TGFR-2; TGFbeta-RII;
AAT1
AAT1 Aortic aneurysm, familial thoracic 1 [ Homo sapiens ]
AAT1; Aortic aneurysm, familial thoracic 1; FAA1;
FAM115A
FAM115A family with sequence similarity 115, member A [ Homo sapiens ]
family with sequence similarity 115, member A; 22201; Ensembl:ENSG00000198420; FLJ56782, KIAA0738; protein FAM115A;
HBQ1
HBQ1 hemoglobin, theta 1 [ Homo sapiens ]
hemoglobin, theta 1; 4833; Ensembl:ENSG00000086506; hemoglobin subunit theta-1; theta-1-globin; hemoglobin theta-1 chain;
Protective antigen of anthrax toxin
Protective antigen of anthrax toxin
anthrax PA; Anthrax Protective Antigen; Anthrax toxins translocating protein; Bacillus anthracis Protective Antigen; PA 83; PA; PA83; Pag; PagA; Protective antigen;
Protein Methylation Assay
As a leading biotechnology services supplier, Creative BioMart offers Histone methylation assay and site identification services. With our expertise as a leader in the field of methylation, Creative BioMart has created a set of new platform technologies. Creative BioMart has a convenient package of ...
High-Throughput Screening
Creative BioMart offers a unique combination of target class and cell biology expertise to provide services tailored to your requirements. Our platforms offer high-throughput screening and high-content profiling using standard cell models, human primary cells or disease-related cell lines. Based ...
High-throughput Protein Production
Creative BioMart's professional team can help accelerate your project by providing high-throughput protein production services of up to 1,000 variants within 30 working days. We provide one-stop high-throughput protein production services, including gene synthesis, mutagenesis, subcloning, pilot-sca...
Protein Pathway Profiling
Signaling pathways are protein networks involved in multiple cell-development processes like apoptosis, angiogenesis, proliferation, differentiation and so on. Creative BioMart specializes in cell pathways profiling. Our specific antibodies enable to analyze the dysregulation and phosphorylation sta...
Human Synthetic Proteins Produced in Mammalian Cell Lines
Creative BioMart has developed a novel approach to both increase biological activities and reduce production costs of human synthetic proteins in mammalian cell lines. The stable transfection of particular cell lines with human sialyltransferases (a set of enzymes involves in protein glycosylation) ...
Food & Healthcare Test Services
With more and more reports on food safety, contamination of the environment and daily supplies, and drug safety problems, the public is becoming increasingly concerned about health issue. Thus, detection on hazardous substance is urgently needed. Creative BioMart provides professional Food Healthca...
Inhibition of Enzyme NOX4 Prevents Liver Fibrosis than TGF-beta
Liver fibrosis is an illness caused by the overproduction of extracellular matrix proteins in the liver tissue. NOX4, a family member of NADPH oxidase enzyme,plays an important role in liver fibrosis by inhibiting it. TGF-beta, a complex cytokine, the transforming growth factor-beta, involves in the...
Rescue Me from the Peanut Allergy by Inhibiting Pim 1 and Runx3?
In the newly 2012 Journal of Allergy and Clinical Immunology, Erwin Gelfand, MD, and his colleagues at National Jewish Health reported that levels of the enzyme Pim 1 kinase rise in the small intestines of peanut-allergic mice and inhibiting activity of Pim 1 markedly reduced the allergic response...
The New Found Genetic Factor-KLF4-is Vital for Cardiovascular Health
On Nov. 19 on the Journal of Clinical Investigation, a new finding regarding cardiovascular diseases, such as atherosclerosis, thrombosis and heart disease and one of its genetic roots has been found. These researchers came from Case Western Reserve University School of Medicine and the study was l...
PLoS ONE: UCP2 Protein Is Important for Natural Born Babies Regarding to Their Subsequent Development
On the PLoS ONE, a finding regarding the impact of mitochondrial uncoupling protein 2 (UCP2) on vaginal birth and caesarean section was published. This research was conducted by a team of Yale School of Medicine, mainly led by Tamas Horvath, the Jean and David W. Wallace Professor of Biomedical Re...
Nature: Fighting Alzheimer's Disease from the Perspective of Immune Transmitter
Nov. is the national Alzheimers disease (AD) Awareness Month for America. And it widely affects old people around the world. It is one of the common forms of dementia. According to some statistics, every seven second, there will be one people suffer AD. In Germany and Switzerland alone, around 1.5...
A New Nanotechnology Brings Hope for MS and Other Immune-related Diseases
Multiple sclerosis (MS), a nervous system disease, affects brain and spinal cord. It damages the myelin sheath. This damage slows down or blocks messages between brain and body, leading to the symptoms of MS. Patients suffering from MS deal with everything from numb limbs to blindness or paralysis...
NK Cells & Brain Tumors: Immune cells attack Therapeutic Viruses
We have natural guard system inside us, such as our immune system, which on one hand protect us, while on other hand hinder us too according to a research of Ohio State University Comprehensive Cancer Center. Their findings were published in the journal of Nature Medicine. They did some researches ...
Regain Our Youth/Rejuvenate?
Talk about the 2012 Nobel Prize in physiology or medicine Many scientific breakthroughs are not predictable. But there are some must factors behind the seemingly arbitrary work. John Bertrand Gurdon, born in Oct. 2, 1933 in England, is an English developmental biologist, won the 2012 Nobel...
Glybera became the first one that gets gene therapy approval
The first gene therapy for rare disease gets approval by European Commission This is an important news about gene therapy. After years of development and repeated rejections, uniQure finally got permission to market its gene therapyGlybera. Glybera was designed for certain patients with lipoprote...
Two proteins, ATG12 and ATG5 Might Help People Developing Innovative Cancer Therapies
Scientists at The Scripps Research Institute (TSRI) have found two key subunits within a cell that helps maintaining cell health. They identified how the two proteins help create organelles. Their discoveries make people think about interfering with the formation of these organelles and lead to new ...
Turning the Fiction Biotechnology into Reality: Advances in Bio-industry Field
We would find lot of amazing concepts or ideas in many well composed fictions or movies. Such as being invisible, fly only with a backpack device, transfer to another place in virtue of molecules shifting etc. and each people are standing on different perspectives to think the corresponding gains. I...
Nature Method: How to Effectively and Safely Produce Stem Cell
Stem cells are biological cells found in all multicellular organisms, that can divide through mitosis and differentiate into diverse specialized cell types or can self renew to produce more stem cells. In mammals, there are two broad types of stem cells: embryonic stem cells (ESCs) that are isolat...
Patients with Digestive Diseases Gain Hope for Selective Therapies by Targeting Specific Neurotransmitter
Recently, Penn State College of Medicine researchers did some studies regarding neuroscience. They found separate nerve pathways regulate diverse organ functions along the upper gastrointestinal (GI) tract, which is different from what researchers found in past studies. The lead investigator of this...
The New Pre-clinical Date of ALN-TMP, an RNAi Therapeutic of Alnylam was Made Public
Recently in the 54th American Society of Hematology Annual Meeting that being held from Dec. 8 to 11, 2012 in Atlanta, Alnylam Pharmaceuticals presented its new pre-clinical data from its RNAi therapeutic program for the treatment of hemoglobinopathies. Its scientists presented related data and show...
Orientation of Antibody with Localized Infection and Systemic Infection
According to a study published in the Journal of Experimental Medicine on December 10th, the orientation of antibody binding to bacteria might decide the life or death to the bug. The new study is led by Pontus Nordenfelt of Harvard University and his colleagues at Lund University in Sweden. These f...
A New Feature of Cell Division: the Interactions among Chromosome, Telomere and Cell Division
The yellow part refers to telomeres, the protective caps on the ends of chromosomes, moving to the outer edge of a cell's nucleus (the blue part) The constant new replacing old and impaired contributes to our life maintenance and growth. You may feel at sea by reading the first sentence, well...
One of the 54th ASH Annual Meeting Presentations: SGEN' Antibody-drug Conjugate Hit a Hope for the Treatment of AML
This year as usual on the 54th American Society of Hematology (ASH) annual meeting, there were lot of new findings and explorations were presented and shared. One of them, the Seattle Genetics ($SGEN) gave a brief presentations on SGN-CD33A, which is one of its early-stage next-generation antibody-d...
microRNA is an Important Factor That Propels How We Become a Human
The Picture Shows the Differentiating Mouse Embryonic Stem Cells (green = mesoderm progenitor cells, red = endoderm progenitor cells). Our human organism is initially starts form an embryo which from one cell to an entire living and breathing body, full of working cells and organs. We never sa...
Nature: Study Led by NIH Depicted the Specific Description of Brain Protein Structure
Researchers from National Institute of Neurological Disorders and Stroke (NINDS) have published the first highly detailed description of how a neuropeptide hormone, neurotensin, which been previously shown has correlation to Parkinsons disease, schizophrenia, temperature regulation, pain, and cancer...
PLoS Biology: Prehistoric Yeast DNA Study Unveil the Controversial Point of Theory of Evolution
There once was a hit topic assumed that might we could clone dinosaur by the fossil they left, on one hand to explored the evolvement history, on the other hand to take back the pre-history amazing animals though later scientist confirmed that the half-decay period of DNA is 521 years, which suggest...
Use a More Cheap with Equal Effect Paper-based Diagnostic Method to Test Whether You Are Pregnant, Have Diabetes, Malaria etc.?
You could find the new finding on the American Chemical Society journalLangmuir. The new advance in diagnostics research was conducted by University of Washington bioengineer Daniel Ratner and his team. Now we already can do home based tests for some conditions, such as for pregnancy, diabetes, mal...
The Chromosome Structure of a RNA Antitoxin Complex and Its Altruistic Mechanism
A new research reveals how some bacterial cells keep a 'suicide complex' ready to hand. In the journal Proceedings of the National Academy of Sciences, you will find an article which talks about some bacterial cells carry a molecular 'suicide complex' to kill themselves in the event of le...
Nature: The Link between Inhibiting NLRP3 and Decreasing Alzheimer's
According to a research led by Eicke Latz, MD from the University of Bonn in Germany, inhibiting a protein complex dubbed NLRP3 might slow the progression of Alzheimer's disease. People have known that the protein complex plays a role in inflammation, but its not clear if it contributes to the patho...
Food Poison: Cellular Toxicity Caused By Nhe Was First Revealed in a Doctoral Thesis
Recently a doctoral research revealed a protein structure of how Bacillus cereus causes toxin. The author is Danh Phung, he found the crystalline structure of NheA. Phung's study is the first to show that the Nhe proteins form structures resembling pores. We know that food poisoning caused byBaci...
Cell Biology: The Importance of PEFs in Cell Mitosis
The picture shows the expression of the chromokinesin NOD (red) stabilizes aberrant interactions between kinetochores and spindle microtubules (green). Cell division helps to maintain the even distribution genome of two daughter cells in which every chromosome need to properly interact wi...
Cell: A Promising Trend That Avoids Foreign Rejection and Replaces Damaged Neurons on self
This is a confocal micrograph of a primary human fibroblast cell grown in culture stained blue for actin, a highly abundant protein that makes up the cytoskeleton of cells. Mitochondria are shown in green. According to some statistics, it is estimated that 25% Americans will suffer from a neurode...
PANS: The Key Role of Mthfd1l for Folic Acid and Neural Tube
In 1940s, Mthfd1l was found. It is an enzyme encoded by Mthfd1l gene in human that involves in THF synthesis in mitochondria. It has been known for long time that certain variants of Mthfd1l are associated neural tube defects. Weeks ago Proceedings of the National Academy of Sciences(PNAS) revealed...
Science: Studies Revealed a New Innate Immunity Sensor of Enzyme and Cell Signaling Pathway
Scientists have known the immune-boosting response of DNA for a long time, but the specific mechanism of the underlying response is unknown. The studies solved the longstanding puzzle by means of a special biochemical approach. The approach is quantitative mass spectrometry which adopts a modern ...
Protein Bax: Reveal One Potential Mechanism of Cell Death
The left picture shows the main researchers of this finding; the right picture shows the visualization of the molecular changes in protein Bax Cell death, or apoptosis, is an important factor in controlling the number of cells in the body. Proper cell numbers ensure our health condition; over...
The Combination of Genome-wide and Proteome-wide Screening
In clinical application or research purpose, plasma screening has been widely used due to its easy accessibility, so as mass spectrometry. Nowadays, gene variants are easy to identify, however theses phenotypes that link to those variants are not easy. Using mass spectrometry, researchers analyze...
Cell: Scientists Found another Role of Enzyme Superoxide Dismutase
Since 1960s, the initial discovery of Superoxide dismutase (SOD1), an enzyme that was believed having solo role in protecting living cells against damage from free radicals by scientists. The enzyme is present in all living cells, from the most ancient bacteria to every cell in the human body. ...
New Clue Was Found Regarding the New Coronavirus: Protein DPP4
Keep tracing on the news we released several days ago about the coronavirus in Europe, we found progression in accordance with the Nature report on Mar. 14. A...
Scientific Report: Testing DNA Methylation with Novel Assay
According to the Scientific Report, researchers have developed a new, single molecule test for detecting methylated DNA. DNA Methylationis abiochemicalprocess that involves the addition of amethyl groupto thecytosineoradenineDNAnucleotides. Through this way, it regulates gene expressionincell...
The Company Acquire of Life Technologies Corp
The auction of Life Technologies Corp, which is a genetic testing company, has been attracting more visitors with exception for previous KKR Co LP, Hellman Friedman LLC, Thermo Fisher Scientific Inc,Danaher Corpand a buyout consortium of Blackstone Group LP, private equity firms and so on. Thi...
Researchers Developed a Model That Explains How Nucleosomes Recognize Protein
The pictures shows the model how proteins move along DNA Most of the DNA in evolved organisms is wrapped around proteins, forming the basic unit of DNA packaging, nucleosomes as the picture shows. But how exactly these nucleosomes are recognized and read by protein is unclear. In order to fin...
Cell: The Role of EDRA Gene in Evolution
The picture shows the mice carrying a human version of the EDAR gene have footpads with more sweat glands (blue tubes). About 30,000 years ago, China was a warm and humid place. Thus people living here usually have more sweat glands to cool self temperature. But why and how is unclear to peop...
Induce Some Cells into other Cells without via Stem Cells
Reprogramme skin and glia cells into nerve cells Re-programmed nerve cell When I mentioned about turning one cell type into other cell type, will you think about stem cells or pluripotentstem cells which can oriented induce some type to...
PNAS: A New Study Revealed the Spread Path of Cell Transmission
Microscope image of Nerve cells: Spreading of protein particles between cells. According to a newly published lab study in the Proceedings of the National Academy of Sciences(PNAS), some protein particles can multiply and spread cell transmission. This finding would be meaningful for neurosci...
Scientists Unveiled the Mysterious Procedure in Human DNA Replication
As an illustration, the picture represents a crucial molecular player in the process, by a hand, which is loading the sliding clamp ring onto DNA. According to the report of eLife on April 2, 2013, the long mysterious mechanism in human DNA replication has been identified for the first t...
Nature: the New Immunity Pathway was Confirmed
Our immune system is a natural defense that keeps harmful things out in normal conditions. But of course, this defense wont always work. Overall, our immune system works by differentiating normal things from abnormal things, such as between cells and microbes. While in terms of microbes, ...
Nature Genetics: the Mapping of Telomerase was Disclosed for the First Time
Telomerase is an important enzyme that adds DNA sequence repeats to the 3 end of DNA strands in the telomere region. It is one of the fundamental enzymes in cell biology. It is a reverse transcriptase and shortened after every replication cycle. In 1970s, scientists have assumed that it was ...
The Role of Protein SFRP2 on Human Cancers and New Clue for Drug Development
When researchers tried to find an alternative to the anti-tumor drugAvastin (bevacizumab) that target on VEGF to inhibit angiogenesis, they found more roles of SFRP2, especially as a stimulator of angiogenesis. Protein SFRP2, secreted frizzed-related protein 2, according to the previous ...
Structural Finding for Us to Better Understand the Role of MITF
Microphthalmia associated transcription factor (MITF) works as a master regulator in cells which produce melanocytes. It is crucial for the development, survival and differentiation of melanocytes. It also plays important roles in other cell type. This time, scientists resolved the structure of...
Scientists Found the Key Protein of P. Aeruginosa Infecting Humans
Pseudomonas aeruginosa, an environmental pathogen, usually exists in soil, water and other environment outside of the body. However, it causes common hospital acquired infection. According to yesterdays mBio report, scientists have discovered the previously unknown virulence factor inP. a...
Protein Localization: Compare the Microscopy-based and Fluorescent Protein Tagging Method
The picture shows the experimentally-determined subcellular localization of almost 500 human proteins using both immunofluorescence and GFP-tagging. Microscopy-based method and fluorescent protein tagging method are two of the most widely used approaches to determine protein localization. But t...
Researchers Discovered the Energy and Pathway of Opening and Closing of Ion Channel
Ion channelsare pore-formingmembraneproteins. They are important components in many biological processes that involve rapid changes in cells, for example,cardiac,skeletal, andsmooth musclecontraction,epithelialtransport of nutrients and ions,T-cellactivation andpancreaticbeta-cellinsulinrele...
Stat5 Protein is an Important Target for the Research of Prostate Cancer
Among many factors that affect prostate cancer, Stat5 is one of the important. As early as in 2003, scientists have discovered that Stat5 protein is critical for viability of prostate cancer cells and growth of prostate tumors in mice. In 2005, researchers demonstrated that Stat5 activity was assoc...
Scientists Reveal the Detailed Structure of Protein C4BP for Pharmaceutical Transport
Protein C4BP, the complement component 4 binding protein, is a part of our innate immune system which serves as the first countermeasures against invading pathogens. It could defend against bacterial in the blood. But in order to find reveal how exactly the protein acts on other molecules, sci...
Scientists Found a New Method to Understand Ion Channel Proteins
Photograph of integrated amplifiers. The well supporting the membrane and channel is noted in the figure. Ion channel are key regulators of cellular function. They are a critical group of important membrane protein drug targets and account for the activity of 10% of the currently marketed drugs...
The Structural Secrets of Actin Nucleation was Found
Actin, a sturdy-like filament, helping cells maintain their shape, is an important factor for human. The filaments, named F-actin, were first discovered in late 1900s and been broadly studied since then. F-actin is composed by G-actin, which self-assemble end-to-end. But people are not clearly a...
Introduction to an Innovative Antibody Selection Method
It is reported in the Cell that researchers have developed a powerful innovative technique to find antibodies, especially therapeutic antibodies. A few years ago, the researchers developed a basic method to select antibodies thatnot only bind to a given target, but also have a desired biolog...
How Some Enzymes Involved in the Handling of Defective Proteins
The 2004 Nobel Prize in Chemistry went to scientists who found the protective program of ubiquitin-mediated protein degradation. Now a group of scientists found some enzymes that got involved in the degradation of defective proteins for the first time. It is well known that many cells are produce...
The Regulation Mechanism of RNA splicing Was Revealed
RNA splicing is a very complicated process which is carried out by spliceosome. Our spliceosomes are assembled from protein and RNA molecules, including 170 different proteins and five small nuclear RNAs (snRNAs). Currently we believed that certain snRNAs represent the tools with which the splic...
Cell: the “Protein backbone” of the Yeast Telosome
A model of the Rap1-Rif1-Rif2 Assembly at Telomeres Researchers have made a molecular, biochemical, and functional dissection on the protein backbone at the core of the yeast telosome. Repeated sequences form the genome as the sequence motif links sequence motif as well as binds proteins. Thes...
The Very Special Structure of an Enzyme
The left shows the single ring structure and the right shows the double ring structure or hexadecameric catenane As the above picture shows, scientists have found a very special shaped enzyme that has never been found previously in biology field. As early as in 2011, Microbiologist Mike has...
The 3D Structure of RSV Has Been Revealed
The mention of Respiratory Syncytial Virus (RSV) reminds people of lung infection in children, which leads to more than 548 deaths every day. However, so far there is no relevant vaccine to prevent the virus due to under-investigation in some aspects. RSV causes flu-like symptoms in healthy a...
Angewandte Chemie: The New Method to Make Therapeutic Proteins Last Longer
Nowadays therapeutic proteins are widely used to relieve sufferers from many conditions, such as cancers (Monoclonal antibodies, Interferons), heart disease and stroke (Enzymes, Blood factors), diabetes (Insulin), anaemia (Erythropoietin), haemophilia (Blood clotting factors) etc. and they show pr...
Methionine Adenosyltransferase II alpha Related Researches and Products
Methionine adenosyltransferase II alpha (MAT2A) is an essential enzyme that is in charge of S-adenosylmethionine (SAMe) biosynthesis. It is extensively distributed within body. In liver, increased MAT2A expression correlates with growth, while SAMe inhibits MAT2A expression and growth. Thus ...
The Method to Boost Protein Yields
Therapeutic proteins are now widely used for clinical purpose. Drugs based on proteins are increasingly important. Usually proteins from microbial cells are used to make drug, while with the demand of high efficacy and stability, animal cells are used to make more complex drugs. Proteins made fro...
The Important Roles of MBNL Proteins in the Pluripotency of Stem Cells
Induced pluripotent stem cells are a vital research direction for the future academic and medical application. In past studies, scientists have paid much attention on the part of transcription, chromatin and non-coding RNA regulators of the pluripotency of embryonic stem (ES) cells. Alternative ...
Epidermal Growth Factor Receptor and Its Applications
The discovery of growth factors won the Nobel Prize in Medicine in 1986, implying their importance. Epidermal growth factor receptor, EGFR, one of such factors, exists on cell surface and is activated by binding of its specific ligands. EGFR is a member of the receptor tyrosine kinase family who...
Scientists Uncover the Crystal Structures of Class B GPCRs and Expand Their Pharmaceutical Importance
GPCRs, a kind of membrane receptors, serve as extracellular signal sensors, including photons, ions, small organic molecules, even the whole proteins. About one third of known drugs use GPCRs to be active targets. Currently, all the published GPCR structures come from class A. But recently the crys...
Two VEGF-related Studies and the Findings
Vascular endothelial growth factor, or VEGF, is a potent growth and angiogenic cytokine. It stimulates proliferation and survival of endothelial cells, and promotes angiogenesis and vascular permeability. VEGF signals through the three receptors: fms-like tyrosine kinase, KDR and the flt4. It is ...
Industry Analysis: The Application and Development Trend of Recombinant Proteins
Recombinant proteins are manufactured by genetic engineering, cell engineering or other technologies, derived from organisms. Recombinant proteins have become one of the most products for current biology industry. From a broad range, recombinant proteins include recombinant proteins of na...
The Therapeutic Applications of Recombinant Interferons
Interferons are members of cytokines. They get the name after their ability to interfere with viral replication within host cells. They play vital functions in activating immune cells, recognition of infection or tumor cells, strengthening the ability of uninfected hot cells to resist new infection ...
Novel Method for Detection of Ovarian Cancer Might Launch Soon
Ovarian cancer is considered to be the most difficult to detect in kinds of cancers. It is difficult to note or detect at early cancer stage, if pain occurs, people might treat it as other symptoms as often been mistaken for other diseases. This makes cancer prevention and control very difficult. D...
Effective Monoclonal Antibodies: Solve the Problems in Preparation
As a key driving force for biotechnology industry, therapeutic antibodies are safe and effective to against cancer, autoimmune diseases and infectious diseases in terms of targeted therapy. In 2011, the worldwide sale of therapeutic antibodies reached $64.57 billion, accounting for 51.8% of biopha...
DNA Methylation—the Hot “Candidate” of 2013 Nobel Prize
The annual Nobel Prize feast is approaching and the whole science field is eager to celebrate laurels and DNA Methylation is one of the expected laurels. DNA methylation is a form of chemical modification of DNA. In the condition of non-DNA code change, it changes indiv...
Scientists Identified the Special Receptor of Baculovirus for the First Time
Previous studies have identified baculovirus receptors. But recently a report recorded an important finding how baculovirus entered and interacted with human cells. The novel receptor is syndecan- 1 receptor. The study provides some ideas for the understanding of viru...
Nature Reports Reveal that MX2 is Also a Powerful Inhibitor for HIV-1
People have known that protein MX1 can suppress the replication of RNA and DNA viruses, HIV-1 in human body, for example for many years, but MX2 was ineffective against influenza virus. Now two reports revealed on Nature that protein MX2 also has the similar but different ...
Scientists Successfully Decode the Structure of Protein LIMP-2
It was unknown for people the structure and functions of protein LIMP-2 during the past days. We only know it is both important for humans and animals and it was mostly found in the lysosomes of the cells where it ensures that a specific enzyme reaches them. Recently a Germany chemist reveals what t...
A Summary of Characteristics of the Bio-pharmaceutical Industry
Bill Gates once predicted that the next richest man in the world replacing him will come from genetic area. With the advancement of modern biotechnology, bio-pharmaceutical industry is getting more and more achievements. Here, Id like to sum the characteristics of the bio-pharmaceutical industry cou...
Things You May Would Like to Know about Recombinant Antibodies
What is a Recombinant Antibody? A recombinant antibody is an antibody that combines genetic material from two or more sources, produced with the help of specific technology, such as recombinant DNA technology. During the process, a fragment of D...
A Potential Way to Measure Injury with the Help of Protein Xin
In a recent study, scientists found a protein that can only be detected after muscle damage due to kinds of reasons, for example trauma, intensive exercise injury and disease. The protein is associated with the degree of damage. The protein is Xin, a muscle-specific actin...
Does Immune Response Depend on the Solar Cycle?
It is known that mammalian circadian clock is affected by environmental factors, such as the sunrise and sunset and the sunset drives the daily rhythm of an individual. However, thanks to new research published in the international journal Science, researchers now know that the circadian clock w...
Scientists Identified the Role of Osteopontin for Mesenchymal Stem Cells
As a kind of stem cells , mesenchymal stem cells (MSCs) play an important role in the repair of damaged tissue due to its differentiation potential, and it has broad application prospects in the field of regenerative medicine. In recent years, many studies agree ...
New Study Revealed the Crystal Structure of Protein TET2
Mammalian TET protein family includes TET1, TET2 and TET3. If TETs are inactivated (loss of function), many diseases, especially blood cancer will be incurred. Recently, a study successfully resolved the crystal 3-D structure of protein TET2the ...
Revealing the Secret of Our Bacteria Expression Systems (E. coli / Bacillus)
In bacterial expression systems, E. coli is one of the most widely used expression hosts. The techniques for protein expressions in E. coli have been well developed and expanded with the development of biotechnical skills. ...
Creative BioMart Leads the Way in Protein Expression
Creative BioMart is a certified recombinant proteins provider that has invested a lot in the services of protein expression and purification. Featuring in a multitude of protein expression systems that are easy to use and deliver high protein yields for every var...
Scientists Revealed the Mystery of Cell Proliferation
According to scientific materials, before cells divide, they create so much genetic material that it must be twined onto spools, proteins called histones, before the two new cells can split apart. Moreover, there histones must multiply at the same moment that cell doubles its DNA. If not, the new DN...
Learn More about Protein Structure Evolution with “Ancient” Proteins
Several months ago, researchers found something that will enlighten peoples understanding on the course of protein structure evolution and give new ideas on the novel protein design in protein engineering and biotechnology. Under the existing conditions, researchers usuall...
Creative BioMart’s Latest Week Meeting—for End of the Year Promotion Plan
December 10, 2014Creative BioMart, a world leading Biotech Company that has served thousands of customers all over the world, today held its week meeting to discuss a suitable End of the Year promotion which would come into effect in the nearly following days. ...
Creative BioMart Released Star of the Year Awards This Monday
Usually, at the end of the year or at the beginning of the near year, a company would release its year of the star award and awards like this type to encourage its excellent employees that have done a lot of contributions to the organization. So does Creative BioMart, a world leading biotech company...
Get Your Money Saved with Creative BioMart Coupons
Recently, Creative BioMart has newly released a series of coupons. And it was said to express thanks to its valued customers. As we all know, releasing coupons is really a good and commonly used way by sellers ...
Creative BioMart Updates New Product—Thrombin
Creative BioMart will update its products on a daily basis. This time, the thrombin is on the shelf and intended customers are accessible to purchase and inquire related information by contacting out experts. Or some of necessary information can be found on our official we...
The 4th International Conference on Biotechnology and Environment Management 2014
When September 15 to 16, 2014 Where Paris, France Introduction The 4th International conference on Biotechnology and Environment Management 2014 (ICBEM 2014) is a f...
Biosimilars Global Congress 2014 Europe within One Week
Biosimilars Global Congress 2014 Europe is going to be held in Sep 17th to Sep 19th 2014 from 8:30 am to 6:00 pm in Financial District, Boston. This Congress is to give a platform for interactive discussion and communication about practical strategies on challenges, innova...
The Sixth PEGS Europe Will Come Next Week
PEGS (Protein Antibody Engineering Summit) Europe, the largest European event covering all aspects of protein and antibody engineering, will be held next week from November 3rd to 7th in Lisbon, Portugal. According to the official office, this y...
Creative BioMart Launches Promotions for Proteins, Enzymes and Custom Services this New Year
On December 22, 2014, just a few days before Christmas, Creative BioMart announced that it has launched the promotion of its featured Products. This special offer will expire on 1/31/2015. This promotion is for featured proteins, enzymes and custom services. Customers can save 10% for purchase of a...
Creative BioMart Launches Promotion Activity for Featured Recombinant Proteins This August
On July 28, 2014, Creative BioMart announced that it has launched the promotion of its featured recombinant proteins, which would be lasted from 1st, August to 31st, August. This promotion is for featured recombinant proteins, and any pur...
Worldwide BiotechBiopharma Alliance within the Two Days
On Nov. 14, 2013, MRC Technology announced that it is collaborating with Dr Zameel Cader at Oxford Universitys Nuffield Department of Clinical Neurosciences, to screen selective and potent potassium channel activators to develop novel therapeutic interventions in migraine. On Nov. 13, 2013, Vit...
Retrospective Viewpoint: Biotechnology Companies Keep Going with Mergers
In face of patent expiration or other threats, big pharmaceutics are facing challenges too. In priority, innovative technology or novel developments are necessary. On 2010, Celgene declared the acquisition of ABII for $2.9 billion for cancer treatment. ...
New Product: Native Lactate Dehydrogenase and the Property
In 1970s, human Lactate Dehydrogenase was broadly reported in studies and literatures, which indicated its great potential. The protein is found predominantly in muscle tissue and belongs to the lactate dehydrogenase family. Mutations in this gene have been linked to exertional myoglobinuria. ...
Discussion: Will Google Invest Bio-pharmaceuticals after Its Health-care Part
Google once said it wanted to declare war against disease. When it said so, 23andMe, invested by it has serviced 200,000 people; iPierian (mainly for stem cells), invested by it was facing a big moment. Thus we dont need to feel surprised when we hear about that Google is going to set up a new compa...
Cleveland Clinic Published Its Selection of Top Three “Groundbreaking” Pharmaceutics
As usual, Cleveland Clinic will pick out some groundbreaking pharmaceutics that may make big difference for healthcare industry in their late development stages. This year who will be picked by Cleveland? According to internal news, Gilead's sofosbuvir, Novartis heart drugs serelaxin as well as Phar...
Do You Support Artificially Synthesized Virus?
Background About two months ago, 22 scientists from Holland, Hong Kong, USA and US singed an open letter that aimed to evaluate the potential risk of H7N9 by doing acquired functional mutation experiment. The letter was published on Nature and S...
Biosimilar Market in India: the Approaching of the Expiration of Herceptin Patent in India
Roches patent on Herceptin will soon expire in India, thus today here we briefly talk about the biosimilar market in India regarding this. According to authority information, there is still no clear trend if the local pharmaceuticals start to march to biosimilar market. ...
Discussion on the Prospect of Biosimilar Monoclonal Antibodies Drugs
In the past few years, monoclonal antibody drugs have dominated the world's largest bio-pharmaceutical drug sales, and in the coming years, monoclonal antibody drugs will continue to be the main force. The rapid development of monoclonal antibody drugs as well as the approaching of patent expirat...
An Interesting Phenomenon for the Input and Output of Pharmaceutical Industry
Unlike pharmaceutical industry, many industries will have smooth progress during developing process. However, pharmaceutical industry may suffer from huge frustration even failure in their RD process. It is estimated that the overall failure rate of developing of a new drug could reach 95%, and the...
The Difference between Mouse Antibodies and Rabbit Antibodies
During past years, conventional antibodies have been widely utilized in researches, for example, protein detection via Western blot analyses, immunohistochemistry [1] and enzyme-linked immunosorbent assays (ELISA) [2] .And there are also newly developed technologies/antib...
Simple Analysis of the Growing Market of Growth Hormone
With the overall improvement of biomedical technology and basic requirements, growth hormone (GH) market is growing rapidly in recent years. Growth hormone is the power source of growing Secreted by anterior pituitary...
How Do You Think about cDNA Being Patentable
A few months ago, the discussions that does gene BRCA1/2 be patentable burst and the US Supreme Court finally rejected Myriads requirement, but the Court do claim that unlike gene BRCA1/2, cDNA is patentable. When it was decided that BRCA1/2 was not patentable, many attentions felt assured, b...
The Brief Inventory of Fines Multinational Pharmaceutical Companies Paid
Following manipulating articles in Journals, GlaxoSmithKline (GSK) entered another trouble time in China. The Public Security Department have begun to investigate its suspicion of commercial bribery, according to Beijing News report, as of July 14, at least four travel ag...
Who will be the Final Bidder for Onyx Pharmaceuticals Inc.?
The first-round bid for Onyx Pharmaceuticals Inc. will begin this week, as told by someone familiar with the matter. From June 30, Onyx enlisted Centerview Partners to help find bidders. ...
MedImmune Works with NGM Biopharmaceuticals to Develop EEC-related Therapeutics
On June 17, 2013, AstraZeneca announced that its global biologics research and development branchMedImmuneand and NGM Biopharmaceuticals, Inc. entered into an exclusive agreement to discover, develop and commercialize novel therapeutics from NGMs enteroendocrine cell (EEC) programme. The main focus ...
Immunocore Cooperates with GlaxoSmithKline to Target on Cancer and Viral Disease
On July 9, 2013, Immunocore announced that it has entered into a partnership with GlaxoSmithKlinefor multiple novel targets after signing the research and licensing agreement to discover and develop novel biological drugsImmune mobilising mTCR Against Cancer (ImmTACs) in earlier times. ...
GlaxoSmithKline’s Scientific Study Data was Questioned
There are always rumors and scandals. This time the scandal spread to scientific community and made GlaxoSmithKline (GSK) becoming the major topic of this week as a panel discusses the potential risks of the questioned drug. GSK, the London-based drug giant recently has co...
The Building of Merck Serono was Bought by A Consortium
On May 22, 2013, it was reported that the former building of drug company Merck Serono in Geneva was bought by the two richest men in Switzerland: Hansjrg Wyss and Ernesto Bertarelli, actually to a consortiumCampus Biotech. Dramatically it is Bertarelli who sold the Serono to Merck in 2007. About...
The 9th Annual International Conference on Predictive Human Toxicity and ADME/Tox Studies
The 9th Annual International Conference on Predictive Human Toxicity and ADME/Tox Studies 2014 ;will be held in Brussels, Belgium in January 2014. The exact time hasnt published yet. The conference dedicated to advances in predicting human toxicities and screening earlier in the drug discover...
The Market Trends of Elisa-kits
According to the GIA report, the US Research ELISA market is expected to reach $75 million by the year 2015. ELISA, or Enzyme-linked Immunosorbent Assay with the microtiter plate format, is a common technique for basic research and high through...
The 23rd Neuropharmacology Conference 2013
The Synaptic Basis of Neurodegenerative Disorders When Nov. 7, 2013 and Nov. 8, 2013 Where Sheraton San Diego Hotel and Marina, San Diego, United States Introduction The conference focuses on neuroscience field. There is increasing evidence that neurodegenerative diseases have at their basis...
Comparing Two Reproductive Cloning Methods: SCNT and iPS
I presumed that many of us still remember the infamous scientific research fraud in 2005, which originated in South Korea when some researchers claimed that they have created human embryonic stem cells via nuclear transfer. Since the geniture of Dolly with somatic cell nuclear transfer (SCNT) in ...
The 2nd Anticancer Agents Congress: Targeting Cancer Stem Cell
When November 21 to 24th 2013 Where Belek, Antalya, Turkey (the congress hotel will be announced soon) Introduction Sponsored by EACR, the meeting aims to bring all kinds of anti-cancer agents researchers together and discuss recent achievements in the field of basic research on ...
Block the Market Survival of Biosimilar?
Pharmaceutical is a quite important market for biology field. Among which, rare diseases attract relatively less attention, while complex diseases, such as cancer and immune diseases draw much. The as stake is also a promising market that could win tens of billions of dollars for expensive biologica...
The Exclusive Right Buyout of Sanofi’s Ophthalmology Antibodies by Regeneron
Sanofi and Regeneron are old partners that have worked together for many times and gained achievements, for example the colon-cancer drug Zaltrap and REGN727. On May 3, 2013, Regeneron Pharmaceuticals announced two preclinical programs for its grow...
The 2013 Asia Antibody Congress
When June 10-13, 2013 Where 392 Havelock Road, Grand Copthorne Waterfront Hotel, Singapore Introduction The 2013 Asia Antibody Congres...
The 2013 World Biotechnology Congress
When June 3-6, 2013 Where 900 Boylston Street, Hynes Convention Center, Boston, MA, United States Introduction The World Biotechnology Co...
Soligenix Collaborates with Intrexon on Promoting Monoclonal Antibody Therapy for Melioidosis
On May 1, 2013, Soligenix, Inc., a biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures announced its collaboration between Intrexon to develop a treatment for Melioidosis. Intrexon is a synthetic biology company that utilizes its...
A New Round of Investment from Capital Royalty for Biotech and Healthcare Industries
On May 2, 2013, Capital Royalty announced that it had gathered an $805 million investment fund to back a new round of loans and royalty deals with biotechs, pharma and other healthcare companies if they are looking for other financing For example, Capital Royalty had its largest investment fo...
The 4th Annual Therapeutic Protein Production Conference
When 15th May, 2013 Where Gunnels Wood Road, Stevenage, Hertfordshire, United Kingdom Introduction This is a small conference. Organized by Euroscicon, the c...
The Translational Kinase Tumor Inhibitor Discovery Consortium between Six Partners
On April 10, 2013, SARomics Biostructures, Prestwick Chemical and ProQinase together with the University of Turin, Italy, the Israel Structural Proteomics Center (ISPC) and the TechMedIll platform of the University of Strasbourg announced that they have created the Translational Kinase Tumor Inhibit...
5th International Conference on Crossroads between Innate and Adaptive Immunity
When Sep. 21, 2013 to Sep. 26, 2013 Where Grecotel Imperial Conference Center, Corfu, Greece Introduction Theme-based on immunology , the conference is organized by...
One of the Biggest Company Acquisition Cases in Life Science
According to Reuters report, Life Technologies Corp. has accepted the cash acquisition offered by Thermo Fisher Scientific for 13.6 billion on April 15, 2013. So far, the company takeover becomes one of the biggest acquisition cases in life science field. Life Technologies is a biotech tool c...
The 2013 Bio Therapeutics Conference
2013 Euroscicon BioTherapeutics Week When May 14 to May 17, 2013 Where The Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, UK Introduction Organized by Euroscicon, the event consists of four channels which all focus on the research, development and standardization ...
2013 Conference in Applied Bioinformatics & Public Health Microbiology
When May 15, 2013 to May 17, 2013 Where Moller Centre, Churchill College, Cambridge, UK Introduction Till now, the conference registration and abstract submission has closed. But the conference indeed accepts waitlist. Organized by Wellcome Trust, the conference aims to recent ...
The New Lawsuit on Pfizer with Previous Blows Back
According to the Reuters report, on Apr 3, 2013, Wed, an appellate judge panel in Boston held the ruling on Pfizer Inc., which is the largest US drugmaker. In the ruling, Kaiser Foundation Health Plan was supported for its appeal to Pfizer that it suffered. Pfizer was asked to pay about $142 million...
Another Forward Step of Laboratory Standardization in Diagnostic Procedure
In medical transplant cases, finding allogeneic stem cells are one challenge, according to the statistics, there are about 50,000 people a year urgently require a stem cell transplant; while another challenge is the precision and speed of detecting the difference between donors and recipient whi...
The 2013 Life Sciences Prize
Some entrepreneurs, including Facebook's Mark Zuckerberg andGoogle's Sergey Brin launched a prize to encourage contributors who devote to the advancement of incentivizing others to pursue research, but not fund research. In this Feb., 11 scientists have each won 2 million as part of aprizeto recogn...
The 9th European Antibody Congress
When Nov. 11 to Nov. 13, 2013 Where Starling Geneva Hotel Conference Center, Geneva, Switzerland Introduction Organized by Terrapinn, the tree days event brings the monoclonal antibody (mAb) and next generation technology industry together. The conference will focus on mAb researc...
14th Annual G Protein-Coupled Receptor (GPCR) Retreat Conference
When Oct. 17th to 19th, 2013 Where 1260 Euclid Avenue, Cleveland,Ohio 44115 , United States Introduction The GPCRRetreat is an annual joint meeting that rotates ar...
Sample Preparation on the Detection and Identification of Virus, Toxin and Pathogen
sample Prep 2013 Conference When May 9 to May 10, 2013 Where San Diego Hilton Resort, San Diego, CA, USA Introduction Sample prep 201...
The Third Session of Drug Development Boot Camp
For Biotech and Pharma Company Executives When November 2021, 2013 Where Harvard Club, Boston, Massachusetts Introduction With the trend o...
MorphoSys AG Collaborates with Heptares Therapeutics on GPCRs
On Feb., MorphoSys AG and the UK-based Heptares Therapeutics signed alliance to discover and develop novel antibody therapeutics targeting G protein-coupled receptors ( GPCRs ) , cataloged in membrane proteins that involve in a broad range of biological processes and diseases. ...
The 2nd Annual Cell Line Development and Engineering in Asia
When March 4th, 2013, to March 6th, 2013 Where Grand Hvatt Shanghai, China Introduction This conference is organized by IBC Asia (s) Pte Ltd and be held al...
The Worldwide Biotech’s Approval or Restricting by FDA (From Feb. 15 to Feb. 22)
On Feb 22, 2013, Roche's ($RHHBY) Genentechpicked up FDA approval for its late-stage breast cancer therapy Kadcyla, formerly T-DM1, which uses antibodies to deliver cancer drugs directly to the offending cells. The treatment combinesImmunoGen's ($IMGN)taxane chemotherapy drug, DM1, with an ant...
The FDA Approval of Flublok
On Jan. 16, 2013, the U.S. Food and Drug Administration (FDA) announced the approval of Flublok for the prevention of seasonal influenza in people aged from 18 to 49. Flublok is the first trivalent influenza vaccine that uses baculovirus expression system and novel recombinant DNA technology. The t...
The 2013 BIA Lifetime Achievement Award Goes to Andy Richards
On Feb. 1st, 2013 during the annual Gala Dinner, the BioIndustry Association (BIA) announced its lifetime achievement award winnerAndy Richards. When presented Andy with the award, the BIA chairman, Tim Edwards gave his comments and praise on the winner, said he is a tr...
For Patients’ Good or Company Rival: The Petition of TEVA to FDA on Biogen Idec
Several days ago, Teva Pharmaceutical Industries Ltd, which has the market-leading multiple sclerosis drug Copaxone, handed a petition to the U.S. FDA. In the petition, Teva asked FDA to, if possible, delay the market entry of Biogen Idec Inc.s new MS drug until its safet...
The Biosimilar Industry Emerging Trends in Asia
At the time when biosimilars market development in the U.S. and Europe still looks a little hazy to analysts, and still many people are thinking over and surprising at how quickly these biologic knockoffs can muscle aside some powerhouse competition from well-known brands. In Asia, multi...
The Optimize 2013: Antibody Engineering & Discovery Conference
When 25 Feb. 2013 to 27 Feb. 2013 Where Maritim Hotel Frankfurt, Theodor-Heuss-Allee , Frankfurt, Germany Introduction With many antibody companies facing shared cha...
The Cooperation between BaroFold and Lonza for PreEMT Protein Refolding Technology
On Jan. 16, 2013, Lonza, a biological development company, and BaroFold, Inc., an innovative protein technology developer, announced a non-exclusive technology and license agreement. The technology will offer them a comprehensive toolbox for microbial recombinant pr...
2013, the 2nd Biotechnology World Congress
Agenda Pharmaceutical Biotechnology: biopharmaceuticals discovery (CNS, cancer, cardiovascular , endocrine, immune); vaccines; antibodies ; protein engineering. Plant and Environm...
Company Acquire: In Face with So Many Suitors, Bausch & Lomb Will Belong to Whom?
According to Bloomberg, the private drug and device company Bausch Lomb Company, which is owned by private equity Warburg Pincus, recently was fiercely chased by many giants, such as by Abbott Laboratories (ABT), Johnson Johnson (JNJ), Sanofi and others. Warbur...
The New Round of Worldwide Biotech Companies’ Executives
ImmunoCellular Therapeutics ( $IMUC ) announced Gary S. Titus joined the company's Board of Directors. Titus now works as senior vice president and CFO of SciClone Pharmaceuticals ($SCLN ). Coronado Biosciences ($CNDO) tapped Harlan F. Weisman as the company's new chairma...
The 5th Immunotherapeutics & Immunomonitoring Conference
When 31 Jan 2013 to 01 Feb 2013 Where The Westin Gaslamp Quarter, San Diego, United States Introduction Immunology is a broad branch of biomedica...
The 2013 Biggest and Most Comprehensive Event for the Vaccine Industry—the 13th Annual World Vaccine Congress & Expo
When From April 16 to April 18, 2013 Where Gaylord National Hotel Convention Center, Maryland MD, US Introduction The 2...
A New Patent of Monoclonal Antibodies for the Treatment of Serious Diseases Research and Development Registered
On Dec. 21, 2012, one of our peer companies, Immunomedics, Inc. (Nasdaq:IMMU) announced that it has received notice its patent application for Anti-CD19 antibodies which would be issued as US patent No. 8,337,840 on Dec. 25, 2012. IMMU primarily attaches importance to the development o...
The Last FDA Approvals in 2012 for World Pharma Regulatory Blockbusters (From Dec. 21 to Dec. 31)
On Dec. 31, 2012, the last day of the year, the FDA came through with a rapid-fire approval of Johnson Johnson's bedaquiline, the first new treatment for drug-resistant tuberculosis in four decades. The approval was based on mid-stage data after JJ ($JNJ) made its case that the urgent nee...
The 2nd Annual Cell Culture World Congress USA in Boston
Introduction The 2nd annual Cell Culture World Congress USA is North America's leading conference focused on the optimization and development of cell culture bioproduction. This is a chance for biopharma, biotechs, biomanufacturing and process experts come to debate advances in cell culture optim...
Worldwide Blockbusters’ Movements (Alliance and Collaboration within this December)
On Dec. 20, 2012, CEVEC Pharmaceuticals (CEVEC), the developer of a novel human expression system derived from amniocytes, and Yuhan Corporation (Yuhan) based in Seoul, South Korea announced the signing of a CAP-Technology license agreement. The license will enable Yuhan to utilize CEVECs CAP-T...
Worldwide Blockbusters' Movements (Alliance and Collaboration within this December)
On Dec. 20, 2012, CEVEC Pharmaceuticals (CEVEC), the developer of a novel human expression system derived from amniocytes, and Yuhan Corporation (Yuhan) based in Seoul, South Korea announced the signing of a CAP-Technology license agreement. The license will enable Yuhan to utilize CEVEC's CAP-T and...
Company Acquire: Amgen Acquired DeCODE Genetics for $415M Which Is Supposed To Be Closed at the End of 2012
Amgen has planned to acquire Iceland-based DeCODE Genetics which is currently owned by Saga Investments, a consortium including Polaris Venture Partners and ARCH Venture Partners, but later out of bankruptcy in 2010, for $415 million cash, aiming in the biotech pioneers presence in personalized medi...
Drug Safety: the Glass Found in Ranbaxy's Generic Lipitor and Different Parties' Response
In terms of the foreign particles found in the glass-lined reactors at an active pharmaceutical ingredient plant in Toanasa, India in Nov. this year, Ranbaxy Laboratories' recall of generic Lipitor has spawned its first legal repercussion. Then the company notified FDA this fact and the foreign par...
FDA Nod for the First Drug-eluting Stent to Treat Peripheral Arterial Disease
On Nov. 15, 2012, The U.S. Food and Drug Administration (FDA) approved the Zilver PTX Drug-Eluting Peripheral Stent (Zilver PTX Stent) to treat peripheral artery disease (PAD) symptoms. This is the first drug-eluting stent to treat PAD. PAD is a progressive process that fatty material (plaque) bu...
The Sapien Artificial Heart Valve of Edwards get Extra Indications by FDA
Before Oct. 19, 2012, patients with aortic valve stenosis who are eligible for surgery but at high risk for serious surgical complications or death were not allowed to use artificial heart valve. While after the day, they could use Sapien Transcatheter Heart Valve (THV) since the U.S. Food and Dru...
The 4th Annual Next Generation Sequencing Congress in 2012
Where senior practitioners both of academia and pharma would gather together Why Over 350 experts from both academia and pharma senior practitioners engaged in kinds of next generation sequencing including personalized healthcare/clinical/diagnostic development, genomics, epigenetics, DNA Met...
Begin to Prepare for the Molecular Diagnostics
The 2013 Molecular Diagnostics World Congress Introduction: The research scope of molecular diagnostics captures the genome expression and proteins expression patterns and uses them to differentiate between what is normal and abnormal. Scientist and practitioners have created and developed man...
The First Meningitis B Vaccine Is Believed to Be Soon Launched in Market
Bexsero of Navarits Meningitidis group B, a main strain of brain disease, attacks the lining of the brain and spinal cord. Parents are scared by it since it mainly threatens infants, as well as adults. It affects up to 40% of cases in North America and 80% in parts of Europe, according to the Wor...
The Global Trial Site Database Brings into J&J, Merck, Lilly
The RD is stepping closer to globalization, for example, recently JJ, Merck and Eli Lilly, the three pharma giants, is reportedly begun to create a one-stop database to help streamline their work with clinical trial sites worldwide. The objective of their action is to collect and share information ...
The Fifth Session of U.S. Pharmacopeial Bioassay Convention
Why This convention will gather Biopharmaceutical/biotechnology industry professionals, Biopharmaceutical development scientists, Pharmaceutical industry professionals, Regulatory experts for biologics, Biosimilar manufacturers, Bioassay practitioners and software experts, Biostatisticians, Analy...
The 2nd Novel Immunotherapeutics Summit of GTC
Why Experts from academia and industry to discuss cutting edge research, immuno-strategies and novel findings and therapeutics against various diseases. Representatives from top leaders in the pharmaceutical and biotech industries including Abbott, Bristol-Myer-Squibbs, Johnson Johnso...
Start to Register for the 2013 BIO International Convention
Introduction In 1993, BIO held its first International Convention, which at that time drew 1,400 representatives. While in 2007, it drew 22,000 representatives. The keynote speakers are also quite expecting for attendees, top bio enterprises, research institutions, public agencies and so on,...
The New Diabetes Drug of Novo Nordisk A/S (NVO) Get Approval by FDA
Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. On Nov. 8, 2012, the Endocrinologic and Metabolic Drugs Advisory Committee of the United States Food and Drug Administration (FDA) completed the New Drug Application (NDA) for insulin degludec...
Thanksgiving Sale 2020
At Creative BioMart, we consider ourselves very fortunate for having a chance to work with such an expert of your caliber. We value your insights and expertise. Thank you for such a great experience working with you. Wish you a very happy and blessed Thanksgiving! What we offer? 5% OF...
2021 Thanksgiving Greetings
Thanksgiving is a time of reflection for all our blessings. Your kindness and support count for so much. We appreciate having you as a customer and a friend. May your Thanksgiving be full of peace, love and joy. Happy Thanksgiving! What we offer? Get 5 10% off for all products and se...
Seize the Season! Saving More!
As the Holiday Season is upon us, we, Creative BioMart, find ourselves reflecting on the past year and on those who have helped us shape our business. May you have a Merry Christmas and New Year filled with Peace and Prosperity. CALL US NOW @ TO ORDERSave 10% on Proteins and EnzymesSave 5% on Cust...
Thanksgiving Day Sale
Thanksgiving Day Sale You prepare massive amounts of delicious food for your holiday, but how do you reward your busy experimental work for the holiday? Our sale will be the gift for you work. What we offer? Every products and services on biomart will have 10% discount for price and products sh...
Thanksgiving Day Sale 2017
Thanksgiving Day Sale 2017 Since this is Thanksgiving, we want to seize this opportunity to thank you for being part of our growing business and welcome you to our long list of satisfied and much valued customers. Our success comes from your continuous faith in the excellence of our products an...
Thanksgiving Sale 2018
Thanksgiving Sale 2018 November is the time to be thankful, a moment to remember and to embrace those who enrich our business. A heartfelt thanks to you for being our customer, our guide, our friend, and for making our work meaningful. What we offer? Get 5% off for all product a...
Thanksgiving Sale 2019
Thanksgiving Sale 2019 When we count our blessings this Thanksgiving, working with you is definitely one of them. We appreciate having you as a customer and even a friend, who makes our business more meaningful. Wish you a peaceful Thanksgiving holiday and the time to truly enjoy it with your...
Thanksgiving Promotion 2023
As Thanksgiving approaches, we would like to take a moment to express our gratitude for your continued support and trust in our services and products. We are truly thankful to have you as our client, and dedicated to providing you with the best possible service that you deserve. What we offer?20%...
Protocol of Preparation of the Total Protein Samples
Proteomics mainly studies the expression of cell proteins and obtains information such as the expression profile of protein. The research object of proteomics is large range protein rather than single protein. Therefore, the research program should be able to obtain proteins as abundant as possi...
Protocol of Preparation of the Subcellular Organelle Protein Samples
In organism, the compartmentalization of cell makes different subcellular organelles have their own protein system, and many functions of protein can be realized through subcellular organelles. In addition, organelles have dynamic structures, such as endoplasmic reticulum, nucleus and Golgi apparatu...
Principle and Protocol of Bradford Method
Experiment Purpose Coomassie Brilliant Blue G-250 method is a complex method combining colorimetry and pigment method. It is simple, fast, highly sensitive and stable. It is a commonly used method. Through this experiment, learn the principle of protein content determination by Coomassie Brillian...
Principle and Protocol of Biuret Method
Experiment Purpose When the urea is heated to about 180 C, one molecule of ammonia is released from two molecules of urea to form biuret (NH2-CO-NH-CO-NH2). Biuret combines with Cu2+ in alkaline solution to form purple complex, which is called biuret reaction. Experimental Principle The pro...
Principle and Protocol of Lowry Method
Experiment Purpose The Folin phenol reagent method consists of two steps. The first step is that under alkaline conditions, the protein reacts with copper to form a protein copper complex. The second step is that this complex will reduce Folin reagent to produce dark blue, and the color depth is ...
Principle and Protocol of BCA Method
Experiment Purpose BCA method is one of the most commonly used protein concentration detection methods in the world at present. It is not affected by ionic and non-ionic detergents in the sample, and the coefficient of variation for detecting different protein molecules is far less than Coomassie...
Principle and Protocol of Kjeldahl Method
Experiment Purpose Protein content determination method is one of the most common and basic analysis methods in biochemical research. Kjeldahl determination of nitrogen is a commonly used method for analyzing nitrogen content of organic compounds at present. It is one of the most accurate and sim...
Guide of Analysis of Promoter Regulatory Elements Based on Plant CARE Prediction Method
PlantCARE (http://bioinformatics.psb.ugent.be/webtools/plantcare/html/) is a database of plant cis-acting elements, enhancers and inhibitors. The database provides information about the location of regulatory elements, consistent sequences and independent sites on specific promoter sequences. At the...
Protocol of the Detection of ³²P Radioactive Markers
The 32P radiolabeling assay is the most classic method for detecting phosphorylated proteins. The combination of 32P radiolabeling and bi-directional gel electrophoresis allows for a holistic view of intracellular protein phosphorylation from a proteomic perspective, and the sensitive and visual det...
Principle and Protocol of the PRO-Q Diamond Staining
The Pro-Q Diamond fluorescent dye introduced here is specially designed for phosphorylated protein dyeing. In 2003, Wavne Patton of Molecular Probes reported a new fluorescent dye, Pro-Q Diamond, which can specifically dye phosphorylated groups (linked to tyrosine, serine or threonine residues). Thi...
Protocol of the Phosphorylated Antibody Detection Method
Protein phosphorylation is a very important and common phenomenon in eukaryotes. Among the three most common phosphorylation forms in eukaryotes, serine phosphorylation is the most, threonine phosphorylation is the second, and tyrosine phosphorylation is the least. The ratio of the three is 800:200:...
Methylation Interference Assay
Background and Principle Many cell related life processes involve the interaction between DNA and proteins. With the development of recombinant DNA technology, a wide range of critical genes have been isolated. Now the key issue is to reveal how environmental factors and developmental signals con...
What is MTHFD2 Protein
See All MTHFD2 Products MTHFD2 protein is a gene-protein product of significant importance to human physiology. Its connection to several critical biological pathways has sparked immense biomedical interest and necessitates a thorough understanding of this gene and its encoding protein. The MTHFD2 g...
What is Klotho Protein
See All Klotho Products Klotho, an intriguing protein named after the mythical Greek goddess Clotho, the spinner of life's thread, holds the key to various physiological processes. Officially known as α-Klotho, it goes by the aliases KL, LCTL, and TCF-1, signifying its multi-faceted nature. Belongin...
What is THRA Protein
See All THRA Protein Products What is THRA Protein? The THRA protein, or Thyroid Hormone Receptor Alpha, a member of the nuclear receptor superfamily, governs the cellular response to thyroid hormones. Structurally, THRA comprises distinct domains - an N-terminal A/B domain, a DNA-binding domain (...
FGF Family Signaling Pathway
The signaling component of the mammalian Fibroblast Growth Factor (FGF) family is comprised of eighteen secreted proteins that interact with four signaling tyrosine kinase FGF receptors (FGFRs). FGF signaling generally follows one of three transduction pathways: Ras/MAP kinase, PI3/AKT, or PLC. ...
mTOR Signaling Pathway
The mammalian target of rapamycin (mTOR) signaling pathway integrates both intracellular and extracellular signals and serves as a central regulator for cell metabolism, growth, proliferation, and survival. mTOR links with other proteins and is a core component of two distinct protein complex...
Wnt Signal Pathway
Abstract The Wnt signal pathway is an evolutionarily conserved signal pathway that regulates cell migration, cell polarity, and neural and organ formation during embryonic development. The major signaling downstream of the Frizzled (Fz) receptor have been identified, including the canonical Wnt/-...
Notch Signal Pathway
In 1917, Morgan and colleagues found a gene in Drosophila, which is named Notch because of a loss of function that leads to a gap in the edge of wings. Subsequent studies found that Notch is expressed in many species from invertebrates to vertebrates. The structure of Notch families is highly co...
JAK-STAT Signal Pathway
JAK-STAT signal pathway is a cytokine-stimulated signal transduction pathway found in recent years. It is involved in many important biological processes such as cell proliferation, differentiation, apoptosis and immune regulation. Compared with other signaling, the JAK-STAT signal pathway is re...
NF-κB Signal Pathway
Background The most basic components of NF-B signaling pathways include receptors, signal adapter proteins, IB kinase (IKK) complex, IB protein and NF-B dimer. When cells are subjected to various intracellular and extracellular stimuli, IKK is activated, resulting in phosphorylation and ubi...
Hippo Signal Pathway
The Hippo signaling pathway is a conserved regulator of proliferation and cell survival in metazoans. The core of the pathway consists of a kinase cascade with the tumor suppressor Hippo (and its mammalian orthologues, MST1 and MST2) as the upstream kinase. Hippo activation is coupled to diverse...
Apoptosis Signal Pathway Overview
Fig1. Apoptosis Signal Pathway Overview Apoptosis is a kind of programmed cell death (PCD) plays a fundamental role in multicellular organism development and tissue homeostasis. We might take it as a regulated cellular suicide mechanism. Abnormal regulation of this process is associated with a wi...
RNA Viruses Triggered Signal Pathway
IPS-1 TRAF3 IKKi TBK1 IRF3 IRF7 IRF3 IRF7 FADD TRADD Caspase-8/-10 NF-B NF-B Figure: RIG-I recognize RNA viruses by detecting short dsRNAs with 5triphosphate ends. MDA5 recognize RNA viruses by detecting long dsRNAs. LGP2 positively regulates RIG-I and MDA5 mediated virus recognition. Ubiq...
Type I Interferon Signal Pathway
IFNAR1 IFNAR2 TYK2 JAK1 STAT1 STAT2 STAT1 STAT1 IRF9 IRF9 STAT1 STAT2 IRS1 Rac1 mTOR 4EBP1 EIF4E RSP6 p38 MSK1 Introduction Following viral infection, the human body triggers a complex regulatory system of innate and adaptive immune responses designed to defend against the virus. One...
The p53 Pathway
The p53 pathway is composed of a network of genes and their products that are targeted to respond to a variety of intrinsic and extrinsic stress signals, which impact cellular homeostatic mechanisms that monitor DNA replication, chromosome segregation, and cell division (Vogelstein et al., 2000)...
